"Rank","Title","Status","Study Results","Conditions","Interventions","Locations","URL"
1,"PAncreatic Adenocarcinoma in Hospital","Completed","No Results Available","Pancreatic Adenocarcinoma",,"CH de Jolimont, Jolimont, Belgium|CH Gabriel Martin, Saint-Paul, La Réunion, France|CHIAP, Aix en Provence, France|CH Angoulême, Angoulême, France|CH d'Aubenas, Aubenas, France|CH Auch, Auch, France|CH Robert Ballanger, Aulnay sous bois, France|CH Avignon, Avignon, France|CH Bagnols sur Ceze, Bagnols sur Ceze, France|CH Bayeux, Bayeux, France|CH Blois, Blois, France|CH Bourg en Bresse, Bourg en Bresse, France|CH de Bourges, Bourges, France|CH Nord Deux Sèvres, Bressuire, France|CH Saint Camille, Bry sur Marne, France|CH Béziers, Béziers, France|HPA Castres Mazamet, Castres, France|CH Chalons en champagne, Chalons en champagne, France|CH Chambery, Chambery, France|CH Chartres, Chartres, France|Ch Cholet, Cholet, France|CH Haut Anjou, Château Gontier, France|CH Châteauroux, Châteauroux, France|CH Compiègne Noyon, Compiègne, France|CH sud francilien, Corbeil Essonnes, France|CH de Creil, Creil, France|CHI Créteil, Créteil, France|CH Dourdan, Dourdan, France|CH Draguignan, Draguignan, France|CH Dreux, Dreux, France|CH Simone Veil, Eaubonne, France|CH Forcilles, Ferolles, France|Chicas, Gap, France|CH Gonesse, Gonesse, France|Centre hospitalier départemental Vendée, La Roche sur Yon, France|Centre Hospitalier de Lagny, Lagny sur Marne, France|CH du Mans, Le Mans, France|Lens, Lens, France|Centre Hospitalier Côté de lumière, Les Sables d'Olonne, France|Hôpital des chanaux, Macon, France|Centre Hospitalier de Meaux, Meaux, France|CH Melun, Melun, France|CHR de Mercy-Metz, Metz, France|CHAM, Montargis, France|CH Montauban, Montauban, France|Centre Hospitalier Montelimar, Montelimar, France|CH Montfermeil, Montfermeil, France|CH Niort, Niort, France|CHG Oloron, Oloron Sainte Marie, France|CHR Orléans, Orléans, France|CH François Mitterand, Pau, France|Centre Hospitalier de Perpignan, Perpignan, France|CHI Poissy Saint Germain, Poissy, France|CH Pontoise, Pontoise, France|CH de la région d'Annecy, Pringy, France|CH Quimper, Quimper, France|CH Roubaix, Roubaix, France|Centre hospitalier Yves Le Foll, Saint Brieuc, France|CH Saint Quentin, Saint Quentin, France|CH de la Fontaine, Saint-Denis, France|Centre Hospitalier de Bigorre, Tarbes, France|CH Sainte Musse, Toulon, France|CH Tourcoing, Tourcoing, France|CH Valenciennes, Valenciennes, France|CHBA de Vannes, Vannes, France|CHIV Villeneuve Saint-Georges, Villeneuve Saint-Georges, France","https://ClinicalTrials.gov/show/NCT01989624"
2,"Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Avelumab and Pepinemab",,"https://ClinicalTrials.gov/show/NCT05102721"
3,"Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma","Unknown status","No Results Available","Pancreatic Adenocarcinoma","Procedure: Allogeneic hematopoietic stem cell transplantation","Center for allogeneic stem cell transplantation, Karolinska University hospital, Stockholm, Sweden","https://ClinicalTrials.gov/show/NCT02207985"
4,"Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: SonoVue®","Société Française d'Endoscopie Digrestive, Paris, France","https://ClinicalTrials.gov/show/NCT01765036"
5,"Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Z-360|Drug: Placebo","Zeria Investigative sites, Japan, Japan|Zeria Investigative Sites, Korea, Korea, Republic of|Zeria Investigative Sites, Taiwan, Taiwan","https://ClinicalTrials.gov/show/NCT02117258"
6,"Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT|Procedure: Computed Tomography|Procedure: Positron Emission Tomography|Other: Laboratory Biomarker Analysis","UT Southwestern Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT03318497"
7,"EUS-Guided Cryothermal Ablation in Patients With Stage III Pancreatic Adenocarcinoma (HybridTherm Study)","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma Non-resectable","Device: Cryothermal ablation","Ospedale San Raffaele Irccs, Milan, MI, Italy","https://ClinicalTrials.gov/show/NCT02336672"
8,"Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Adenocarcinoma","Drug: Gemzar (Gemcitabine)|Drug: TH-302","Birmingham Hematology and Oncology Associates, LLC, Birmingham, Alabama, United States|Mayo Clinic Arizona, Scottsdale, Arizona, United States|Arizona Oncology Associates, PC - HOPE, Tucson, Arizona, United States|University of Arizona, Tucson, Arizona, United States|Saint Edward Mercy Medical Center, Fort Smith, Arkansas, United States|Disney Family Cancer Center, Burbank, California, United States|Scripps Clinical Research Services, La Jolla, California, United States|UCLA Medical Center, Los Angeles, California, United States|Palo Alto Medical Foundation, Mountain View, California, United States|Los Palos Oncology and Hematology, Salinas, California, United States|Sharp Memorial Hospital, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|Rocky Mountain Cancer Centers, Denver, Colorado, United States|Hematology Oncology Associates, PC, Stamford, Connecticut, United States|Florida Cancer Institute - New Hope, New Port Richey, Florida, United States|Ocala Oncology Center, Ocala, Florida, United States|Martin Memorial Cancer Center, Stuart, Florida, United States|Atlanta Cancer Care, Atlanta, Georgia, United States|Loyola University Medical Center, Maywood, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Indiana University Melvin and Bren Simon Cancer, Indianapolis, Indiana, United States|Purchase Cancer Group, Paducah, Kentucky, United States|Medical Oncology, Baton Rouge, Louisiana, United States|Ochsner Cancer Institute, New Orleans, Louisiana, United States|LSU Health Sciences Center - Feist Weiller Cancer Center, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Massachusetts Medical Center, Worcester, Massachusetts, United States|Virgina Piper Cancer Institute, Minneapolis, Minnesota, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|Hematology and Oncology Associates at BridgePoint, Tupelo, Mississippi, United States|Missouri Cancer Associates, Columbia, Missouri, United States|Montana Cancer Institute Foundation, Missoula, Montana, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|New York Oncology Hematology, P.C., Hudson, New York, United States|Cancer Care of Western North Carolina, PA, Asheville, North Carolina, United States|Alamance Oncology Hematolgy Associates, Burlington, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Carolina Oncology Specialists, PA, Hickory, North Carolina, United States|Emerywood Hematology and Oncology, High Point, North Carolina, United States|Signal Point Clinical Research Center, Middletown, Ohio, United States|Kaiser Permanente Northwest Region Oncology Hematology, Portland, Oregon, United States|Northwest Cancer Specialists, P.C., Portland, Oregon, United States|Greater Philadelphia Cancer and Hematology Specialists, P.C., Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Institute for Translational Oncology Research (ITOR), Greenville, South Carolina, United States|Vanderbilt University Medical Center, Div. of Medical Oncology, Nashville, Tennessee, United States|Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center, Beaumont, Texas, United States|Texas Oncology-Dallas Presbyterian Hospital, Dallas, Texas, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|Texas Oncology- Fort Worth - 12th Avenue, Fort Worth, Texas, United States|Texas Oncology-Seton Williamson, Round Rock, Texas, United States|Texas Oncology-Sherman, Sherman, Texas, United States|Texas Oncology-Wichita Falls Texoma Cancer Center, Wichita Falls, Texas, United States|Fairfax Northern Virginia Hematology Oncology, PC, Fairfax, Virginia, United States|Providence Everett Regional Medical Center, Cancer Research Dept., Everett, Washington, United States|Columbia Basin Hematology and Oncology0, Kennewick, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01144455"
9,"Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.","Unknown status","No Results Available","Pancreatic Adenocarcinoma","Device: PET/MRI","Pitié Salpetriere Hospital, Paris, France","https://ClinicalTrials.gov/show/NCT03202199"
10,"Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Adenocarcinoma","Drug: FOLFIRINOX|Device: Electroporation",,"https://ClinicalTrials.gov/show/NCT02592395"
11,"Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)","Not yet recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Anakinra","Baylor University Medical Center, Charles A Sammons Cancer Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT04926467"
12,"A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Liposomal Irinotecan|Drug: FOLFOX regimen","University of Florida, Gainesville, Florida, United States|Orlando Health UF Health Cancer Center, Orlando, Florida, United States|Tallahassee Memorial Health Care, Tallahassee, Florida, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT03483038"
13,"Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: batiraxcept|Drug: Nab paclitaxel|Drug: Gemcitabine","UCLA Health, Santa Monica, California, United States|Boca Raton Regional Hospital / Lynn Cancer Institute, Boca Raton, Florida, United States|Moffit Cancer Center, Tampa, Florida, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Michigan Medicine - University of Michigan, Ann Arbor, Michigan, United States|Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States|Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States|Duke University Medical Center (DUMC), Durham, North Carolina, United States|Gabrail Cancer Center Research, Canton, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University / Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04983407"
14,"Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Device: Electroporation|Drug: gemcitabine|Drug: nab-paclitaxel","The University of Texas Health Science Center at Houston, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02514421"
15,"The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Diagnostic Test: EUS FNA (endoscopic ultrasound fine needle aspiration)","""Carol Davila"" University Central Emergency Hospital, Bucharest, Sector 1, Romania|""Prof Dr Agrippa Ionescu"" Emergency Hospital, Bucharest, Sector 1, Romania|Clinical Emergency Hospital Bucharest, Bucharest, Sector 1, Romania|Fundeni Clinical Institute, Bucharest, Sector 2, Romania|""Victor Babes"" National Pathology Institute, Bucharest, Sector, Romania","https://ClinicalTrials.gov/show/NCT04765410"
16,"9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: 9-ING-41|Drug: Retifanlimab|Drug: Gemcitabine|Drug: Abraxane","Kansas University Cancer center, Fairway, Kansas, United States","https://ClinicalTrials.gov/show/NCT05239182"
17,"Locally Advanced or Metastatic Pancreatic Adenocarcinoma","Enrolling by invitation","No Results Available","Pancreatic Adenocarcinoma","Drug: chemotherapy: TS-1, Leucovorin and Gemcitabine","China Medical University Hospital, Taichung, Taiwan|Chang-Gung Memorial Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT03559348"
18,"Diffusion MRI for Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Radiation: Diffusion-weighted nuclear magnetic resonance imaging",,"https://ClinicalTrials.gov/show/NCT02896946"
19,"Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Device: ExAblate 2100","Stanford Cancer Center, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT04298242"
20,"Pancreatic Adenocarcinoma Neoadjuvant Combination Chemotherapy and Stereotactic Body Radiation Therapy Before Surgery","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: mFOLFIRINOX|Drug: Gemcitabine / Nab-paclitaxel|Radiation: Stereotactic body radiation therapy","Juravinski Hospital, Hamilton, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04452461"
21,"Biological and Clinical Database for Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Other: Collection of biological samples","University Hospital Bordeaux, Bordeaux, France|Beaujon Hospital, Clichy La Garenne, France|University Hospital Lille, Lille, France|University Hospital of Lille, Lille, France|Centre Léon Bérard, Lyon, France|Private Hospital Jean Mermoz, Lyon, France|Hopital La Timone, Marseille, France|Hospital Nord, Marseille, France|Institut Regional du Cancer de Montpellier, Montpellier, France|University Hospital Montpellier, Montpellier, France|University Hospital of NICE, Nice, France|Saint-Louis Hospital, Paris, France|Clinique du Trocadero, Paris, France|Pau Hospital, Pau, France|University Hospital Toulouse, Toulouse, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT02818829"
22,"Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: nab-paclitaxel","Virginia mason medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03703089"
23,"Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Pancrelipase","Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04098237"
24,"Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma",,,"https://ClinicalTrials.gov/show/NCT03266757"
25,"Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: nab-paclitaxel|Drug: gemcitabine|Drug: m-FOLFOX","Spanish Cooperative for Digestive Tumour Therapy (TTD), Madrid, Spain","https://ClinicalTrials.gov/show/NCT02504333"
26,"RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Ramucirumab","Agios Savvas Anticancer Hospital, Athens, Attiki, Greece|Aretaieio Hospital, Athens, Attiki, Greece|""Attikon"" University Hospital, Chaïdári, Attiki, Greece|Metropolitan General Hospital, Cholargós, Attiki, Greece|Metropolitan Hospital, Néo Fáliro, Attiki, Greece|Ygeia Hospital, Psychikó, Attiki, Greece|3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Nea Kifisia, Greece|Agii Anargiri Cancer Hospital, Athens, Nea Kifisia, Greece|University Hospital of Patra, Río, Patra, Greece|EUROMEDICA General Clinic of Thessaloniki, Thessaloníki, Thessaloniki, Greece|Haematology- Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens ""Alexandra"", Athens, Greece|Department of Medical Oncology, Ioannina University Hospital, Ioánnina, Greece|General University Hospital of Larissa, Larissa, Greece","https://ClinicalTrials.gov/show/NCT03745430"
27,"Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Nivolumab|Procedure: Irreversible Electroporation","University of Louisville, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT03080974"
28,"Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Nivolumab (Cohort A)|Drug: Ipilimumab (Cohort A and B)|Drug: Hydroxychloroquine (HCQ) (Cohort B)|Drug: Nab-paclitaxel (nP) (Cohort A and B)|Drug: Gemcitabine (gem) (Cohort A and B)","University of California, Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States|M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04787991"
29,"Neoadjuvant GMCI Plus Chemoradiation for Advanced Non-Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Biological: GMCI (aglatimagene besadenovec + valacyclovir)|Drug: Chemotherapy|Radiation: Radiation|Procedure: Surgery","Lee Health/Regional Cancer Center, Fort Myers, Florida, United States|Ohio State University, Columbus, Ohio, United States|University of Virginia, Charlottesville, Virginia, United States|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico","https://ClinicalTrials.gov/show/NCT02446093"
30,"A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma Non-resectable","Biological: Poly-ICLC|Biological: dendritic cell","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01677962"
31,"A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma","Recruiting","No Results Available","Resectable Pancreatic Adenocarcinoma","Drug: neoadjuvant modified FOLFIRINOX","Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT05066802"
32,"Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)","Unknown status","No Results Available","Pancreatic Adenocarcinoma","Device: NovoTTF-100L|Drug: Gemcitabine|Drug: nab-Paclitaxel","Hospital General Universitario de Elche, Elche, Spain|Hospital 12 de Octubre, Madrid, Spain|Ramon Y Cajal, Madrid, Spain|Hospital Universitario Carlos Haya, Malaga, Spain|Hospital Universitario Santander, Santander, Spain|HFR-Hopital Cantonal, Freiburg, Switzerland","https://ClinicalTrials.gov/show/NCT01971281"
33,"Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: oxaliplatin|Drug: gemcitabine|Drug: 5-FU/LV","National Taiwan Univeristy Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT00154791"
34,"Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Biological: REOLYSIN®|Drug: Chemotherapy|Drug: Gemcitabine|Drug: Irinotecan|Drug: Leucovorin|Drug: 5-fluorouracil|Drug: Pembrolizumab","Cancer Therapy & Research Center at UTHSCSA, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT02620423"
35,"Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: capecitabine","Cambridge University Hospitals NHS Foundation Trust, University of Cambridge Oncology Centre, Cambridge, United Kingdom|Edinburgh Cancer Centre, Western General Hospital, Edinburgh, United Kingdom","https://ClinicalTrials.gov/show/NCT00854477"
36,"Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma","Active, not recruiting","Has Results","Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Nab-paclitaxel|Drug: Durvalumab|Drug: Tremelimumab","Tom Baker Cancer Centre, Calgary, Alberta, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|The Moncton Hospital, Moncton, New Brunswick, Canada|The Vitalite Health Network - Dr. Leon Richard, Moncton, New Brunswick, Canada|Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, Canada|Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Grand River Regional Cancer Centre, Kitchener, Ontario, Canada|London Regional Cancer Program, London, Ontario, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, Canada|Algoma District Cancer Program, Sault Ste. Marie, Ontario, Canada|Niagara Health System, St. Catharines, Ontario, Canada|Odette Cancer Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|St. Joseph's Health Centre, Toronto, Ontario, Canada|Hopital de la Cite-de-la-Sante, Laval, Quebec, Canada|L'Hotel-Dieu de Levis, Levis, Quebec, Canada|CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|The Jewish General Hospital, Montreal, Quebec, Canada|The Research Institute of the McGill University, Montreal, Quebec, Canada|Centre Integre Universitaire De Sante Et De Services, Montreal, Quebec, Canada|CHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec, Canada|Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT02879318"
37,"Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: APX005M|Drug: Nivolumab|Drug: Nab-Paclitaxel|Drug: Gemcitabine","University of California, Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States|M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03214250"
38,"4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation","Completed","Has Results","Pancreatic Adenocarcinoma","Other: Contrast-enhanced 4D computed tomography","Ummc Msgcc, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01764659"
39,"A Phase 1b/2, Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Ivaltinostat|Drug: Capecitabine",,"https://ClinicalTrials.gov/show/NCT05249101"
40,"Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Gemcitabine - Trastuzumab - Erlotinib","Centre Val d'Aurelle, Montpellier, France","https://ClinicalTrials.gov/show/NCT01204372"
41,"A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Abraxane|Drug: FOLFIRINOX|Radiation: Chemoradiation","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01839799"
42,"Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: XELOXIRI-3|Drug: Gemcitabine","University Hospital of Besançon, Besancon, France|Hôpital Nord Franche-Comté, Montbéliard, France|CH Mulhouse, Mulhouse, France|CHU Nancy, Nancy, France|CHU Reims, Reims, France","https://ClinicalTrials.gov/show/NCT03974854"
43,"A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Adenocarcinoma","Drug: 5 Fluorouracil|Drug: Leucovorin|Drug: Irinotecan|Drug: Oxaliplatin","NorthShore University HealthSystem, Evanston, Illinois, United States","https://ClinicalTrials.gov/show/NCT01660711"
44,"Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Adenocarcinoma Metastatic","Drug: Cabozantinib 40 MG|Drug: Erlotinib 100Mg Tab","Indiana University Health Hospital, Indianapolis, Indiana, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT03213626"
45,"Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Adenocarcinoma","Drug: Intraperitoneal Gemcitabine","Washington Cancer Institute at MedStar Washington Hospital Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT01206296"
46,"Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Other: Blood draw","Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States|Memorial Sloan Kettering West Harrison, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States|Memoral Sloan Kettering Cancer Center at Phelps, Sleepy Hollow, New York, United States","https://ClinicalTrials.gov/show/NCT01474564"
47,"Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma","Drug: NanoPac®","Cedars-Sinai Medical Center, Los Angeles, California, United States|Parkview Cancer Institute, Fort Wayne, Indiana, United States|Texas Tech University Health Sciences Center, El Paso, Texas, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03077685"
48,"Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Capecitabine|Drug: Oxaliplatin|Drug: Irinotecan","Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong","https://ClinicalTrials.gov/show/NCT01558869"
49,"Stereotactic Radiotherapy + Anti PD-1 Therapy in Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Locally Advanced Unresectable Pancreatic Adenocarcinoma","Drug: Nivolumab|Radiation: Stereotactic radiotherapy","Klinika Onkologie a radioterapie, Fakultní nemocnice Hradec Králové, Hradec Králové, Czechia|Onkologická klinika, Fakultní nemocnice Olomouc, Olomouc, Czechia|Onkologická klinika, Thomayerova nemocnice, Praha, Czechia|Ústav radiační onkologie, Nemocnice Na Bulovce, Praha, Czechia","https://ClinicalTrials.gov/show/NCT04098432"
50,"LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: LEE011|Drug: Everolimus","Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT02985125"
51,"Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Erlotinib","University of Cincinnati, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00728000"
52,"Phase II Study to Evaluate MAintenance Therapy With Olaparib or Selumetinib Plus Durvalumab According to BRCAness and KRAS Somatic Status Personalized in Metastatic Pancreatic Adenocarcinoma Patients","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Arm A - Olaparib|Drug: ARM B - durvalumab plus selumetinib|Drug: ARM C FOLFIRI","Institut Sainte Catherine, Avignon, France|CHRU Jean Minjoz, Besançon, France|Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France|Centre François Baclesse, Caen, France|Hôpital Beaujon, Clichy, France|GHPSO Site de Creil, Creil, France|Centre Georges François Leclerc, Dijon, France|CHU Dijon, Dijon, France|CHU Grenoble Alpes Hôpital Michallon, Grenoble, France|Hôpital Franco-Britannique, Levallois-Perret, France|CHRU Lille, Lille, France|centre Léon Bérard, Lyon, France|Hôpital Privé Jean Mermoz, Lyon, France|Hôpital Saint Joseph Saint Luc, Lyon, France|CHU La Timone, Marseille, France|Hôpital Européen, Marseille, France|Institut Paoli Calmette, Marseille, France|Hôpital Nord Franche Comté, Montbéliard, France|GH Diaconesses Croix Saint Simon, Paris, France|Hôpital Européen Georges Pompidou, Paris, France|Hôpital Pitié Salpêtrière, Paris, France|Hôpital Saint Antoine, Paris, France|Institut Mutualiste Montsouris, Paris, France|CHU Poitiers, Poitiers, France|CHU Robert Debré, Reims, France|ICO Site de Saint Herblain, Saint-Herblain, France|Centre Paul Strauss, Strasbourg, France|CHU Toulouse IUCT Rangueil, Toulouse, France|Hôpital Trousseau, Tours, France","https://ClinicalTrials.gov/show/NCT04348045"
53,"The Study of Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: S-1,Leucovorin,Oxaliplatin,Gemcitabine","National Taiwan University Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT01415713"
54,"First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: GEMBRAX|Drug: FOLFIRINOX","Institut regional du Cancer - Val d Aurelle, Montpellier, France","https://ClinicalTrials.gov/show/NCT01964287"
55,"Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol","Terminated","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Capecitabine, Oxaliplatin and Irinotecan (CAPOXIRI)","Mount Sinai Beth Israel, New York, New York, United States|St-Lukes Roosevelt Hospital Medical Center, New York, New York, United States|Beth Israel Comprehensive Care Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01760252"
56,"Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: imexon|Drug: gemcitabine","Arizona Clinical Research Center, Tucson, Arizona, United States|US Oncology Orlando, Cancer Centers of FL, Ocoee, Florida, United States|US Oncology Indiana, Indianapolis, Indiana, United States|Univ of Michigan, Ann Arbor, Michigan, United States|US Oncology Albany, New York Oncology, Albany, New York, United States|US Oncology Kettering, Kettering, Ohio, United States|Fox Chase Cancer Ctr., Philadelphia, Pennsylvania, United States|US Oncology, Virginia Oncology Assoc, Norfolk, Virginia, United States|US Oncology Northwest, Northwest Cancer Specialists, Vancouver, Washington, United States","https://ClinicalTrials.gov/show/NCT00327327"
57,"Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)","Completed","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: Ibrutinib|Drug: Gemcitabine|Drug: Nab-paclitaxel","Oncology Specialties, PC; Clearview Cancer Institute, Huntsville, Alabama, United States|Arizona Center for Cancer Care, Avondale, Arizona, United States|St. Mary's Medical Center, Daly City, California, United States|Moores UCSD Cancer Center, La Jolla, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Norwalk Hospital, Norwalk, Connecticut, United States|Eastern Connecticut Hematology/Oncology Assoc., Norwich, Connecticut, United States|Bethesda Memorial Hospital, Boynton Beach, Florida, United States|Florida Hospital Tampa, Tampa, Florida, United States|University Cancer & Blood Center, LLC, Athens, Georgia, United States|Northwest Georgia Oncology Centers, PC, Marietta, Georgia, United States|Ingalls Memorial Hospital Cancer Research Center, Harvey, Illinois, United States|Joliet Oncology-Hematology Associates, LTD, Joliet, Illinois, United States|Investigative Clinical Research of Indiana, Indianapolis, Indiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States|Center for Cancer and Blood Disorders, Bethesda, Maryland, United States|Berkshire Hematology Oncology Services at Berkshire Medical Center Cancer and Infusion Center, Pittsfield, Massachusetts, United States|Saint Joseph Mercy Health System, Chelsea, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|Nebraska Medicine - Peggy D. Cowdery Patient Care Center, Omaha, Nebraska, United States|The Presbyterian Hospital, Charlotte, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Gibbs Cancer Center, Spartanburg, South Carolina, United States|Scott & White Memorial Hospital, Temple, Texas, United States|MultiCare Health System Institute for Research and Innovation, Tacoma, Washington, United States|Wenatchee Valley Hospital & Clinics, Wenatchee, Washington, United States|ULB Hôpital Erasme, Bruxelles, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|Grand Hôpital de Charleroi, Gilly, Belgium|UZ Leuven, Leuven, Belgium|C. H. U. Sart Tilman, Liège, Belgium|Centre Antoine Lacassagne, Nice cedex 02, Alpes Maritimes, France|Centre Paul Strauss, Strasbourg cedex, Bas Rhin, France|Hôpital de la Timone, Marseille cedex 5, Bouches-du-Rhône, France|Centre Georges François Leclerc, Dijon cedex, Côte-d'Or, France|CHU Besançon - Hôpital Jean Minjoz, Besançon, Doubs, France|Groupe Hospitalier Saint André - Hôpital Saint André, Bordeaux, Gironde, France|CHU de Toulouse - Hôpital Rangueil, Toulouse Cedex 9, Haute Garonne, France|Hôpital Nord Franche Comté, Doubs, Montbeliard, France|Hôpital Saint-Antoine, Paris cedex 12, Paris, France|CHU Poitiers - Hôpital la Milétrie, Poitiers Cedex, Vienne, France|Groupe Hospitalier Pitie-Salpetriere, Paris, France|Universitaetsklinikum Tuebingen, Tuebingen, Baden Wuerttemberg, Germany|Universitaetsklinikum Ulm, Ulm, Baden Wuerttemberg, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Hessen, Germany|Universitaetsklinikum Koeln, Koeln, Nordrhein Westfalen, Germany|Gemeinschaftspraxis Haematologie und Onkologie, Dresden, Sachsen Anhalt, Germany|Universitaetsklinikum Leipzig AoeR, Leipzig, Sachsen, Germany|Onkologische Schwerpunktpraxis Kurfuerstendamm, Berlin, Germany|Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy|Azienda Ospedaliero Universitaria San Martino, Genova, Italy|Ospedale San Raffaele, Milano, Italy|IEO Istituto Europeo di Oncologia, Milano, Italy|Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, Italy|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy|IOV - Istituto Oncologico Veneto IRCCS, Padova, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Italy|IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of|Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|ICO l´Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Specialist, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic i Provincial de Barcelona, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clinico Universitario Virgen de la Victoria, Málaga, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Derriford Hospital, Plymouth, Devon, United Kingdom|Broomfield Hospital, Chelmsford, Essex, United Kingdom|The Christie, Manchester, Greater Manchester, United Kingdom|Southampton General Hospital, Southampton, Hampshire, United Kingdom|The Clatterbridge Cancer Centre, Liverpool, Merseyside, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, United Kingdom|Royal Free Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT02436668"
58,"A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Biological: REOLYSIN|Drug: Gemcitabine","Montefiore Medical Center, New York, New York, United States|Cancer Therapy & Research Center at UTHSCSA, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00998322"
59,"A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)","Completed","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: CO-1.01|Drug: Gemcitabine","Arizona Center for Hematology Oncology, Glendale, Arizona, United States|Wilshire Oncology Medical Group, Inc., Corona, California, United States|White Memorial Medical Center, Los Angeles, California, United States|Cancer Care Institute, Los Angeles, California, United States|Newport Cancer Care Medical, Newport Beach, California, United States|Hematology Oncology Associates, Oakland, California, United States|Sharp Clinical Oncology Research, San Diego, California, United States|Rocky Mountain Cancer Centers, Denver, Colorado, United States|Hartford Hospital Clinical Research, Hartford, Connecticut, United States|Oncology Associates of Bridgeport, Trumbull, Connecticut, United States|Annapolis Oncology Center, Annapolis, Maryland, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|New Mexico Cancer Care Alliance, Albuquerque, New Mexico, United States|Arena Oncology Associates, PC, Lake Success, New York, United States|Bend Memorial Clinic, Bend, Oregon, United States|Cancer Center of the Carolinas, Greenville, South Carolina, United States|Cancer Specialists of South Texas, P.A., Corpus Christi, Texas, United States|Valley Cancer Associates, Harlingen, Texas, United States|South Texas Oncology and Hematology, PA, San Antonio, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Policlínica Privada Instituto de Medicina Nuclear, Buenos Aires, Bahia Blanca, Argentina|Instituto Especializado Alexander Fleming, Cuidad Autónoma de Buenos Aires, Buenos Aires, Argentina|Hospital de Gastroenterología, Loma Hermosa, Buenos Aires, Argentina|Clínica Universitaria Reina Fabiola, Córdoba, Argentina|ISIS Centro Especializado, Santa Fe, Argentina|Newcastle Private Hospital, New Lambton Heights, New South Wales, Australia|Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia|Southern Medical Day Oncology Care Centre, Wollongong, New South Wales, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Saint Vincent's Hospital, Fitzroy, Victoria, Australia|Border Medical Oncology, Murray Valley Private Hospital, Wodonga, Victoria, Australia|Universitair Ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium|Cliniques Universitaires Saint Luc, Brussels, Belgium|Centre Hospitalier de Jolimont-Lobbes, Haine-Saint-Paul, Belgium|Hospital Universitario, Brasilia, Distrito Federal, Brazil|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil|Irmandade da Santa, Porto Alegre, Rio Grande do Sul, Brazil|Hospital São Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|CEPON-Centro de pesquisas Oncologicas, Florianópolis, Santa Catarina, Brazil|Hospital do Cancer de Barretos, Barretos, Sao Paulo, Brazil|Fundacao Hospital, Jau, Sao Paulo, Brazil|Faculdade de Medicina do ABC, Santo Andre, Sao Paulo, Brazil|Instituto Nacional do Cancer, Rio de Janeiro, Brazil|Cross Cancer Institute, Edmonton, Alberta, Canada|Centre Hospitalier de la Cote Basque, Bayonne Cedex, France|Hôpital Saint André, Service d'Oncologie Médicale, Bordeaux, France|Clinique François Chénieux, Limoges Cedex, France|Centre Hospitalier Régional Universitaire Hôpital Saint Eloi, Montpellier Cedex 5, France|Centre Regional de Lutte contre le Cancer Val d'Aurelle, Montpellier, France|Centre René Gauducheau, Saint Herblain cedex, France|Institut Gustave-Roussy - Centre de Lutte Contre le Cancer, Villejuif Cedex, France|Ludwig-Maximilians-Universität, Medizinische Klinik und Poliklinikversität München, München, Bayern, Germany|Klinikum der Ernst-Moritz-Arndt-Universität, Greifswald, Mecklenburg-Vorpommern, Germany|Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Nordrhein-Westfalen, Germany|Universitätsklinikum Jena, Jena, Thueringen, Germany|Charité Universitätsmedizin Berlin, Berlin, Germany|Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Klinik der Otto-Von-Guericke-Universität Magdeburg, Magdeburg, Germany|Medizinische Universitätsklinik Ulm, Abt. Innere Medizin I, Ulm, Germany|Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Emilia-Romagna, Italy|Fondazione San Raffaele del Monte Tabor, Milano, Italy|Instituto Oncologico Veneto, Oncologia Medica 1, Padova, Italy|Ospedali Riuniti di Ancona, Torrette di Ancona, Italy|Centro Ricerche Cliniche di Verona, Verona, Italy|Vrije Universiteit Medisch Centrum, Amsterdam, Noord-Holland, Netherlands|Sørlandet sykehus HF, Kristiansand, Norway|Oslo Universitetssykehus, Ullevål, Oslo, Norway|Republic Clinical Oncology Center, Izhevsk, Republic of Udmurtia, Russian Federation|Sverdlovsk Regional Oncology Center, Ekaterinburg, Russian Federation|Regional Oncology Center, Irkutsk, Russian Federation|Clinical Oncology Center #1, Krasnodar, Russian Federation|Kursk Regional Oncology Center, Kursk, Russian Federation|Blokhin Cancer Research Center, Moscow, Russian Federation|Novosibirsk, City Clinical Hospital #1, Novosibirsk, Russian Federation|Leningrad Regional Clinical Hospital, St. Petersburg, Russian Federation|Mechnikov St. Petersburg State Medical Academy, St. Petersburg, Russian Federation|St. Petersburg City Oncology Center, St. Petersburg, Russian Federation|Tambov Regional Oncology Center, Tambov, Russian Federation|Tula Regional Oncology Center, Tula, Russian Federation|Regional Clinical Oncology Hospital, Yaroslavl, Russian Federation|Lanssjukhuset Ryhov, Jonkoping, Sweden|Linköping University Hospital, Linköping, Sweden|Växjö Centrallasarettet, Växjö, Sweden|Dnipropetrovsk City Multispecialty Clinical Hospital #4, Department of Chemotherapy, Dnipropetrovsk State Medical Academy, Department of Oncology and Medical Radiology, Dnipropetrovsk, Ukraine|Public Clinical Treatment and Prophylaxis Institution ""Donetsk Regional Antitumor Center"", Oncosurgery Department #6, Donetsk, Ukraine|""Public Healthcare Institution """"Kharkiv Regional Clinical Oncology Center"""", Abdominal Department, Kharkiv, Ukraine|National Cancer Institute, Department of Tumors of Abdominal Cavity and Retroperitoneum, Kiev, Ukraine|State Regional Diagnostics and Treatment Oncology Center, Chemotherapy Department, Lviv, Ukraine|Mykolayiv Regional Oncology Center, Surgery Department #1, Mykolayiv, Ukraine|Zakarpatya Regional Clinical Oncology Center, Chemotherapy Department, Uzhorod, Ukraine|Clinical Facility: Public Institution ""Zaporizhya City Clinical Hospital #3"", Regional Center of Hepatic, Biliary Tract and Pancreatic Surgery, Surgery Department #1, Zaporizhya, Ukraine|Hammersmith Hospital, London, England, United Kingdom|Christie Hospital, Manchester, England, United Kingdom|Beatson West of Scotland Cancer Centre, Cancer Research UK Clinical Trials Unit (CTU), Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT01124786"
60,"mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cancer Non-resectable","Radiation: SBRT+mFOLFIRINOX|Drug: mFOLFIRINOX","Asan Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04986930"
61,"Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: CO-1.01","Arizona Cancer Center at University of Arizona, Tucson, Arizona, United States|Rocky Mountain Cancer Center, Denver, Colorado, United States|Palm Beach Institute / Collaborative Research Group, Boynton Beach, Florida, United States|University of Miami, Miami, Florida, United States|Piedmont Healthcare Research Institute (PHRI), Atlanta, Georgia, United States|Norton Cancer Institute Research Program, Louisville, Kentucky, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital (MGH), Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Columbia University Medical Center, Milstein Hospital, New York, New York, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01233375"
62,"The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC)","Recruiting","No Results Available","Pancreas Adenocarcinoma","Procedure: Biological Samples","Centre Léon Bérard, Lyon, France","https://ClinicalTrials.gov/show/NCT03472716"
63,"Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)","Drug: mFolfirinox|Drug: Gemcitabine","Tom Baker Cancer Centre, Calgary, Alberta, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|CancerCare Manitoba, St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Dr Leon Richard Oncology Centre, Moncton, New Brunswick, Canada|The Royal Victoria Hospital - Cancer Care Program, Barrie, Ontario, Canada|Juravinski Cancer centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada|Ottawa Health Research Institute, Ottawa, Ontario, Canada|Niagara Health System, St. Catharines, Ontario, Canada|Department of Medical Oncology Health Sciences North, Sudbury, Ontario, Canada|General Surgery - TGH Site, Univ. Health Network, Toronto, Ontario, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada|McGill University (Department of Oncology), Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Allain Blair Cancer Centre, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada|The Moncton Hospital, Moncton, Canada|CHUQ - Hotel-Dieu de Quebec, Quebec, Canada|Algoma District Cancer Program, Sault Area Hospital, Sault Ste. Marie, Canada|CHU Nord, Amiens, France|ICO Paul Papin, Angers, France|Hôpital Avicenne, Bobigny, France|Institut Bergonié, Bordeaux, France|CHU Côte de Nacre, Caen, France|Hôpital Beaujon, Clichy, France|Hôpital Louis Pasteur, Colmar, France|CHU de Dijon - Site Bocage, Dijon, France|CHD Vendée, La Roche Sur Yon, France|Hôpital Huriez, Lille, France|Centre Léon Bérard, Lyon, France|Hôpital de la Croix-Rousse, Lyon, France|Hôpital Privé Jean Mermoz, Lyon, France|CHU Nord, Marseille, France|CHU Timone Adulte, Marseille, France|Fondation Ambroise Paré / Hôpital Européen, Marseille, France|Institut Paoli Calmettes, Marseille, France|CH Layné, Mont de Marsan, France|CHU De ST Eloi, Montpellier, France|CRCL Val d'Aurelle, Montpellier, France|Centre Antoine-Lacassagne, Nice, France|CHR Orléans - La Source, Orleans, France|Groupe Hospitalier Paris Saint Joseph, Paris, France|Groupe Hospitalier Pitié-Salpêtrière, Paris, France|Hôpital Saint-Jean, Perpignan, France|Hôpital Haut-Lévêque, Pessac, France|Centre hospitalier de Reims, Reims, France|CHU Rouen, Rouen, France|Centre René Gauducheau, Saint Herblain, France|Centre Paul Strauss, Strasbourg, France|Hôpital Trousseau, Tours, France|Centre Alexis Vautrin, Vandoeuvre Les Nancy, France|Hôpital de Brabois-CHU de Nancy, Vandœuvre-lès-Nancy, France","https://ClinicalTrials.gov/show/NCT01526135"
64,"Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Adenocarcinoma","Biological: modified CEA peptide (10mcg)|Biological: modified CEA peptide (100mcg)|Biological: modified CEA peptide (1000mcg)","The University of Chicago, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00203892"
65,"Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma Metastatic|Chemotherapy Effect","Drug: Sequential Treatment","The second affiliated hospital of Zhejiang University, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT03633734"
66,"Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cancer","Biological: Autologous DC vaccine","Baylor College of Medicine Medical Center - McNair Campus, Houston, Texas, United States|Baylor St. Lukes Medical Center, Houston, Texas, United States|Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04157127"
67,"Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma","Completed","Has Results","Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma","Drug: TH-302|Drug: Gemcitabine|Drug: Placebo (5 percent dextrose - D5W)","Please Contact U.S. Medical Information, Rockland, Massachusetts, United States|Please Contact Merck Communication Center, Darmstadt, Germany","https://ClinicalTrials.gov/show/NCT01746979"
68,"Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma","Recruiting","No Results Available","Colorectal Cancer|Pancreatic Adenocarcinoma","Drug: Trametinib|Drug: Ruxolitinib","National Cancer Centre, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT04303403"
69,"Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Nab-paclitaxel + Gemcitabine","Institut Paoli-Calmettes, Marseille, France","https://ClinicalTrials.gov/show/NCT02174887"
70,"HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Neoplasms|Pancreatic Adenocarcinoma","Procedure: Hyperthermic intraperitoneal chemotherapy|Procedure: Open pancreaticoduodenectomy|Drug: Gemcitabine","Carolinas Medical Center, Charlotte, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02850874"
71,"Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma","Terminated","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma","Drug: Bevacizumab-800CW","University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands","https://ClinicalTrials.gov/show/NCT02743975"
72,"Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids","Withdrawn","No Results Available","Pancreas Adenocarcinoma","Other: Treatment prediction PDT platform",,"https://ClinicalTrials.gov/show/NCT04821219"
73,"Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma","Unknown status","No Results Available","Advanced Gastric Adenocarcinoma|Pancreatic Adenocarcinoma","Genetic: CAR-CLD18 T Cells","Changhai Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT03159819"
74,"CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Pancreas Adenocarcinoma","Drug: CPI-613® (Dose level -1.0 250 mg/m^2)|Drug: CPI-613® (Dose level 1.0 500 mg/m^2)|Drug: CPI-613® (Dose level 2.0 1,000 mg/m^2)|Drug: CPI-613® (Dose level 3.0 1,500 mg/m^2)|Drug: CPI-613® Maximum Tolerated Dose (MTD)|Drug: Gemcitabine|Radiation: Intensity-modulated Radiation Therapy","Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT05325281"
75,"Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)","Recruiting","No Results Available","Pancreas Adenocarcinoma","Device: NovoTTF-100L(P)|Drug: Gemcitabine|Drug: nab paclitaxel","Grandview Medical Center, Cancer Center, Birmingham, Alabama, United States|Infirmary Cancer Care, Mobile, Alabama, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, United States|Arizona Oncology Associates, PC- HOPE - US Oncology Research, Tucson, Arizona, United States|University of Arizona Cancer Center, Tucson, Arizona, United States|Pacific Cancer Medical Center, Anaheim, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Dignity Health - Mercy Cancer Centers, Sacramento, California, United States|Sutter Cancer Center Sacramento, Sacramento, California, United States|Boca Raton Regional Hospital, Lynn Cancer Institute, Boca Raton, Florida, United States|Mayo Clinic Hospital - Florida, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|AdventHealth Neuro Oncology, Orlando, Florida, United States|BRCR Medical Center INC, Plantation, Florida, United States|Florida Cancer Specialists, Saint Petersburg, Florida, United States|Florida Hospital Tampa, Tampa, Florida, United States|Piedmont Cancer Institute, Atlanta, Georgia, United States|Illinois Cancer Specialist - US Oncology Research, Arlington Heights, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Kansas Medical Cancer Center, Fairway, Kansas, United States|Norton Cancer Institute, Norton Healthcare Pavilion, Louisville, Kentucky, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Central Maine Medical Center, Clinical Research Department, Lewiston, Maine, United States|University of Maryland Comprehensive Cancer Center, Baltimore, Maryland, United States|Maryland Oncology Hematology, P.A - US Oncology Research, Columbia, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|Cancer and Hematology Centers of Western Michigan, PC, Grand Rapids, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|MidAmerica Division, Kansas City, Missouri, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Kaleida Health, Buffalo, New York, United States|NYU Langone Arena Oncology, Lake Success, New York, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Willamette Valley Cancer Institute and Research Center - US Oncology Research, Eugene, Oregon, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Vita Medical Associates, P.C., Fountain Hill, Pennsylvania, United States|UT/Erlanger Oncology & Hematology, Chattanooga, Tennessee, United States|Tennessee Cancer Specialists, Knoxville, Tennessee, United States|Tennessee Oncology, Nashville, Tennessee, United States|Texas Oncology - Beaumont Mamie McFaddin Ward Cancer Center - US Oncology Research, Beaumont, Texas, United States|Texas Oncology - Bedford - US Oncology Reasearch, Bedford, Texas, United States|Methodist Regional Cancer Center, Dallas, Texas, United States|Texas Oncology - Baylor - US Oncology Research, Dallas, Texas, United States|Texas Oncology - El Paso Cancer Treatment Center Gateway - US Oncology Research, El Paso, Texas, United States|Houston Methodist Cancer Center, Houston, Texas, United States|Baylor Scott and White Medical Center, Temple, Texas, United States|Texas Oncology - Tyler - US Oncology Research, Tyler, Texas, United States|Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - US Oncology Research, Roanoke, Virginia, United States|Vista Oncology Inc PS, Olympia, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|West Virginia University Cancer Institute, Morgantown, West Virginia, United States|Greenslopes Private Hospital, Greenslopes, Queensland, Australia|St. John of God Murdoch Hospital, Murdoch, Western Australia, Australia|Medical University Graz, Graz, Austria|Univ. Klinik für Innere Medizin III der PMU, Salzburg, Austria|Landes-Krankenhaus Steyr, Steyr, Austria|UZ Leuven, Leuven, Belgium|London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada|Centre Hospitalier de I'Universitaire de de Montreal (CHUM), Montréal, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke CIUSSS de l'Estrie - CHUS, Sherbrooke, Quebec, Canada|Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou, Guangdong, China|Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China|Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China|The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an, Shaanxi, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Beijing Cancer Hospital, Beijing, China|Guangdong provincial people's hospital, Guangzhou, China|Jilin Guowen Hospital, Jilin, China|Shanghai Changhai Hospital, Shanghai, China|Xingtai People's Hospital, Xingtai, China|Henan Provincial Peoples Hospital, Zhengzhou, China|University Hospital Centre Zagreb, Zagreb, Croatia|Nemocnice Nový Jičín, Nový Jičín, Czechia|University Hospital Olomouc, Olomouc, Czechia|General University Hospital in Prague, Praha 2, Czechia|Nemocnice Na Bulovce, Praha 8, Czechia|Hopital haut-Léveque CHU Bordeaux - Service d'Hépato- Gastroentérologie et d'Oncologie digestive, Pessac, Bordeaux, France|Institut de Cancérologie de l'Ouest, Angers cedex, France|Centre Hospitalier de Bretagne Sud /Site du Scorff, Lorient, France|Centre Léon Bérard, Lyon, France|Service d'Oncologie médicale du Pr. Andre, Hôpital Saint-Antoine, Paris, France|Hôpital Privé des Côtes d'Armor, Plérin, France|Clinique Sainte Anne - Groupe Hospitalier Saint-Vincent, Strasbourg Oncologie Libérale, Strasbourg, France|VK und K Studien GbR Landshut-Achdorf, Landshut, Germany|Klinikum München Bogenhausen, Klinik für Gastroenterologie und Gastroenterologische Onkologie, München, Germany|Universitätsklinikum Ulm, Ulm, Germany|Queen Mary Hospital, Hong Kong, Hong Kong|National Institute of Oncology, Budapest, Hungary|Bekes County Hospital, Gyula, Hungary|Bacs-Kiskun County Hospital, Kecskemét, Hungary|Tolna County Hospital, Szekszárd, Hungary|Jasz-Nagykun-Szolnok County Hospital, Szolnok, Hungary|Rambam Health Care Campus, Oncology Institute, Haifa, Israel|Sourasky Medical Center, Oncology Department, Tel Aviv, Israel|A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Università Campus Bio-Medico di Rome, Roma, Italy|A.O.U Città della Salute e della Scienza di Torino, Torino, Italy|Oncology Clinic Clinical Hospital of Przemienienia Pańskiego UM in Poznaniu, Poznań, Poland|Centrum Medyczne MrukMed, Rzeszów, Poland|Oncology and Radiotherapy Clinic, Oncology Center - Institute, Warsaw, Poland|Jan Mikulicz-Radecki University Teaching Hospital, Wrocław, Poland|Instituto Oncòlogico Dr. Rosell, Barcelona, Spain|Vall d´Hebron University Hospital, Barcelona, Spain|Hospital General Universitario de Elche, Elche, Spain|HM Hospitales - Centro Integral Oncologico Clara Campal - CIOCC, Madrid, Spain|Hospital Universitario Carlos Haya de Malaga, Málaga, Spain|Clinica Universiatria de Navarra, Pamplona, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Instituto Valenciano de Oncología IVO, Valencia, Spain|Hôpital Fribourgeois/Freiburger Spital, Fribourg, Switzerland|KS Winterthur, Winterthur, Switzerland","https://ClinicalTrials.gov/show/NCT03377491"
76,"Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreas Adenocarcinoma","Radiation: Cyberknife","Capital Health Medical Center-Hopewell, Pennington, New Jersey, United States","https://ClinicalTrials.gov/show/NCT04998552"
77,"A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)","Terminated","No Results Available","Advanced Pancreatic Adenocarcinoma","Procedure: Comparator: [18F]-FDG PET/CT and Volumetric CT",,"https://ClinicalTrials.gov/show/NCT01050283"
78,"Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Niraparib + Nivolumab|Drug: Niraparib + Ipilimumab","University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03404960"
79,"The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma.","Withdrawn","No Results Available","Pancreas Adenocarcinoma","Drug: Gemcitabine",,"https://ClinicalTrials.gov/show/NCT04045730"
80,"The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Neoplasms|Pancreatic Adenocarcinoma","Procedure: Pancreatic resection","Department of Abdominal Surgery, Leuven, Vlaams-Brabant, Belgium","https://ClinicalTrials.gov/show/NCT00644254"
81,"Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma","Completed","No Results Available","Adenocarcinoma Pancreas","Procedure: PET/MRI","Washington Unviversity School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02028377"
82,"FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: FOLFOX","APHP - Groupe Hospitalier Pitié-Salpêtrière, Paris, France","https://ClinicalTrials.gov/show/NCT04167007"
83,"Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Gene Therapy product CYL-02|Drug: Gemcitabine","APHP Hôpital Beaujon, Clichy, France|Hôpital privé Jean Mermoz, Lyon, France|Institut Paoli Calmettes, Marseille, France|CHU de Marseille Hôpital Nord, Marseille, France|Institut régional du Cancer, Montpellier, France|Rangueil Hospital, Toulouse, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT02806687"
84,"Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Nab-paclitaxel|Drug: Gemcitabine|Drug: Cisplatin|Drug: Anakinra","Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT02550327"
85,"EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma Non-resectable","Procedure: Endoscopic ultrasound guided radiofrequency ablation|Radiation: chemoradiotherapy","Jianfeng Yang, Hangzhou, Zhejiang, China|Hangzhou First People's Hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT03772756"
86,"SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma","Completed","Has Results","Adenocarcinoma of the Pancreas","Radiation: Stereotactic Body Radiation Therapy (SBRT)","UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01357525"
87,"Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma","Completed","No Results Available","Resectable Pancreatic Adenocarcinoma|Pancreatic Cancer","Biological: GM-CSF","Chao Family Comprehensive Cancer Center, Orange, California, United States","https://ClinicalTrials.gov/show/NCT00600002"
88,"Durvalumab and ""Booster"" Radiation in Metastatic Adenocarcinoma of the Pancreas","Active, not recruiting","No Results Available","Adenocarcinoma of the Pancreas","Drug: Durvalumab|Radiation: Radiation Therapy","Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT03490760"
89,"Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Glufosfamide|Drug: Fluorouracil","Comprehensive Cancer Care Medical Group, Inc., Corona, California, United States|Compassionate Care Research Group, Inc., Fountain Valley, California, United States|Hao Wei Zhang MD, Inc., Los Angeles, California, United States|Compassionate Cancer Care Medical Group, Inc., Riverside, California, United States|Innovative Clinical Research Institute, Whittier, California, United States|Christina Care Health System, Newark, Delaware, United States|Lakeland Regional Cancer Center, Lakeland, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Simmons Cancer Institute, Springfield, Illinois, United States|Investigative Clinical Research of Indiana, LLC, Indianapolis, Indiana, United States|RHHP/Hope Center, Terre Haute, Indiana, United States|McFarland Clinic Oncology, Ames, Iowa, United States|CBC Group Consulting in Blood Disorders and Cancer, PSC, Louisville, Kentucky, United States|Reliant Medical Group, Worcester, Massachusetts, United States|Saint Louis University Cancer Center, Saint Louis, Missouri, United States|Dartmouth-Hitchcock Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Regional Cancer Care Associates, Sparta, New Jersey, United States|University of Rochester, Rochester, New York, United States|Gabrail Cancer Center Research, Canton, Ohio, United States|Allegheny Singer Research Institute- West Penn, Pittsburgh, Pennsylvania, United States|Center for Biomedical Research, Knoxville, Tennessee, United States|Texas Health Physicians Group, Arlington, Texas, United States","https://ClinicalTrials.gov/show/NCT01954992"
90,"Prevalence of Pancreatic Anomalies of Patients With a 1st Degree Familial History of Pancreatic Adenocarcinoma","Completed","No Results Available","Prevalence of Pancreas Adenocarcinomas","Procedure: Pancreatic MRI","Clinique Convert, Bourg-en-Bresse, France|Infirmerie Protestante, Caluire et Cuire, France|Clinique du Val d'Ouest, Ecully, France|Groupe Hospitalier Mutualiste des Eaux Claires, Grenoble, France|Centre des maladies du foie et de l'appareil digestif, Irigny, France|Centre Hospitalier Saint Joseph Saint Luc, Lyon, France|Hôpital privé Jean Mermoz, Lyon, France|Hôpital de Villefranche, Villefranche sur Saône, France|Clinique des Portes du Sud, Vénissieux, France","https://ClinicalTrials.gov/show/NCT02810730"
91,"Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemcitabine and Erlotinib","Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Hospital del Mar, Barcelona, Spain|Institut Català d'Oncologia (ICO) de L'Hospitalet, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Santa Creu y Sant Pau, Hospital Sant Pau, Barcelona, Spain|Instituto Catalán de Oncología, Girona, Spain|Hospital Virgen de la Arrixaca, Murcia, Spain|Hospital la Fe de Valencia, Valencia, Spain|Clínico Universitario de Valencia, Valencia, Spain","https://ClinicalTrials.gov/show/NCT01389440"
92,"Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Biological: Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)","CHUV Oncology Department, Lausanne, Vaud, Switzerland","https://ClinicalTrials.gov/show/NCT04627246"
93,"Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma","Recruiting","No Results Available","Adenocarcinoma of the Pancreas","Drug: Hydroxychloroquine sulfate","West Virginia University Cancer Institute Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT04911816"
94,"PDAC Peripheral and Portal Vein Sampling","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Diagnostic Test: Portal vein sampling","Manchester University NHS Foundation Trust, Manchester, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT04289961"
95,"Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Device: TraceIT tissue marker injection","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03307564"
96,"Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Durvalumab|Radiation: Stereotactic Ablative Body Radiotherapy (SABR)","Cedars-Sinai Medical Center, Los Angeles, California, United States|Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States","https://ClinicalTrials.gov/show/NCT03245541"
97,"Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: eryaspase|Drug: Gemcitabine plus Abraxane|Drug: Irinotecan plus 5-FU plus leucovorin","Arizona Cancer Center, Scottsdale, Arizona, United States|St. Joseph Heritage Healthcare, Fullerton, California, United States|University of California Davis Medical Center, Sacramento, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Minnesota Health Clinics and Surgery Center, Minneapolis, Minnesota, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Weill Cornell Medicine, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University, Stony Brook, New York, United States|Duke University, Durham, North Carolina, United States|Medical Oncology Associates, Spokane, Washington, United States|Institut de Cancerologie, Brest, France|Hammersmith Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03665441"
98,"Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Preoperative modified FOLFIRINOX and postoperative gemcitabine","Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT02749136"
99,"Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemzar","Haukeland University Hospital, Bergen,, Norway","https://ClinicalTrials.gov/show/NCT01674556"
100,"Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)","Terminated","No Results Available","Pancreatic Adenocarcinoma","Dietary Supplement: Nestle IMPACT Advanced Recovery|Dietary Supplement: Nestle Boost High Protein Drink","University of Louisville, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT02838966"
101,"Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC","Completed","No Results Available","Locally Advanced Pancreatic Adenocarcinoma","Device: Irreversible electroporation|Drug: Gemcitabine","Institutional Review Board of Guangzhou FUDA Cancer Hospital, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT03673137"
102,"A Study of MLN0264 in Patients With Pancreatic Cancer","Terminated","Has Results","Pancreatic Adenocarcinoma","Drug: MLN0264","Aurora, Colorado, United States|St. Petersburg, Florida, United States|Tampa, Florida, United States|Boston, Massachusetts, United States|Cincinnati, Ohio, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States|Brugge, Belgium|Leuven, Belgium|Barcelona, Spain|Madrid, Spain|Malaga, Spain|Sevilla, Spain|London, Greater London, United Kingdom|Manchester, Greater Manchester, United Kingdom|Sutton, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT02202785"
103,"Gene Therapy of Pancreatic Ductal Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma","Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes","Toulouse Universitary Hospital (Rangueil), Department of Gastroenterology At Rangueil Hospital, Toulouse, France","https://ClinicalTrials.gov/show/NCT01274455"
104,"Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cancer|Pancreas Neoplasm","Device: HTP treatment","Istituto Clinico Humanitas, Rozzano, Milano, Italy","https://ClinicalTrials.gov/show/NCT03649035"
105,"A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas","Not yet recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Irinotecan liposome injection|Drug: Folinic Acid|Drug: 5-Fluorouracil",,"https://ClinicalTrials.gov/show/NCT05383352"
106,"Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas","Terminated","Has Results","Adenocarcinoma Pancreas","Procedure: Surgery|Genetic: Genetic Expression|Drug: Chemotherapy","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01783054"
107,"QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer","Suspended","No Results Available","Pancreatic Adenocarcinoma Metastatic","Drug: NANT-008|Drug: Fluorouracil Injectable Product|Drug: Avastin Injectable Product|Drug: Leucovorin Calcium Injection|Drug: Eloxatin Injectable Product","Chan Soon-Shiong Institutes for Medicine, El Segundo, California, United States","https://ClinicalTrials.gov/show/NCT03127124"
108,"Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates","Active, not recruiting","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma|Pancreas Ductal Adenocarcinoma","Drug: Nab-paclitaxel and gemcitabine for R-PDAC Patients|Drug: Nab-paclitaxel and gemcitabine for BR-PDAC Patients","Mayo Clinic Hospital, Scottsdale, Arizona, United States|University of Arizona, Tucson, Arizona, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|New York University, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02723331"
109,"A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Cancer|Metastatic Pancreatic Cancer|Metastatic Pancreatic Adenocarcinoma","Drug: zolbetuximab|Drug: nab-paclitaxel|Drug: gemcitabine","Cancer Treatment Centers of Phoenix, Goodyear, Arizona, United States|St. Joseph Heritage Medical Group, Fullerton, California, United States|UCLA Hematology Oncology, Santa Monica, California, United States|Innovative Clinical Research Institute, Whittier, California, United States|Midstate Medical Center, Meriden, Connecticut, United States|Lynn Cancer Institute, Boca Raton, Florida, United States|Baptist Health, Miami, Florida, United States|Cancer Treatment Centers of Atlanta, Newnan, Georgia, United States|The University of Chicago, Chicago, Illinois, United States|Cancer Treatment Centers of America, Chicago, Zion, Illinois, United States|PMG Research of McFarland Clinic, Ames, Iowa, United States|University of Kansas Cancer Center, Overland Park, Kansas, United States|Our Lady of the Lake, Baton Rouge, Louisiana, United States|Ochsner Health System, New Orleans, Louisiana, United States|David C Pratt Cancer Center, Creve Coeur, Missouri, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Northwell Health Cancer Institute, Lake Success, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Mercy Clinic Oklahoma Communities, Inc, Oklahoma City, Oklahoma, United States|Cancer Treatment Centers of America at Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States|Oncology Consultants PA, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|MultiCare Regional Cancer Center - Gig Harbor, Gig Harbor, Washington, United States|Site AU61008, Gosford, New South Wales, Australia|Site AU61007, Wollongong, New South Wales, Australia|Site AU61002, North Adelaide, South Australia, Australia|Site AU61005, Fitzroy, Victoria, Australia|Site AU61006, Warrnambool, Victoria, Australia|Site FR33008, Besancon, Besancon Cedex, France|Site FR33010, Brest, Brest Cedex, France|Site FR33004, Saint-Étienne, Cedex 02, France|Site FR33015, Caen, Cedex 5, France|Site FR33006, Chambray, Cedex 9, France|Site FR33011, Dijon, Dijon Cedex, France|Site FR33012, Herblain, Herblain Cedex, France|Site FR33016, La Chaussee Saint Victor, Loir-et-Cher, France|Site FR33009, Nancy, Nancy Cedex, France|Site FR33017, Rouen, Normandy, France|Site FR33003, Aquitaine, Pessac, France|Site FR33013, Villejuif, Villejuif Cedex, France|Site FR33001, Bayonne Cedex, France|Site FR33002, Grenoble, France|Site FR33014, Plerin, France|Site FR33005, Pringy Cedex, France|Site FR33007, Strasbourg, France|Site IR35301, Elm Park, Dublin, Ireland|Site IE35303, Cork, Ireland|Site IT39006, Rozzano, Milan, Italy|Site IT39004, Candiolo, Torino, Italy|Site IT39002, Cremona, Italy|Site IT39003, Milan, Italy|Site JP81007, Nagoya, Aichi, Japan|Site JP81001, Kashiwa, Chiba, Japan|Site JP81005, Sapporo, Hokkaido, Japan|Site JP81006, Yokohama, Kanagawa, Japan|Site JP81003, Kashihara, Nara, Japan|Site JP81008, Suita, Osaka, Japan|Site JP81011, Bunkyo-ku, Tokyo, Japan|Site JP81012, Chuo-ku, Tokyo, Japan|Site JP81014, Koto-ku, Tokyo, Japan|Site JP81013, Mitaka, Tokyo, Japan|Site JP81002, Shinjuku-ku, Tokyo, Japan|Site JP81015, Ube, Yamaguchi, Japan|Site JP81004, Fukuoka, Japan|Site JP81010, Osaka, Japan|Site JP81009, Wakayama, Japan|Site KR82005, Seongnam-Si, Gyeonggi-do, Korea, Republic of|Site KR82008, Suwon-si, Gyeonggi-do, Korea, Republic of|Site KR82001, Seoul, Korea, Republic of|Site KR82003, Seoul, Korea, Republic of|Site KR82004, Seoul, Korea, Republic of|Site KR82007, Seoul, Korea, Republic of|Site KR82002, Seoul, Korea, Republic of|Site KR82006, Seoul, Korea, Republic of|Site ES34004, Llobregat, Barcelona, Spain|Site ES34001, Sabadell, Barcelona, Spain|Site ES34011, A Coruna, Galicia, Spain|Site ES34003, Pamplona, Navarra, Spain|Site ES34010, Barcelona, Spain|Site ES34013, Barcelona, Spain|Site ES34007, Barcelona, Spain|Site ES34014, Caceres, Spain|Site ES34002, Girona, Spain|Site ES34005, Lleida, Spain|Site ES34015, Madrid, Spain|Site ES34016, Madrid, Spain|Site ES34006, Madrid, Spain|Site ES34009, Madrid, Spain|Site ES34012, Madrid, Spain|Site ES34008, Madrid, Spain|Site TW88604, Tainan, East District, Taiwan|Site TW88606, Taoyuan, Guishan District, Taiwan|Site TW88607, Tainan City, Liuying District, Taiwan|Site TW88602, Taichung City, Taiwan|Site TW88603, Tainan City, Taiwan|Site TW88605, Taipei City, Taiwan|Site TW88601, Taipei City, Taiwan","https://ClinicalTrials.gov/show/NCT03816163"
110,"A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: BBI608|Drug: Nab-paclitaxel|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Leucovorin|Drug: Irinotecan|Drug: Fluorouracil|Drug: MM-398","Mayo Clinic Arizona, Phoenix, Arizona, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States|Parkview Research Center, Fort Wayne, Indiana, United States|Indiana University Health Goshen Center for Cancer Care, Goshen, Indiana, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|The University of Tennessee Medical Center, Knoxville, Tennessee, United States|Texas Oncology - Austin Midtown, Austin, Texas, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States|Texas Oncology - SAT&BC, San Antonio, Texas, United States|Virginia Oncology Associates, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT02231723"
111,"Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer","Completed","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: Ibrutinib|Drug: Paclitaxel|Drug: Gemcitabine","University of California, San Francisco, San Francisco, California, United States|Oregon Health and Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02562898"
112,"Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Adenocarcinoma Resectable","Drug: gemcitabine|Drug: Vismodegib|Procedure: Neoadjuvant chemotherapy","Antwerp University Hospital (UZA), Edegem, Antwerpen, Belgium|Erasme University Hospital (ULB), Brussels, Belgium","https://ClinicalTrials.gov/show/NCT01713218"
113,"A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: metformin alone (Arm A)|Drug: metformin (Arm B)|Drug: rapamycin (Arm B)","Scottsdale Healthcare Hospitals DBA Honor Health, Scottsdale, Arizona, United States|Johns Hopkins SKCCC, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02048384"
114,"PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer","Terminated","No Results Available","Pancreatic Adenocarcinoma Non-resectable","Drug: PEGylated Recombinant Human Hyaluronidase (PEGPH20)|Drug: Gemcitabine|Radiation: Radiation","Scripps Cancer Center, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT02910882"
115,"S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer","Active, not recruiting","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: PEGPH20|Drug: Oxaliplatin|Drug: Leucovorin|Drug: Irinotecan|Drug: 5-fluorouracil","Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States|The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States|Sutter Auburn Faith Hospital, Auburn, California, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills - Peninsula Hospitals, Burlingame, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|City of Hope Corona, Corona, California, United States|UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States|Sutter Davis Hospital, Davis, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Fremont - Rideout Cancer Center, Marysville, California, United States|Memorial Medical Center, Modesto, California, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States|Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States|Sutter Cancer Research Consortium, Novato, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|Sutter General Hospital, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|City of Hope West Covina, West Covina, California, United States|Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States|Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States|Medical Oncology and Hematology Group PC-Guilford, Guilford, Connecticut, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States|Smilow Cancer Hospital-Orange Care Center, Orange, Connecticut, United States|Charlotte Hungerford Hospital Center for Cancer Care, Torrington, Connecticut, United States|Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States|Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Fruitland, Fruitland, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Meridian, Meridian, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, United States|Saint Luke's Mountain States Tumor Institute-Twin Falls, Twin Falls, Idaho, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Cancer Care Center of Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Radiation Oncology of Northern Illinois, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Cancer Care Specialists of Illinois-Swansea, Swansea, Illinois, United States|Kansas Institute of Medicine Cancer and Blood Center, Lenexa, Kansas, United States|Minimally Invasive Surgery Hospital, Lenexa, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Capital Region Medical Center-Goldschmidt Cancer Center, Jefferson City, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Randolph Hospital, Asheboro, North Carolina, United States|Cone Health Cancer Center at Alamance Regional, Burlington, North Carolina, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|Hendersonville Hematology and Oncology at Pardee, Hendersonville, North Carolina, United States|Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States|Cone Heath Cancer Center at Mebane, Mebane, North Carolina, United States|Annie Penn Memorial Hospital, Reidsville, North Carolina, United States|Southeastern Medical Oncology Center-Wilson, Wilson, North Carolina, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Oncology and Hematology Care Southeast, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Medical Center-Edmonds, Edmonds, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Seattle Cancer Care Alliance at EvergreenHealth, Kirkland, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Minor and James Medical PLLC, Seattle, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|Group Health Cooperative-Seattle, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|Rockwood Clinic Cancer Treatment Center-Valley, Spokane Valley, Washington, United States|Rockwood Cancer Treatment Center-DHEC-Downtown, Spokane, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States","https://ClinicalTrials.gov/show/NCT01959139"
116,"Panc CA Risk Model & Biomarker Testing In High-Risk Cohort","Not yet recruiting","No Results Available","Pancreatic Adenocarcinoma","Diagnostic Test: Blood Specimen","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT05287347"
117,"Prospective Evaluation of the Role of MRI in the Perioperative Management of Pancreas Adenocarcinomas","Completed","No Results Available","Pancreas Adenocarcinomas","Other: Pre- and postoperative MRI","University of Lausanne Hospital, Lausanne, Vaud, Switzerland","https://ClinicalTrials.gov/show/NCT03714542"
118,"Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Advanced Pancreatic Cancer|Metastatic Pancreatic Cancer|Pancreatic Adenocarcinoma","Drug: PRI-724","USC Norris Comprehensive Cancer Center, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Washington Seattle Cancer Care Alliance, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01764477"
119,"Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas","Unknown status","No Results Available","Recurrent Adenocarcinoma of the Pancreas|Metastatic Adenocarcinoma of the Pancreas","Drug: Genexol-PM|Drug: Gemcitabine","Samyang Biopharmaceuticals, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT02739633"
120,"Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.","Unknown status","No Results Available","Circulating Tumor Cells|Pancreatic Adenocarcinoma|Circulating Tumor DNA (KRAS)|CA 19.9","Other: Pancreatic adenocarcinoma diagnosis","UH Rouen, Rouen, France","https://ClinicalTrials.gov/show/NCT02072616"
121,"Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery (""Personalized Medicine"")","Unknown status","No Results Available","Pancreatic Adenocarcinoma","Drug: Targeted chemotherapy prior to surgery|Drug: standard FOLFIRINOX chemotherapy prior to surgery|Drug: Gemcitabine after surgery|Other: No additional therapy after surgery|Drug: Targeted chemotherapy after surgery|Radiation: Chemoradiotherapy (cXRT)","University of Cincinnati Cancer Center, Cincinnati, Ohio, United States|Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01726582"
122,"Immunochemoradiotherapy in Patients With Pancreatic Cancer","Completed","No Results Available","Locally Advanced Pancreatic Adenocarcinoma","Biological: tadalafil and vaccination","Providence Health & Services, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01342224"
123,"Pancreatic Juice Diagnosis From Duodenum","Completed","Has Results","Pancreatic Adenocarcinoma","Other: Tumor markers","Mayo Clinic Jacksonville, Jacksonville, Florida, United States|Kyushu University, Fukuoka-shi, Fukuoka-ken, Japan","https://ClinicalTrials.gov/show/NCT01699698"
124,"Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas","Completed","Has Results","Adenocarcinoma of the Pancreas","Drug: MK-1775|Drug: Gemcitabine|Radiation: Radiation Therapy","University of Michigan Hospital, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT02037230"
125,"Spectroscopy From Duodenum","Completed","No Results Available","Pancreatic Adenocarcinoma","Other: Spectroscopy device","Mayo Clinic Florida, Jacksonville, Florida, United States|The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States|Hôpital Erasme, Bruxelles, Brussels-Capital Region, Belgium|Università Cattolica del Sacro Cuore, Rome, Lazio, Italy","https://ClinicalTrials.gov/show/NCT01753479"
126,"EUS-guided Laser Ablation in Pancreatic Adenocarcinoma","Terminated","No Results Available","Pancreatic Adenocarcinoma|Pancreas Cancer","Device: EUS-guided laser ablation","Fondazione Policlinico Universitario Agostino Gemelli, Roma, RM, Italy|Universita' Cattolica del Sacro Cuore, Rome, Italy","https://ClinicalTrials.gov/show/NCT03784417"
127,"Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Other: MRIs with and without intravenous contrast (up to 2)","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02775786"
128,"FOLFIRINOX + 9-Ing-41 + Losartan In Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma Metastatic","Drug: FOLFIRNINOX|Drug: Losartan|Drug: 9-ING-41","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT05077800"
129,"Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma|Interventional Imaging","Device: NanoKnife","CHU Poitiers, Poitiers, France","https://ClinicalTrials.gov/show/NCT03105921"
130,"Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Metastatic Colorectal Cancer|Colorectal Adenocarcinoma|Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer","Drug: Durvalumab|Biological: CV301|Drug: Capecitabine|Drug: Bevacizumab","Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT03376659"
131,"A Pilot Study of IRE for Resectable Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Adenocarcinoma Resectable","Procedure: Irreversible Electroporation","University of Saskatchewan, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT03337997"
132,"EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemcitabine","Digestive Disease Research Center, Shariati ospital, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT01834170"
133,"Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Adenocarcinoma","Other: Data record","Damien JOLLY, Reims, France","https://ClinicalTrials.gov/show/NCT04406571"
134,"A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid","Centro Ricerche Cliniche, Verona, Italy","https://ClinicalTrials.gov/show/NCT03528785"
135,"PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Other: Quality of live questionnaires|Other: Optional translational project","HELIOS Klinikum Bad Saarow, Bad Saarow, Germany|Institute for Clinical Cancer Research Krankenhaus Nordwest, Frankfurt, Germany|Marien Hospital Herne, Herne, Germany|BAG Innere Medizin - Hämatologie - Onkologie, Regensburg, Germany|Elblandklinikum Riesa, Riesa, Germany","https://ClinicalTrials.gov/show/NCT04119362"
136,"Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma","Genetic: Invitae Multi-Cancer Panel ®","Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico","https://ClinicalTrials.gov/show/NCT05305001"
137,"Second Line Chemotherapy for Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: FOLFIRI","A.O. Treviglio-Caravaggio, P.le Ospedale n1, Treviglio, Bergamo, Italy|Azienda Ospedaliera ""Di Liegro"", Gaeta, Latina, Italy|A.O. Ospedale S.Paolo, Milano, MI, Italy|A.O. S.Salvatore, Pesaro, PS, Italy|Ospedale Morelli, Sondalo, SO, Italy|Ospedali Riuniti Umberto I - GM Lancisi-G Salesi, Ancona, Italy|Ospedali Riuniti, Largo Barozzi, 1, Bergamo, Italy|Fondazione Poliambulanza, Via Bissolati 57, Brescia, Italy|A.O. Carlo Poma - Via Albertoni, 1, Mantova, Italy","https://ClinicalTrials.gov/show/NCT01543412"
138,"S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery","Active, not recruiting","Has Results","Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma","Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Drug: Irinotecan Hydrochloride|Drug: Oxaliplatin|Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Procedure: Pancreatectomy","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Regional Hospital, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|University of Arizona Cancer Center at Saint Joseph's, Phoenix, Arizona, United States|University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Sutter Auburn Faith Hospital, Auburn, California, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States|Kaiser Permanente-Bellflower, Bellflower, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Sutter Davis Hospital, Davis, California, United States|Epic Care-Dublin, Dublin, California, United States|Bay Area Breast Surgeons Inc, Emeryville, California, United States|Epic Care Partners in Cancer Care, Emeryville, California, United States|Kaiser Permanente-Fontana, Fontana, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Palo Alto Medical Foundation-Fremont, Fremont, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|Kaiser Permanente - Harbor City, Harbor City, California, United States|Kaiser Permanente-Irvine, Irvine, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Kaiser Permanente-Cadillac, Los Angeles, California, United States|Contra Costa Regional Medical Center, Martinez, California, United States|Memorial Medical Center, Modesto, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States|Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States|USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States|Sutter Cancer Research Consortium, Novato, California, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Kaiser Permanente - Panorama City, Panorama City, California, United States|Keck Medical Center of USC Pasadena, Pasadena, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Kaiser Permanente-Riverside, Riverside, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|University of California San Diego, San Diego, California, United States|Kaiser Permanente-San Diego Mission, San Diego, California, United States|Kaiser Permanente-San Diego Zion, San Diego, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Marcos, San Marcos, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser San Rafael-Gallinas, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Kaiser Permanente-Woodland Hills, Woodland Hills, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Mountain Blue Cancer Care Center, Golden, Colorado, United States|Grand Valley Oncology, Grand Junction, Colorado, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Christiana Gynecologic Oncology LLC, Newark, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|Nanticoke Memorial Hospital, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States|Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida, United States|UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida, United States|The Watson Clinic, Lakeland, Florida, United States|Jackson Memorial Hospital-Holtz Children's Hospital, Miami, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States|UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States|Cleveland Clinic-Weston, Weston, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Hawaii Oncology Inc-Pali Momi, 'Aiea, Hawaii, United States|Pali Momi Medical Center, 'Aiea, Hawaii, United States|The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii, United States|Hawaii Cancer Care Inc-POB II, Honolulu, Hawaii, United States|Hawaii Oncology Inc-POB I, Honolulu, Hawaii, United States|Island Urology, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States|Hawaii Oncology Inc-Kuakini, Honolulu, Hawaii, United States|Kuakini Medical Center, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Mountain States Tumor Institute-Twin Falls, Twin Falls, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Garneau, Stewart C MD (UIA Investigator), Moline, Illinois, United States|Spector, David MD (UIA Investigator), Moline, Illinois, United States|Trinity Medical Center, Moline, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Radiation Oncology of Northern Illinois, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Cancer Care Specialists of Illinois-Swansea, Swansea, Illinois, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Deaconess Clinic Downtown, Evansville, Indiana, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, United States|Woodland Cancer Care Center, Michigan City, Indiana, United States|Chancellor Center for Oncology, Newburgh, Indiana, United States|Reid Health, Richmond, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|Constantinou, Costas L MD (UIA Investigator), Bettendorf, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Coffeyville Regional Medical Center, Coffeyville, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Saint Catherine Hospital, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|Saint Rose Ambulatory and Surgery Center, Great Bend, Kansas, United States|Hays Medical Center, Hays, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|University of Kansas Cancer Center-West, Kansas City, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Kansas Institute of Medicine Cancer and Blood Center, Lenexa, Kansas, United States|Minimally Invasive Surgery Hospital, Lenexa, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Olathe Medical Center, Olathe, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Via Christi Hospital-Pittsburg, Pittsburg, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|Saint Francis Hospital and Medical Center - Topeka, Topeka, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Baptist Health Corbin, Corbin, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Oncology Hematology Care Inc-Crestview, Crestview Hills, Kentucky, United States|Hardin Memorial Hospital, Elizabethtown, Kentucky, United States|Baptist Health Lexington, Lexington, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Saint Joseph London, London, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Baptist Health Louisville, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|Jewish Hospital Medical Center Northeast, Louisville, Kentucky, United States|Baptist Health Madisonville/Merle Mahr Cancer Center, Madisonville, Kentucky, United States|Baptist Health Paducah, Paducah, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|Ochsner Health Center-Summa, Baton Rouge, Louisiana, United States|Medical Center of Baton Rouge, Baton Rouge, Louisiana, United States|Ochsner Medical Center Kenner, Kenner, Louisiana, United States|University Health-Conway, Monroe, Louisiana, United States|Louisiana State University Health Science Center, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Harold Alfond Center for Cancer Care, Augusta, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|Penobscot Bay Medical Center, Rockport, Maine, United States|Frederick Memorial Hospital, Frederick, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Winchester Hospital, Winchester, Massachusetts, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Beaumont Hospital - Farmington Hills, Farmington Hills, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|William Beaumont Hospital-Grosse Point, Grosse Pointe, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Monroe Cancer Center, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|Michigan Cancer Specialists, Roseville, Michigan, United States|Oakland Colon and Rectal Association, Royal Oak, Michigan, United States|Cancer Care Associates PC, Royal Oak, Michigan, United States|Comprehensive Medical Center PLLC, Royal Oak, Michigan, United States|Hematology Oncology Consultants PC, Royal Oak, Michigan, United States|Oakland Medical Group, Royal Oak, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Premier Hematology Oncology Care, Sterling Heights, Michigan, United States|Mitchell Folbe MD PC, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Michigan Institute of Urology-Town Center, Troy, Michigan, United States|Claudia BR Herke MD PC, Troy, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Hematology Oncology Consultants PC-Troy, Troy, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Lake Region Healthcare Corporation-Cancer Care, Fergus Falls, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States|Fairview Maple Grove Medical Center, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Essentia Health Virginia Clinic, Virginia, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States|Baptist Cancer Center-Grenada, Grenada, Mississippi, United States|Hattiesburg Clinic - Hematology/Oncology Clinic, Hattiesburg, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, United States|Cox Cancer Center Branson, Branson, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Truman Medical Center, Kansas City, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States|The University of Kansas Cancer Center-South, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|The University of Kansas Cancer Center-North, Kansas City, Missouri, United States|The University of Kansas Cancer Center-Lee's Summit, Lee's Summit, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|Heartland Hematology and Oncology, Kearney, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Hematology and Oncology Consultants PC, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Norris Cotton Cancer Center-Manchester, Manchester, New Hampshire, United States|Norris Cotton Cancer Center-Nashua, Nashua, New Hampshire, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|Inspira Medical Center Woodbury, Woodbury, New Jersey, United States|Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Memorial Medical Center - Las Cruces, Las Cruces, New Mexico, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, United States|Montefiore Medical Center-Einstein Campus, Bronx, New York, United States|Montefiore Medical Center-Weiler Hospital, Bronx, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, United States|Glens Falls Hospital, Glens Falls, New York, United States|Orange Regional Medical Center, Middletown, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|University of Rochester, Rochester, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Hematology Oncology Associates of Central New York-Onondaga Hill, Syracuse, New York, United States|Randolph Hospital, Asheboro, North Carolina, United States|AdventHealth Infusion Center Asheville, Asheville, North Carolina, United States|Cone Health Cancer Center at Alamance Regional, Burlington, North Carolina, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|AdventHealth Hendersonville, Hendersonville, North Carolina, United States|Onslow Memorial Hospital, Jacksonville, North Carolina, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States|Vidant Oncology-Kinston, Kinston, North Carolina, United States|Cape Fear Cancer Specialists-Leland, Leland, North Carolina, United States|Cone Heath Cancer Center at Mebane, Mebane, North Carolina, United States|Annie Penn Memorial Hospital, Reidsville, North Carolina, United States|Cape Fear Cancer Specialists, Wilmington, North Carolina, United States|New Hanover Regional Medical Center/Zimmer Cancer Center, Wilmington, North Carolina, United States|Southeast Clinical Oncology Research Consortium NCORP, Winston-Salem, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States|Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States|Miami Valley Hospital South, Centerville, Ohio, United States|Geauga Hospital, Chardon, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Oncology Hematology Care Inc-Eden Park, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Mercy West, Cincinnati, Ohio, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Oncology Hematology Care Inc - Anderson, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Blue Ash, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Mount Carmel East Hospital, Columbus, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio, United States|Miami Valley Hospital North, Dayton, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Delaware Radiation Oncology, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Mercy Cancer Center-Elyria, Elyria, Ohio, United States|Oncology Hematology Care Inc-Healthplex, Fairfield, Ohio, United States|Armes Family Cancer Center, Findlay, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Orion Cancer Care, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Dayton Physicians LLC-Atrium, Franklin, Ohio, United States|Dayton Physicians LLC-Wayne, Greenville, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Cleveland Clinic Cancer Center Independence, Independence, Ohio, United States|Greater Dayton Cancer Center, Kettering, Ohio, United States|First Dayton Cancer Care, Kettering, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, United States|Cleveland Clinic Cancer Center Mansfield, Mansfield, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|OhioHealth Marion General Hospital, Marion, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States|UH Seidman Cancer Center at Landerbrook Health Center, Mayfield Heights, Ohio, United States|UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States|UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights, Ohio, United States|Dayton Physicians LLC-Signal Point, Middletown, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|University Hospitals Parma Medical Center, Parma, Ohio, United States|Mercy Health Perrysburg Cancer Center, Perrysburg, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|UH Seidman Cancer Center at Firelands Regional Medical Center, Sandusky, Ohio, United States|Dayton Physicians LLC-Wilson, Sidney, Ohio, United States|Springfield Regional Cancer Center, Springfield, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio, United States|ProMedica Flower Hospital, Sylvania, Ohio, United States|The Toledo Hospital/Toledo Children's Hospital, Toledo, Ohio, United States|Mercy Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Dayton Physicians LLC-Upper Valley, Troy, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|University Hospitals Sharon Health Center, Wadsworth, Ohio, United States|South Pointe Hospital, Warrensville Heights, Ohio, United States|University Pointe, West Chester, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|UH Seidman Cancer Center at Saint John Medical Center, Westlake, Ohio, United States|UHHS-Westlake Medical Center, Westlake, Ohio, United States|Cleveland Clinic Wooster Family Health and Surgery Center, Wooster, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Oncology and Hematology Care Southeast, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Kaiser Permanente Northwest, Portland, Oregon, United States|Salem Hospital, Salem, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Abington Memorial Hospital, Abington, Pennsylvania, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States|Lewistown Hospital, Lewistown, Pennsylvania, United States|Riddle Memorial Hospital, Media, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, United States|Community Medical Center, Scranton, Pennsylvania, United States|Geisinger Medical Oncology-Selinsgrove, Selinsgrove, Pennsylvania, United States|Grand View Hospital, Sellersville, Pennsylvania, United States|Geisinger Medical Group, State College, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Roper Hospital, Charleston, South Carolina, United States|Charleston Oncology - Roper, Charleston, South Carolina, United States|Lowcountry Hematology Oncology PA-North Charleston, Charleston, South Carolina, United States|Bon Secours Saint Francis Hospital, Charleston, South Carolina, United States|Charleston Oncology - Saint Francis, Charleston, South Carolina, United States|Lowcountry Hematology Oncology PA-West Ashley, Charleston, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Greenville Health System Cancer Institute-Andrews, Greenville, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Lowcountry Hematology Oncology PA-Mount Pleasant, Mount Pleasant, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Prisma Health Cancer Institute - Spartanburg, Spartanburg, South Carolina, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Wellmont Bristol Regional Medical Center, Bristol, Tennessee, United States|Wellmont Medical Associates Oncology and Hematology-Bristol, Bristol, Tennessee, United States|Memorial Hospital, Chattanooga, Tennessee, United States|Integrity Oncology PLLC-Collierville, Collierville, Tennessee, United States|Vanderbilt-Ingram Cancer Center Cool Springs, Franklin, Tennessee, United States|Pulmonary Medicine Center of Chattanooga-Hixson, Hixson, Tennessee, United States|Wellmont Medical Associates Oncology and Hematology-Johnson City, Johnson City, Tennessee, United States|Regional Cancer Center at Indian Path Community Hospital, Kingsport, Tennessee, United States|Wellmont Holston Valley Hospital and Medical Center, Kingsport, Tennessee, United States|Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States|Baptist Memorial Hospital for Women, Memphis, Tennessee, United States|Family Cancer Center-Memphis, Memphis, Tennessee, United States|Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, United States|Meharry Medical College, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Memorial GYN Plus, Ooltewah, Tennessee, United States|Texas Oncology-Austin Midtown, Austin, Texas, United States|Texas Oncology - Central Austin Cancer Center, Austin, Texas, United States|Texas Oncology - South Austin Cancer Center, Austin, Texas, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Parkland Memorial Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|Ben Taub General Hospital, Houston, Texas, United States|Texas Oncology - Round Rock Cancer Center, Round Rock, Texas, United States|Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas, United States|University Hospital, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Farmington Health Center, Farmington, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|South Jordan Health Center, South Jordan, Utah, United States|Central Vermont Medical Center/National Life Cancer Treatment, Berlin, Vermont, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|Norris Cotton Cancer Center-North, Saint Johnsbury, Vermont, United States|Wellmont Medical Associates-Bristol, Bristol, Virginia, United States|Bon Secours Memorial Regional Medical Center, Mechanicsville, Virginia, United States|Bon Secours Saint Francis Medical Center, Midlothian, Virginia, United States|Southwest VA Regional Cancer Center, Norton, Virginia, United States|Bon Secours Saint Mary's Hospital, Richmond, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, United States|Swedish Cancer Institute-Eastside Oncology Hematology, Bellevue, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Minor and James Medical PLLC, Seattle, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Kaiser Permanente Washington, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|Rockwood Clinic Cancer Treatment Center-Valley, Spokane Valley, Washington, United States|Rockwood Cancer Treatment Center-DHEC-Downtown, Spokane, Washington, United States|Rockwood North Cancer Treatment Center, Spokane, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|West Virginia University Charleston Division, Charleston, West Virginia, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Duluth Clinic Ashland, Ashland, Wisconsin, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, United States|HSHS Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States|Aurora Health Center-Fond du Lac, Fond Du Lac, Wisconsin, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States|Bellin Memorial Hospital, Green Bay, Wisconsin, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Marshfield Medical Center, Marshfield, Wisconsin, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, United States|Lakeview Medical Center-Marshfield Clinic, Rice Lake, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States|Ascension Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, United States|Aurora Medical Center in Summit, Summit, Wisconsin, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States|Aurora Cancer Care-Waukesha, Waukesha, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, United States|Ascension Saint Clare's Hospital, Weston, Wisconsin, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, United States|Aspirus UW Cancer Center, Wisconsin Rapids, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States|Big Horn Basin Cancer Center, Cody, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT02562716"
139,"Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)","Recruiting","No Results Available","Pancreas Adenocarcinoma","Genetic: Analysis of genetic mutations and the gene expression profile of lung metastasis and primary neoplasia|Other: Radiomics analysis on TAC imaging at diagnosis of lung metastasis and, if possible, of the primary tumor","IRCCS San Raffaele Diagnostic Radiology Unit, Milan, Italy|IRCCS San Raffaele Medical Oncology Unit, Milan, Italy|IRCCS San Raffaele Pathological Anatomy Unit, Milan, Italy|IRCCS San Raffaele Thoracic Surgery Unit, Milan, Italy","https://ClinicalTrials.gov/show/NCT04435067"
140,"KEBI-Cyto Study - Use of the Biocartis Idylla","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Lung Cancer","Diagnostic Test: Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF mutations in liquid based cytology and blood plasma samples","Royal Cornwall Hospital, Truro, Cornwall, United Kingdom","https://ClinicalTrials.gov/show/NCT04236102"
141,"Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Chemotherapy|Radiation: Stereotactic Body Radiation Therapy","Mayo Clinic in Florida, Jacksonville, Florida, United States","https://ClinicalTrials.gov/show/NCT04975516"
142,"Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Gemcitabine|Drug: Nab-paclitaxel","Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT04115163"
143,"Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Cancer|Adenocarcinoma of the Pancreas|Adenocarcinoma","Drug: Motixafortide|Drug: Cemiplimab|Drug: Gemcitabine|Drug: Nab paclitaxel","Columbia University Irving Medical Center, New York, New York, United States|Brown University, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT04543071"
144,"EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment","Completed","No Results Available","Metastatic Pancreas Cancer|Locally Advanced Pancreatic Cancer|Pancreatic Adenocarcinoma","Drug: EndoTAG-1|Drug: Gemcitabine","Compassionate Cancer Care Medical Group, Inc, Corona, California, United States|Emory University Hospital, Atlanta, Georgia, United States|John B. Amos Cancer Center / IACT Health, Columbus, Georgia, United States|Orchard Healthcare Research (OHR) Inc., Skokie, Illinois, United States|Investigator Clinical Research Centers of Indiana, Indianapolis, Indiana, United States|Cotton O'Neil Cancer Center (Stormont-Vail Cancer Center), Topeka, Kansas, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|North Mississippi Hematology & Oncology Associates, Ltd., Tupelo, Mississippi, United States|Southeast Nebraska Cancer Center (SNCC) - Central Clinic - Main Clinic, Lincoln, Nebraska, United States|Guthrie - Corning Hospital - Guthrie Cancer Center, Sayre, Pennsylvania, United States|Charleston Cancer Center, North Charleston, South Carolina, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States|Scott & White Vasicek Cancer Treatment Center, Temple, Texas, United States|Renovatioclinical, The Woodlands, Texas, United States|University of Virginia Hospital, Charlottesville, Virginia, United States|CHU Angers, Angers, France|CHRU - Besançon, Besançon, France|Hopital Haut Leveque, Bordeaux, France|CHRU Brest - Hôpital Morvan, Brest, France|Centre Hospitalier de Cholet, Cholet, France|Centre Georges François Leclerc, Dijon, France|Centre Hospitalier Départemental, La Roche-sur-Yon, France|Hôpital Privé Jean Mermoz, Lyon, France|La Timone, Marseille, France|Institut de Cancérologie de Lorraine, Nancy, France|Centre Antoine-Lacassagne, Nice, France|Hopital La Pitié Salpétrière, Paris, France|CH Saint Jean, Perpignan, France|Centre Eugène Marquis, Rennes, France|Clinique Sainte Anne/Strasbourg Oncologie Leberale, Strasbourg, France|Dél-pesti Centrumkórház - Országos Hematológia és Infektológia Intézet, Budapest, Hungary|Magyar Honvédség Egészségügyi Központ, Budapest, Hungary|Országos Onkológiai Intézet, Budapest, Hungary|Bács-Kiskun Megyei Kórház Onkoradiológiai Központ, Kecskemét, Hungary|Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház, Miskolc, Hungary|Pécsi Tudomány Egyetem Onkoterápiás Intézet, Pécs, Hungary|Oncology Department, Hillel Yafe MC, Hadera, Israel|Rambam Health Center, Haifa, Israel|Meir Medical Center, Kfar Sava, Israel|Rabin MC, Petach Tikva, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Chungnam National University Hospital, Daejeon, Korea, Republic of|National Cancer Center, Goyang-si, Korea, Republic of|Inha University Hospital, Incheon-si, Korea, Republic of|Chonnam National University Hwasun Hospital, Jeongnam, Korea, Republic of|CHA Bundang Medical Center, Seongnam, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of|Arkhangelsk Clinical Oncological Dispensary, Arkhangel'sk, Russian Federation|Kursk State Clinical Oncology Dispensary, Kursk, Russian Federation|Federal State Budgetary Scientific Institution ""Russian Oncological Scientific Center named after N.N.Blokhin"", Moscow, Russian Federation|Private clinnic ""Medicine 24/7"", Moscow, Russian Federation|Budget Institution of Healthcare of Omsk Region ""Clinical Oncology Dispensary"", Omsk, Russian Federation|State Budget Healthcare Institution ""Orenburg Region Clinical Oncological Dispensary"", Orenburg, Russian Federation|State Budgetary Healthcare Institution Leningrad Regional Oncology Center, Saint Petersburg, Russian Federation|Changhua Christian Hospital, Changhua, Taiwan|Chang Gung Medical Foundation - Kaohsiung Branch, Kaohsiung, Taiwan|E-Da Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|Mackay Memorial Hospital-Taipei Branch, Taipei, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Tri-Service General Hospital (TSGH), Taipei, Taiwan|Chang Gung Medical Foundation - Linkou Branch, Taoyuan, Taiwan","https://ClinicalTrials.gov/show/NCT03126435"
145,"Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas","Terminated","Has Results","Pancreatic Cancer|Adenocarcinoma of the Pancreas","Radiation: Radiation therapy|Drug: 5-FU|Drug: Vorinostat","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00948688"
146,"Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma Resectable|Pancreatic Adenocarcinoma Locally Advanced|Pancreatic Adenocarcinoma Metastatic","Drug: Gemcitabine|Drug: Abraxane","Antwerp University Hospital (UZA), Edegem, Antwerpen, Belgium|Erasme University Hospital (ULB), Brussels, Belgium","https://ClinicalTrials.gov/show/NCT01715142"
147,"Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Adenocarcinoma",,"Faculty of Medicine, Sohag University, Sohag, Egypt","https://ClinicalTrials.gov/show/NCT05228808"
148,"Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Resectable Pancreatic Ductal Adenocarcinoma","Drug: Fluorouracil|Drug: Irinotecan|Drug: Irinotecan Hydrochloride|Drug: Leucovorin|Drug: Leucovorin Calcium|Biological: Nivolumab|Drug: Oxaliplatin|Procedure: Therapeutic Conventional Surgery","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT03970252"
149,"NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma","Device: NanoKnife Low Energy Direct Current (LEDC) System Ablation","Policlinico ""G.B. Rossi"", University of Verona, Department of Surgery, Verona, Italy","https://ClinicalTrials.gov/show/NCT01369420"
150,"Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer","Completed","Has Results","Pancreatic Adenocarcinoma","Drug: Pimasertib|Drug: Gemcitabine|Drug: Placebo","For Recruiting Locations in the United States, please Contact U.S. Medical Information, Rockland, Massachusetts, United States|For Recruiting Locations outside the United States, Please contact the Merck KGaA Communication Center, Darmstadt, Germany","https://ClinicalTrials.gov/show/NCT01016483"
151,"A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers","Recruiting","No Results Available","Pancreatic Adenocarcinoma",,"The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT03840460"
152,"SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Refractory Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Biological: Nivolumab|Radiation: Radiation Therapy|Drug: TLR9 Agonist SD-101","University of California Davis Comprehensive Cancer Center, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT04050085"
153,"A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Nab-Paclitaxel|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Leucovorin|Drug: Fluorouracil|Drug: Atezolizumab|Drug: Cobimetinib|Drug: PEGPH20|Drug: BL-8040|Drug: Selicrelumab|Drug: Bevacizumab|Drug: RO6874281|Drug: AB928|Drug: Tiragolumab|Drug: Tocilizumab","City of Hope Comprehensive Cancer Center, Duarte, California, United States|Helen Diller Fam Comp Can Ctr, San Francisco, California, United States|Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States|Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States|Uni of Chicago Medical Center; Room M454, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Morristown Medical Center, Morristown, New Jersey, United States|Columbia University, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Oregon Health and Science University, Portland, Oregon, United States|Hillman Cancer Center;Medical Oncology, Pittsburgh, Pennsylvania, United States|Sarah Cannon Cancer Center, Germantown, Tennessee, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Charite - Campus Virchow-Klinikum, Berlin, Germany|Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung, Essen, Germany|National Cancer Center Hospital East, Chiba, Japan|Kanagawa Cancer Center, Kanagawa, Japan|National Cancer Center Hospital, Tokyo, Japan|Seoul National University Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hosp. G. U Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain","https://ClinicalTrials.gov/show/NCT03193190"
154,"The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Procedure: No Periadventitial dissection of the SMA|Procedure: Periadventitial dissection of the SMA","University Hospitals Birmingham NHS Foundation Trust, Birmingham, County (Optional), United Kingdom","https://ClinicalTrials.gov/show/NCT04902352"
155,"Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: GS|Drug: GnP","Takehiro Okabayashi, Kochi, Japan","https://ClinicalTrials.gov/show/NCT05268692"
156,"Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma","Withdrawn","No Results Available","Pancreatic Adenocarcinoma","Drug: FOLFIRI|Drug: FOLFIRINOX|Device: TriSalus Infusion System","Roger Williams Medical Center, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT04270929"
157,"Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.","Not yet recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Nab paclitaxel|Drug: Gemcitabine|Drug: mFOLFIRINOX",,"https://ClinicalTrials.gov/show/NCT04835064"
158,"Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study","Not yet recruiting","No Results Available","Pancreatic Adenocarcinoma","Other: Observationnal cohort",,"https://ClinicalTrials.gov/show/NCT04814251"
159,"Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma","Procedure: Fluorescence Imaging|Biological: Panitumumab|Drug: Panitumumab-IRDye800","Stanford University, School of Medicine, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT03384238"
160,"Selective Transvenous Chemoembolization of Primary Pancreatic Tumors","Withdrawn","No Results Available","Pancreatic Adenocarcinoma","Drug: Retrograde venous infusion of gemcitabine/lipiodol","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03865563"
161,"Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study","Not yet recruiting","No Results Available","Pancreatic Adenocarcinoma","Procedure: Anesthesia Procedure|Drug: General Anesthesia Procedure|Procedure: Resection","Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT04992507"
162,"Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: nab paclitaxel|Drug: Onivyde|Drug: Leucovorin|Drug: 5-fu","Virginia mason medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03703063"
163,"Pancreatic Cancer Biomarker Study","Recruiting","No Results Available","Pancreatic Adenocarcinoma",,"Mercy Health Saint Mary's Hospital, Grand Rapids, Michigan, United States","https://ClinicalTrials.gov/show/NCT04143152"
164,"Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreas Adenocarcinoma","Drug: 5FU|Drug: nab-paclitaxel|Drug: bevacizumab|Drug: calcium leucovorin|Drug: oxaliplatin","Northwestern University, Chicago, Illinois, United States|Tufts - New England Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Karmanos Cancer Center Wayne State University, Detroit, Michigan, United States|Cornell University Weill Medical College, New York, New York, United States|Gibbs Cancer Center and Research Institute, Spartanburg, South Carolina, United States|Virginia Mason Cancer Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02620800"
165,"Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Adenocarcinoma",,"Ospedale San Raffaele, Milano, Italy","https://ClinicalTrials.gov/show/NCT03673423"
166,"Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)","Terminated","No Results Available","Pancreatic Adenocarcinoma","Drug: Abraxane|Drug: Gemcitabine","Addenbrookes Hospital, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT02124369"
167,"Stromal TARgeting for PAncreatic Cancer (STAR_PAC)","Completed","No Results Available","Pancreatic Adenocarcinoma","Drug: ATRA|Drug: Gemcitabine|Drug: Nab-paclitaxel","Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Barts and The London NHS, St Bartholomew's Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College NHS Trust, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03307148"
168,"Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer","Terminated","No Results Available","Pancreatic Adenocarcinoma","Radiation: neoadjuvant RTx|Procedure: Surgery","Klinikum rechts der Isar, Technische Universität München, Munich, Germany","https://ClinicalTrials.gov/show/NCT01419002"
169,"Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery","Terminated","Has Results","Pancreatic Adenocarcinoma","Drug: Cetuximab-IRDye800|Drug: Cetuximab","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT02736578"
170,"Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Adenocarcinoma of the Pancreas|Pancreatic Cancer|Advanced Cancer|Digestive System Neoplasms|Pancreatic Neoplasms|Endocrine Gland Neoplasms|Digestive System Diseases|Endocrine System Diseases|Pancreatic Diseases","Dietary Supplement: Ocoxin-Viusid®","""Hermanos Ameijeiras"" Surgical Clinical Hospital, La Habana, Cuba","https://ClinicalTrials.gov/show/NCT03717298"
171,"Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study","Terminated","Has Results","Pancreatic Adenocarcinoma|Poorly Differentiated Malignant Neoplasm|Resectable Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Undifferentiated Pancreatic Carcinoma","Drug: Irinotecan Hydrochloride|Drug: Oxaliplatin|Drug: Leucovorin Calcium|Drug: Fluorouracil|Other: Laboratory Biomarker Analysis","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02345460"
172,"A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma","Genetic: VCN-01|Drug: Gemcitabine|Drug: Abraxane®","Institut Català d'Oncologia, L'Hospitalet De Llobregat, Barcelona, Spain|Centro Integral Oncológico Clara Campal, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02045589"
173,"Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Paclitaxel","CH de Bayeux, Bayeux, France|CH Simone Veil, Beauvais, France|CHU Jean Minjoz, Besançon, France|Hôpital Duchenne, Boulogne-sur-Mer, France|CH du Cotentin, Cherbourg, France|Centre Georges François Leclerc, Dijon, France|Centre Léon Bérard, Lyon, France|Hospices civils de Lyon, Lyon, France|CHU La Timone, Marseille, France|Hôpital Européen de Marseille, Marseille, France|Hôpital Saint-Joseph, Marseille, France|Institut Paoli Calmettes, Marseille, France|Hôpital Nord Franche Comté, Montbéliard, France|Centre Antoine Lacassagne, Nice, France|Hôpital Saint-Louis, Paris, France|Institut Mutualiste Montsouris, Paris, France|Hôpital Pitié-Salpétrière, Paris, France|Institut Godinot, Reims, France|Centre Eugène Marquis, Rennes, France|CHU Rouen, Rouen, France|Institut Curie, Saint-Cloud, France|Institut de Cancérologie de l'Ouest, Saint-Herblain, France|Hôpital Broussais, Saint-Malo, France|CHU de Saint-Etienne, Saint-Étienne, France|Hôpital Trousseau, Tours, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT03943667"
174,"Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma","Not yet recruiting","No Results Available","Resectable Pancreatic Adenocarcinoma|Borderline Resectable Pancreatic Adenocarcinoma","Radiation: Stereotactic Ablative Body Radiotherapy (SABR)",,"https://ClinicalTrials.gov/show/NCT04915417"
175,"GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma|Esophageal Adenocarcinoma|Esophageal Squamous Cell Carcinoma|Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Triple Negative Breast Cancer|Castration-resistant Prostate Cancer|Microsatellite Stable Colorectal Cancer|Non-small Cell Lung Cancer|Small-cell Lung Cancer|Head and Neck Squamous Cell Carcinoma|Urothelial Carcinoma|Renal Cell Carcinoma|Hepatocellular Carcinoma","Drug: GB1275|Drug: nab-paclitaxel and gemcitabine|Drug: pembrolizumab","UCSF Medical Center at Mission Bay, San Francisco, California, United States|University of Colorado Hospital, Anschutz Cancer Pavilion (ACP), Aurora, Colorado, United States|Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|The Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States|The Royals Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT04060342"
176,"Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer","Terminated","No Results Available","Pancreatic Adenocarcinoma","Drug: Temsirolimus|Drug: Gemcitabine","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00593008"
177,"Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Cancer",,"Columbia University Irving Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01129167"
178,"Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Drug: NASOX","Hallym University Medical Center, Anyang, Gyeonggi, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04662112"
179,"Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B","Withdrawn","No Results Available","Adenocarcinoma of the Pancreas|Pancreas Cancer","Drug: CCX872-B","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT03778879"
180,"Scheduling Nab-paclitaxel With Gemcitabine","Completed","No Results Available","Pancreatic Adenocarcinoma Metastatic","Drug: Abraxane (nab-paclitaxel)|Drug: Gemcitabine","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom|Peterborough City Hospital, Peterborough, Cambridgeshire, United Kingdom|Ysbyty Gwynedd, Bangor, United Kingdom|Belfast City Hospital, Belfast, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|Bristol Haematology & Oncology Centre, Bristol, United Kingdom|Velindre Cancer Centre, Cardiff, United Kingdom|Colchester Hospital, Colchester, United Kingdom|University Hospitals Coventry & Warwickshire, Coventry, United Kingdom|Edinburgh Cancer Research Centre, Edinburgh, United Kingdom|The Beatson Oncology Centre, Glasgow, United Kingdom|The Royal Surrey County Hospital, Guildford, United Kingdom|St James' Institute of Oncology, Leeds, United Kingdom|Leicester Royal Infirmary, Leicester, United Kingdom|Clatterbridge Cancer Centre, Liverpool, United Kingdom|Barts Health NHS Trust, London, United Kingdom|Hammersmith Hospital, London, United Kingdom|The Royal Free Hospital, London, United Kingdom|University College London Hospital, London, United Kingdom|The Christie Hospital, Manchester, United Kingdom|Churchill Hospital, Oxford, United Kingdom|Weston Park Hospital, Sheffield, United Kingdom|Royal Cornwall Hospital, Truro, United Kingdom","https://ClinicalTrials.gov/show/NCT03529175"
181,"Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma","Recruiting","No Results Available","Cancer of Pancreas|Pancreas Adenocarcinoma|Resectable Pancreatic Cancer","Drug: Preoperative chemotherapy|Radiation: Preoperative radiotherapy","CNAO, Pavia, Italy","https://ClinicalTrials.gov/show/NCT03822936"
182,"Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer","Drug: Nab-Paclitaxel|Drug: Gemcitabine|Drug: Indoximod","Stanford University, Palo Alto, California, United States|Augusta University, Augusta, Georgia, United States|University of Kentucy, Lexington, Kentucky, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|The Vally Hospital, Paramus, New Jersey, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Greenville Health Systems, Greenville, South Carolina, United States|Gibbs Cancer Center and Research Institute, Spartanburg, South Carolina, United States|The West Clinic, Memphis, Tennessee, United States|Huntsman Cancer Center, Salt Lake City, Utah, United States|University of Vermont Medical Center, Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT02077881"
183,"Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer|Cancer of the Pancreas|Pancreas Adenocarcinoma","Device: MR-guided stereotactic body radiation therapy|Drug: Defactinib|Procedure: Tumor biopsy|Procedure: Research blood draw","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT04331041"
184,"Identify microRNAs in Cachexia in Pancreatic Carcinoma","Not yet recruiting","No Results Available","Resectable Pancreatic Adenocarcinoma","Other: Pancreatic cancer microRNA and messenger RNA expression.","Stephenson Cancer Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT05275075"
185,"Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma","Completed","No Results Available","Pancreatic Adenocarcinoma Metastatic","Drug: ERY001|Drug: Gemcitabine|Drug: 5-fluoro-uracil/oxaliplatin/leucovorin (folfox)","Saint Catherine Institute, Avignon, France|Institut de Cancerologie, Brest, France|Hopital Beaujon, Clichy, France|Hospital Henri Mondor, Creteil, France|Groupe Hospitalier Mutualiste Grenoble, Grenoble, France|Centre Hospitalier Departemental Vendee - Les Oudairies, La Roche-sur-Yon, France|Centre Oscar Lambret, Lille, France|Cnetre Leon Berard, Lyon, France|Institut Regional du Cancer-Montpellier Val d'Aurelle, Montpellier, France|Institute Mutualiste Montsouris, Paris, France|Hospital Saint Antoine, Paris, France|Hospital Pitie Salpetriere, Paris, France|CHU de Poitiers, Poitiers, France|CHU Reims, Reims, France|CHU Toulouse - Rangueil, Toulouse, France|CHU de Tours, Tours, France","https://ClinicalTrials.gov/show/NCT02195180"
186,"BATs Treatment for Pancreatic Cancer, Phase Ib/II","Recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma","Drug: EGFR BATs after standard of care chemo","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT03269526"
187,"Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Cancer","Radiation: Stereotactic Body Radiation Therapy|Radiation: Preoperative Fractionated Radiation Therapy and Chemotherapy","Froedtert Hospital & Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03704662"
188,"A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: capecitabine|Drug: gemcitabine|Drug: nab-paclitaxel","IRCCS S Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT01730222"
189,"Study of Proton Therapy in Adjuvant Pancreatic Cancer","Recruiting","No Results Available","Resected Pancreatic Adenocarcinoma","Drug: mFOLFIRINOX|Radiation: Proton beam radiation","Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT03885284"
190,"Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer","Recruiting","No Results Available","Untreated Resectable Pancreatic Adenocarcinoma|Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Adenocarcinoma","Drug: Paclitaxel protein bound|Drug: Gemcitabine|Drug: Cisplatin|Drug: Hydroxychloroquine","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT04669197"
191,"tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr","Recruiting","No Results Available","Pancreatic Adenocarcinoma Metastatic|Pancreatic Adenocarcinoma Recurrent","Drug: Decitabine 50 MG [Dacogen]","Irccs S. Raffaele - Milano, Milano, Italy|Istituto Nazionale Tumori Di Napoli Irccs Pascale, Napoli, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy|Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena, Rome, Italy|Policlinico A. Gemelli E C.I.C.- Policlinico Universitario A. Gemelli, Rome, Italy|Az.Osp.Universitaria Integrata Verona- Borgo Roma, Verona, Italy","https://ClinicalTrials.gov/show/NCT05360264"
192,"Pancreatic Adenocarcinoma Signature Stratification for Treatment","Recruiting","No Results Available","Pancreatic Cancer Metastatic|Pancreatic Ductal Adenocarcinoma|Advanced Pancreatic Cancer","Drug: Folfirinox|Drug: Gemcitabine/nab-paclitaxel","Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Northwell Health, New Hyde Park, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|BC Cancer Agency Vancouver, Vancouver, British Columbia, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04469556"
193,"Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer","Recruiting","No Results Available","Resectable Pancreatic Adenocarcinoma","Drug: HIPEC-gemcitabine","Hospital Universitario de Ciudad Real, HGUCR, Ciudad Real, Spain","https://ClinicalTrials.gov/show/NCT03251365"
194,"CTC Pancreatic Adenocarcinoma","Completed","No Results Available","Adenocarcinoma|Circulating Tumor Cells|Pancreatic Neoplasms","Drug: Desflurane","Kantonsspital St. Gallen, St. Gallen, Switzerland|Kantonsspital Winterthur, Winterthur, Switzerland|University Hospital Zurich, Zurich, Switzerland|Stadtspital Triemli, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT02335151"
195,"Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Epacadostat|Drug: Pembrolizumab|Biological: CRS-207|Drug: CY|Biological: GVAX","The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03006302"
196,"Intraoperative Radiation Therapy for Resectable Pancreatic Cancer","Active, not recruiting","No Results Available","Resectable Pancreatic Adenocarcinoma","Device: Intraoperative radiation therapy (IORT)","Gangnam Severance Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03273374"
197,"Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer","Withdrawn","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: CPI-613|Drug: Gemcitabine|Drug: Any non-gemcitabine chemotherapies or best supportive care","Eastchester Center for Cancer Care, Bronx, New York, United States|Temple Vasicek Cancer Treatment Center, Temple, Texas, United States","https://ClinicalTrials.gov/show/NCT01830322"
198,"Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients","Completed","No Results Available","Unresectable Pancreatic Adenocarcinoma","Device: wrist-worn accelerometer|Other: Auto-questionnaires","Chu Dijon Bourogne, Dijon, France","https://ClinicalTrials.gov/show/NCT03490604"
199,"GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab","Completed","Has Results","Previously Treated Metastatic Adenocarcinoma of the Pancreas","Biological: CRS-207|Drug: nivolumab|Biological: GVAX|Drug: CY","University of California, San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Providence Portland Medical Center, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02243371"
200,"Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Carcinoma Metastatic","Drug: Nab-paclitaxel 125 mg/m2 weeks 1,2,3/4|Drug: Gemcitabine 1000 weeks 1,2,3/4","Hospital General de Granollers, Granollers, Barcelona, Spain|Centre Hospitalari de Manresa, Manresa, Barcelona, Spain|Hospital Universitario de Cruces, Barakaldo, Gipuzkoa, Spain|Hospital Clinico Universitario Virgen de La Arrixaca, El Palmar, Murcia, Spain|Hospital Xeral de Vigo, Vigo, Pontevedra, Spain|Complejo Hospitalario Universitario de Canarias, San Cristóbal de La Laguna, Tenerife, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Infanta Cristina, Badajoz, Spain|Hospital Universitario Vall D'Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Ico Girona, Girona, Spain|Complejo Hospitalario de Jaén, Jaén, Spain|C. Hospitalario Universitario Insularmaterno-Infantil, Las Palmas de Gran Canaria, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Hm Sanchinarro, Madrid, Spain|Hospital Quirón Madrid, Madrid, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, Spain|Complejo Hospitalario Regional Virgen Macarena, Sevilla, Spain|Hospital Virgen Del Rocio, Sevilla, Spain","https://ClinicalTrials.gov/show/NCT02391662"
201,"p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Tetrahydrouridine|Drug: Decitabine","University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02847000"
202,"Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202)","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: BL-8040|Drug: Pembrolizumab|Drug: Chemotherapy of Onivyde","Mayo Clinic, Phoenix, Arizona, United States|Honor Health, Scottsdale, Arizona, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Massachusetts General Hospital (MGH), Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center (BIDMAC), Boston, Massachusetts, United States|DF/HCC, Boston, Massachusetts, United States|Karmanos Cancer Center, Wayne State University, Detroit, Michigan, United States|Washington University of St Louis, Saint Louis, Missouri, United States|Atlantic Medical Group, Morristown, New Jersey, United States|NYU Langone Health, New York, New York, United States|Cornell Medical College, New York, New York, United States|University of Rochester, Rochester, New York, United States|Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Rambam Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Rabin Medical Center, Petaẖ Tiqwa, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Sourasky Medical Center, Tel Aviv, Israel|Samsung Medical Center, Seoul, Korea, Republic of|Hospital General Universitario de Elche, Alicante, Spain|Vall d'Hebron, Barcelona, Spain|Gregorio Marañón Hospital, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|La Paz, Madrid, Spain|Hospitalario Universitario de Ourense, Ourense, Spain|Clinic Universidad de Navarra, Pamplona, Spain|University Hospital of Salamanca, Salamanca, Spain|Marques de Valdecilla de Santander, Santander, Spain|Hospital Universitari i Politècnic La Fe,, Valencia, Spain","https://ClinicalTrials.gov/show/NCT02826486"
203,"Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer","Terminated","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: Regorafenib|Drug: Gemcitabine Hydrochloride","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02383433"
204,"Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer","Completed","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Taxotere|Drug: Xeloda|Drug: Cisplatin|Drug: Irinotecan","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02324543"
205,"FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer","Completed","Has Results","Metastatic Pancreatic Adenocarcinoma","Drug: Ipilimumab|Biological: Vaccine|Drug: FOLFIRINOX","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01896869"
206,"Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas","Terminated","No Results Available","Adenocarcinoma of the Pancreas|Locally Advanced|Unresectable","Drug: Gemcitabine|Drug: AMG 479|Drug: Placebo","Research Site, San Francisco, California, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Salzburg, Austria|Research Site, Steyer, Austria|Research Site, Wien, Austria|Research Site, Edegem, Belgium|Research Site, Haine St. Paul - La Louviere, Belgium|Research Site, Hradec Kralove, Czech Republic|Research Site, Olomouc, Czech Republic|Research Site, Praha 10, Czech Republic|Research Site, Herlev, Denmark|Research Site, Hamburg, Germany|Research Site, Budapest, Hungary|Research Site, Debrecen, Hungary|Research Site, Miskolc, Hungary|Research Site, Szolnok, Hungary|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Lodz, Poland|Research Site, Poznan, Poland|Research Site, Warszawa, Poland|Research Site, Lisboa, Portugal|Research Site, Porto, Portugal|Research Site, Chelyabinsk, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Saint Petersburg, Russian Federation|Research Site, Samara, Russian Federation|Research Site, Barcelona, CataluÃ±a, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Guys Hospital, United Kingdom|Research Site, London, United Kingdom|Research Site, Preston, United Kingdom","https://ClinicalTrials.gov/show/NCT01318642"
207,"Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma","Unknown status","No Results Available","Adenocarcinomas of the Pancreas","Drug: Gemcitabine","University Hospital, Tübingen, Baden-Württemberg, Germany","https://ClinicalTrials.gov/show/NCT02863471"
208,"Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer","Drug: Bethanechol|Drug: Gemcitabine|Drug: nab-paclitaxel","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05241249"
209,"Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: ON 01910.Na|Drug: Gemcitabine","UCSD Moores Cancer Center, La Jolla, California, United States|Desert Comprehensive Cancer Center, Palm Springs, California, United States|Pacific Cancer Care, Salinas, California, United States|Premiere Oncology, Santa Monica, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Kaiser Permanente Colorado, Denver, Colorado, United States|Poudre Valley Cancer Center of the Rockies, Fort Collins, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|University of Kansas Cancer Center, Westwood, Kansas, United States|UMASS Medical School, Worcester, Massachusetts, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|New York University Langone Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|Hendersonville Hematology and Oncology at Pardee, Hendersonville, North Carolina, United States|Rex Cancer Center UNC Healthcare, Raleigh, North Carolina, United States|St. Alexis Medical Center-Mid Dakota Clinic PC, Bismarck, North Dakota, United States|University of Cincinnati Cancer Center, Cincinnati, Ohio, United States|Kaiser Permanente NW, Portland, Oregon, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Medical University of South Carolina - Hollings Cancer Center, Charleston, South Carolina, United States|McLeod Regional Medical Center, Florence, South Carolina, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|Semmelweis University Department of Diagnostic Radiology and Oncotherapy, Budapest, Hungary|Semmelweis University, 3rd Department of Internal Medicine, Budapest, Hungary|Hetenyi Geza Hospital 5004, Szolnok, Hungary, Szolnok, Hungary|Basavatarakam Indo-American Cancer Hospital, Hyderabad, Andhra Pradesh, India|Regional Cancer Center, Thiruvananthapuram, Kerala, India|Jaslok Hospital & Research Centre, Mumbai, Maharashtra, India|Shatabdi Superspeciality Hospital, Nashik, Maharashtra, India|Ruby Hall Clinic, Pune, Maharashtra, India|Lifeline Multispeciality Hospitals, Chennai, Tamil Nadu, India|State Budget Medical Institution of the Arkhangelsk Region, Arkhangelsk, Russian Federation|Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk, Russian Federation|State Budget Medical Institution Clinical Oncology Center 1, Krasnodar, Russian Federation|Budget Medical Institution of the Omsk Region: Clinical Oncology Center, Omsk, Russian Federation|State Budget Medical Institution: Leningrad Regional Clinical Hospital, Saint Petersburg, Russian Federation|State Medical Institution: Tula Regional Oncology Center, Tula, Russian Federation|Zakarpattia Regional Clinical Oncology Center Department of Chemotherapy, Uzhhorod, Ukraine","https://ClinicalTrials.gov/show/NCT01360853"
210,"Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer","Unknown status","No Results Available","Metastatic Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Erlotinib|Drug: Oxaliplatin|Drug: Folinic Acid|Drug: Irinotecan|Drug: 5-FU","University of Munich, Munich, Germany","https://ClinicalTrials.gov/show/NCT01729481"
211,"Hyperthermia European Adjuvant Trial","Unknown status","No Results Available","Resected Pancreatic Adenocarcinoma","Device: Gemcitabine + Cisplatin + regional hyperthermia|Drug: Gemcitabine + Capecitabine","Klinikum Grosshadern, Medical Center, University of Munich, Munich, Bavaria, Germany","https://ClinicalTrials.gov/show/NCT01077427"
212,"Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer","Withdrawn","No Results Available","Locally Advanced Pancreatic Adenocarcinoma","Radiation: Carbon Ion Radiation Therapy (CIRT)|Radiation: Intensity Modulated Radiation Therapy (IMRT)","University of Texas Southwestern Medical Center, Dallas, Texas, United States|National Institute of Radiological Sciences,4-9-1, Anagawa, Inage-ku,, Chiba, Japan","https://ClinicalTrials.gov/show/NCT03536182"
213,"Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma","Not yet recruiting","No Results Available","Pancreas Adenocarcinoma|Cachexia",,"Levine Cancer Institute, Charlotte, North Carolina, United States","https://ClinicalTrials.gov/show/NCT05376592"
214,"A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment","Active, not recruiting","No Results Available","Metastatic Adenocarcinoma of the Pancreas","Drug: Irinotecan Liposomal Injection|Drug: Oxaliplatin|Drug: 5Fluorouracil|Drug: Leucovorin|Drug: Nab-paclitaxel|Drug: Gemcitabine","University of Alabama at Birmingham, Birmingham, Alabama, United States|Banner Health- MD Anderson Cancer Center, Gilbert, Arizona, United States|Mayo Clinic - Scottsdale, Phoenix, Arizona, United States|Comprehensive Blood And Cancer Center, Bakersfield, California, United States|University of California- Irvine Health Cancer Cente, Costa Mesa, California, United States|City of Hope National Medical Center, Duarte, California, United States|University of California, Los Angeles (UCLA), Los Angeles, California, United States|St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare, Orange, California, United States|University of California - Irvine Medical Center, Orange, California, United States|Torrance Memorial Physician Network Cancer Care, Redondo Beach, California, United States|Sutter Health Sacramento, Sacramento, California, United States|Presbyterian Intercommunity Hospital (PIH), Whittier, California, United States|UC Health Memorial Hospital, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Center, Denver, Colorado, United States|Mount Sinai Medical Center of Florida, Inc., Miami Beach, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|Florida Cancer Specialists - Fort Myers, Sarasota, Florida, United States|Florida Cancer Specialists - Panhandle, Tallahassee, Florida, United States|Florida Cancer Specialists - St. Petersburg, Tampa, Florida, United States|Florida Cancer Specialists - East, West Palm Beach, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Edward Hospital - Elmhurst, Elmhurst, Illinois, United States|Edward Hospital, Naperville, Illinois, United States|Illinois CancerCare - Peoria, Peoria, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States|Siouxland Hematology - Oncology Associates, LLP, Sioux City, Iowa, United States|University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States|Pikeville Medical Center, Pikeville, Kentucky, United States|Hematology Oncology Clinic, Baton Rouge, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Willis-Knighton Cancer Center, Shreveport, Louisiana, United States|Maine Center for Cancer Medicine, Scarborough, Maine, United States|Maryland Oncology Hematology, Silver Spring, Maryland, United States|Beth Israel Deaconess, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States|Health Partners Institute, Minneapolis, Minnesota, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Research Medical Center, Kansas City, Missouri, United States|Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States|Frontier Cancer Center, Billings, Montana, United States|Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Clinical Research Alliance, Inc, Lake Success, New York, United States|David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Messino Cancer Center, Asheville, North Carolina, United States|The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James), Columbus, Ohio, United States|Toledo Clinic Cancer Center, Toledo, Ohio, United States|Mercy Health - St. Elizabeth Youngstown Hospital, Youngstown, Ohio, United States|University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma, United States|Oncology Associates of Oregon, Eugene, Oregon, United States|Compass Oncology - Rose Quarter Cancer Center, Portland, Oregon, United States|Kaiser Permanente - Northwest, Portland, Oregon, United States|Oregon Health & Science University (OHSU), Portland, Oregon, United States|University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|Greenville Hospital System, Greenville, South Carolina, United States|Chattanooga Oncology Hematology Care - Tennessee Oncology, Chattanooga, Tennessee, United States|The West Cancer Center, Memphis, Tennessee, United States|Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States|Texas Oncology - Austin, Austin, Texas, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Research Institute, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Oncology Consultants, Houston, Texas, United States|Texas Oncology - Tyler, Tyler, Texas, United States|Texas Oncology - Wichita Falls, Wichita Falls, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States|Blue Ridge Cancer Care, Wytheville, Virginia, United States|Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States|ProHealth Care Medical Associates, Waukesha, Wisconsin, United States|Bankstown-Lidcombe Hospital, Bankstown, Australia|Monash Medical Centre, Clayton, Australia|Fiona Stanley Hospital, Murdoch, Australia|Sir Charles Gairdner Hospital, Nedlands, Australia|St John of God Subiaco Hospital, Subiaco, Australia|Queen Elizabeth Hospital, Woodville South, Australia|Medizinische Universitaet Graz, Graz, Austria|Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Austria|SCRI-CCCIT Gemeinnutzige Gmbh- Gemeinnutzige Salzburger Landeskliniken Betriebsgesmbh, Salzburg, Austria|Medical University of Vienna, Vienna, Austria|Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium|ASBL Grand Hôpital de Charleroi (GHdC), Site Notre Dame, Charleroi, Belgium|Universitair Ziekenhuis Antwerpen (UZA), Edegem, Belgium|University Hospital Gent, Gent, Belgium|Hospital centre Jolimont, Haine-Saint-Paul, Belgium|University Hospital (UZ) Leuven, Leuven, Belgium|University Hospital Mont-Godinne, Yvoir, Belgium|Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, Brazil|Centro Regional Integrado de Oncologia (CRIO), Ceara, Brazil|Instituto de Oncologia do Parana - IOP, Curitiba, Brazil|Centro de Pesquisas Oncológicas - CEPON, Florianópolis, Brazil|Hospital de Caridade de Ijui, Ijuí, Brazil|Clinica Neoplasias Litoral, Itajaí, Brazil|Hospital Bruno Born, Lajeado, Brazil|Centro de Pesquisas Clinicas de Natal - CPCLIN, Natal, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil|Instituto Nacional Do Cancer (INCA), Rio de Janeiro, Brazil|Instituto COI, Rio De Janeiro, Brazil|Instituto Brasileiro de Controle do Cancer - IBCC (Sao Paulo), San Paolo, Brazil|CIP Centro Integrado de Pesquisas do Hospital de Base, São José Do Rio Preto, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Instituto do Cancer do Estado de São Paulo (ICESP), São Paulo, Brazil|Alberta Health Services Cross Cancer Institute, Edmonton, Canada|Queen Elizabeth II Health Sciences Centre, Halifax, Canada|McGill University Faculty of Medicine - Royal Victoria Hospital, Montréal, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada|Masarykuv onkologicky ustav, Brno, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Králové, Czechia|University Hospital Olomouc, Department of Oncology, Olomouc, Czechia|Thomayerova Nemocnice, Praha, Czechia|CHRU de Tours - Hôpital Trousseau, Chambray-lès-Tours, France|Centre Oscar Lambret, Lille, France|Hôpital Edouard Herriot, Lyon, France|Centre Leon Berard, Lyon, France|Hopital Prive Jean Mermoz, Lyon, France|Centre Antoine-Lacassagne, Nice, France|Hopital Saint Louis, Paris, France|CHU Bordeaux - Hopital Haut-Leveque, Pessac, France|Centre Hospitalier Universitaire de Poitiers - Poitiers University Hospital, Poitiers Cedex, France|Strasbourg Oncologie Liberale, Strasbourg, France|Charité - Universitaetsmedizin Berlin, Berlin, Germany|St. Josef-Hospital, Bochum, Germany|Klinikum Esslingen GmbH, Esslingen, Germany|Krankenhaus Nordwest, Frankfurt, Germany|Studiengesellschaft BSF, Halle, Germany|Martin Luther Universitat Halle-Wittenberg, Halle, Germany|Facharztzentrum Eppendorf, Hamburg, Germany|Marienkrankenhaus Hamburg, Hamburg, Germany|Asklepios Klinik Altona, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Slk-Kliniken, Heilbronn, Germany|Klinikum Mannheim, Mannheim, Germany|Krankenhaus St. Franziskus - Kliniken Maria Hilf GmbH, Mönchengladbach, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Universitaetsklinikum Ulm, Ulm, Germany|Agios Savvas Anticancer Hospital, Athens, Greece|General Hospital of Athens - Laiko, Athens, Greece|National and Kapodistrian University of Athens, Athens, Greece|University General Hospital of Ioannina, Ioánnina, Greece|Theagenion Hospital, Thessaloníki, Greece|Dél-pesti Centrumkórház - Szent László Kórház telephely, Budapest, Hungary|Országos Onkológiai Intézet, Budapest, Hungary|Semmelweis Egyetem Belgyógyászati és Hematológiai Klinika, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Petz Aladar Megyei Oktato Korhaz, Győr, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvár, Hungary|Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Rendelointézet, Szolnok, Hungary|Soroka Medical Center, Beer Sheva, Israel|Rambam Health Care Campus, Haifa, Israel|Policlinico S. Orsola-Malpighi, Bologna, Italy|Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy|Istituto Europeo di Oncologia, Milano, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, Italy|AUSL di Piacenza-Ospedale Guglielmo Da Saliceto, Piacenza, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Italy|AOU Ospedali Riuniti di Ancona, Torrette, Italy|Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma, Verona, Italy|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|National Cancer Center, Goyang-si, Korea, Republic of|CHA Bundang Medical Center, Gyeonggi-do, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Hospital de Braga, Braga, Portugal|Centro Hospitalar Universitario de Lisboa Norte - Hospital de Santa Maria, Lisboa, Portugal|Champalimaud Cancer Center, Lisbon, Portugal|Unidade Local de Saude Matosinhos E.P.E. Hospital Pedro Hispano, Senhora da Hora, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho EPE, Vila Nova de Gaia, Portugal|Evimed LLC, Chelyabinsk, Russian Federation|Limited Liability Company- Clinica Druzhkovyh, Kazan, Russian Federation|Kursk Regional Clinical Oncology Dispensary, Kursk, Russian Federation|Main Military Clinical Hospital named after N.N. Burdenko, Moscow, Russian Federation|Volga District Medical Centre, Novgorod, Russian Federation|Federal State Budgetary Institution - Russian Scientific Center of Radiology and Surgical Technologies n.a. academician A.M.Granov, Saint-Petersburg, Russian Federation|Hospital General Universitario de Elche, Alicante, Spain|Hospital Universitario de Badajoz, Badajoz, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Quironsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau Barcelona, Barcelona, Spain|Hospital Vall D Hebron, Barcelona, Spain|Hospital Clinic Barcelona, Barcelona, Spain|Corporacio Sanitaria Parc Tauli - Hospital de Sabadell, Barcelona, Spain|Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Spain|Complejo Hospitalario Universitario de Granada - Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital General Universitario Gregorio Marañon, Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Centro Integral Oncologico Clara Campal, Madrid, Spain|Hospital Regional Universitario de Malaga, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Marques de Valdecilla, Santander, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom|Royal Marsden Foundation Trust, London, United Kingdom|Royal Marsden Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Cancer Research UK - Christie Hospital Foundation NHS Trust - Dept of Medical Oncology, Manchester, United Kingdom|Nottingham City Hospital, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT04083235"
215,"Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","Recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma","Combination Product: Gabrinox|Radiation: MRI-GUIDED STEREOTACTIC RADIOTHERAPY","Centre Georges-François Leclerc, Dijon, Côte d'Or, France|CHU Carémeau, Nîmes, Gard, France|CHU Saint-Eloi, Montpellier, Herault, France|Institut régional du Cancer de Montpellier, Montpellier, Hérault, France|Hôpital Pitié Salpétriêre, Paris, France","https://ClinicalTrials.gov/show/NCT04570943"
216,"Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer","Terminated","Has Results","Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8","Biological: Pembrolizumab|Biological: Wild-type Reovirus","Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT03723915"
217,"Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy","Terminated","No Results Available","Adenocarcinoma of the Pancreas|Metastatic Disease","Drug: AUY922","Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01484860"
218,"Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer","Recruiting","No Results Available","Pancreas Adenocarcinoma|Resectable Pancreatic Cancer","Drug: Gemcitabine 1000 mg|Drug: nab-paclitaxel|Radiation: Stereotactic Body Radiation Therapy","Loma Linda University Health, Loma Linda, California, United States","https://ClinicalTrials.gov/show/NCT03492671"
219,"Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers","Active, not recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma",,"EUROPAC study, University of Liverpool, Liverpool, United Kingdom|ADEPTS study, University College London, London, United Kingdom|Imperial College London, London, United Kingdom|Royal London Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT04449406"
220,"Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection","Completed","No Results Available","Locally Advanced Pancreatic Adenocarcinoma","Procedure: Pancreatic resection after preoperative chemotherapy|Procedure: Pancreatic resection","San Raffaele Hospital, Milan, Italy","https://ClinicalTrials.gov/show/NCT01278368"
221,"Germline Mutations in Pancreatic Adenocarcinoma","Completed","No Results Available","Germline Mutation Abnormality|Pancreatic Cancer|Predisposition, Genetic|Hereditary Cancer","Genetic: Mutations","Hellenic Oncology Cooperative Group, Athens, Greece","https://ClinicalTrials.gov/show/NCT03982446"
222,"The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreas Cancer, Duct Cell Adenocarcinoma","Other: Systemic immune-inflammatory markers","Regional Institute of Gastroenterology and Hepatology ""Prof. Dr. O. Fodor"", Cluj-Napoca, Cluj, Romania","https://ClinicalTrials.gov/show/NCT05025371"
223,"A Study of ASP2138 in Adults With Stomach Cancer or Pancreatic Cancer","Not yet recruiting","No Results Available","Gastric Adenocarcinoma|Gastroesophageal Junction (GEJ) Adenocarcinoma|Pancreatic Adenocarcinoma","Drug: ASP2138",,"https://ClinicalTrials.gov/show/NCT05365581"
224,"Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)","Terminated","Has Results","Metastatic Adenocarcinoma of the Pancreas","Drug: Gemcitabine, Intravenous and oral Ascorbic Acid (Vitamin C)","Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01654861"
225,"Pancreatic Adenocarcinoma Gene Environment Risk Study","Recruiting","No Results Available","Pancreatic Cancer",,"University of Pittsburgh, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00912717"
226,"Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.","Completed","No Results Available","Pancreatic Adenocarcinoma Advanced or Metastatic","Drug: Paclitaxel|Drug: Metformin","ICESP, Sao Paulo, SP, Brazil","https://ClinicalTrials.gov/show/NCT01971034"
227,"Translational Research on Locally Advanced Pancreatic Adenocarcinoma","Unknown status","No Results Available","Pancreatic Cancer","Other: order of treatment","Cancer Institute and Hospital ,China Academy of Medical Sciences, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT03009253"
228,"Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma","Unknown status","No Results Available","Resectable Pancreatic Duct Adenocarcinoma","Drug: FOLFOX neoadjuvant chemotherapy|Drug: FOLFIRINOX neoadjuvant chemotherapy|Procedure: curative surgery for resectable pancreatic duct adenocarcinoma|Drug: Standard adjuvant chemotherapy|Drug: adjuvant chemotherapy","Rouen University Hospital, Rouen, France","https://ClinicalTrials.gov/show/NCT02959879"
229,"Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Ivosidenib|Drug: mFOLFIRINOX","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT05209074"
230,"APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Advanced Pancreatic Cancer","Drug: APG-1387 for Injection|Drug: Gemcitabine|Drug: Nab paclitaxel","Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04643405"
231,"Phase II Trial of TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer","Drug: TAS 102","Department of Clinical Oncology, HKU, Hong Kong, Hong Kong","https://ClinicalTrials.gov/show/NCT04923529"
232,"Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study","Terminated","No Results Available","Pancreatic Ductal Adenocarcinoma (PDAC)","Drug: FOLFIRINOX (oxaliplatin, leucovorin, irinotecan)","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT02782182"
233,"Management of Symptomatic Advanced Pancreatic Adenocarcinoma","Unknown status","No Results Available","Pancreas|Management Supportive Care Program","Procedure: Integrative supportive care","Institut Sainte Catherine, Avignon, France|Hôpital Beaujon, Clichy, France|Hôpital Henri Mondor, Créteil, France|Institut Hospitalier Franco-Britannique, Levallois Perret, France|Centre Léon Bérard, Lyon, France|CH Layne, Mont de Marsan, France|Grope Hospitalier Paris Saint Joseph, Paris, France|Hôpital Cochin, Paris, France|Hôpital Pitié Salpêtrière, Paris, France|Institut Mutualiste Montsouris, Paris, France|Hopitaux du Léman, Thonon les Bains, France|CHU Tours - Hôpital Trousseau, Tours, France","https://ClinicalTrials.gov/show/NCT02979483"
234,"A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma","Withdrawn","No Results Available","Pancreas Cancer","Drug: Entinostat|Drug: FOLFOX regimen",,"https://ClinicalTrials.gov/show/NCT03760614"
235,"Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer","Drug: Bazedoxifene 20 mg","HFR Fribourg - cantonal hospital, Fribourg, Switzerland","https://ClinicalTrials.gov/show/NCT04812808"
236,"A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma","Completed","Has Results","Metastatic Cholangiocarcinoma|Cholangiocarcinoma|Pancreatic Cancer|Metastatic Pancreatic Cancer|Unresectable Pancreatic Cancer|Unresectable Cholangiocarcinoma","Drug: Entinostat|Drug: Nivolumab","Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03250273"
237,"Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy","Enrolling by invitation","No Results Available","Resectable Pancreatic Ductal Adenocarcinoma|Recurrent Pancreatic Ductal Adenocarcinoma","Other: Standardized surveillance","Radboud University Medical Center, Nijmegen, Gelderland, Netherlands|Catharina Ziekenhuis, Eindhoven, Noord-Brabant, Netherlands|Amsterdam University Medical Center VUmc, Amsterdam, Noord-Holland, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Noord-Holland, Netherlands|Amsterdam University Medical Center AMC, Amsterdam, Noord-Holland, Netherlands|Medisch Spectrum Twente, Enschede, Overijssel, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Utrecht, Netherlands|University Medical Center Groningen, Groningen, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands","https://ClinicalTrials.gov/show/NCT04875325"
238,"Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma","Recruiting","No Results Available","Carcinoma|Pancreatic Ductal","Other: Adipose tissue sampling during surgery and urine sampling","Damien JOLLY, Reims, France","https://ClinicalTrials.gov/show/NCT04429490"
239,"Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Metastatic Pancreatic Cancer","Drug: nanoliposomal irinotecan|Radiation: spleen irradiation",,"https://ClinicalTrials.gov/show/NCT05363007"
240,"FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer|Adenocarcinoma|Pancreatic Neoplasms","Drug: FOLFIRINOX, IPI-926","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01383538"
241,"Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Cancer|Advanced Pancreatic Ductal Adenocarcinoma","Drug: Gemcitabine|Drug: Nab-paclitaxel|Drug: PEGPH20","Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford, Connecticut, United States|Miami Cancer Institute, Miami, Florida, United States|Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02921022"
242,"Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer","Drug: Folfirinox|Drug: Gemcitabine|Radiation: radiation therapy|Procedure: Pancreatectomy","University of Cincinnati Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT04594772"
243,"Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.","Recruiting","No Results Available","Pancreas Cancer","Diagnostic Test: Endoscopic ultrasound","Hôpital Jean Mermoz, Lyon, France","https://ClinicalTrials.gov/show/NCT04851106"
244,"Cholesterol Disruption in Combination With FOLFIRINOX in Patients With Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer|Pancreas Cancer|Metastatic Cancer","Drug: Cholesterol metabolism disruption","CHU de Québec-Université Laval, Quebec city, Quebec, Canada","https://ClinicalTrials.gov/show/NCT04862260"
245,"Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer","Procedure: Irreversible Electroporation (IRE)|Drug: Gemcitabine|Drug: FOLFIRINOX","University of Louisville, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT03484299"
246,"Endoscopic Ultrasound Elastography in Pancreatic Masses","Completed","No Results Available","Pancreatic Adenocarcinoma|Chronic Pancreatitis",,"Erasme University, Brussels, Belgium|Universite Chatolique Louvain, Brussels, Belgium|Gentofte University Hospital, Copenhagen, Denmark|University Hospital, Odense, Denmark|Institute Paoli Calmettes, Marseille, France|Caritas-Krankenhaus, Bad Mergentheim, Germany|St. Josef Hospital, Bochum, Germany|SRH Klinik, Gera, Germany|University Clinic Mainz, Mainz, Germany|Dr.Horst-Schmidt-Klinik, Wiesbaden, Germany|HELIOS Klinikum Wuppertal, University of Witten/Herdecke, Wuppertal, Germany|Hospital San Raffaele, Milan, Italy|Erasme Medisch Centrum, Rotterdam, Netherlands|University of Haukeland, Bergen, Norway|University of Medicine and Pharmacy Craiova, Craiova, Romania|University Hospital Santiago, Santiago, Spain|Glasgow Royal Infirmary, Glasgow, United Kingdom|Newcastle Upon Tyne Hospitals, Newcastle, United Kingdom","https://ClinicalTrials.gov/show/NCT00909103"
247,"Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Cancer","Drug: Pembrolizumab|Drug: Ciprofloxacin 500mg PO BID days 1-29|Drug: Metronidazole 500mg PO TID days 1-29","NYU Langone Health, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03891979"
248,"Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Adenocarcinoma of the Pancreas","Drug: Gemcitabine, Sorafenib|Procedure: Radiotherapy","Indiana University Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT00375310"
249,"Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer","Drug: CCX872-B","Saint Louis, Missouri, United States|Rochester, New York, United States|Amsterdam, Netherlands|Nijmegen, Netherlands|Netherland, Rotterdam, Netherlands|Sittard, Netherlands","https://ClinicalTrials.gov/show/NCT02345408"
250,"GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma","Recruiting","No Results Available","Resectable Pancreatic Cancer","Drug: Modified Folforinox (mFFX)","BC Cancer Agency Vancouver, Vancouver, British Columbia, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|Sunnybrook Hospital/Odette Cancer Centre, Toronto, Ontario, Canada|Unity Health (St. Joseph's and St. Michael's), Toronto, Ontario, Canada|Jewish General Hospital, Montréal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT04472910"
251,"Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma","Completed","No Results Available","Neoplastic Cells, Circulating|Pancreatic Cancer|Biological Markers","Other: No intervention/exposures","Johns Hopkins University, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02974764"
252,"Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Pancreatic Neoplasm","Drug: mFOLFIRINOX or gemcitabine-nabpaclitaxel","Hopital Erasme, Brussels, Belgium","https://ClinicalTrials.gov/show/NCT05083247"
253,"Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Pancreatic Cancer","Radiation: High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)","Johns Hopkins Hospital, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT05141513"
254,"A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma","Completed","Has Results","Carcinoma, Pancreatic Ductal","Drug: Napabucasin|Drug: Nab-paclitaxel|Drug: Gemcitabine","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Clearview Cancer Institute (CCI), Huntsville, Alabama, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, United States|Mayo Clinic, Phoenix, Arizona, United States|Highlands Oncology Group, Fayetteville, Arkansas, United States|Comprehensive Blood and Cancer Center, Bakersfield, California, United States|Los Angeles Hematology Oncology Medical Group, Los Angeles, California, United States|University of Southern California, Los Angeles, California, United States|St. Joseph Hospital of Orange, Orange, California, United States|Torrance Health Association DBA Torrance Memorial, Redondo Beach, California, United States|UC Davis, Sacramento, California, United States|UCLA Medical Center Santa Monica Hematology And Oncology, Santa Monica, California, United States|Kaiser Permanente - Vallejo Medical Center, Vallejo, California, United States|Norwalk Hospital The C Anthony and Jean Whittingham Cancer Center, Norwalk, Connecticut, United States|The C Anthony and Jean Whittingham Cancer Center, Norwalk, Connecticut, United States|Helen F. Graham Cancer Center, Newark, Delaware, United States|Georgetown University Medical Center (GUMC), Washington, District of Columbia, United States|Florida Cancer Specialists & Research Institute, Fort Myers, Florida, United States|Memorial Regional Hospital, Hollywood, Florida, United States|Mayo Clinic Cancer Center, Jacksonville, Florida, United States|Cancer Specialists of North Florida, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, United States|UF Health Cancer Center - Orlando Health, Orlando, Florida, United States|Florida Cancer Specialists North, Saint Petersburg, Florida, United States|Florida Cancer Specialists East Region, Wellington, Florida, United States|University Cancer & Blood Center, Athens, Georgia, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Columbus Regional Research Institute, Columbus, Georgia, United States|Saint Alphonsus Health System, Boise, Idaho, United States|NorthShore University Health Systems, Evanston, Illinois, United States|Ingalls Cancer Research Center, Harvey, Illinois, United States|Carle Cancer Center CCOP, Urbana, Illinois, United States|Northwestern Medicine Regional Medical Group, Warrenville, Illinois, United States|Parkview Physician Group (PPG), Fort Wayne, Indiana, United States|Indiana University - Melvin and Bren Simon Cancer, Indianapolis, Indiana, United States|Cotton O'Neil Cancer Center, Topeka, Kansas, United States|Cancer Center of Kansas, Wichita, Kansas, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Louisiana Hematology Oncology Associates (LHOA), Baton Rouge, Louisiana, United States|Maine Center for Cancer Medicine - Scarborough, Scarborough, Maine, United States|Greater Baltimore Medical Center, Baltimore, Maryland, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|St. Luke's Hospital of Duluth, Duluth, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Metro MN Clinical Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Jackson Oncology Associates, Jackson, Mississippi, United States|University of Missouri - Ellis Fischel Cancer Cent, Columbia, Missouri, United States|Saint Luke's Hospital, Kansas City, Missouri, United States|HCA Midwest Division (Kansas City), Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Clinic - Cancer & Hematology, Springfield, Missouri, United States|St. Vincent Frontier Cancer Center, Billings, Montana, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|UNM Cancer Research and Treatment Center, Albuquerque, New Mexico, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|Montefiore Cancer Center, Bronx, New York, United States|Basset Medical Center, Cooperstown, New York, United States|North Shore Hematology Oncology Associates PC, East Setauket, New York, United States|Hematology Oncology Associates of Central New York, East Syracuse, New York, United States|Clinical Research Alliance, Lake Success, New York, United States|Weill Cornell Medicine/ NewYork-Presbyterian, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University, Stony Brook, New York, United States|UNC Chapel Hill / Lineberger Comprehensive Cancer, Chapel Hill, North Carolina, United States|Southeastern Medical Oncology Center, Goldsboro, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|FirstHealth Outpatient Cancer Center, Pinehurst, North Carolina, United States|Wake Forest Baptist Hospital, Winston-Salem, North Carolina, United States|Gabrail Cancer Center (GCC) - Canton Facility, Canton, Ohio, United States|Toledo Clinic Cancer Centers, Toledo, Ohio, United States|Cancer Center of Southwest Oklahoma, Lawton, Oklahoma, United States|Mercy Clinic Oncology and Hematology - McAuley, Oklahoma City, Oklahoma, United States|Kaiser Permanente - Westside Medical Office, Hillsboro, Oregon, United States|OHSU Knight Cancer Institute, Portland, Oregon, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Fox Chase Cancer Center (FCCC) - Philadelphia, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Charleston Hematology Oncology Associates, Charleston, South Carolina, United States|Medical University of South Carolina (MUSC), Charleston, South Carolina, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|GHS Cancer Institute, Greenville, South Carolina, United States|Avera Medical Group, Sioux Falls, South Dakota, United States|Tennessee Oncology Chattanooga, Chattanooga, Tennessee, United States|University of Tennessee Medical Center, Knoxville, Tennessee, United States|SCRI - Tennessee Oncology, Nashville, Tennessee, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Bon Secours Cancer Institute Medical Oncology, Midlothian, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States|Oncology and Hematology Associates of Southwest Virginia, Roanoke, Virginia, United States|The Everett Clinic, Everett, Washington, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, United States|West Virginia University Mary Babb Randolph Cancer Center (MBRCC), Morgantown, West Virginia, United States|HSHS St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Ltd. - West Green Bay, Green Bay, Wisconsin, United States|Aurora St. Luke's Medical Center - Vince Lombardi, Milwaukee, Wisconsin, United States|Border Medical Oncology, East Albury, New South Wales, Australia|Macquarie University Hospital, Sydney, New South Wales, Australia|ICON Cancer Care, South Brisbane, South Australia, Australia|Cabrini Hospital, Malvern, Victoria, Australia|Blacktown Cancer and Haematology Centre, Blacktown, Australia|Border Medical Oncology, East Albury, Australia|The Austin Hospital, Heidelberg, Australia|Cabrini Hospital, Malvern, Australia|Sir Charles Gairdner Hospital, Nedlands, Australia|Prince of Wales Private Hospital, Randwick, Australia|ICON Cancer Care, South Brisbane, Australia|Macquarie University Hospital, Sydney, Australia|The Tweed Hospital, Tweed Heads, Australia|Sydney Adventist Hospital, Wahroonga, Australia|LKH Universitätsklinikum Graz, Graz, Austria|Landeskrankenhaus Medical University Innsbruck, Innsbruck, Austria|Landeskrankenhaus Feldkirch, Rankweil, Austria|Universitatsklinik far Innere Medizin III, Salzburg, Austria|Medical University Vienna, Vienna, Austria|ULB Erasme, Bruxelles, Belgium|Antwerp University Hospital, Edegem, Belgium|UZ Ghent, Gent, Belgium|UZ Brussel, Jette, Belgium|UZ Leuven, Leuven, Belgium|CHU de Liege, Liège, Belgium|CHU Dinant Godinne, Yvoir, Belgium|Dr. Everett Chalmers Regional Hospital, Fredericton, New Brunswick, Canada|The Atlantic Clinical Cancer Research Unit (ACCRU), Halifax, Nova Scotia, Canada|Centre Hospitalier de St. Mary, Pointe-Claire, Quebec, Canada|Ciusssmcq, Trois-Rivières, Quebec, Canada|Cross Cancer Institute, Edmonton, Canada|University of Toronto - St. Michael's Hospital, Toronto, Canada|Beijing Cancer Hospital, Beijing, China|Chinese PLA General Hospital, Beijing, China|Jilin Cancer Hospital, Changchun, China|The first hospital of jilin university, Changchun, China|Fujian Medical University Union Hospital, Fuzhou, China|Cancer Center of Guangzhou Medical University, Guangzhou, China|Guangdong General Hospital, Guangzhou, China|The First Affiliated Hospital Zhejiang University, Hangzhou, China|The Second Affiliated Hospital Zhejiang University, Hangzhou, China|Sir Run Shaw Hospital School of Medicine Zhejiang University, Hangzhou, China|Zhejiang Cancer Hospital, Hangzhou, China|Harbin Medical University Cancer Hospital, Harbin, China|The First Affiliated Hospital of Anhui Medical University, Hefei, China|The Second Affiliated Hospital of Anhui Medical University, Hefei, China|The 81 Hospital of the Chinese Peoples Liberation Army, Nanjing, China|Jiangsu Cancer Hospital, Nanjing, China|The Affiliated Hospital of Qingdao University, Qingdao, China|Fudan University Shanghai Cancer Center, Shanghai, China|Huashan Hospital, Shanghai, China|Ren Ji Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China|East Hospital of Tongji University, Shanghai, China|The First Affiliated Hospital of Soochow University, Suzhou, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|The First Affiliated Hospital of Xian Jiao Tong University, Xian, China|General Hospital of Ningxia Medical University, Yinchuan, China|Henan Cancer Hospital, Zhengzhou, China|Onkologicke oddeleni, Benešov, Czechia|Fakultni nemocnice Brno Interni hematoonkologicka klinika, Brno, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czechia|University Hospital Olomouc, Olomouc, Czechia|Onkologické oddělení, Zlín, Czechia|Hôpital Sud - CHU Amiens Picardie, Amiens, France|Hôpital Trousseau, CHRU de Tours, Chambray-lès-Tours, France|Hopital Edourard Herriot, Lyon Cedex 03, France|CHU-Hôtel Dieu, Nantes Cedex 1, France|Centre Antoine Lacassagne, Nice, France|Hopital Europeen Georges Pompidou, Paris, France|Poitiers University Hospital, Poitiers, France|Centre Eugene Marquis, Rennes, France|Clinique Saint Anne, Strasbourg, France|Hopital Civil de strasbourg, Strasbourg, France|Institute de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, France|Gesundheitszentrum St. Marien GmbH, Amberg, Germany|University Hospital Bonn, Bonn, Germany|Klinikum Chemnitz, Chemnitz, Germany|Krankenhaus Nordwest, Frankfurt am main, Germany|Medizinische Hochschule, Hannover, Germany|SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany|Universitätsmedizin Mannheim, Mannheim, Germany|Klinikum Bogenhausen, München, Germany|Klinikum Oldenburg AöR - UK für Innere Medizin, Oldenburg, Germany|Fondazione Poliambulanza, Brescia, Italy|Istituto Ricerca e la Cura del Cancro (IRCC), Candiolo, Italy|AOU Mater Domini, Catanzaro, Italy|Ospedale degli Infermi, Faenza, Italy|Santa Maria de Prato Hospital, Feltre, Italy|IRCCS - Studio e la Cura dei Tumori, Meldola, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|AO SM Misericordia, Perugia, Italy|IRCCS Azienda Ospedaliera S.Maria Nuova, Reggio Emilia, Italy|Ospedale degli Infermi, Rimini, Italy|Dermatological Hospital San Lazzaro, Torino, Italy|ASST Settelaghi, Varese, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi, Japan|Shikoku Cancer Center, Matsuyama, Ehime, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, Japan|Kanagawa Cancer Center, Yokohama, Kanagawa, Japan|Tochigi Cancer Center, Utsunomiya, Tochigi, Japan|University of Tokyo Hospital, Bunkyō-Ku, Tokyo, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|The Cancer Institute Hospital Of JFCR, Koto-Ku, Tokyo, Japan|Kyorin University Hopsital, Mitaka, Tokyo, Japan|Kyoto University Hospital, Kyoto, Japan|Osaka International Cancer Institute, Osaka, Japan|Saitama Cancer Center, Saitama, Japan|Shizuoka Cancer Center, Shizuoka, Japan|Seoul national University Bundang Hospital, Gyeonggi-do, Korea, Republic of|Chonnam National University Hwasun Hospital, Jeongnam, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Medisch Centrum Leeuwarden (MCL), Leeuwarden, Netherlands|Zuyderland Medical Center, Sittard, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Isala Ziekenhuis, Zwolle, Netherlands|Uniwersyteckie Centrum Kliniczne, Gdańsk, Poland|Centrum Onkologii-Instytut im.M.Sklodowskiej-Curie, Gliwice, Poland|Przychodnia Lekarska KOMED, Konin, Poland|Klinika Chirurgii Onkologicznej, Lublin, Poland|Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland|Samodzielny Publiczny Szpital Kliniczny, Poznań, Poland|Wojewodzki Szpital Zespolony, Toruń, Poland|Fundação Champalimaud, Lisboa, Portugal|Hospital da Luz, Lisboa, Portugal|Centro Hospitalar Lisboa Norte, Lisbon, Portugal|Centro Hospitalar do Porto, E.P.E, Porto, Portugal|IPO Porto Francisco Gentil, E.P.E., Porto, Portugal|Centro Hospitalar Entre Douro e Vouga, Santa Maria Da Feira, Portugal|Kursk Regional Clinical Oncology Dispensary, Kislino, Kursk, Russian Federation|Arkhangelsk Regional Clinical Oncology Dispensary, Arkhangel'sk, Russian Federation|Republican Clinical Oncology Dispensary, Cheboksary, Russian Federation|Llc Evimed, Chelyabinsk, Russian Federation|Railway Clinical Hospital on station Chelyabinsk, Chelyabinsk, Russian Federation|Republic Clinical Oncology Dispensary, Kazan, Russian Federation|N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation|Privolzhsk District Medical Center, Nizhny Novgorod, Russian Federation|Budgetary Healthcare Institution of Omsk Region, Omsk, Russian Federation|Orenburg Regional Clinical Oncology Dispensary, Orenburg, Russian Federation|Pyatigorsk Oncology Dispensary, Pyatigorsk, Russian Federation|St.Petersburg Medical Universitet n.a. I.P. Pavlov, Saint Petersburg, Russian Federation|FSBI ""Russian Research Centre of Radiology and Surgical Technologies"", Saint Petersburg, Russian Federation|City Clinical Oncology Dispensary, Saint Petersburg, Russian Federation|Multi-type clinic 'REAVIZ', Samara, Russian Federation|National Research Mordovia State University, Saransk, Russian Federation|National Cancer Centre Singapore, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Hospital Vall d´Hebron, Barcelona, Spain|Hospital Clínico y Provincial de Barcelona, Barcelona, Spain|(ICO) Hospital Duran i Reynals, Barcelona, Spain|Hospital Universitario Germans Trias i Pujol, Barcelona, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Centro Integral Oncologico Clara Campal, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Universitario Fundacion Alcorcon, Madrid, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan|China Medical University Hospital, Taichung, Taiwan|Taipei Veterans General Hospital, Taipei City, Taiwan|LinKou Chang Gung Memorial Hospital, Taoyuan, Taiwan|Zaytsev Institute General and Urgent Surgery of National Academy Medical Science of Ukraine, Kharkiv, Ukraine|National Institute of Cancer, Kyiv, Ukraine","https://ClinicalTrials.gov/show/NCT02993731"
255,"Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Neoplasms",,,"https://ClinicalTrials.gov/show/NCT02977702"
256,"Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer","Drug: Tosedostat|Drug: Capecitabine|Procedure: Fresh tissue biopsy","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02352831"
257,"Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Cancer Metastatic","Drug: Dasatinib|Drug: mFOLFOX6","UF Health Cancer Center, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT01652976"
258,"Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma","Recruiting","No Results Available","Pancreatic Cancer","Drug: mFOLFIRINOX|Radiation: Stereotactic body radiotherapy (SBRT)","Yale University School of Medicine, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT03991962"
259,"OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer","Drug: oxaliplatin, irinotecan, capecitabine","National Cancer Centre, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT02368860"
260,"Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma","Recruiting","No Results Available","Advanced Solid Tumors|Gastric Cancer|Esophagogastric Junction Cancer|Pancreatic Cancer","Drug: IM92 CAR-T cells","Chinese PLA GENERAL HOSPITAL, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT05275062"
261,"Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes","Unknown status","No Results Available","Pancreatic Neoplasms","Drug: Gemcitabine|Radiation: TS-1 with radiation","Division of Medical Oncology, Peking Union Medical College Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT02754180"
262,"Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: neoadjuvant mFOLFIRINOX|Drug: Stereotactic body radiotherapy (SBRT)","Smilow Cancer Hospital, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT03099265"
263,"Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas","Completed","No Results Available","Adenocarcinoma of Head of Pancreas","Device: Type WallFlex or Evolution biliary, stent system","Institut Paoli Calmettes, Marseille, France","https://ClinicalTrials.gov/show/NCT02487836"
264,"M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas","Terminated","Has Results","Cancer of Pancreas|Pancreas Cancer|Pancreatic Adenocarcinoma|Pancreatic Cancer|Pancreatic Neoplasms","Drug: M7824|Drug: Gemcitabine","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT03451773"
265,"A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Cancer","Drug: Pertuzumab|Drug: Erlotinib","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01108458"
266,"TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)","Terminated","Has Results","Pancreatic Cancer","Drug: TAS-102","Malcom Randall VA Medical Center, Gainesville, Florida, United States|UF Health Cancer Center, Gainesville, Florida, United States|Tallahasee Memorial HealthCare, Tallahassee, Florida, United States","https://ClinicalTrials.gov/show/NCT02921737"
267,"Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine","Completed","No Results Available","Advanced or Metastatic Pancreatic Adenocarcinoma","Drug: everolimus","Novartis Investigative Site, Halle, Germany|Novartis Investigative Site, Merseburg, Germany|Novartis Investigative Site, München, Germany|Novartis Investigative Site, Oberstaufen, Germany|Novartis Investigative Site, Ulm, Germany","https://ClinicalTrials.gov/show/NCT00560963"
268,"Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Cancer","Drug: Gemcitabine|Drug: Capecitabine|Radiation: Stereotactic Body Radiation Therapy (SBRT)","UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01360593"
269,"Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma","Unknown status","No Results Available","Pancreatic Cancer","Drug: PBI 05204","Scottsdale Healthcare Hospitals, Scottsdale, Arizona, United States|Florida Hospital Tampa, Tampa, Florida, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02329717"
270,"Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection","Completed","Has Results","Pancreatic Cancer","Drug: PEGPH20|Drug: Cetuximab|Device: DW & DCE-MRI|Other: blood draws","Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02241187"
271,"Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Ductal Adenocarcinoma","Drug: LDE225-600mg|Drug: Gemcitabine|Drug: nab-paclitaxel|Drug: LDE225-400mg|Drug: LDE225-800mg","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01431794"
272,"Peroperative Assessment of Tumour Resection Margins Using High-resolution 18F-FDG-PET/CT in Pancreatic Adenocarcinoma","Recruiting","No Results Available","Fluorodeoxyglucose F18","Diagnostic Test: Positron Emissie Tomografie - Computer Tomografie","University Hospital Ghent, Ghent, East-flanders, Belgium","https://ClinicalTrials.gov/show/NCT05023291"
273,"Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Neoplasms|Pancreatic Cancer|Adenocarcinoma","Drug: nab-paclitaxel, gemcitabine, capecitabine","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01161186"
274,"Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma","Not yet recruiting","No Results Available","Pancreatic Cancer Non-resectable|Pancreatic Cancer Metastatic","Drug: Irinotecan Liposome Injection|Drug: Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Nab paclitaxel|Drug: Gemcitabine",,"https://ClinicalTrials.gov/show/NCT05047991"
275,"Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreas, Adenocarcinoma","Biological: Biological/Vaccine: BC-819","Winthrop University Hospital, Mineola, New York, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Joe Arrington Cancer Research & Treatment Center, Lubbock, Texas, United States|Carmel Medical Center, Haifa, Israel|Rambam Medical Center, Haifa, Israel|Hadassah Medical Organization, Jerusalem, Israel|Meir Medical Center, Kfar Saba, Israel|Galil Maaravi, Nahariya, Israel|Tel Aviv Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT01413087"
276,"FOLFIRINOX in Patients With Inoperable Pancreatic Cancer","Terminated","Has Results","Adenocarcinoma of Pancreas","Drug: Irinotecan, Oxaliplatin, Leucovorin, 5-FU","University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT01359007"
277,"FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Neoplasms","Drug: Oxaliplatin|Drug: Irinotecan|Drug: Leucovorin|Drug: Fluorouracil|Other: laboratory biomarker analysis|Other: flow cytometry|Other: immunohistochemistry staining method|Other: pharmacological study|Drug: PF-04136309","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01413022"
278,"Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Cancer","Drug: Avastin|Drug: Tarceva|Radiation: Radiation Therapy","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00735306"
279,"Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Cancer","Drug: Chemotherapy|Drug: Chemotherapy + ChemoRadiotherapy","University of Florida Shands Cancer Center, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT01470417"
280,"Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Cancer","Drug: Capecitabine|Drug: Oxaliplatin","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00585078"
281,"Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Cancer","Drug: Synthetic Human Secretin","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00587132"
282,"Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Neoplasms|Adenocarcinoma","Drug: Gemcitabine|Drug: Etanercept","Ohio State University Medical Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00201838"
283,"Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer","Drug: nal-IRI|Drug: 5 fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin","University of South Alabama, Mobile, Alabama, United States|University of South Alabama - Mobile, Mobile, Alabama, United States|Arizona Center for Cancer Care, Avondale, Arizona, United States|Mayo Clinic Cancer Center, Scottsdale, Arizona, United States|University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California, Los Angeles (UCLA) Medical Center - Santa Monica Cancer Center, Santa Monica, California, United States|University of Colorado (CU) Cancer Center - Anschutz Cancer Pavilion, Aurora, Colorado, United States|Mayo Clinic Cancer Center - Jacksonville, Jacksonville, Florida, United States|University of Miami, Miami, Florida, United States|Mayo Clinic Cancer Center - Rochester, Rochester, Minnesota, United States|US Oncology - Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, Nevada, United States|Holy Name Medical Center - Teaneck, Teaneck, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Levine Cancer Institute, Carolinas Healthcare System - Oncology, Charlotte, North Carolina, United States|Wake Forest University Baptist Medical Center (WFUBMC), Winston-Salem, North Carolina, United States|University of Oklahoma Health Sciences Center (OUHSC) Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|Gettysburg Cancer Center, Gettysburg, Pennsylvania, United States|Medical Group of the Carolinas - Spartanburg Regional Health Services, Spartanburg, South Carolina, United States|Houston Methodist Cancer Center and Institute of Academic Medicine, Houston, Texas, United States|Oncology Consultants - Houston, Houston, Texas, United States|Joe Arrington Cancer Research and Treatment Center - Lubbock, Lubbock, Texas, United States|St. John of God Health Care - Subiaco, Subiaco, Western Australia, Australia|Hospital General Universitario de Elche - Elche, Elche, Alicante, Spain|Hospital Universitario de Fuenlabrada - Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario Madrid Sanchinarro Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain","https://ClinicalTrials.gov/show/NCT02551991"
284,"Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer",,"Columbia University Irving Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01219829"
285,"Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma","Completed","Has Results","Pancreatic Cancer","Device: CyberKnife based stereotactic radiotherapy|Drug: Gemcitabine|Drug: Fludeoxyglucose (18F) (FDG)","Stanford University School of Medicine, Stanford, California, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01146054"
286,"A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Cancer","Drug: Simtuzumab|Drug: Gemcitabine|Drug: Placebo to match simtuzumab","Birmingham Hematology and Oncology Associates, LLC, Birmingham, Alabama, United States|University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States|Central Hematology Oncology Medical Group, Inc., Alhambra, California, United States|Comprehensive Blood and Cancer Center, Bakersfield, California, United States|California Cancer Associates for Research and Excellence (CCARE), Fresno, California, United States|Pacific Shores Medical Group, Long Beach, California, United States|UCLA Community Oncology Practice, Los Angeles, California, United States|Stanford University Medical Center, Palo Alto, California, United States|Wilshire Oncology Medical Group, Inc., Rancho Cucamonga, California, United States|Sharp Health Care, San Diego, California, United States|San Jose Medical Group, San Jose, California, United States|Saint Mary's Regional Cancer Center, Grand Junction, Colorado, United States|Hematology Oncology Associates, PC, Stamford, Connecticut, United States|Florida Cancer Specialists, Tampa, Florida, United States|Georgia Cancer Specialists, P.C., Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Oncology Hematology Care, Inc., Crestview Hills, Kentucky, United States|Anne Arundel Medical Center, Annapolis Oncology Center, Annapolis, Maryland, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Providence Cancer Center Oncology and Hematology Care Clinic-Eastside Portland, Southfield, Michigan, United States|Hematology and Oncology Associates at BridgePoint, Tupelo, Mississippi, United States|Saint Joseph Oncology, Inc., Saint Joseph, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Montana Cancer Institute Foundation c/o Montana Cancer Specialists, Missoula, Montana, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, United States|Saint Luke's-Roosevelt Hospital Center, New York, New York, United States|Beth Israel Comprehensive Cancer Center, New York, New York, United States|Duke University Medical Center, Comprehensive Cancer Center, Durham, North Carolina, United States|Emerywood Hematology and Oncology, High Point, North Carolina, United States|Oncology Hematology Care, Inc., Blue Ash, Ohio, United States|PinnacleHealth, Harrisburg, Pennsylvania, United States|Abington Hematology Oncology Associates, Inc., Willow Grove, Pennsylvania, United States|Charleston Hematology Oncology Associates, PA, Charleston, South Carolina, United States|South Carolina Oncology Associates, Columbia, South Carolina, United States|Tennessee Cancer Specialists, Knoxville, Tennessee, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, United States|Coastal Bend Cancer Center, Corpus Christi, Texas, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|Center for Cancer and Blood Disorders, PC, Fort Worth, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States|Republic Clinical Oncology Dispensary of the Ministry of Healthcare of Republic of Bashkortostan, Ufa, Bashkortostan, Russian Federation|Medical Radiological Research Center of Russian Academy of Medical Sciences, Obninsk, Obninsk, Kaluga, Russian Federation|State Institution of Healthcare ""Arkhangelsk Regional Clinical Oncology Dispensary"", Arkhangelsk, Primorskiy, Russian Federation|Republican Clinical Oncologic Dispensary of Ministry of health of Republic Tatarstan, Kazan, Tatarstan, Russian Federation|Regional Oncology Dispensary, Ivanovo, Russian Federation|Kursk Regional Oncologic Dispensary, Kursk, Russian Federation|Blokhin Cancer Research Center of Russia, Dept. of clinical pharmacology, Moscow, Russian Federation|State Institution ""Blokhin Cancer Research Centre RAMS"", Moscow, Russian Federation|Non-State Institution of healthcare ""Central Clinical Hospital #1 OAO RZD, Moscow, Russian Federation|Non-state Healthcare Institution ""N.A. Semashko Central Clinical Hospital #2 of JSC ""Russian Railway, Moscow, Russian Federation|State Budgetary Healthcare Institution ""Nizhny Novgorod Regional Oncological Dispensary"", Nizhny Novgorod, Russian Federation|Budgetary Healthcare Institution of Omsk Region ""Clinical Oncologic Dispensary"", Omsk, Russian Federation|Petrov Research Oncology Institute, Saint Petersburg, Russian Federation","https://ClinicalTrials.gov/show/NCT01472198"
287,"Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors","Active, not recruiting","Has Results","Neoplasms With Mesothelin Expression|Epithelioid Mesothelioma|Cholangiocarcinoma, Extrahepatic|Adenocarcinoma, Pancreatic","Drug: LMB-100|Drug: Tofacitinib|Device: Mesothelin Expression","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT04034238"
288,"Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Duct Cell Adenocarcinoma of the Pancreas|Stage IV Pancreatic Cancer","Drug: bortezomib|Drug: gemcitabine hydrochloride","North Central Cancer Treatment Group, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00052689"
289,"1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma","Recruiting","No Results Available","Advanced Pancreatic Cancer","Drug: galeterone|Drug: Gemcitabine","University of Maryland Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04098081"
290,"A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation","Withdrawn","No Results Available","Pancreatic Ductal Adenocarcinoma|Non-small Cell Lung Cancer|Squamous Cell Carcinoma of Head and Neck","Biological: Durvalumab|Biological: Oleclumab","Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04262388"
291,"A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Neoplasms","Drug: ARQ 197|Drug: gemcitabine","Oddzial Kliniczny Kliniki Onkologii Szpital Uniwersytecki w Krakowie, Krakow, Poland|Oddzial Chemioterapii, Wojewodzki Szpital Specjalistyczny, Krakow, Poland|Oddział Onkologii Klinicznej, Regionalny Szpital Specjalistyczny ""Latawiec"", Swidnica, Poland|Oddział Onkologii Klinicznej SP ZOZ Wojewódzki Szpital Zespolony im. L. Rydygiera, Torun, Poland|Klinika Onkologii WIM Warszawa, Warszawa, Poland|Oddział Chemioterapii Dolnośląskie Centrum Onkologii, Wroclaw, Poland","https://ClinicalTrials.gov/show/NCT00558207"
292,"Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma","Terminated","No Results Available","Pancreatic Cancer","Genetic: Ad5-yCD/mutTKSR39rep-ADP","Henry Ford Health System, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT00415454"
293,"Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla","Terminated","Has Results","Ductal Adenocarcinoma of Pancreas|Adenocarcinoma of Ampulla","Drug: Gemcitabine and nanoparticle albumin bound paclitaxel|Drug: 5-fluorouracil and irinotecan|Radiation: Preoperative chemoradiation|Procedure: Definitive resection","Essentia Health Cancer Center, Duluth, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02626520"
294,"A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma","Completed","No Results Available","Metastatic Pancreatic Cancer","Drug: vacc. w/ Poly-ICLC & peptide-pulsed dendritic cells","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01410968"
295,"Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma","Completed","No Results Available","Pancreatic Neoplasms|Adenocarcinoma|Neoplasm Circulating Cells|Tumor Markers, Biological|Monitoring, Immunologic","Procedure: Pancreatic resection (PD)","Department of Abdominal Surgery, Catholic University Leuven, Leuven, Vlaams-Brabant, Belgium","https://ClinicalTrials.gov/show/NCT00495924"
296,"PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma","Completed","No Results Available","Neoplasm","Drug: PTK787/ZK222584","Scottsdale Healthcare, Scottsdale, Arizona, United States|University of Arizona/Arizona Cancer Center, Tucson, Arizona, United States|Tower Hematology Oncology Medical Group, Beverly Hills, California, United States|Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins, Baltimore, Maryland, United States|Virginia Piper Cancer Institute/Abbott Northwestern Hospital, Minneapolis, Minnesota, United States|Sarah Cannon Research Institute, Nashville, Tennessee, United States|South Texas Oncology and Hematology, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00226005"
297,"Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region","Completed","No Results Available","Pancreatic Neoplasms","Radiation: Stereotactic Body Radiation","Indiana University Health Hospital, Indianapolis, Indiana, United States|Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT02780648"
298,"Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage I-III Pancreatic Cancer","Drug: metformin hydrochloride|Radiation: stereotactic radiosurgery","University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02153450"
299,"Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients","Completed","No Results Available","Metastatic Adenocarcinoma of the Pancreas","Drug: capecitabine + erlotinib","Hospital Arquitecto Marcide, Ferrol, La Coruña, Spain|Complejo Hospitalario Universitario de La Coruña, La Coruña, Spain|Centro Oncológico de Galicia, La Coruña, Spain|Complejo Hospitalario Xeral Calde, Lugo, Spain|Complejo Hospitalario de Orense, Orense, Spain|Hospital do Meixoeiro, Vigo, Spain|Complejo Hospitalario Xeral Cies, Vigo, Spain|Hospital POVISA, Vigo, Spain","https://ClinicalTrials.gov/show/NCT00873353"
300,"Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma Resectable|Neoadjuvant Chemotherapy","Drug: AG regimen|Drug: mFolfirinox","The second affiliated hospital of Zhejiang University, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT03750669"
301,"MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer|Pancreatic Adenocarcinoma","Drug: MK-0646|Drug: Gemcitabine|Drug: Erlotinib","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00769483"
302,"Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma","Suspended","No Results Available","Locally Advanced and Unresectable, But Non-Metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma","Drug: Association of gemcitabine, oxaliplatin and radiotherapy","Erasme University Hospital, Brussels, Belgium|Jules Bordet Institute, Brussels, Belgium|University Hospital Ghent, Ghent, Belgium|CHU Sart-Tilman, Luik, Belgium","https://ClinicalTrials.gov/show/NCT00286013"
303,"Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer","Active, not recruiting","Has Results","Pancreatic Adenocarcinoma|Borderline Resectable Adenocarcinoma of the Head of the Pancrease","Radiation: radiation therapy|Procedure: surgery|Drug: mFOLFIRINOX|Drug: FOLFOX","Southern Cancer Center PC-Mobile, Mobile, Alabama, United States|Southern Cancer Center PC-Springhill, Mobile, Alabama, United States|University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|University Oncology Associates, Clovis, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|Memorial Hospital West, Pembroke Pines, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Edward Hospital/Cancer Center, Naperville, Illinois, United States|Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford, Biddeford, Maine, United States|MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford, Sanford, Maine, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|Saint Agnes Hospital, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Renown Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Atrium Health Stanly/LCI-Albemarle, Albemarle, North Carolina, United States|Mission Hospital Inc-Memorial Campus, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Atrium Health Lincoln/LCI-Lincoln, Charlotte, North Carolina, United States|Levine Cancer Institute-SouthPark, Charlotte, North Carolina, United States|Atrium Health University City/LCI-University, Charlotte, North Carolina, United States|Levine Cancer Institute-Mallard Creek, Charlotte, North Carolina, United States|Levine Cancer Institute-Ballantyne, Charlotte, North Carolina, United States|Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Atrium Health Union/LCI-Union, Monroe, North Carolina, United States|Atrium Health Cleveland/LCI-Cleveland, Shelby, North Carolina, United States|NHRMC Radiation Oncology - Supply, Supply, North Carolina, United States|New Hanover Regional Medical Center/Zimmer Cancer Center, Wilmington, North Carolina, United States|NHRMC Radiation Oncology - 16th Street, Wilmington, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Pottstown Hospital, Pottstown, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Greenville Health System Cancer Institute-Faris, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Eastside, Greenville, South Carolina, United States|Levine Cancer Institute-Rock Hill, Rock Hill, South Carolina, United States|Greenville Health System Cancer Institute-Seneca, Seneca, South Carolina, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|IMG Hematology Oncology 8501, Fairfax, Virginia, United States|IMG Hematology Oncology 8505, Fairfax, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02839343"
304,"Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy","Recruiting","No Results Available","Pancreas Adenocarcinoma",,"NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si, Gyeonggi-do, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04241367"
305,"Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Neoplasms|Adenocarcinoma of the Pancreas","Procedure: 2 passes during EUS-guided fine needle biopsy|Procedure: 3 passes during EUS-guided fine needle biopsy","Orlando Health, Orlando, Florida, United States","https://ClinicalTrials.gov/show/NCT05043532"
306,"Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas","Completed","Has Results","Pancreatic Cancer","Drug: Hydroxychloroquine|Drug: Gemcitabine","UPCI/UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01128296"
307,"Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors","Not yet recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cancer Resectable","Drug: Folfirinox and Stereotactic Body Radiotherapy",,"https://ClinicalTrials.gov/show/NCT05181605"
308,"An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study","Recruiting","No Results Available","Gastric Adenocarcinoma|Pancreatic Adenocarcinoma","Other: Aerobic Exercise|Other: Dietary Intervention|Other: Nutritional Intervention|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Resistance Training","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05056805"
309,"Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Liver Metastases","Drug: Floxuridine (FUDR)|Device: Hepatic Artery Infusion Pump|Drug: Heparinized Saline","Spectrum Health, Grand Rapids, Michigan, United States","https://ClinicalTrials.gov/show/NCT03856658"
310,"The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Adenocarcinoma|Chemotherapy Effect","Drug: Chemotherapy (Gemcitabine + nab-paclitaxel)","Seoul National University Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03401827"
311,"Liquid Biopsy in Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma",,"Odense University Hospital, Odense, Denmark","https://ClinicalTrials.gov/show/NCT05400681"
312,"EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients","Not yet recruiting","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma","Procedure: EUS-guided Portal Vein sampling",,"https://ClinicalTrials.gov/show/NCT05247164"
313,"Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Radiation: Intensity-Modulated Radiation Therapy|Drug: Irinotecan Hydrochloride|Drug: Leucovorin Calcium|Drug: Oxaliplatin","Montefiore Medical Center-Weiler Hospital, Bronx, New York, United States","https://ClinicalTrials.gov/show/NCT01897454"
314,"Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma","Completed","No Results Available","Adenocarcinoma Pancreas","Other: Gemcitabine|Drug: CP-870,893","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01456585"
315,"INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors","Recruiting","No Results Available","Pancreas Cancer|Pancreatic Adenocarcinoma",,"Hop Claude Huriez Chu Lille, Lille, France","https://ClinicalTrials.gov/show/NCT04436679"
316,"Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery","Active, not recruiting","Has Results","Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma","Drug: Fluorouracil|Drug: Gemcitabine|Radiation: Image Guided Radiation Therapy|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Drug: Nab-paclitaxel|Procedure: Therapeutic Conventional Surgery","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02427841"
317,"Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC","Recruiting","No Results Available","Pancreas Cancer|Metastatic Pancreatic Cancer|Pancreatic Adenocarcinoma|Metastatic Adenocarcinoma","Combination Product: Modified GCN+TTF treatment","Mayo Clinic, Jacksonville, Florida, United States","https://ClinicalTrials.gov/show/NCT04605913"
318,"Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma","Radiation: Stereotactic Body Radiation Therapy (SBRT)|Drug: FOLFIRINOX","Indiana University Melvin & Bren Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT04130399"
319,"Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: tanespimycin","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00577889"
320,"High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery","Terminated","Has Results","Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer","Radiation: low intensity radiation therapy|Drug: Capecitabine|Drug: Gemcitabine|Radiation: high intensity radiation therapy|Drug: nab-Paclitaxel","Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Saint Joseph Hospital, Chicago, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|McFarland Clinic PC-William R Bliss Cancer Center, Ames, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Sanford Clinic North-Bemidgi, Bemidji, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County, Mount Holly, New Jersey, United States|Capital Health Medical Center-Hopewell, Pennington, New Jersey, United States|University of Rochester, Rochester, New York, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Roger Maris Cancer Center, Fargo, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|M D Anderson Cancer Center, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Central Vermont Medical Center/National Life Cancer Treatment, Berlin, Vermont, United States|University of Vermont Medical Center, Burlington, Vermont, United States|Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Mary's Hospital, Green Bay, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Door County Cancer Center, Sturgeon Bay, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01921751"
321,"Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® Needles","Completed","No Results Available","Pancreas Cancer|Pancreatic Adenocarcinoma","Device: 20-GAUGE PROCORE® first, then 22-GAUGE ACQUIRE®|Device: 22-GAUGE ACQUIRE® first, then 20-GAUGE PROCORE®","David Karsenti, Charenton-le-Pont, Ile De France, France","https://ClinicalTrials.gov/show/NCT03567863"
322,"Predicting Effective Therapy in Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma","Diagnostic Test: CTC isolocation and analysis","Memoral Sloan Kettering Cancer Center Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States|Memoral Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States","https://ClinicalTrials.gov/show/NCT03033927"
323,"A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors","Recruiting","No Results Available","Solid Tumor|Pancreatic Adenocarcinoma","Drug: OBI-3424","Scripps Clinic Torrey Pines, La Jolla, California, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03592264"
324,"Micrometastasis in Gastrointestinal Cancer","Unknown status","No Results Available","Pancreatic Adenocarcinoma|Colorectal Cancer",,"Oslo University Hospital, Oslo, Norway","https://ClinicalTrials.gov/show/NCT01919151"
325,"A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors","Terminated","No Results Available","Metastatic Pancreatic Adenocarcinoma|BRAF Mutated Melanoma","Drug: MEK162|Drug: AMG 479","Massachusetts General Hospital Mass General 2, Boston, Massachusetts, United States|University of Utah / Huntsman Cancer Institute Huntsman, Salt Lake City, Utah, United States|Pfizer Investigative Site, Parkville, Victoria, Australia|Pfizer Investigative Site, Leuven, Belgium|Pfizer Investigative Site, Toronto, Ontario, Canada|Pfizer Investigative Site, Toulouse Cedex 9, France|Pfizer Investigative Site, Napoli, Italy|Pfizer Investigative Site, Barcelona, Catalunya, Spain|Pfizer Investigative Site, Sutton, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT01562899"
326,"AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)","Completed","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cancer","Biological: AdV-tk|Drug: Valacyclovir","City of Hope Medical Center, Duarte, California, United States|Scripps Green Hospital/Scripps Cancer Center, La Jolla, California, United States|The Ohio State University, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00638612"
327,"Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms","Unknown status","No Results Available","Advanced Esophageal Squamous Carcinoma|Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Colorectal Adenocarcinoma","Biological: Personalized mRNA Tumor Vaccine","Changhai Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT03468244"
328,"Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection","Completed","No Results Available","Stage IA Pancreatic Adenocarcinoma|Stage IB Pancreatic Adenocarcinoma|Stage IIA Pancreatic Adenocarcinoma|Stage IIB Pancreatic Adenocarcinoma","Drug: nab-paclitaxel|Drug: gemcitabine","Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Shanghai Pancreatic Cancer Institute; Pancreatic Cancer Institute, Fudan University. Shanghai, China, Shanghai, China","https://ClinicalTrials.gov/show/NCT02023021"
329,"3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7","Radiation: 3-Dimensional Conformal Radiation Therapy|Drug: Triapine","Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00288093"
330,"Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96","Unknown status","No Results Available","Liver Cancer|Pancreatic Adenocarcinoma","Biological: autologous gp96 vaccination","Cancer Insititute and Hospital,Chinese Academy of Medical Sciences, Beijing, China","https://ClinicalTrials.gov/show/NCT02133079"
331,"Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24)","Unknown status","No Results Available","Pancreas Adenocarcinoma","Behavioral: psychological support","IRCCS S Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT04396093"
332,"Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Olaparib|Biological: Pembrolizumab","Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Cancer Center at Saint Joseph's, Phoenix, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States|PCR Oncology, Arroyo Grande, California, United States|Sutter Auburn Faith Hospital, Auburn, California, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Sutter Davis Hospital, Davis, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Palo Alto Medical Foundation-Fremont, Fremont, California, United States|Memorial Medical Center, Modesto, California, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States|Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States|Mills Health Center, San Mateo, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Boulder Community Foothills Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|The Women's Imaging Center, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Western Surgical Care, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Rocky Mountain Cancer Centers - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|The Melanoma and Skin Cancer Institute, Englewood, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|Medical Center of the Rockies, Loveland, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, United States|Danbury Hospital, Danbury, Connecticut, United States|Norwalk Hospital, Norwalk, Connecticut, United States|Beebe South Coastal Health Campus, Frankford, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|Sibley Memorial Hospital, Washington, District of Columbia, United States|Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Illinois CancerCare-Dixon, Dixon, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Illinois CancerCare - Washington, Washington, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Reid Health, Richmond, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Saint Anthony Regional Hospital, Carroll, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Jennie Edmundson Memorial Hospital, Council Bluffs, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|Saint Joseph London, London, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|UofL Health Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Ascension Borgess Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States|Ascension Providence Hospitals - Novi, Novi, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Ascension Providence Hospitals - Southfield, Southfield, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States|Cambridge Medical Center, Cambridge, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States|Baptist Cancer Center-Grenada, Grenada, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Parkland Health Center - Farmington, Farmington, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|GenesisCare USA - Henderson, Henderson, Nevada, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pebble, Henderson, Nevada, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, United States|Desert West Surgery, Las Vegas, Nevada, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States|GenesisCare USA - Las Vegas, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|GenesisCare USA - Fort Apache, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|University Cancer Center, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Radiation Oncology Associates, Reno, Nevada, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States|Vidant Oncology-Kenansville, Kenansville, North Carolina, United States|Vidant Oncology-Kinston, Kinston, North Carolina, United States|Vidant Oncology-Richlands, Richlands, North Carolina, United States|Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Saint Elizabeth Boardman Hospital, Boardman, Ohio, United States|Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States|Miami Valley Hospital South, Centerville, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|Mount Carmel East Hospital, Columbus, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio, United States|Miami Valley Hospital North, Dayton, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Dublin Methodist Hospital, Dublin, Ohio, United States|Armes Family Cancer Center, Findlay, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Orion Cancer Care, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Dayton Physicians LLC-Atrium, Franklin, Ohio, United States|Central Ohio Breast and Endocrine Surgery, Gahanna, Ohio, United States|Dayton Physicians LLC-Wayne, Greenville, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Mount Carmel Grove City Hospital, Grove City, Ohio, United States|Greater Dayton Cancer Center, Kettering, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Saint Rita's Medical Center, Lima, Ohio, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|OhioHealth Marion General Hospital, Marion, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|Springfield Regional Cancer Center, Springfield, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|Saint Vincent Mercy Medical Center, Toledo, Ohio, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Dayton Physicians LLC-Upper Valley, Troy, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Saint Joseph Warren Hospital, Warren, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Saint Elizabeth Youngstown Hospital, Youngstown, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Integris Southwest Medical Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|Saint Vincent Hospital, Erie, Pennsylvania, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States|Jefferson Hospital, Jefferson Hills, Pennsylvania, United States|Forbes Hospital, Monroeville, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|West Penn Hospital, Pittsburgh, Pennsylvania, United States|Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States|Avera Cancer Institute-Aberdeen, Aberdeen, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, United States|Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Hendrick Medical Center, Abilene, Texas, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Farmington Health Center, Farmington, Utah, United States|University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Overlake Medical Center, Bellevue, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Jefferson Healthcare, Port Townsend, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Valley Medical Center, Renton, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States|Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, United States|Cheyenne Regional Medical Center-West, Cheyenne, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT04548752"
333,"A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma.","Unknown status","No Results Available","Pancreas Adenocarcinoma",,"Ruijin Hospital,Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China|Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China|Changhai Hospital Affiliated to Naval Medical University, Shanghai, Shanghai, China|Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04147403"
334,"A Phase I/Expansion Study of Dasatinib","Terminated","No Results Available","Refractory Solid Tumors|Pancreatic Adenocarcinoma","Drug: gemcitabine|Drug: dasatinib","UNC Lineberger, Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00598091"
335,"MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.","Active, not recruiting","No Results Available","Carcinoma|Metastatic Pancreatic Adenocarcinoma","Biological: oleclumab|Biological: durvalumab|Combination Product: gemcitabine|Combination Product: nab-paclitaxel|Combination Product: oxaliplatin|Combination Product: leucovorin|Combination Product: 5-FU","Research Site, La Jolla, California, United States|Research Site, Aurora, Colorado, United States|Research Site, Fort Myers, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Ann Arbor, Michigan, United States|Research Site, Buffalo, New York, United States|Research Site, Durham, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Nashville, Tennessee, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Charlottesville, Virginia, United States|Research Site, Seattle, Washington, United States|Research Site, Madison, Wisconsin, United States|Research Site, Blacktown, Australia|Research Site, Clayton, Australia|Research Site, Heidelberg, Australia|Research Site, St Leonards, Australia|Research Site, Oslo, Norway|Research Site, Barcelona, Spain|Research Site, Fuenlabrada, Spain|Research Site, Oviedo, Spain|Research Site, Pamplona, Spain","https://ClinicalTrials.gov/show/NCT03611556"
336,"Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)","Active, not recruiting","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma|Pancreatic Adenocarcinoma|Pancreas Metastases|Adenocarcinoma","Drug: Paricalcitol (Zemplar)","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT03415854"
337,"Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Biological: Siltuximab|Biological: Spartalizumab","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT04191421"
338,"Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Fluorouracil|Drug: Gemcitabine|Drug: Gemcitabine Hydrochloride|Drug: Leucovorin|Drug: Leucovorin Calcium|Drug: Liposomal Irinotecan|Drug: Nab-paclitaxel|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Mount Carmel East Hospital, Columbus, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Dublin Methodist Hospital, Dublin, Ohio, United States|Central Ohio Breast and Endocrine Surgery, Gahanna, Ohio, United States|Mount Carmel Grove City Hospital, Grove City, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|OhioHealth Marion General Hospital, Marion, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT04233866"
339,"Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Binimetinib|Drug: Hydroxychloroquine","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04132505"
340,"Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer","Withdrawn","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Biological: Pegylated Recombinant Human Hyaluronidase PH20|Biological: Pembrolizumab","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04058964"
341,"Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula","Recruiting","No Results Available","Adenocarcinoma of the Pancreas|Adenocarcinoma of the Duodenum|Ampullary Adenocarcinoma","Procedure: total pancreatectomy|Biological: intraportal islet autotransplantation","Hop Claude Huriez Chu Lille, Lille, France","https://ClinicalTrials.gov/show/NCT05116072"
342,"A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Cancer|Metastatic Pancreatic Adenocarcinoma","Drug: Gemcitabine combined with nab-paclitaxel|Drug: Dose -SM-88|Drug: Dose -mFOLFIRINOX|Drug: Dose - Pamrevlumab combined with gemcitabine and nab-paclitaxel|Drug: Dose- Canakinumab and Spartalizumab combined with nab-paclitaxel and gemcitabine","University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|University of Florida College of Medicine, Gainesville, Florida, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan - Rogel Cancer Center, Ann Arbor, Michigan, United States|Siteman Cancer Center - Washington University Medical Campus, Saint Louis, Missouri, United States|New York University Langone Medical Center - Perlmutter Cancer Center, New York, New York, United States|Evelyn H. Lauder Breast Center - Memorial Sloan Kettering Cancer Center, New York, New York, United States|Weill Cornell Physicians - Solid Tumor/Gastrointestinal Oncology, New York, New York, United States|University of Pennsylvania - Abramson Cancer Center, Philadelphia, Pennsylvania, United States|The University of Texas Southwestern Medical Center, Dallas, Texas, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Virginia Mason Hospital & Seattle Medical Center, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04229004"
343,"Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer","Recruiting","No Results Available","Pancreas Adenocarcinoma","Procedure: Venous sampling","Tongji Hospital, Tongji Medical College, HUST, Wuhan, Hubei, China","https://ClinicalTrials.gov/show/NCT04636788"
344,"EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas","Completed","No Results Available","Adenocarcinoma|Metastasis|Pancreas Neoplasms","Drug: Gemcitabine alone|Drug: EndoTAG-1 and Gemcitabine","Prague, Czech Republic|Budapest, Hungary|Kiev, Ukraine","https://ClinicalTrials.gov/show/NCT00377936"
345,"PRECISE: Pancreatic Cancer and Exercise","Recruiting","No Results Available","Pancreas Adenocarcinoma","Other: Exercise","Belfast City Hospital, Belfast, United Kingdom","https://ClinicalTrials.gov/show/NCT04305067"
346,"FAZA PET/MRI Pancreas","Recruiting","No Results Available","Pancreatic Adenocarcinoma Non-resectable|Locally Advanced Pancreatic Adenocarcinoma|Unresectable Pancreatic Cancer","Drug: 18F-FAZA","Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04395469"
347,"Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas","Terminated","No Results Available","Pancreatic Cancer","Drug: Gemcitabine|Drug: Losartan","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01276613"
348,"Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients","Completed","No Results Available","Adenocarcinoma Pancreas","Drug: Nab-paclitaxel|Drug: Gemcitabine|Other: Best Supportive Care","Universitätsklinikum Mannheim II. Medizinische Klinik, Mannheim, Germany","https://ClinicalTrials.gov/show/NCT02812992"
349,"Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: sunitinib malate","Cancer and Leukemia Group B, Chicago, Illinois, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00397787"
350,"Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy","Completed","No Results Available","Adenocarcinoma of Pancreas","Other: Hand Therapy Until CIPN","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT05374876"
351,"QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas","Terminated","No Results Available","Adenocarcinoma of the Pancreas|Advanced Solid Tumors|Cancer|Cancer of Pancreas|Cancer of the Pancreas|Metastases|Metastatic Cancer|Metastatic Pancreatic Cancer|Pancreas Cancer|Pancreatic Cancer|Bone Metastases|Endocrine Cancer|Oncology|Oncology Patients|Solid Tumors|Advanced Malignancy","Drug: AMG 479|Drug: Placebo|Drug: gemcitabine","Research Site, Fullerton, California, United States|Research Site, La Jolla, California, United States|Research Site, Los Angeles, California, United States|Research Site, Los Angeles, California, United States|Research Site, Rancho Mirage, California, United States|Research Site, Redondo Beach, California, United States|Research Site, Santa Maria, California, United States|Research Site, Chicago, Illinois, United States|Research Site, Harvey, Illinois, United States|Research Site, Quincy, Illinois, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Detroit, Michigan, United States|Research Site, Grand Rapids, Michigan, United States|Research Site, Durham, North Carolina, United States|Research Site, Bend, Oregon, United States|Research Site, Providence, Rhode Island, United States|Research Site, Providence, Rhode Island, United States|Research Site, Charleston, South Carolina, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Fort Worth, Texas, United States|Research Site, Paris, Texas, United States|Research Site, Abingdon, Virginia, United States|Research Site, Spokane Valley, Washington, United States|Research Site, Kogarah, New South Wales, Australia|Research Site, South Brisbane, Queensland, Australia|Research Site, Kurralta Park, South Australia, Australia|Research Site, Woodville South, South Australia, Australia|Research Site, Bentleigh East, Victoria, Australia|Research Site, Parkville, Victoria, Australia|Research Site, Innsbruck, Austria|Research Site, Salzburg, Austria|Research Site, Steyr, Austria|Research Site, Wien, Austria|Research Site, Bruxelles, Belgium|Research Site, Charleroi, Belgium|Research Site, Edegem, Belgium|Research Site, Gent, Belgium|Research Site, Leuven, Belgium|Research Site, Libramont, Belgium|Research Site, Salvador, Bahia, Brazil|Research Site, Curitba, ParanÃ¡, Brazil|Research Site, Porto Alegre, Rio Grande do Sul, Brazil|Research Site, ItajaÃ-, Santa Catarina, Brazil|Research Site, SÃ£o Paulo, Brazil|Research Site, Sofia, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Varna, Bulgaria|Research Site, Vancouver, British Columbia, Canada|Research Site, Oshawa, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Quebec, Canada|Research Site, Brno, Czech Republic|Research Site, Brno, Czech Republic|Research Site, Hradec Kralove, Czech Republic|Research Site, Olomouc, Czech Republic|Research Site, Praha 2, Czech Republic|Research Site, Praha 5, Czech Republic|Research Site, Aalborg, Denmark|Research Site, Herlev, Denmark|Research Site, Odense, Denmark|Research Site, HUS, Finland|Research Site, Lahti, Finland|Research Site, Tampere, Finland|Research Site, Turku, Finland|Research Site, BesanÃ§on Cedex, France|Research Site, Brest cedex, France|Research Site, Clermont Ferrand Cedex 1, France|Research Site, Pessac Cedex, France|Research Site, Berlin, Germany|Research Site, Dresden, Germany|Research Site, Halle (Saale), Germany|Research Site, Mainz, Germany|Research Site, Mannheim, Germany|Research Site, Marburg, Germany|Research Site, MÃ¼nster, Germany|Research Site, Villingen-Schwenningen, Germany|Research Site, Athens, Greece|Research Site, Heraklion, Greece|Research Site, Patra, Greece|Research Site, Thessaloniki, Greece|Research Site, Kowloon, Hong Kong|Research Site, Sha Tin, Hong Kong|Research Site, Tuen Mun, Hong Kong|Research Site, Budapest, Hungary|Research Site, Budapest, Hungary|Research Site, Debrecen, Hungary|Research Site, Gyor, Hungary|Research Site, Miskolc, Hungary|Research Site, Genova, Italy|Research Site, Messina, Italy|Research Site, Napoli, Italy|Research Site, San Giovanni Rotondo FG, Italy|Research Site, Nagoya-city, Aichi, Japan|Research Site, Kashiwa, Chiba, Japan|Research Site, Yokohama-city, Kanagawa, Japan|Research Site, Sunto-gun, Shizuoka, Japan|Research Site, Mitaka-city, Tokyo, Japan|Research Site, Tokyo, Japan|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Kaunas, Lithuania|Research Site, Vilnius, Lithuania|Research Site, Amsterdam, Netherlands|Research Site, Eindhoven, Netherlands|Research Site, Groningen, Netherlands|Research Site, Leiden, Netherlands|Research Site, Gdansk, Poland|Research Site, Konin, Poland|Research Site, Lodz, Poland|Research Site, Poznan, Poland|Research Site, Warszawa, Poland|Research Site, Warszawa, Poland|Research Site, Warszawa, Poland|Research Site, Barreiro, Portugal|Research Site, Lisboa, Portugal|Research Site, Lisboa, Portugal|Research Site, Porto, Portugal|Research Site, Porto, Portugal|Research Site, Bucharest, Romania|Research Site, Cluj Napoca, Romania|Research Site, Cluj-Napoca, Romania|Research Site, Sibiu, Romania|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Saint Petersburg, Russian Federation|Research Site, Belgrade, Serbia|Research Site, Belgrade, Serbia|Research Site, Sremska Kamenica, Serbia|Research Site, Bardejov, Slovakia|Research Site, Bratislava, Slovakia|Research Site, Kosice, Slovakia|Research Site, Nitra, Slovakia|Research Site, Poprad, Slovakia|Research Site, Ljubljana, Slovenia|Research Site, Ljubljana, Slovenia|Research Site, Santander, Cantabria, Spain|Research Site, Badalona, CataluÃ±a, Spain|Research Site, Barcelona, CataluÃ±a, Spain|Research Site, Barcelona, CataluÃ±a, Spain|Research Site, Elche, Comunidad Valenciana, Spain|Research Site, Valencia, Comunidad Valenciana, Spain|Research Site, A CoruÃ±a, Galicia, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Eskilstuna, Sweden|Research Site, LinkÃ¶ping, Sweden|Research Site, Uppsala, Sweden|Research Site, Basel, Switzerland|Research Site, Geneva 14, Switzerland|Research Site, Winterthur, Switzerland|Research Site, Niaosong Township, Kaohsiung, Taiwan|Research Site, Taipei City, Taipei, Taiwan|Research Site, Gueishan Township, Taoyuan, Taiwan|Research Site, Belfast, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Cottingham, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Northampton, United Kingdom","https://ClinicalTrials.gov/show/NCT01231347"
352,"Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer","Recruiting","No Results Available","Advanced Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Gemcitabine|Drug: Hydroxychloroquine|Drug: Nab-paclitaxel|Drug: Paricalcitol","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hosptial, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT04524702"
353,"A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas","Drug: Paricalcitol|Drug: Abraxane|Drug: Gemcitabine","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02030860"
354,"First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Cancer|Locally Advanced Pancreatic Adenocarcinoma","Drug: [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.","University of California Davis, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT04665947"
355,"AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Cancer|Locally Advanced Pancreatic Adenocarcinoma","Drug: Nab paclitaxel plus gemcitabine|Drug: mFOLFIRINOX","Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04617821"
356,"Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: CXCR4 Antagonist BL-8040|Biological: Pembrolizumab|Other: Pharmacological Study","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02907099"
357,"Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas","Terminated","No Results Available","Pancreatic Cancer|Neoplasm Metastasis|Adenocarcinoma","Drug: talabostat mesylate tablets|Drug: gemcitabine","Northwest Alabama Cancer Center, PC, Florence, Alabama, United States|Northwest Alabama Cancer Center, PC, Muscle Shoals, Alabama, United States|Oncology Associates, PC, Hartford, Connecticut, United States|Palm Beach Institute of Hematology and Oncology, Boynton Beach, Florida, United States|Cancer Center of Florida, Ocoee, Florida, United States|Hematology Oncology Associates of Central Brevard, Rockledge, Florida, United States|Gulfcoast Oncology Associates, St. Petersburg, Florida, United States|Yagnesh V. Oza, MD, Mt. Vernon, Illinois, United States|Indiana Oncology Hematology Consultants, Indianapolis, Indiana, United States|Cancer Care Center, Inc., New Albany, Indiana, United States|Medical Oncology LLC, Baton Rouge, Louisiana, United States|Huron Medical Center, Port Huron, Michigan, United States|Billings Clinic, Billings, Montana, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|New York Oncology Hematology/Albany Regional Cancer Center, Albany, New York, United States|Hematology-Oncology Associates of Rockland, New City, New York, United States|Dayton Oncology and Hematology, Kettering, Ohio, United States|Lawrence M. Stallings, MD, Wooster, Ohio, United States|Trilogy Cancer Center, Wooster, Ohio, United States|Providence Portland Medical Center, Portland, Oregon, United States|Oregon Clinic, The, Portland, Oregon, United States|Cancer Center of the Carolinas, Greenville, South Carolina, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States|Texas Oncology, PA, Presbyterian, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Elkins Pancreas Center, Houston, Texas, United States|Saint Luke's Episcopal Hospital, Houston, Texas, United States|Cancer Care Northwest, Spokane, Washington, United States","https://ClinicalTrials.gov/show/NCT00116389"
358,"Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas","Unknown status","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Radiation: brachytherapy|Radiation: phosphorus P32|Radiation: radiation therapy","USF Physician's Group, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT00079365"
359,"Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses","Completed","No Results Available","Adenocarcinoma Pancreas|Chronic Pancreatitis",,"Department of Surgical Gastroenterology, Gentofte & Herlev Hospital, University of Copenhagen, Copenhagen, Denmark|Center for Surgical Ultrasound, Department of Surgery, Odense University Hospital, Odense, Denmark|Paoli-Calmettes Institut, Marseilles, France|Caritas-Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany|SRH Wald-Klinikum, Gera, Germany|Department of Internal Medicine II, Hospital Meiningen, Meiningen, Germany|Helios Klinikum, University of Witten/Herdecke, Wuppertal, Germany|Gastroenterology and Gastrointestinal Endoscopy Unit, Vita Salute San Raffaele University, Milan, Italy|Insitute of Medicine, University of Bergen and National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway|Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest, Romania|Gastroenterology Department, University of Medicine and Pharmacy, Craiova, Romania|University Hospital, Santiago de Compostela, Santiago de Compostela, Spain|Hepatobiliary Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom|Institute of Hepatology, University College London, London, United Kingdom","https://ClinicalTrials.gov/show/NCT01315548"
360,"Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas","Completed","No Results Available","Stage IVA Pancreatic Cancer|Stage III Pancreatic Cancer|Adenocarcinoma of the Pancreas","Drug: fluorouracil|Drug: gemcitabine","Radiation Oncology Branch, Bethesda, Maryland, United States|Surgery Branch, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00020345"
361,"Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)","Completed","No Results Available","Cancer of Pancreas|Chemotherapy Effect|Metastatic Pancreatic Cancer","Drug: Gemcitabine fluorouracil","Menoufia University, Faculty of medicine, Shebin Elkom, Menoufia, Egypt","https://ClinicalTrials.gov/show/NCT04769414"
362,"Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas","Completed","Has Results","Pancreatic Cancer","Drug: Oxaliplatin|Drug: Irinotecan|Drug: 5-FU|Drug: Gemcitabine|Radiation: Radiation Therapy","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01560949"
363,"Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer","Completed","Has Results","Pancreatic Adenocarcinoma Non-resectable|Pancreatic Adenocarcinoma Metastatic|Colorectal Cancer Metastatic","Biological: RENCA macrobeads","Weill Cornell Medical Center / The Rogosin Institute, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01053013"
364,"Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: erlotinib hydrochloride|Drug: selumetinib|Other: laboratory biomarker analysis","UCSF-Mount Zion, San Francisco, California, United States|Ohio State University Medical Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT01222689"
365,"A Study of CP-4126 in Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Advanced Adenocarcinoma of Pancreas","Drug: IV CP-4126","Clinique d'Oncologie Médicale, Institut Jules Bordet, Brussels, Belgium|Oslo University Hospital, The Norwegian Radium Hospital,, Oslo, Norway|Oslo University Hospital, Ullevål, Oslo, Norway","https://ClinicalTrials.gov/show/NCT00913198"
366,"Dasatinib in Treating Patients With Metastatic Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: dasatinib|Procedure: laboratory biomarker analysis|Procedure: physiologic testing","Case Western Reserve University, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00474812"
367,"Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy","Active, not recruiting","Has Results","Germline BRCA1/2 Mutations and|Metastatic Adenocarcinoma of the Pancreas","Drug: Olaparib|Drug: Placebo","Research Site, Gilbert, Arizona, United States|Research Site, Orange, California, United States|Research Site, Stanford, California, United States|Research Site, Aurora, Colorado, United States|Research Site, New Haven, Connecticut, United States|Research Site, Boca Raton, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Chicago, Illinois, United States|Research Site, Baltimore, Maryland, United States|Research Site, Boston, Massachusetts, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Commack, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, Columbus, Ohio, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Houston, Texas, United States|Research Site, Seattle, Washington, United States|Research Site, Campbelltown, Australia|Research Site, Randwick, Australia|Research Site, St Leonards, Australia|Research Site, Antwerpen, Belgium|Research Site, Brussel, Belgium|Research Site, Leuven, Belgium|Research Site, London, Ontario, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Sherbrooke, Quebec, Canada|Research Site, Toronto, Canada|Research Site, Amiens, France|Research Site, Besançon, France|Research Site, Bordeaux, France|Research Site, Brest Cedex, France|Research Site, Clichy Cedex, France|Research Site, La Roche sur Yon, France|Research Site, Lille, France|Research Site, Lyon Cedex 03, France|Research Site, Nice, France|Research Site, Paris CEDEX 14, France|Research Site, Paris, France|Research Site, Poitiers, France|Research Site, STRASBOURG Cedex, France|Research Site, Toulouse, France|Research Site, Villejuif, France|Research Site, Berlin, Germany|Research Site, Berlin, Germany|Research Site, Bochum, Germany|Research Site, Bonn, Germany|Research Site, Dresden, Germany|Research Site, Frankfurt am Main, Germany|Research Site, Hamburg, Germany|Research Site, Hamburg, Germany|Research Site, Hannover, Germany|Research Site, Leipzig, Germany|Research Site, München, Germany|Research Site, Schweinfurt, Germany|Research Site, Ulm, Germany|Research Site, Beer Sheva, Israel|Research Site, Haifa, Israel|Research Site, Holon, Israel|Research Site, Nahariya, Israel|Research Site, Petah Tikva, Israel|Research Site, Ramat Gan, Israel|Research Site, Rehovot, Israel|Research Site, Tel Aviv, Israel|Research Site, Zefir, Israel|Research Site, Bologna, Italy|Research Site, Milano, Italy|Research Site, Milano, Italy|Research Site, Padova, Italy|Research Site, Parma, Italy|Research Site, Pescara, Italy|Research Site, Roma, Italy|Research Site, Roma, Italy|Research Site, San Giovanni Rotondo, Italy|Research Site, Verona, Italy|Research Site, Seongnam-si, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Amsterdam, Netherlands|Research Site, Barcelona, Spain|Research Site, Girona, Spain|Research Site, L'Hospitalet de Llobregat, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Málaga, Spain|Research Site, Pamplona, Spain|Research Site, Sabadell, Spain|Research Site, Santiago de Compostela, Spain|Research Site, Valencia, Spain|Research Site, Zaragoza, Spain|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Northwood, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT02184195"
368,"Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer","Completed","No Results Available","Ductal Adenocarcinoma of the Pancreas","Drug: Gem/nab-Pac|Drug: FOLFIFINOX","Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfranken, Würzburg, Bayern, Germany","https://ClinicalTrials.gov/show/NCT02125136"
369,"Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Resectable Pancreatic Adenocarcinoma|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8","Biological: Durvalumab|Drug: Gemcitabine|Drug: Nab-paclitaxel|Biological: Oleclumab","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04940286"
370,"Pre-operative Treatment for Patients With Untreated Pancreatic Cancer","Active, not recruiting","No Results Available","Resectable Pancreatic Cancer|Unresectable Pancreatic Cancer|Pancreatic Adenocarcinoma|Neoadjuvant Pancreatic Cancer","Drug: Paclitaxel Protein Bound (Abraxane)","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT03138720"
371,"A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.","Withdrawn","No Results Available","Metastatic Pancreatic Adenocarcinoma|Pancreatic Cancer|Metastatic Pancreatic Cancer","Drug: 90Y-hPAM4|Drug: 90Y-hPAM4 + gemcitabine","Banner Healthcare, Gilbert, Arizona, United States|Scottsdale Healthcare, Scottsdale, Arizona, United States|Christiana Care Health Services Helen Graham Cancer Center, Newark, Delaware, United States|Sylvester Comprehensive Cancer Center Univ. Miami, Miami, Florida, United States|Jackson North Medical Center, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Winship Cancer Institute, Atlanta, Georgia, United States|Mountain States Tumor Institute, Boise, Idaho, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Detroit Clinical Research Center, Detroit, Michigan, United States|St. Mary's Trinity Healthcare, Grand Rapids, Michigan, United States|New Mexico Cancer Care Alliance, Albuquerque, New Mexico, United States|Weill Cornell NY Presbyterian Hospital, New York, New York, United States|Mt. Sinai Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of North Carolina Medical Center, Chapel Hill, North Carolina, United States|Ohio State University Medical Center, Columbus, Ohio, United States|Kimmel Cancer Center at Jefferson University, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|Institute of Translational Oncology Research, Greenville, South Carolina, United States|Tyler Cancer Center, Tyler, Texas, United States|VA Oncology Associates, Norfolk, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01510561"
372,"Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas","Unknown status","No Results Available","Carcinoma, Pancreatic Ductal","Other: samples of blood, saliva and urine","Rambam - health care campus, Haifa, Israel","https://ClinicalTrials.gov/show/NCT02817308"
373,"Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas","Unknown status","No Results Available","Pancreatic Cancer|Nab-paclitaxel|Gemcitabine|S1","Drug: S1 or Gemcitabine","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China","https://ClinicalTrials.gov/show/NCT03779464"
374,"Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Unresectable Pancreatic Carcinoma","Drug: Adavosertib|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Nab-paclitaxel|Other: Pharmacological Study|Other: Placebo Administration","Northwestern University, Chicago, Illinois, United States|Case Western Reserve University, Cleveland, Ohio, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT02194829"
375,"Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas","Completed","Has Results","Metastatic Pancreatic Cancer","Drug: Gemcitabine, nab-Paclitaxel, GDC-0449","Translational Genomics Research Institute (TGen), Scottsdale, Arizona, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01088815"
376,"CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: 6,8-bis(benzylthio)octanoic acid","Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01839981"
377,"OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas","Withdrawn","No Results Available","Pancreatic Cancer, Metastatic","Drug: Gemcitabine, Erlotinib, OSI-906|Drug: Gemcitabine, Erlotinib","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01600807"
378,"Durvalumab Plus ""Booster"" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)","Withdrawn","No Results Available","Metastatic Pancreas Cancer","Drug: Durvalumab|Radiation: Radiation Therapy",,"https://ClinicalTrials.gov/show/NCT02885727"
379,"Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas","Withdrawn","No Results Available","Metastatic Pancreatic Cancer",,,"https://ClinicalTrials.gov/show/NCT02205788"
380,"Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas","Recruiting","No Results Available","Pancreatic Cancer","Drug: Cyclophosphamide|Biological: GVAX pancreatic cancer|Drug: Nivolumab|Drug: Urelumab|Drug: BMS-986253","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02451982"
381,"Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas","Recruiting","No Results Available","Pancreatic Cancer|Metastasis|Surgery|Oligometastatic Disease","Drug: nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)","University Aachen, Aachen, Germany|University of Berlin, Charité, Campus Benjamin-Franklin, Berlin, Germany|University of Bonn, Bonn, Germany|Städtisches Klinikum Dresden, Dresden, Germany|University of Düsseldorf, Düsseldorf, Germany|University of Freiburg, Freiburg, Germany|University of Halle (Saale), Halle (Saale), Germany|Klinikum Großhadern, LMU München, München, Germany|Klinikum Rechts der Isar Technische Universität München, München, Germany|University of Regensburg, Regensburg, Germany","https://ClinicalTrials.gov/show/NCT04617457"
382,"Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas","Completed","No Results Available","Pancreatic Cancer Metastatic","Drug: CPI 613, mFolfirinox|Drug: Folfirinox","Banner MD Anderson Cancer Center, Gilbert, Arizona, United States|The University of Arizona Cancer Center, Tucson, Arizona, United States|City of Hope, Duarte, California, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, United States|UCLA Medical Center, Los Angeles, California, United States|Pacific Hematology Oncology Associates, San Francisco, California, United States|Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, United States|Georgetown University Medical Center, Washington, District of Columbia, United States|Mayo Clinic Hospital, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Northwestern Memorial Hospital - Arkes Family Pavilion, Chicago, Illinois, United States|University of Chicago, Harvey, Illinois, United States|The University of Kansas Cancer Center - Clinical Research Center - Fairway Office Park, Fairway, Kansas, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|University of Micihgan, Ann Arbor, Michigan, United States|Karmanos cancer Center, Detroit, Michigan, United States|Mayo Clinic Cancer Center (MCCC), Rochester, Minnesota, United States|Washington University, Saint Louis, Missouri, United States|Comprehensive Cancer centers of Nevada, Las Vegas, Nevada, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|Atlantic Health System, Morristown, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|New York University Langone Medical Center, New York, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Levine cancer Institute, Charlotte, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States|Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio, United States|University Hospitals - Seidman Cancer Center, Cleveland, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|University of Pittsburgh-Hillman cancer ceter, Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center-Henry-Joyce Cancer Clinic, Nashville, Tennessee, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Huntsman cancer Institute, Salt Lake City, Utah, United States|University of Virginia Cancer Center - Emily Couric Clinical Cancer Center, Charlottesville, Virginia, United States|VCU Massey Cancer Center, Richmond, Virginia, United States|Blue Ridge Cancer Care, Roanoke, Virginia, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|Hôpital Erasme, Bruxelles, Brussel, Belgium|UZ Leuven, Leuven, VBR, Belgium|CHRU Brest - Hôpital Morvan, Brest, France|Hôpital Beaujon, Clichy, France|Centre Hospitalier Départemental Vendée - Hôpital de la Roche-sur-Yon, La Roche-sur-Yon, France|L'ICM, Institut régional du Cancer de Montpellier, Montpellier, France|CHU de Nantes - Hôpital Nord Laennec, Nantes Cedex 1, France|CHU Hopitaux de Bordeaux - Hôpital Saint-André, Pessac, France|CHU de Poitiers, Poitiers, France|Centre Eugène Marquis, Rennes, France|Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France|Gustave Roussy Cancer Campus Grand Paris (Institut de Cancerologie Gustave-Roussy), Villejuif, France|SLK-Kliniken Heilbronn GmbH, Heilbronn, BW, Germany|Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Hillel Yaffe Medical Center, Hadera, Haifa, Israel|Rambam Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Sanz Medical Center - Laniado Hospital, Netanya, Israel|The Chaim Sheba Medical Center - Sheba Cancer Research Center (SCRC), Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Assaf-Harofeh Medical Center, Zerifin, Israel|The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital), Seocho, Seoul, Korea, Republic of|Seoul National University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Gachon University Gil Hospital, Incheon, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Severance Hospital - Yonsei Cancer Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|National Cancer Center, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03504423"
383,"Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: Cyclophosphamide|Drug: GVAX|Drug: Pembrolizumab|Drug: IMC-CS4","Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03153410"
384,"Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: Cisplatin|Drug: Gemcitabine|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Veliparib","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada|Shaare Zedek Medical Center, Jerusalem, Israel|Chaim Sheba Medical Center, Tel Hashomer, Israel","https://ClinicalTrials.gov/show/NCT01585805"
385,"Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: oxaliplatin|Drug: irinotecan|Drug: leucovorin|Drug: 5-fluorouracil|Drug: capecitabine|Radiation: radiation|Procedure: surgery|Drug: gemcitabine","UC San Diego Moores Cancer Center, La Jolla, California, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Mayo Clinic, Rochester, Minnesota, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University Pointe, West Chester, Ohio, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01821612"
386,"Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint","Terminated","Has Results","Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer|Pancreatic Cancer","Drug: Gemcitabine|Drug: panitumumab",,"https://ClinicalTrials.gov/show/NCT00613730"
387,"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic Cancer","Recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma|Locally Advanced Unresectable Pancreatic Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma","Radiation: Hypofractionated Radiation Therapy|Drug: Peposertib|Other: Placebo Administration","City of Hope Comprehensive Cancer Center, Duarte, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Northwestern University, Chicago, Illinois, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Truman Medical Centers, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|Wake Forest University at Clemmons, Clemmons, North Carolina, United States|Wake Forest Baptist Health - Wilkes Medical Center, Wilkesboro, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT04172532"
388,"Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer","Drug: siG12D LODER","Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Organization, Jerusalem, Israel|Sheba Medical Center, Ramat Gan, Israel","https://ClinicalTrials.gov/show/NCT01188785"
389,"Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas","Completed","Has Results","Metastatic Pancreatic Cancer","Drug: Albumin-bound paclitaxel (ABI-007)|Drug: Gemcitabine","UAB Comprenhensive Cancer Center at University of Alabama, Birmingham, Alabama, United States|Clearview Cancer Institute Oncology Specialities, P.C., Huntsville, Alabama, United States|TGEN Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States|Mayo Clinic-Scottsdale, Scottsdale, Arizona, United States|Northern Arizona Hematology and Oncology Associates-AOA, Sedona, Arizona, United States|Arizona Cancer Center, University of Arizona, Tucson, Arizona, United States|Genesis Cancer Center, Hot Springs, Arkansas, United States|Tower Cancer Research Foundation, Beverly Hills, California, United States|City of Hope, Duarte, California, United States|Pacific Shores Medical Group, Long Beach, California, United States|UCLA, Los Angeles, California, United States|Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Rocky Mountain Cancer Center, Denver, Colorado, United States|University Cancer Institute, LLC, Boynton Beach, Florida, United States|Collaborative Research Group, Boynton Beach, Florida, United States|FL Cancer Specialist, Fort Myers, Florida, United States|Lakeland Regional Cancer Center, Lakeland, Florida, United States|Ocala Oncology Center, Ocala, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Lake County Oncology and Hematology, Tavares, Florida, United States|Phoebe Putney Cancer Center, Albany, Georgia, United States|Northeast Georgia Cancer Care, LLC, Athens, Georgia, United States|Piedmont Hospital Research Institute, Atlanta, Georgia, United States|Georgia Cancer Specialists, Atlanta, Georgia, United States|Atlanta Cancer Care, Atlanta, Georgia, United States|Cancer Care & Hemaotology Specialists of Chicagoland, Arlington Heights, Illinois, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Cancer Care & Hematology Specialists of Chicagoland, Niles, Illinois, United States|Illinois Cancer Care, Peoria, Illinois, United States|Orchard Research, Skokie, Illinois, United States|Indiana University Simon Cancer Center, Indianapolis, Indiana, United States|Hutchinson Clinic, PA, Hutchinson, Kansas, United States|Owsley Brown Frazier Cancer Center, Louisville, Kentucky, United States|Hematology Oncology Clinic, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Central Maine Medical Center, Lewiston, Maine, United States|Mercy Hospital Portland, ME, Portland, Maine, United States|Maine Center for Cancer Medicine, Scarborough, Maine, United States|Sidney Kimmel Comphrensive Cancer Center, John Hopkins University, Baltimore, Maryland, United States|Center for Cancer & Blood Disorders, Bethesda, Maryland, United States|Lahey Clinic, Burlington, Massachusetts, United States|Cancer Center of Excellence/University of MA Medical School, Worcester, Massachusetts, United States|St. Mary's/ Duluth Clinic, Duluth, Minnesota, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, United States|Saint Louis University, Saint Louis, Missouri, United States|St. John's Medical Research Institute, Springfield, Missouri, United States|The Center for Cancer and Hematologic Disease, Cherry Hill, New Jersey, United States|Hem Onc Associates-NM, Albuquerque, New Mexico, United States|University of New Mexico, Albuquerque, New Mexico, United States|New York Oncology Hematology PC, Albany, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Arena Oncology Associates, PC, Lake Success, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Piedmont Hematology Oncology, Winston-Salem, North Carolina, United States|Oncology Hematology Care, Cincinnati, Ohio, United States|Mid Ohio Oncology/Hematology Inc, Columbus, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Signal Point Clinical Research Center, LLC, Middletown, Ohio, United States|Cancer Centers of SW OK, Lawton, Oklahoma, United States|University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, United States|Mercy Physicians of Oklahoma, Oklahoma City, Oklahoma, United States|Cancer Care Associates- Tulsa, Tulsa, Oklahoma, United States|St. Mary Medical Center Hem-Onc Group, PC, Langhorne, Pennsylvania, United States|University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, United States|South Carolina Oncology Associates, Columbia, South Carolina, United States|Chattanooga Oncology Hematology Associates, Chattanooga, Tennessee, United States|Tennessee Oncology, Nashville, Tennessee, United States|Medical City Dallas-US Oncology, Dallas, Texas, United States|Texas Oncology, PA, Dallas, Texas, United States|Texas Oncology, PA/ Methodist Charlton Cancer Center, Dallas, Texas, United States|Texas Oncology Laboratories, Fort Worth, Texas, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States|The University of Texas Medical School at Houston, Houston, Texas, United States|Texas Oncology- Plano East, Plano, Texas, United States|Texas Oncology, PA, Round Rock, Texas, United States|Texas Oncology-Round Rock, Round Rock, Texas, United States|South Texas Oncology and Hematology, P.A, San Antonio, Texas, United States|Texas Oncology, PA, Wichita Falls, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Fairfax-Northern Virginia Hematology-Oncology, P.C., Fairfax, Virginia, United States|Virginia Cancer Specialist, PC, Fairfax, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Swedish Health Services, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Evergreen Hematology & Oncology, Spokane, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Macarthur Cancer Therapy Center, Campbelltown, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St. Vincent's Hospital, Darlinghurst, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Newcastle Hospital, Waratah, New South Wales, Australia|Southern Medical Day Care Centre, Wollongong, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Haemotology & Oncology Australasia (HOCA), Milton, Queensland, Australia|Haematology Oncology Clinics of Australasia-Gold Coast, Milton, Queensland, Australia|Adelaide Cancer Centre (T/A Ashford Cancer Ctr), Ashford, South Australia, Australia|Flinders Medical Center, Bedford Park, South Australia, Australia|Calvary North Adelaide Hospital, North Adelaide, South Australia, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Medical Oncology Unit, Bendigo Health, Bendigo, Victoria, Australia|Monash Medical Centre, East Bentleigh, Victoria, Australia|Western Hospital, Footscray, Victoria, Australia|Peninsula Oncology Centre, Frankston, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Border Medical Oncology, Wodonga, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Perth, Western Australia, Australia|Krankenhaus der Barmherzigen Schwestern Linz, Linz, Austria|Landesklinikum St. Pölten, St. Pölten, Austria|Medizinische Universität Wien, Vienna, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, Austria|Imelda VZW , Gastro-Enterology, Bonheiden, Belgium|Hôpital Erasme, Gastro-Enterology, Brussels, Belgium|AZ Groeninge - Campus Sint-Niklaas, Kortrijk, Belgium|H.-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium|Tom Baker Cancer Centre, Calgary, Alberta, Canada|BC Cancer Agency-Vancouver, Vancouver, British Columbia, Canada|The Royal Victoria Hospital-Barrie, Barrie, Ontario, Canada|Hopital du Sacre-Coeur, Montreal, Quebec, Canada|Centre Hospitalier de L'Universite de Montreal St-Luc, Montreal, Canada|Princess Margaret Hospital, Ontario, Canada|Hotel-Dieu de Quebec, Quebec, Canada|Centre Regional de lutte contre le cancer Paul Papin, Angers, France|Hôpital Saint Antoine, Paris, France|Hôpital Beaujon, Paris, France|Kliniken Essen-Mitte, Essen, Germany|Klinikum Freising, Freising, Germany|Praxis für Innere Medizin, Dr. Oettle Helmut, Friedrichshafen, Germany|LMU Klinikum der Universität, Munich, Germany|Klinikum Oldenburg, Oldenburg, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|I.R.C.C.S. ""Giovanni Paolo II"" - Istituto Oncologico, Bari, Italy|E. O. Ospedali Galliera, Struttura Complessa Oncologia Medica, Genova, Italy|Nazionale per la Ricerca sul Cancro, Genova, Italy|Fondazione Centro San Raffaele del Monte Tabor, Milano, Italy|Oncologia Medica Falck, Milano, Italy|Istituto Oncologico Veneto, Padova, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Azienda Ospedaliero universitaria Pisana, Pisa, Italy|Arcispedale Santa Maria Nuova, Unità Operativa di Oncologia Medica, Reggio Emilia, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|Istituto Nazionale Tumori ""Regina Elena"", Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Foggia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|Med Radiological Centre of the Russian Academy of Med Sciences, Obninsk, Kaluga Region, Russian Federation|Tatarstan Republican Onc Ctr, Kazan, Republic Of Tatarstan, Russian Federation|Altai Territorial Oncological Center, Barnaul, Russian Federation|Chelyabinsk Regional Onc Ctr, Chelyabinsk, Russian Federation|Ivanovo Regional Oncology Center, Ivanovo, Russian Federation|Regional Oncological Center # 2, Magnitogorsk, Russian Federation|Moscow Municipal Onc Hosp #62, Moscow Region, Russian Federation|Moscow City Clinical Hosp #57 Chemotherapy Dept, Moscow, Russian Federation|Blokhin Cancer Research Center, Moscow, Russian Federation|Russian Res Ctr of Radiology under the Fed Agency for Hi-Tech Med Care, Moscow, Russian Federation|Russian Research Ctr of Surgery n.a. B.V. Petrovskiy under the Russian Academy of Med Sciences, Moscow, Russian Federation|Central Clinical Hosp of the President of the Russian Federation, Moscow, Russian Federation|Semashko Central Hosp #2, Moscow, Russian Federation|Omsk Regional Onc Ctr, Omsk, Russian Federation|Orenburg Regional Onc Ctr, Orenburg, Russian Federation|Pyatigorsk Affiliate of Stavropol Regional Onc Ctr, Pyatigorsk, Russian Federation|St. Petersburg State Med Academy n.a.Mechnikov, St Petersburg, Russian Federation|Russian Research Ctr for Radiology and Surgical Technologies, St Petersburg, Russian Federation|Clinical Hosp # 122 n.a. L.G. Sokolov, St. Petersburg, Russian Federation|Leningrad Regional Clinical Hosp, St. Petersburg, Russian Federation|St. Petersburg City Onc Ctr, St. Petersburg, Russian Federation|Tula Regional Oncology Center, Tula, Russian Federation|Bashkortostan Republican Onc Ctr, Ufa, Russian Federation|Yaroslavl Regional Onc Ctr, Yaroslavl, Russian Federation|Hospital Vall D´Hebron, Barcelona, Spain|Hospital Clinic i Provincial, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Centro Integral Oncológico Clara Campal, Madrid, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Dnepropetrovsk City Hosp #4, Dnepropetrovsk, UK, Ukraine|Donetsk Regional Antitumor Ctr, Donetsk, UK, Ukraine|Kirovohrad Regional Oncology Center, Department of Chemotherapy, Kirovohrad, UK, Ukraine|National Institute of Cancer, Department of Tumors of Abdominal Cavity and Retroperitoneum, Kyiv, UK, Ukraine|Kyiv City Clinical Hospital #10, Center for Hepatic, Bile Duct and Pancreatic Surgery, Kyiv, UK, Ukraine|Volyn Regional Oncology Center Department of Oncochemotherapy, Lutsk, UK, Ukraine|Lviv Regional Diagnostics and Treatment and Diagnostics Onc Ctr, Lviv, UK, Ukraine|O.F. Herbachevskyi Regional Clinical Hospital, Surgery Center, Zhytomyr, UK, Ukraine|Kharkov Regional Onc Ctr, Kharkov, Ukraine|Kherson Regional Onc Ctr, Kherson, Ukraine|Odessa Regional Onc Ctr, Odessa, Ukraine|Zaporizhia Medical Academy of Postgraduate Education, Zaporizhia, Ukraine","https://ClinicalTrials.gov/show/NCT00844649"
390,"Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: Cyclophosphamide|Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1/GM-Neo vaccine|Radiation: Stereotactic Body Radiation (SBRT)|Drug: FOLFIRINOX","The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01595321"
391,"A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas","Terminated","Has Results","Pancreatic Cancer","Drug: Gemcitabine|Radiation: Radiation therapy|Procedure: pancreaticoduodenectomy","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States","https://ClinicalTrials.gov/show/NCT01240304"
392,"Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas","Terminated","No Results Available","Pancreatic Neoplasms","Drug: TNP-470","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00038701"
393,"Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma","Completed","No Results Available","Cancer|Pancreas","Radiation: Radiation Therapy|Drug: Capecitabine|Drug: Oxaliplatin","Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00707278"
394,"Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma","Biological: Anetumab Ravtansine|Drug: Gemcitabine Hydrochloride|Biological: Ipilimumab|Biological: Nivolumab","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States|Northwestern University, Chicago, Illinois, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Truman Medical Centers, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|M D Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03816358"
395,"Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Adenocarcinoma|Inoperable Disease|Localized Pancreatic Adenocarcinoma","Drug: SCO-101|Drug: Gemcitabine|Drug: Nab paclitaxel","Aalborg University Hospital, Aalborg, Denmark|Odense Universitetshospital, Odense, Denmark|Catholic Hospital Bochum - St. Josef-Hospital, Bochum, Germany|University Hospital Of Ulm, Ulm, Germany","https://ClinicalTrials.gov/show/NCT04652206"
396,"Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection","Completed","No Results Available","Stage IA Pancreatic Adenocarcinoma|Stage IB Pancreatic Adenocarcinoma|Stage IIA Pancreatic Adenocarcinoma|Stage IIB Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: Metformin|Drug: placebo","Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, China","https://ClinicalTrials.gov/show/NCT02005419"
397,"Pancreatic Cancer Early Detection Program","Recruiting","No Results Available","Pancreatic Cancer|Pancreas Cancer|Pancreatic Adenocarcinoma|Familial Pancreatic Cancer|BRCA 1/2|HNPCC|Lynch Syndrome|Hereditary Pancreatitis|FAMMM|Familial Atypical Multiple Mole Melanoma|Peutz Jeghers Syndrome","Procedure: Endoscopic Ultrasound|Procedure: Magnetic Resonance Imaging (MRI)","White Plains Hospital, White Plains, New York, United States","https://ClinicalTrials.gov/show/NCT02206360"
398,"High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain","Suspended","No Results Available","Pain|Pancreatic Adenocarcinoma|Ductal Adenocarcinoma","Procedure: High intensity focused ultrasound, HIFU","University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00637364"
399,"Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer","Recruiting","No Results Available","Metastatic Lung Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Neuroendocrine Carcinoma|Metastatic Pancreatic Adenocarcinoma|Stage III Lung Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Unresectable Lung Small Cell Carcinoma|Unresectable Malignant Solid Neoplasm|Unresectable Neuroendocrine Carcinoma|Unresectable Pancreatic Adenocarcinoma","Drug: Elimusertib|Drug: Irinotecan Hydrochloride|Drug: Topotecan Hydrochloride","Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States|Yale University, New Haven, Connecticut, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04514497"
400,"Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer","Recruiting","No Results Available","Non-small Cell Lung Cancer|Advanced Pancreatic Adenocarcinoma|Unresectable Pancreatic Cancer|Ductal Adenocarcinoma of the Pancreas","Drug: AGuIX|Radiation: Radiotherapy","Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04789486"
401,"Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas","Recruiting","No Results Available","Gastric Adenocarcinoma|Adenocarcinoma of the Gastroesophageal Junction|Hepatocellular Carcinoma|Pancreatic Adenocarcinoma|Low Grade Lymphoma|Colorectal Adenocarcinoma","Dietary Supplement: Tea Made of Graviola Leaves","Auxilio Mutuo Cancer Center, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT04773769"
402,"Perioperative Therapy for Resectable Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: docetaxel|Drug: capecitabine|Radiation: intensity-modulated radiation therapy|Drug: oxaliplatin|Procedure: pancreatic surgical procedure|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis","Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00609336"
403,"PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma","Recruiting","No Results Available","Pancreas Adenocarcinoma|Pancreas Cancer",,"Universitätsklinikum Ulm, Ulm, Germany","https://ClinicalTrials.gov/show/NCT04099134"
404,"Hypofractionated Stereotactic Body Radiation Therapy and Fluorouracil or Capecitabine With or Without Zoledronic Acid in Treating Patients With Locally Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage I Pancreatic Cancer AJCC v6 and v7|Stage IA Pancreatic Cancer AJCC v6 and v7|Stage IB Pancreatic Cancer AJCC v6 and v7|Stage II Pancreatic Cancer AJCC v6 and v7|Stage IIA Pancreatic Cancer AJCC v6 and v7|Stage IIB Pancreatic Cancer AJCC v6 and v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: Capecitabine|Drug: Fluorouracil|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Radiation: Stereotactic Body Radiation Therapy|Drug: Zoledronic Acid","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT03073785"
405,"Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors","Recruiting","No Results Available","Solid Tumor|Gastric Cancer|Pancreatic Adenocarcinoma","Drug: AB011 Injection","Anhui Provincial Hospital, Hefei, Anhui, China|Beijing Cancer Hospital, Beijing, Beijing, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China|Henan Cancer Hospital, Zhengzhou, Henan, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|Xiangya Hospital Central South University, Changsha, Hunan, China|Huaihua Second People's Hospital, Huaihua, Hunan, China|Linyi Cancer Hospital, Linyi, Shandong, China|Zhongshan Hospital, Zhongshan University, Shanghai, Shanghai, China|Shanghai East Hospital, Shanghai, Shanghai, China|The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04400383"
406,"Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreas Cancer|Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma","Drug: Romidepsin|Drug: Azacitidine|Drug: nab-Paclitaxel|Drug: Gemcitabine|Drug: Durvalumab|Drug: Lenalidomide capsule","Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Universitätsmedizin Göttingen, Göttingen, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Uniklinik Köln, Köln, Germany|Ludwig-Maximilians-Universität München, München, Germany|Klinikum Nürnberg, Nürnberg, Germany|Universitätsklinikum Ulm, Ulm, Germany|Universitätsklinikum Würzburg, Würzburg, Germany","https://ClinicalTrials.gov/show/NCT04257448"
407,"A Proof-of-Concept Study Evaluating LINFU™","Recruiting","No Results Available","Pancreas Adenocarcinoma|Dysplasia","Diagnostic Test: LINFU™","Gastroenterology Associates of Sarasota, Sarasota, Florida, United States","https://ClinicalTrials.gov/show/NCT05161013"
408,"Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer","Active, not recruiting","No Results Available","Extrahepatic Bile Duct Adenocarcinoma, Biliary Type|Gallbladder Adenocarcinoma, Biliary Type|Metastatic Pancreatic Adenocarcinoma|Recurrent Cholangiocarcinoma|Recurrent Gallbladder Carcinoma|Recurrent Hepatocellular Carcinoma|Recurrent Intrahepatic Cholangiocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Gallbladder Cancer AJCC V7|Stage III Hepatocellular Carcinoma AJCC v7|Stage III Intrahepatic Cholangiocarcinoma AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IIIA Gallbladder Cancer AJCC v7|Stage IIIA Hepatocellular Carcinoma AJCC v7|Stage IIIB Gallbladder Cancer AJCC v7|Stage IIIB Hepatocellular Carcinoma AJCC v7|Stage IIIC Hepatocellular Carcinoma AJCC v7|Stage IV Gallbladder Cancer AJCC v7|Stage IV Hepatocellular Carcinoma AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Gallbladder Cancer AJCC v7|Stage IVA Hepatocellular Carcinoma AJCC v7|Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7|Stage IVB Gallbladder Cancer AJCC v7|Stage IVB Hepatocellular Carcinoma AJCC v7|Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7|Unresectable Gallbladder Carcinoma|Unresectable Pancreatic Carcinoma","Biological: Durvalumab|Drug: Guadecitabine","USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03257761"
409,"ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cancer|Resectable Pancreatic Cancer","Diagnostic Test: Germline genetic testing","Invitae SF, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT05380557"
410,"Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreas Cancer|Pancreas Metastases","Diagnostic Test: endoscopic ultrasound-guided fine needle biopsy","Gastrointestinal Unit, University of Bologna/Hospital of Imola, Bologna, Italy","https://ClinicalTrials.gov/show/NCT05226572"
411,"Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: dasatinib|Drug: gemcitabine hydrochloride|Other: laboratory biomarker analysis|Genetic: mutation analysis|Genetic: nucleic acid sequencing|Other: immunohistochemistry staining method","Central Hematology Oncology Medical Group, Inc., Alhambra, California, United States|TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center), Fullerton, California, United States|Pacific Shores Medical Group, Long Beach, California, United States|UCLA medical center, Los Angeles, California, United States|Translational Oncology Research International (TORI) Network, Los Angeles, California, United States|TORI NORTHRIDGE (North Valley Hematology/Oncology Medical Group), Northridge, California, United States|UCLA Pasadena, Pasadena, California, United States|TORI Inland Valley (Wilshire Oncology Medical Group, Inc. ), Pomona, California, United States|TORI REDONDO BEACH (Cancer Care Associates Medical Group, Inc.), Redondo Beach, California, United States|TORI SANTA BARBARA I (Santa Barbara Hematology Oncology Medical Group, Inc.), Santa Barbara, California, United States|TORI SANTA BARBARA II (SANSUM Clinic), Santa Barbara, California, United States|TORI SANTA MARIA (Central Coast Medical Oncology Corporation), Santa Maria, California, United States|UCLA Valencia, Valencia, California, United States|Suburban Hematology-Oncology Associates, P.A., Lawrenceville, Georgia, United States|Northwest Georgia Oncology Centers, P.C., Marietta, Georgia, United States|Chevy Chase Healthcare Management, LLC, Chevy Chase, Maryland, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States","https://ClinicalTrials.gov/show/NCT01234935"
412,"Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues","Unknown status","No Results Available","Pancreatic Cancer|Pancreas Adenocarcinoma","Procedure: Biopsy","Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT03544255"
413,"Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Cancer","Biological: ganitumab|Drug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatin|Other: placebo|Other: questionnaire administration",,"https://ClinicalTrials.gov/show/NCT01473303"
414,"Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer","Recruiting","No Results Available","Stage IA Pancreatic Adenocarcinoma|Stage IB Pancreatic Adenocarcinoma|Stage IIA Pancreatic Adenocarcinoma|Stage IIB Pancreatic Adenocarcinoma","Drug: nab-paclitaxel|Drug: Gemcitabine|Drug: tegafur","Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China, Shanghai, China","https://ClinicalTrials.gov/show/NCT04216758"
415,"Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Biological: panitumumab|Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride","Aurora Presbyterian Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States|St. Anthony Central Hospital, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|CCOP - Colorado Cancer Research Program, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|North Suburban Medical Center, Thornton, Colorado, United States|Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States|Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Kapiolani Medical Center at Pali Momi, Aiea, Hawaii, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|OnCare Hawaii, Incorporated - Lusitana, Honolulu, Hawaii, United States|Queen's Cancer Institute at Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Incorporated, Honolulu, Hawaii, United States|Hawaii Medical Center - East, Honolulu, Hawaii, United States|OnCare Hawaii, Incorporated - Kuakini, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Pacific Cancer Institute - Maui, Wailuku, Hawaii, United States|Illinois CancerCare - Bloomington, Bloomington%, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Illinois CancerCare - Canton, Canton, Illinois, United States|Illinois CancerCare - Carthage, Carthage, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Illinois CancerCare - Eureka, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Illinois CancerCare - Galesburg, Galesburg, Illinois, United States|Illinois CancerCare - Havana, Havana, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Illinois CancerCare - Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare - Macomb, Macomb, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Trinity Cancer Center at Trinity Medical Center - 7th Street Campus, Moline, Illinois, United States|Moline, Illinois, United States|Illinois CancerCare - Monmouth, Monmouth, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Illinois CancerCare - Pekin, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare - Peru, Peru, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Illinois CancerCare - Princeton, Princeton, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Illinois CancerCare - Spring Valley, Spring Valley, Illinois, United States|St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, United States|Elkhart Clinic, LLC, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Howard Community Hospital, Kokomo, Indiana, United States|Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States|Reid Hospital & Health Care Services, Richmond, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology-Oncology, PC - South Bend, South Bend, Indiana, United States|Saint Joseph Regional Medical Center, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|McFarland Clinic, PC, Ames, Iowa, United States|Bettendorf, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, Clive, Iowa, United States|Mercy Capitol Hospital, Des Moines, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas, PA - Liberal, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Ochsner Health Center - Bluebonnet, Baton Rouge, Louisiana, United States|Ochsner Health Center - Covington, Covington, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Ochsner Cancer Institute at Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Dickinson County Healthcare System, Iron Mountain, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, PC, Lambertville, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|Lakeside Cancer Specialists, PLLC, Saint Joseph, Michigan, United States|Lakeland Regional Cancer Care Center - St. Joseph, St. Joseph, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|Alexandria, Minnesota, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Fergus Falls Medical Group, PA, Fergus Falls, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Minnesota Oncology Hematology, PA - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic - River Campus, Saint Cloud, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|St. Francis Cancer Center at St. Francis Medical Center, Shakopee, Minnesota, United States|Regions Hospital Cancer Care Center, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Big Sky Oncology, Great Falls, Montana, United States|Great Falls Clinic - Main Facility, Great Falls, Montana, United States|Sletten Cancer Institute at Benefis Healthcare, Great Falls, Montana, United States|Great Falls, Montana, United States|Northern Montana Hospital, Havre, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology at KRMC, Kalispell, Montana, United States|Guardian Oncology and Center for Wellness, Missoula, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Immanuel Medical Center, Omaha, Nebraska, United States|Alegant Health Cancer Center at Bergan Mercy Medical Center, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|North Coast Cancer Care - Clyde, Clyde, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Community Cancer Center, Elyria, Ohio, United States|Hematology Oncology Center, Elyria, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|Fisher-Titus Medical Center, Norwalk, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anne Mercy Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Clinton Memorial Hospital, Wilmington, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|Adventist Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Cancer Institute at Geisinger Health, Danville, Pennsylvania, United States|Geisinger Hazleton Cancer Center, Hazleton, Pennsylvania, United States|Guthrie Cancer Center at Guthrie Clinic Sayre, Sayre, Pennsylvania, United States|Geisinger Medical Group - Scenery Park, State College, Pennsylvania, United States|Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States|AnMed Cancer Center, Anderson, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|Marshfield Clinic - Chippewa Center, Chippewa Falls, Wisconsin, United States|Marshfield Clinic Cancer Care at Regional Cancer Center, Eau Claire, Wisconsin, United States|Luther Midlelfort Hospital, Eau Claire, Wisconsin, United States|Midelfort Clinic - Luther, Eau Claire, Wisconsin, United States|Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center - Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Holy Family Memorial Medical Center Cancer Care Center, Manitowoc, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States|Marshfield Clinic - Lakeland Center, Minocqua, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Ministry Medical Group at Saint Mary's Hospital, Rhinelander, Wisconsin, United States|Marshfield Clinic - Indianhead Center, Rice Lake, Wisconsin, United States|Marshfield Clinic at Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Marshfield Clinic - Wausau Center, Wausau, Wisconsin, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00550836"
416,"Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Adenocarcinoma","Drug: Oxaliplatin|Drug: Docetaxel|Drug: Leucovorin|Drug: Irinotecan|Drug: 5-Fluorouracil","The University of Chicago, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04361708"
417,"Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma","Unknown status","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin","Centre Paul Papin, Angers, France|C.H.G. Beauvais, Beauvais, France|Hopital Saint Andre, Bordeaux, France|CHU Ambroise Pare, Boulogne Billancourt, France|CMC Bligny, Briis Sous Forges, France|Hopital Louis Pasteur, Chartres, France|Chu-Hopital Gabriel Montpied, Clermont Ferrand, France|Hopital Beaujon, Clichy, France|Hopital Louis Mourier, Colombes, France|Hopital Drevon, Dijon, France|Centre Hospitalier Departemental, La Roche Sur Yon, France|Hopital Saint - Louis, La Rochelle, France|Centre Hospitalier de Lagny, Lagny Sur Marne, France|Hopital Andre Mignot, Le Chesnay, France|Centre Jean Bernard, Le Mans, France|C. H. Du Mans, Le Mans, France|Hopital Robert Boulin, Libourne, France|Centre Hospital Universitaire Hop Huriez, Lille, France|Clinique Saint Jean, Lyon, France|Hopital de la Croix Rousse, Lyon, France|Hopital Notre-Dame de Bon Secours, Metz, France|Intercommunal Hospital, Montfermeil, France|American Hospital of Paris, Neuilly Sur Seine, France|Hopital Europeen Georges Pompidou, Paris, France|Hopital Bichat - Claude Bernard, Paris, France|Hopital de la Croix St. Simon, Paris, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|CHU Pitie-Salpetriere, Paris, France|Hopital Tenon, Paris, France|Maison Medicale Marzet, Pau, France|Hopital Haut Leveque, Pessac, France|Centre Hospitalier Lyon Sud, Pierre Benite, France|Clinique Ste - Marie, Pontoise, France|Polyclinique De Courlancy, Reims, France|C. H. De Saumur, Saumur, France|C.H. Senlis, Senlis, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT00075452"
418,"FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreas Cancer|Adenocarcinoma of the Pancreas","Drug: Digoxin|Drug: 5Fluorouracil|Drug: Calcium Leucovorin|Drug: Irinotecan|Drug: Oxaliplatin","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT04141995"
419,"Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer","Recruiting","No Results Available","Advanced Pancreatic Adenocarcinoma|Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Drug: Gemcitabine|Drug: Nab-paclitaxel|Drug: L-glutamine","Tower Hematology Oncology Medical Group (THO), Beverly Hills, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04634539"
420,"Assessment of What Patients and Healthcare Providers Value","Recruiting","No Results Available","Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Pancreatic Neuroendocrine Carcinoma","Other: Survey Administration","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04483349"
421,"Study of SBP-101 in Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Ductal Adenocarcinoma of the Pancreas","Drug: SBP-101","HonorHealth Research Institute, Scottsdale, Arizona, United States|Mayo Clinic, Scottsdale, Arizona, United States|Ashford Cancer Centre, Kurralta Park, South Australia, Australia|Austin Hospital, Heidelberg, Victoria, Australia","https://ClinicalTrials.gov/show/NCT02657330"
422,"First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine","Active, not recruiting","No Results Available","Metastatic Pancreatic Cancer|Adenocarcinoma of the Pancreas","Drug: nab-paclitaxel and gemcitabine|Drug: gemcitabine mono and nab-paclitaxel and gemcitabine","Kliniken Nordoberpfalz AG, Klinikum Weiden, Weiden, Germany","https://ClinicalTrials.gov/show/NCT02564146"
423,"Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma|Pancreatic Cyst","Procedure: Biopsy","Stony Brook University, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT03140592"
424,"A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo","Withdrawn","No Results Available","Pancreatic Adenocarcinoma|Advanced Disease|Metastatic Disease","Drug: 18F-Fluoroazomycin arabinoside",,"https://ClinicalTrials.gov/show/NCT02496832"
425,"Resilience and Exercise in Advanced Cancer Treatment","Completed","No Results Available","Pancreatic Adenocarcinoma|Gastric Adenocarcinoma|Adenocarcinoma of the Gastroesophageal Junction","Behavioral: Band Together|Other: Exercise Education","Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02680990"
426,"Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: triapine","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00085371"
427,"Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Stage III Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Drug: fluorouracil|Drug: nelfinavir mesylate|Radiation: stereotactic body radiation therapy|Radiation: hypofractionated radiation therapy|Procedure: therapeutic conventional surgery","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT01068327"
428,"To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers","Completed","No Results Available","Pancreatic Adenocarcinoma Metastatic|Ovarian Serous Adenocarcinoma|Colorectal Cancer Metastatic","Drug: Plerixafor","Addenbrookes Hospital, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT02179970"
429,"Pancreatic Enzyme Suppletion in Pancreatic Cancer","Withdrawn","No Results Available","Adenocarcinoma of the Pancreas|Normal Pancreatic Exocrine Function","Other: Timing of start treatment with pancreatic enzymes","Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands","https://ClinicalTrials.gov/show/NCT01401387"
430,"Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: nab-Paclitaxel + Cisplatin + Gemcitabine","HonorHealth Research Institute, Scottsdale, Arizona, United States|University of Miami, Miami, Florida, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03915444"
431,"Olaparib in Treating Patients With Stage IV Pancreatic Cancer","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: Olaparib","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02677038"
432,"DCE MRI in Patients With Pancreatic Cancer","Recruiting","No Results Available","Hereditary Pancreatic Carcinoma|Pancreatic Adenocarcinoma|Pancreatic Intraductal Papillary-Mucinous Neoplasm","Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|Drug: Ferumoxytol","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02070705"
433,"Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: cisplatin|Drug: epirubicin|Drug: gemcitabine","Istituto Scientifico H. San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT01150630"
434,"Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy","Completed","No Results Available","Pancreatic Cancer","Drug: trabectedin","Istituto Scientifico H. San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT01339754"
435,"Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma|Resectable Pancreatic Adenocarcinoma","Drug: Leucovorin Calcium|Drug: Fluorouracil|Drug: Irinotecan Hydrochloride|Drug: Oxaliplatin|Procedure: Resection","Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands|Amsterdam UMC, Amsterdam, Netherlands|OLVG, Amsterdam, Netherlands|Amphia Hospital, Breda, Netherlands|Catharina Hospital, Eindhoven, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Tjongerschans Hospital, Heerenveen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht UMC+, Maastricht, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Erasmus MC University Medical Center, Rotterdam, Netherlands|Maasstad Ziekenhuis, Rotterdam, Netherlands|Regional Academic Center Utrecht, Antonius Hospital, Utrecht, Netherlands|Isala Hospital, Zwolle, Netherlands","https://ClinicalTrials.gov/show/NCT04927780"
436,"Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors","Active, not recruiting","No Results Available","Mismatch Repair Proficient Colorectal Cancer|Pancreatic Adenocarcinoma|Leiomyosarcoma","Biological: Durvalumab|Drug: Olaparib|Drug: Cediranib","Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03851614"
437,"Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery","Withdrawn","No Results Available","Pancreatic Cancer","Biological: bevacizumab|Drug: capecitabine|Drug: gemcitabine hydrochloride|Other: flow cytometry|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: computed tomography|Procedure: neoadjuvant therapy",,"https://ClinicalTrials.gov/show/NCT00524069"
438,"Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer|Adenocarcinoma of the Pancreas","Drug: Bevacizumab|Drug: Erlotinib|Drug: Gemcitabine","Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00366457"
439,"Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction","Completed","No Results Available","Pancreatic Cancer|Pancreatic Neoplasms|Pancreatic Adenocarcinoma","Procedure: EUS-BD|Procedure: ERCP","Center for Interventional Endoscopy - Florida Hospital, Orlando, Florida, United States","https://ClinicalTrials.gov/show/NCT03054987"
440,"Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: efavirenz|Procedure: quality-of-life assessment","Institut Bergonie, Bordeaux, France","https://ClinicalTrials.gov/show/NCT00964171"
441,"Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma","Terminated","Has Results","Pancreatic Cancer","Drug: Pancrelipase","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03469258"
442,"Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study","Recruiting","No Results Available","Advanced Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8","Other: Educational Intervention|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Resistance Training","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04837118"
443,"FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer","Active, not recruiting","Has Results","Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: Fluorouracil|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Veliparib","University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|John L McClellan Memorial Veterans Hospital, Little Rock, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|PCR Oncology, Arroyo Grande, California, United States|Sutter Auburn Faith Hospital, Auburn, California, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|AIS Cancer Center at San Joaquin Community Hospital, Bakersfield, California, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States|Kaiser Permanente-Bellflower, Bellflower, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Sutter Davis Hospital, Davis, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Epic Care-Dublin, Dublin, California, United States|Bay Area Breast Surgeons Inc, Emeryville, California, United States|Epic Care Partners in Cancer Care, Emeryville, California, United States|Kaiser Permanente-Fontana, Fontana, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Palo Alto Medical Foundation-Fremont, Fremont, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|Kaiser Permanente - Harbor City, Harbor City, California, United States|Kaiser Permanente-Irvine, Irvine, California, United States|City of Hope Antelope Valley, Lancaster, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Kaiser Permanente West Los Angeles, Los Angeles, California, United States|Contra Costa Regional Medical Center, Martinez, California, United States|Fremont - Rideout Cancer Center, Marysville, California, United States|Memorial Medical Center, Modesto, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States|Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States|USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States|Sutter Cancer Research Consortium, Novato, California, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Kaiser Permanente-Ontario, Ontario, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Kaiser Permanente - Panorama City, Panorama City, California, United States|Keck Medical Center of USC Pasadena, Pasadena, California, United States|Eisenhower Medical Center, Rancho Mirage, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Kaiser Permanente-Riverside, Riverside, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|Kaiser Permanente-San Diego Mission, San Diego, California, United States|Kaiser Permanente-San Diego Zion, San Diego, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Marcos, San Marcos, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, United States|City of Hope South Pasadena, South Pasadena, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|City of Hope Upland, Upland, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Kaiser Permanente-Woodland Hills, Woodland Hills, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|Kaiser Permanente-Franklin, Denver, Colorado, United States|National Jewish Health-Main Campus, Denver, Colorado, United States|The Women's Imaging Center, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Mountain Blue Cancer Care Center, Golden, Colorado, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, United States|Grand Valley Oncology, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Rocky Mountain Cancer Centers-Greenwood Village, Greenwood Village, Colorado, United States|Kaiser Permanente-Rock Creek, Lafayette, Colorado, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Kaiser Permanente-Lone Tree, Lone Tree, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, United States|National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States|Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States|Smilow Cancer Hospital Care Center - Guiford, Guilford, Connecticut, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Middlesex Hospital, Middletown, Connecticut, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States|Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States|Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States|Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Halifax Health Medical Center-Centers for Oncology, Daytona Beach, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|University Cancer and Blood Center LLC, Athens, Georgia, United States|Augusta University Medical Center, Augusta, Georgia, United States|Dekalb Medical Center, Decatur, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Low Country Cancer Care, Savannah, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Summit Cancer Care-Memorial, Savannah, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|Pali Momi Medical Center, 'Aiea, Hawaii, United States|Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii, United States|The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States|Island Urology, Honolulu, Hawaii, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States|Kuakini Medical Center, Honolulu, Hawaii, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Mac Neal Hospital, Berwyn, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Weiss Memorial Hospital, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Duly Health and Care Joliet, Joliet, Illinois, United States|Presence Saint Mary's Hospital, Kankakee, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|West Suburban Medical Center, River Forest, Illinois, United States|SwedishAmerican Regional Cancer Center/ACT, Rockford, Illinois, United States|North Shore Medical Center, Skokie, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Deaconess Clinic Downtown, Evansville, Indiana, United States|Franciscan Health Indianapolis, Indianapolis, Indiana, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, United States|Woodland Cancer Care Center, Michigan City, Indiana, United States|Memorial Regional Cancer Center Day Road, Mishawaka, Indiana, United States|Franciscan Health Mooresville, Mooresville, Indiana, United States|Chancellor Center for Oncology, Newburgh, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Union Hospital, Terre Haute, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Genesis Medical Center - East Campus, Davenport, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Coffeyville Regional Medical Center, Coffeyville, Kansas, United States|Saint Catherine Hospital, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center-West, Kansas City, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Kansas Institute of Medicine Cancer and Blood Center, Lenexa, Kansas, United States|Minimally Invasive Surgery Hospital, Lenexa, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Oncology Hematology Care Inc-Crestview, Crestview Hills, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|UofL Health Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States|Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Physicians Group - Medical Oncology, Baton Rouge, Louisiana, United States|Northshore Oncology Associates-Covington, Covington, Louisiana, United States|Oncology Center of The South Incorporated, Houma, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Harold Alfond Center for Cancer Care, Augusta, Maine, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|Penobscot Bay Medical Center, Rockport, Maine, United States|Saint Agnes Hospital, Baltimore, Maryland, United States|MedStar Montgomery Medical Center, Olney, Maryland, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|McLaren Cancer Institute-Bay City, Bay City, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Beaumont Hospital - Farmington Hills, Farmington Hills, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|William Beaumont Hospital-Grosse Pointe, Grosse Pointe, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|McLaren Cancer Institute-Lapeer Region, Lapeer, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Monroe Cancer Center, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|McLaren Cancer Institute-Central Michigan, Mount Pleasant, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Ascension Providence Hospitals - Novi, Novi, Michigan, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|Michigan Cancer Specialists, Roseville, Michigan, United States|Oakland Colon Rectal Associates, Royal Oak, Michigan, United States|Cancer Care Associates PC, Royal Oak, Michigan, United States|Comprehensive Medical Center PLLC, Royal Oak, Michigan, United States|Hematology Oncology Consultants PC, Royal Oak, Michigan, United States|Oakland Medical Group, Royal Oak, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Ascension Providence Hospitals - Southfield, Southfield, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Premier Hematology Oncology Care, Sterling Heights, Michigan, United States|Mitchell Folbe MD PC, Sterling Heights, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Michigan Institute of Urology-Town Center, Troy, Michigan, United States|Claudia BR Herke MD PC, Troy, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Hematology Oncology Consultants PC-Troy, Troy, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Hattiesburg Clinic - Hematology/Oncology Clinic, Hattiesburg, Mississippi, United States|Forrest General Hospital / Cancer Center, Hattiesburg, Mississippi, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, United States|Cox Cancer Center Branson, Branson, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Truman Medical Centers, Kansas City, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|The University of Kansas Cancer Center-South, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|Heartland Hematology and Oncology, Kearney, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Nebraska Hematology and Oncology, Lincoln, Nebraska, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska, United States|Faith Regional Health Services Carson Cancer Center, Norfolk, Nebraska, United States|Great Plains Health Callahan Cancer Center, North Platte, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Hematology and Oncology Consultants PC, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Nebraska Cancer Specialists - Omaha, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Oncology Hematology West PC, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Regional West Medical Center Cancer Center, Scottsbluff, Nebraska, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|GenesisCare USA - Henderson, Henderson, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|GenesisCare USA - Las Vegas, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|Cancer Therapy and Integrative Medicine, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|GenesisCare USA - Fort Apache, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|University Cancer Center, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Chilton Medical Center, Pompton, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States|Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States|Presbyterian Kaseman Hospital, Albuquerque, New Mexico, United States|Memorial Medical Center - Las Cruces, Las Cruces, New Mexico, United States|Christus Saint Vincent Regional Cancer Center, Santa Fe, New Mexico, United States|James J Peters VA Medical Center, Bronx, New York, United States|State University of New York Downstate Medical Center, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Garnet Health Medical Center, Middletown, New York, United States|University of Rochester, Rochester, New York, United States|Dickstein Cancer Treatment Center, White Plains, New York, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, United States|Hendersonville Hematology and Oncology at Pardee, Hendersonville, North Carolina, United States|Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, United States|Onslow Memorial Hospital, Jacksonville, North Carolina, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States|Vidant Oncology-Kinston, Kinston, North Carolina, United States|FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina, United States|WG Hefner VA Medical Center, Salisbury, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States|Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States|Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States|Miami Valley Hospital South, Centerville, Ohio, United States|Geauga Hospital, Chardon, Ohio, United States|Oncology Hematology Care Inc-Eden Park, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Mercy West, Cincinnati, Ohio, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Anderson, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Blue Ash, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio, United States|Miami Valley Hospital North, Dayton, Ohio, United States|Mercy Cancer Center-Elyria, Elyria, Ohio, United States|Oncology Hematology Care Inc-Healthplex, Fairfield, Ohio, United States|Armes Family Cancer Center, Findlay, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Orion Cancer Care, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Dayton Physicians LLC-Atrium, Franklin, Ohio, United States|Dayton Physicians LLC-Wayne, Greenville, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Greater Dayton Cancer Center, Kettering, Ohio, United States|First Dayton Cancer Care, Kettering, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|UH Seidman Cancer Center at Landerbrook Health Center, Mayfield Heights, Ohio, United States|UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States|UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights, Ohio, United States|Dayton Physicians LLC-Signal Point, Middletown, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|University Hospitals Parma Medical Center, Parma, Ohio, United States|Mercy Health Perrysburg Cancer Center, Perrysburg, Ohio, United States|UH Seidman Cancer Center at Firelands Regional Medical Center, Sandusky, Ohio, United States|Dayton Physicians LLC-Wilson, Sidney, Ohio, United States|Springfield Regional Cancer Center, Springfield, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|ProMedica Flower Hospital, Sylvania, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Dayton Physicians LLC-Upper Valley, Troy, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|University Hospitals Sharon Health Center, Wadsworth, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|UH Seidman Cancer Center at Saint John Medical Center, Westlake, Ohio, United States|UHHS-Westlake Medical Center, Westlake, Ohio, United States|Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Integris Southwest Medical Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Integris Cancer Institute of Oklahoma, Oklahoma City, Oklahoma, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Jefferson Abington Hospital, Abington, Pennsylvania, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Ephrata Cancer Center, Ephrata, Pennsylvania, United States|Ephrata Community Hospital, Ephrata, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States|Sechler Family Cancer Center, Lebanon, Pennsylvania, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States|Lewistown Hospital, Lewistown, Pennsylvania, United States|UPMC Cancer Center at UPMC McKeesport, McKeesport, Pennsylvania, United States|Riddle Memorial Hospital, Media, Pennsylvania, United States|UPMC-Coraopolis/Heritage Valley Radiation Oncology, Moon, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Presbyterian Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States|Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania, United States|Community Medical Center, Scranton, Pennsylvania, United States|Geisinger Medical Oncology-Selinsgrove, Selinsgrove, Pennsylvania, United States|UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States|Geisinger Medical Group, State College, Pennsylvania, United States|UPMC Uniontown Hospital Radiation Oncology, Uniontown, Pennsylvania, United States|UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|UPMC Susquehanna, Williamsport, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|WellSpan Health-York Cancer Center, York, Pennsylvania, United States|WellSpan Health-York Hospital, York, Pennsylvania, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Cancer Institute - Laurens, Clinton, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Tidelands Georgetown Memorial Hospital, Georgetown, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Avera Cancer Institute-Aberdeen, Aberdeen, South Dakota, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Bristol Regional Medical Center, Bristol, Tennessee, United States|Wellmont Medical Associates Oncology and Hematology-Bristol, Bristol, Tennessee, United States|Memorial Hospital, Chattanooga, Tennessee, United States|Vanderbilt-Ingram Cancer Center Cool Springs, Franklin, Tennessee, United States|Pulmonary Medicine Center of Chattanooga-Hixson, Hixson, Tennessee, United States|Wellmont Medical Associates Oncology and Hematology-Johnson City, Johnson City, Tennessee, United States|Ballad Health Cancer Care - Kingsport, Kingsport, Tennessee, United States|Wellmont Holston Valley Hospital and Medical Center, Kingsport, Tennessee, United States|Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, United States|Meharry Medical College, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Memorial GYN Plus, Ooltewah, Tennessee, United States|Dell Seton Medical Center at The University of Texas, Austin, Texas, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Parkland Memorial Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States|Farmington Health Center, Farmington, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|South Jordan Health Center, South Jordan, Utah, United States|Wellmont Medical Associates-Bristol, Bristol, Virginia, United States|Centra Lynchburg Hematology-Oncology Clinic Inc, Lynchburg, Virginia, United States|Southwest VA Regional Cancer Center, Norton, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|VCU Community Memorial Health Center, South Hill, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Seattle Cancer Care Alliance at EvergreenHealth, Kirkland, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Skagit Valley Hospital Regional Cancer Care Center, Mount Vernon, Washington, United States|Skagit Valley Hospital, Mount Vernon, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|Kaiser Permanente Washington, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Seattle Cancer Care Alliance at Northwest Hospital, Seattle, Washington, United States|University of Washington Medical Center - Montlake, Seattle, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Valley, Spokane Valley, Washington, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane, Washington, United States|Spokane Valley Cancer Center-Mayfair, Spokane, Washington, United States|MultiCare Deaconess Cancer and Blood Specialty Center - North, Spokane, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|United Hospital Center, Bridgeport, West Virginia, United States|West Virginia University Charleston Division, Charleston, West Virginia, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States|WVUH-Berkely Medical Center, Martinsburg, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Camden Clark Medical Center, Parkersburg, West Virginia, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States|Aurora Health Center-Fond du Lac, Fond Du Lac, Wisconsin, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States|Marshfield Clinic - Ladysmith Center, Ladysmith, Wisconsin, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, United States|Aurora Medical Center in Summit, Summit, Wisconsin, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, United States|Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States|Cheyenne Regional Medical Center-West, Cheyenne, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT02890355"
444,"Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery","Completed","Has Results","Pancreatic Cancer","Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride|Procedure: therapeutic conventional surgery","Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Kaiser Permanente Medical Center - Los Angeles, Los Angeles, California, United States|Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States|St. Vincent's Medical Center, Bridgeport, Connecticut, United States|Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland, Florida, United States|St. Francis Hospital Cancer Care Services, Indianapolis, Indiana, United States|Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, United States|St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States|University of Mississippi Cancer Clinic, Jackson, Mississippi, United States|Methodist Estabrook Cancer Center, Omaha, Nebraska, United States|NYU Cancer Institute at New York University Medical Center, New York, New York, United States|Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Surgical Oncology Associates, Newport News, Virginia, United States|Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown, West Virginia, United States|University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States|Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00733746"
445,"Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: ifosfamide|Drug: mitomycin C","Istituto Scientifico H. San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT00967291"
446,"Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: Irofulven","MGI Pharma, Incorporated, Bloomington, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00033735"
447,"Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Refractory Malignant Solid Neoplasm|Stage IV Pancreatic Cancer AJCC v8","Drug: Chemotherapy|Drug: Disulfiram|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis","Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States|Essentia Health - Deer River Clinic, Deer River, Minnesota, United States|Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Essentia Health - Fosston, Fosston, Minnesota, United States|Fairview Grand Itasca Clinic &amp; Hospital, Grand Rapids, Minnesota, United States|Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States|Fairview Range Medical Center, Hibbing, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|Essentia Health - Park Rapids, Park Rapids, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Essentia Health Sandstone, Sandstone, Minnesota, United States|Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, United States|Essentia Health Virginia Clinic, Virginia, Minnesota, United States|Sanford Cancer Center Worthington, Worthington, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02671890"
448,"MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","Has Results","Pancreatic Cancer","Biological: ipilimumab","Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States|NCI - Surgery Branch, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00112580"
449,"Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: cisplatin|Drug: docetaxel|Drug: epirubicin hydrochloride|Drug: gemcitabine hydrochloride","San Raffaele Scientific Institute, Milan, Italy","https://ClinicalTrials.gov/show/NCT00966706"
450,"Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Adenosquamous Carcinoma|Resectable Pancreatic Adenocarcinoma|Pancreatic Cancer","Drug: Oxaliplatin|Drug: Irinotecan Hydrochloride|Drug: Leucovorin Calcium|Drug: Fluorouracil|Procedure: Resection|Other: Questionnaire Administration","University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Memorial Medical Center, Modesto, California, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Danbury Hospital, Danbury, Connecticut, United States|Norwalk Hospital, Norwalk, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|AdventHealth Altamonte, Altamonte Springs, Florida, United States|Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|University of Illinois, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Baptist Health Lexington, Lexington, Kentucky, United States|Baptist Health Louisville, Louisville, Kentucky, United States|Baptist Health Madisonville/Merle Mahr Cancer Center, Madisonville, Kentucky, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Mount Carmel East Hospital, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Dublin Methodist Hospital, Dublin, Ohio, United States|Mount Carmel Grove City Hospital, Grove City, Ohio, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Aspirus Medford Hospital, Medford, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Aspirus UW Cancer Center, Wisconsin Rapids, Wisconsin, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT04340141"
451,"New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study","Not yet recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Ductal Adenocarcinoma|Resectable Pancreatic Ductal Adenocarcinoma","Drug: Cisplatin|Drug: Fluorouracil|Drug: Gemcitabine|Drug: Irinotecan|Drug: Leucovorin|Drug: Nab-paclitaxel|Drug: Oxaliplatin|Radiation: Radiation Therapy","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04481204"
452,"Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Dolastatin 10","University of Chicago Cancer Research Center, Chicago, Illinois, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003677"
453,"Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: bevacizumab|Drug: gemcitabine hydrochloride|Drug: oxaliplatin","Mobile Infirmary Medical Center, Mobile, Alabama, United States|Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Aurora Presbyterian Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States|St. Mary-Corwin Regional Medical Center, Pueblo, Colorado, United States|North Suburban Medical Center, Thorton, Colorado, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Kapiolani Medical Center at Pali Momi, Aiea, Hawaii, United States|Cancer Research Center of Hawaii, Honolula, Hawaii, United States|OnCare Hawaii, Incorporated - Lusitana, Honolulu, Hawaii, United States|Queen's Cancer Institute at Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Incorporated, Honolulu, Hawaii, United States|OnCare Hawaii, Incorporated - Kuakini, Honolulu, Hawaii, United States|St. Francis Medical Center, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|St. Anthony's Memorial Hospital, Effingham, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Galesburg Clinic, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex, Hopedale, Illinois, United States|Joliet Oncology-Hematology Associates, Limited - West, Joliet, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Trinity Medical Center - East, Moline, Illinois, United States|Moline, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|St. Margaret's Hospital, Spring Valley, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States|McFarland Clinic, P. C., Ames, Iowa, United States|Bettendorf, Iowa, United States|St. Luke's Hospital, Cedar Rapids, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Mercy Capitol Hospital, Des Moines, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Ottumwa Regional Health Center Cancer Center, Ottumwa, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, West Des Moines, Iowa, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Green Bay Oncology, Limited - Iron Mountain, Iron Mountain, Michigan, United States|Foote Hospital, Jackson, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, P.C., Lambertville, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital System, Monroe, Michigan, United States|Seton Cancer Institute - Saginaw, Saginaw, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|Alexandria, Minnesota, United States|MeritCare Clinic - Bemidji, Bemidji, Minnesota, United States|Brainerd Medical Center, Brainerd, Minnesota, United States|St. Joseph's Medical Center, Brainerd, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Fergus Falls, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Meeker County Memorial Hospital, Lichfield, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Chippewa County - Montevideo Hospital, Montevideo, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Adult and Pediatric Urology, P.L.L.P., Sartell, Minnesota, United States|Saint Francis Cancer Center, Shakopee, Minnesota, United States|St. Joseph's Hospital, St Paul, Minnesota, United States|CentraCare Clinic - River Campus, St. Cloud, Minnesota, United States|Park Nicollet Health Services, St. Louis Park, Minnesota, United States|Regions Hospital Cancer Care Center, St. Paul, Minnesota, United States|United Hospital, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Woodwinds Health Campus, Woodbury, Minnesota, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare, Billings, Montana, United States|Deaconess Billings Clinic Cancer Center, Billings, Montana, United States|Deaconess Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|St. James Community Hospital, Butte, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Center, Missoula, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Bryan LGH Medical Center - West, Lincoln, Nebraska, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|St. Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Cancer Care Center at Medcenter One Hospital, Bismarck, North Dakota, United States|Mid Dakota Clinic, P. C., Bismarck, North Dakota, United States|St. Alexius Medical Center, Bismarck, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|MeritCare Medical Group, Fargo, North Dakota, United States|Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Fremont Memorial Hospital, Fremont, Ohio, United States|Kenton Oncology, Incorporated, Kenton, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|Firelands Regional Medical Center, Sandusky, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Promedica Cancer Center at Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|Toledo Surgical Specialists, Toledo, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Geisinger Medical Group - Scenery Park, State College, Pennsylvania, United States|Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States|AnMed Health Cancer Center, Anderson, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States|Green Bay Oncology, Limited at St. Vincent Hospital, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center - Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Franciscan Skemp Healthcare, La Crosse, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00112528"
454,"Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Drug: rhuMAB-VEGF|Drug: docetaxel","Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00066677"
455,"Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer","Active, not recruiting","No Results Available","Resectable Pancreatic Cancer|Ductal Adenocarcinoma of the Pancreas","Drug: perioperative nab-paclitaxel/gemcitabine|Drug: adjuvant nab-paclitaxel/gemcitabine","University of Ulm, Dept. of Internal Medicine I, Ulm, Germany","https://ClinicalTrials.gov/show/NCT02047513"
456,"Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Radiation: radiation therapy","Northeast Alabama Regional Medical Center, Anniston, Alabama, United States|Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States|Naval Medical Center - San Diego, San Diego, California, United States|Veterans Affairs Medical Center - San Diego, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|Veterans Affairs Medical Center - Washington, DC, Washington, District of Columbia, United States|Broward General Medical Center, Fort Lauderdale, Florida, United States|Memorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|West Suburban Center for Cancer Care, River Forest, Illinois, United States|Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Hematology Oncology Associates of the Quad Cities, Bettendorf, Iowa, United States|Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States|Baptist Hospital East - Louisville, Louisville, Kentucky, United States|Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States|Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph, Saint Joseph, Michigan, United States|Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota Cancer Center, Minneapolis, Minnesota, United States|Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States|Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Siteman Cancer Center at Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Missouri Baptist Cancer Center, Saint Louis, Missouri, United States|UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Veterans Affairs Medical Center - Las Vegas, Las Vegas, Nevada, United States|New Hampshire Oncology-Hematology, PA - Hooksett, Hooksett, New Hampshire, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cooper University Hospital, Camden, New Jersey, United States|Veterans Affairs Medical Center - Buffalo, Buffalo, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., East Syracuse, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Queens Cancer Center of Queens Hospital, Jamaica, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|University Hospital at State University of New York - Upstate Medical University, Syracuse, New York, United States|Veterans Affairs Medical Center - Syracuse, Syracuse, New York, United States|Veterans Affairs Medical Center - Asheville, Asheville, North Carolina, United States|Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|NorthEast Oncology Associates - Concord, Concord, North Carolina, United States|Veterans Affairs Medical Center - Durham, Durham, North Carolina, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, United States|Lenoir Memorial Hospital Cancer Center, Kinston, North Carolina, United States|FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States|Zimmer Cancer Center at New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Arthur G. James Cancer Hospital at Ohio State University, Columbus, Ohio, United States|Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|Lifespan: The Miriam Hospital, Providence, Rhode Island, United States|Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States|Vermont Cancer Center at University of Vermont, Burlington, Vermont, United States|Martha Jefferson Hospital, Charlottesville, Virginia, United States|Virginia Oncology Associates - Norfolk, Norfolk, Virginia, United States|MBCCOP - Massey Cancer Center, Richmond, Virginia, United States|Oncology and Hematology Associates of Southwest Virginia, Incorporated - Roanoke, Roanoke, Virginia, United States|St. Mary's Medical Center, Huntington, West Virginia, United States","https://ClinicalTrials.gov/show/NCT00026130"
457,"Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors","Completed","No Results Available","Locally Advanced Solid Tumors|Metastatic Solid Tumors|Pancreatic Adenocarcinoma","Genetic: VCN-01|Drug: Gemcitabine|Drug: Abraxane®","Hospital Vall d'Hebron, Barcelona, Spain|Institut Català d'Oncologia, Hospitalet De Llobregat, Spain|Centro Integral Oncológico Clara Campal, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02045602"
458,"Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Radiation: radiation therapy","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00003426"
459,"R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: tipifarnib","Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00005843"
460,"Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy","Terminated","No Results Available","Locally Advanced Pancreatic Cancer|Adenocarcinoma, Pancreas|Metastatic Pancreatic Cancer","Drug: Clopidogrel|Drug: Placebo","Service d'oncologie digestive - Institut Sainte Catherine, Avignon, France","https://ClinicalTrials.gov/show/NCT02404363"
461,"Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: vitespen","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00003025"
462,"Next Generation Sequencing of Tumor Cells in Locally Advanced Pancreatic Adenocarcinoma","Completed","No Results Available","Adenocarcinoma","Procedure: Biopsy EUS guided","Istituto Clinico Humanitas, Rozzano, Milano, Italy","https://ClinicalTrials.gov/show/NCT03578939"
463,"Bethanechol Prior to Pancreatic Surgery","Recruiting","No Results Available","Pancreas Cancer","Drug: Bethanechol","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03572283"
464,"Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery","Withdrawn","No Results Available","Pancreatic Cancer","Dietary Supplement: genistein","UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00882765"
465,"S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: dipyridamole|Drug: fluorouracil|Drug: leucovorin calcium|Drug: mitomycin C","MBCCOP - University of South Alabama, Mobile, Alabama, United States|CCOP - Greater Phoenix, Phoenix, Arizona, United States|Veterans Affairs Medical Center - Phoenix (Hayden), Phoenix, Arizona, United States|Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States|Arizona Cancer Center, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Beckman Research Institute, City of Hope, Los Angeles, California, United States|Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California Davis Medical Center, Sacramento, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Veterans Affairs Medical Center - Denver, Denver, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States|Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States|Boston Medical Center, Boston, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Veterans Affairs Medical Center - Detroit, Detroit, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|CCOP - Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States|Providence Hospital - Southfield, Southfield, Michigan, United States|Veterans Affairs Medical Center - Biloxi, Biloxi, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, United States|Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi, United States|Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, United States|MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States|Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Kettering, Ohio, United States|Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States|Veterans Affairs Medical Center - Oklahoma City, Oklahoma City, Oklahoma, United States|Oregon Cancer Center at Oregon Health Sciences University, Portland, Oregon, United States|Veterans Affairs Medical Center - Portland, Portland, Oregon, United States|CCOP - Columbia River Program, Portland, Oregon, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Texas Tech University Health Science Center, Lubbock, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, United States|Veterans Affairs Medical Center - Temple, Temple, Texas, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, United States|CCOP - Virginia Mason Research Center, Seattle, Washington, United States|Swedish Cancer Institute, Seattle, Washington, United States|Veterans Affairs Medical Center - Seattle, Seattle, Washington, United States|CCOP - Northwest, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00003018"
466,"Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Drug: erlotinib hydrochloride|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT00470535"
467,"Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Radiation: stereotactic body radiation therapy","Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01025882"
468,"Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: docetaxel|Drug: gemcitabine hydrochloride","Indiana University Cancer Center, Indianapolis, Indiana, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|New England Medical Center Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Veterans Affairs Medical Center - Nashville, Nashville, Tennessee, United States|Vanderbilt Cancer Center, Nashville, Tennessee, United States|Veterans Affairs Medical Center - Madison, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00003810"
469,"Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: irofulven","University of Nebraska Medical Center, Omaha, Nebraska, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|San Antonio Cancer Institute, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00003760"
470,"Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride","CHU de la Timone, Marseille, France","https://ClinicalTrials.gov/show/NCT01416662"
471,"Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies","Terminated","Has Results","Metastatic Cancer Pancreas","Drug: PF-03084014|Drug: Gemcitabine|Drug: Nab-paclitaxel","Anschutz Inpatient Pavilion, Aurora, Colorado, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|University of Colorado Denver, CTO (CTRC), Aurora, Colorado, United States|University of Rochester Investigational Drug Pharmacy, Rochester, New York, United States|University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT02109445"
472,"Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: perifosine","CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|Tufts - New England Medical Center, Boston, Massachusetts, United States|CCOP - Duluth, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|MBCCOP-Our Lady of Mercy Cancer Center, Bronx, New York, United States|CCOP - Merit Care Hospital, Fargo, North Dakota, United States|CCOP - Scott and White Hospital, Temple, Texas, United States","https://ClinicalTrials.gov/show/NCT00059982"
473,"Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer","Suspended","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage IV Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: Selinexor|Other: Pharmacological Study|Other: Laboratory Biomarker Analysis|Drug: Nab paclitaxel","Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Stony Brook University Cancer Center, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT02178436"
474,"Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer","Terminated","Has Results","Stage IV Pancreatic Cancer","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003531"
475,"Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage III Pancreatic Cancer","Drug: porfimer sodium|Procedure: endoscopic ultrasonography|Procedure: photodynamic therapy|Drug: gemcitabine hydrochloride","IU Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT01770132"
476,"Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Neoplasm|Metastatic Pancreatic Cancer|Locally Advanced Pancreatic Adenocarcinoma","Drug: Anlotinib+Toripalimab+Nab-paclitaxel","The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04718701"
477,"Chemoradiation in Locally Advanced Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Biological: recombinant interferon alfa|Drug: cisplatin|Drug: fluorouracil|Radiation: radiation therapy|Procedure: Resection of tumor","Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00262951"
478,"Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: interferon-alfa-2b|Drug: cisplatin|Drug: 5-fluorouracil|Radiation: radiation therapy","University of Florida Shands Cancer Center, Gainesville, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Fairview University Medical Center - University Campus, Minneapolis, Minnesota, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Presbyterian Hospital of Dallas, Dallas, Texas, United States|Baylor University Medical Center - Houston, Houston, Texas, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00059826"
479,"Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer","Withdrawn","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage I Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: bevacizumab|Drug: gemcitabine hydrochloride|Procedure: adjuvant therapy|Procedure: anti-cytokine therapy|Procedure: antiangiogenesis therapy|Procedure: antibody therapy|Procedure: biological therapy|Procedure: chemotherapy|Procedure: conventional surgery|Procedure: growth factor antagonist therapy|Procedure: monoclonal antibody therapy|Procedure: surgery",,"https://ClinicalTrials.gov/show/NCT00253526"
480,"Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: cisplatin|Drug: epirubicin hydrochloride|Drug: fluorouracil|Drug: gemcitabine hydrochloride","Istituto Scientifico H. San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT00960284"
481,"Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: ISIS 2503|Drug: gemcitabine hydrochloride","CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|Siouxland Hematology-Oncology, Sioux City, Iowa, United States|CCOP - Wichita, Wichita, Kansas, United States|CCOP - Duluth, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic, Saint Cloud, Minnesota, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Medcenter One Health System, Bismarck, North Dakota, United States|CCOP - Merit Care Hospital, Fargo, North Dakota, United States|CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States|CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States","https://ClinicalTrials.gov/show/NCT00006467"
482,"Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery","Active, not recruiting","No Results Available","Pancreatic Cancer","Biological: allogenic GM-CSF plasmid-transfected pancreatic tumor cell vaccine","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00389610"
483,"Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)","Terminated","Has Results","Pancreatic Cancer","Drug: Ruxolitinib|Drug: Placebo|Drug: Capecitabine","Avondale, Arizona, United States|Chandler, Arizona, United States|Gilbert, Arizona, United States|Glendale, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Scottsdale, Arizona, United States|Surprise, Arizona, United States|Tucson, Arizona, United States|Hot Springs, Arkansas, United States|Jonesboro, Arkansas, United States|Anaheim, California, United States|Bakersfield, California, United States|Berkeley, California, United States|Beverly Hills, California, United States|Chula Vista, California, United States|Covina, California, United States|Downey, California, United States|El Cajon, California, United States|Fullerton, California, United States|Gilroy, California, United States|Glendale, California, United States|La Mesa, California, United States|Long Beach, California, United States|Los Angeles, California, United States|Lynwood, California, United States|Modesto, California, United States|Montebello, California, United States|Northridge, California, United States|Oceanside, California, United States|Orange, California, United States|Redondo Beach, California, United States|San Diego, California, United States|San Francisco, California, United States|San Luis Obispo, California, United States|Santa Ana, California, United States|Santa Maria, California, United States|Santa Monica, California, United States|Torrance, California, United States|Whittier, California, United States|Aurora, Colorado, United States|Boulder, Colorado, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Grand Junction, Colorado, United States|Longmont, Colorado, United States|Thornton, Colorado, United States|New Britain, Connecticut, United States|New Haven, Connecticut, United States|Southington, Connecticut, United States|Trumbull, Connecticut, United States|Newark, Delaware, United States|Boca Raton, Florida, United States|Hollywood, Florida, United States|Miami, Florida, United States|Pembroke Pines, Florida, United States|Atlanta, Georgia, United States|Austell, Georgia, United States|Carrollton, Georgia, United States|Cartersville, Georgia, United States|Douglasville, Georgia, United States|Marietta, Georgia, United States|Newnan, Georgia, United States|Rome, Georgia, United States|Thomasville, Georgia, United States|Arlington Heights, Illinois, United States|Chicago, Illinois, United States|Hinsdale, Illinois, United States|Niles, Illinois, United States|Urbana, Illinois, United States|Goshen, Indiana, United States|Indianapolis, Indiana, United States|Topeka, Kansas, United States|Ashland, Kentucky, United States|Louisville, Kentucky, United States|Metairie, Louisiana, United States|New Orleans, Louisiana, United States|Scarborough, Maine, United States|Annapolis, Maryland, United States|Baltimore, Maryland, United States|Bethesda, Maryland, United States|Rockville, Maryland, United States|Worcester, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Kalamazoo, Michigan, United States|Lansing, Michigan, United States|Woodbury, Minnesota, United States|Bolivar, Missouri, United States|Kansas City, Missouri, United States|Saint Louis, Missouri, United States|Kalispell, Montana, United States|Hastings, Nebraska, United States|Omaha, Nebraska, United States|Papillion, Nebraska, United States|Las Vegas, Nevada, United States|Lebanon, New Hampshire, United States|East Orange, New Jersey, United States|Farmington, New Mexico, United States|Binghamton, New York, United States|Bronx, New York, United States|Fresh Meadows, New York, United States|Hudson, New York, United States|Johnson City, New York, United States|New York, New York, United States|Nyack, New York, United States|Rochester, New York, United States|Durham, North Carolina, United States|Wake Forest, North Carolina, United States|Winston-Salem, North Carolina, United States|Canton, Ohio, United States|Columbus, Ohio, United States|Middletown, Ohio, United States|Oregon, Ohio, United States|Toledo, Ohio, United States|Eugene, Oregon, United States|Portland, Oregon, United States|Springfield, Oregon, United States|Tualatin, Oregon, United States|Philadelphia, Pennsylvania, United States|Charleston, South Carolina, United States|Seneca, South Carolina, United States|Spartanburg, South Carolina, United States|Chattanooga, Tennessee, United States|Knoxville, Tennessee, United States|Memphis, Tennessee, United States|Nashville, Tennessee, United States|Arlington, Texas, United States|Austin, Texas, United States|Beaumont, Texas, United States|Bedford, Texas, United States|Cedar Park, Texas, United States|Dallas, Texas, United States|Denton, Texas, United States|El Paso, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Plano, Texas, United States|Round Rock, Texas, United States|San Antonio, Texas, United States|Temple, Texas, United States|Tyler, Texas, United States|Waco, Texas, United States|Ogden, Utah, United States|Salt Lake City, Utah, United States|Blacksburg, Virginia, United States|Richmond, Virginia, United States|Roanoke, Virginia, United States|Salem, Virginia, United States|Wytheville, Virginia, United States|Seattle, Washington, United States|Vancouver, Washington, United States|Madison, Wisconsin, United States|Australian Capital Territory, Australia|New South Wales, Australia|South Australia, Australia|Victoria, Australia|Aalst, Belgium|Brugge, Belgium|Bruxelles, Belgium|Edegem, Belgium|Gent, Belgium|Gilly, Belgium|Kortrijk, Belgium|Leuven, Belgium|Calgary, Alberta, Canada|Oshawa, Ontario, Canada|Sault Ste. Marie, Ontario, Canada|Toronto, Ontario, Canada|Greenfield Park, Quebec, Canada|Laval, Quebec, Canada|Montreal, Quebec, Canada|Aschaffenburg, Germany|Berlin, Germany|Bochum, Germany|Essen, Germany|Frankford, Germany|Koeln, Germany|Velbert, Germany|Aviano, Italy|Bari, Italy|Bergamo, Italy|Brescia, Italy|Cremona, Italy|Firenze, Italy|Genova, Italy|Lido di Camaiore, Italy|Milano, Italy|Napoli, Italy|Pisa, Italy|Rimini, Italy|Roma, Italy|Hwasun-gun, Korea, Republic of|Seongnam-si, Korea, Republic of|Seoul, Korea, Republic of|Auckland, New Zealand|Christchurch, New Zealand|Hamilton, New Zealand|Badajoz, Spain|Barcelona, Spain|Madrid, Spain|Malaga, Spain|Seville, Spain|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Patumwan, Thailand|Ratchathewi, Thailand|Seetatarom, Thailand|Aberdeen, United Kingdom|Bangor, United Kingdom|Birmingham, United Kingdom|Boston, United Kingdom|Bristol, United Kingdom|Cardiff, United Kingdom|Glasgow, United Kingdom|Guildford, United Kingdom|Harlow, United Kingdom|Huddersfield, United Kingdom|Lancaster, United Kingdom|Leeds, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Newcastle upon Tyne, United Kingdom|Nottingham, United Kingdom|Plymouth, United Kingdom|Southampton, United Kingdom|Sutton, United Kingdom|Welwyn Garden City, United Kingdom|Wirral, United Kingdom","https://ClinicalTrials.gov/show/NCT02117479"
484,"Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer","Terminated","Has Results","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage IV Pancreatic Cancer","Drug: bortezomib|Drug: carboplatin|Other: laboratory biomarker analysis","MD Anderson Cancer Network, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00416793"
485,"Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer","Recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma|Chemotherapy Effect|Borderline Resectable Pancreatic Adenocarcinoma|Pancreatectomy","Drug: Folfirinox","Oslo University Hospital, Oslo, Norway","https://ClinicalTrials.gov/show/NCT04423731"
486,"Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: epoetin alfa|Biological: filgrastim|Drug: cisplatin|Drug: fluorouracil|Drug: gemcitabine hydrochloride|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy","CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States|Yale Comprehensive Cancer Center, New Haven, Connecticut, United States|Lynn Regional Cancer Center of Boca Raton Community Hospital, Boca Raton, Florida, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Emory University Hospital - Atlanta, Altanta, Georgia, United States|Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Hematology and Oncology Associates, Chicago, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States|Mercy Hospital and Medical Center, Chicago, Illinois, United States|Swedish Covenant Hospital, Chicago, Illinois, United States|St. Anthony's Memorial Hospital, Effingham, Illinois, United States|Eureka Hospital, Eureka, Illinois, United States|Evanston Northwestern Health Care - Evanston Hospital, Evanston, Illinois, United States|Galesburg Clinic, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|InterCommunity Cancer Center of Western Illinois, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex, Hopedale, Illinois, United States|Midwest Center for Hematology/Oncology, Joliet, Illinois, United States|Joliet Oncology Hematology Associates, Limited - West, Joliet, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|Deerpath Medical Associates, Lake Forest, Illinois, United States|North Shore Oncology and Hematology Associates, Limited - Libertyville, Libertyville, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Northwest Medical Specialist P.C., Niles, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Swedish American Hospital, Rockford, Illinois, United States|Hematology Oncology Associates - Skokie, Skokie, Illinois, United States|Hematology/Oncology of the North Shore, Skokie, Illinois, United States|Midwest Cancer Research Group, Incorporated, Skokie, Illinois, United States|St. Margaret's Hospital, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States|Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States|Saint Joseph Regional Medical Center - Plymouth Campus, Plymouth, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|McFarland Clinic, P.C., Ames, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Siouxland Hematology-Oncology Associates, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, P.A. - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Kingman, Kingman, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Ottawa, Ottawa, Kansas, United States|Cancer Center of Kansas, P.A. - Parsons, Parsons, Kansas, United States|Pratt Cancer Center of Kansas, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates in Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas, P.A., Wichita, Kansas, United States|Cancer Center of Kansas, P.A. - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Baton Rouge General Regional Cancer Center, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center - Baton Rouge, Baton Rouge, Louisiana, United States|Cancer Center at Medical Center of Louisiana - New Orleans, New Orleans, Louisiana, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Franklin Medical Center, Greenfield, Massachusetts, United States|Holyoke Medical Center, Incorporated, Holyoke, Massachusetts, United States|Baystate Regional Cancer Program at D'Amour Center for Cancer Care, Springfield, Massachusetts, United States|Noble Hospital, Westfield, Massachusetts, United States|MeritCare Clinic - Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Mercy and Unity Hospitals, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Meeker County Memorial Hospital, Litchfield, Minnesota, United States|St. John's Hospital, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Cancer Care Center at Regions Hospital, Saint Paul, Minnesota, United States|Saint Francis Cancer Center, Shakopee, Minnesota, United States|St. Joseph's Hospital, St Paul, Minnesota, United States|Park Nicollet Clinic, St. Louis Park, Minnesota, United States|United Hospital, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Woodwinds Hospital, Woodbury, Minnesota, United States|CCOP - Northern New Jersey, Hackensack, New Jersey, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Medcenter One Health System, Bismarck, North Dakota, United States|Mid Dakota Clinic, P.C., Bismarck, North Dakota, United States|St. Alexius Medical Center, Bismarck, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|MeritCare Medical Group, Fargo, North Dakota, United States|St. Elizabeth Boardman Cancer Center, Boardman, Ohio, United States|St. Rita's Medical Center, Lima, Ohio, United States|St. Joseph Health Care Center, Warren, Ohio, United States|St. Elizabeth Cancer Center at St. Elizabeth Health Center - Youngstown, Youngstown, Ohio, United States|St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania, United States|Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Lewistown Hospital, Lewistown, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Mount Nittany Medical Center, State College, Pennsylvania, United States|Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States|Avera McKennan Hospital and University Health Center, Sioux Falls, South Dakota, United States|Medical X-Ray Center, Sioux Falls, South Dakota, United States|Erlanger Cancer Center, Chattanooga, Tennessee, United States|West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division, Charleston, West Virginia, United States|Green Bay Oncology, Limited at St. Vincent Hospital, Green Bay, Wisconsin, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center, Green Bay, Wisconsin, United States|Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00049348"
487,"Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Glufosfamide","Augusta Oncology Associates, Los Angeles, California, United States|Kenmar Research Institute, Los Angeles, California, United States|Mile High Oncology, Denver, Colorado, United States|Northwestern Connecticut Oncology - Hematology Associates, Torrington, Connecticut, United States|Palm Beach Institute of Hematology and Oncology, Boynton Beach, Florida, United States|Hematology/Oncology of the North Shore, Skokie, Illinois, United States|Fort Wayne Medical Oncology/Hem, Fort Wayne, Indiana, United States|Norton Healthcare Center, Louisville, Kentucky, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Hattiesburg Clinic Oncology, Hattiesburg, Mississippi, United States|Columbia Comprehensive Cancer Care Clinic, Columbia, Missouri, United States|Bond Clinic, Rolla, Missouri, United States|Deaconess Billings Clinic, Billings, Montana, United States|Office of Clinical Trials, Paramus, New Jersey, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States|Hanover Medical Specialists, Wilmington, North Carolina, United States|Vita Hematology Oncology PC, Bethlehem, Pennsylvania, United States|The Family Cancer Center , PLLC, Collierville, Tennessee, United States|Center for Oncology Research and Treatment, Dallas, Texas, United States|JPS Center for Cancer Care, Fort Worth, Texas, United States|Northern Utah Associates, Ogden, Utah, United States|Cancer Outreach Association, Abingdon, Virginia, United States|Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States|Hospital Interzonal General de Agudos, Buenos Aires, Argentina|Hospital Posadas, Buenos Aires, Argentina|Policlinica Privada Instituto de Medicina Nuclear, Buenos Aires, Argentina|Hospital Udaondo, Buenos Aires, Argentina|Hospital Alvarez, Buenos Aires, Argentina|Hospital Churruca - Visca, Buenos Aires, Argentina|Instituto Medico Alexander Fleming, Buenos Aires, Argentina|Instituto CAICI, Santa Fe, Argentina|Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos, Brazil|Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, Brazil|Hospital Vera Cruz - Clinica de Oncologia, Belo Horizonte, Brazil|Hospital Luxemburgo, Belo Horizonte, Brazil|Hospital de Clínicas da UFPR, Curitiba, Brazil|Associacao de Combate ao Cancer em Goias, Hospital Araujo Jorge, Setor de Oncologia Clinica, Goiania, Brazil|Hospital Nossa Senhora da Conceicao, Porto Alegre, Brazil|Instituto Nacional do Cancer - INCA, Rio de Janeiro, Brazil|Clinica de Oncologia Medica S/C Ltda, Sao Paulo, Brazil|Hospital do Cancer - AC Camargo, Sao Paulo, Brazil|Grupo Paulista Oncologia Integrada, São Paulo, Brazil|Department of Chemotherapy Dr. Georgi Stranski General Hospital of Pleven University, Pleven, Bulgaria|First Internal Department Plovdiv Regional Oncology Center with In-patient Department, Plovdiv, Bulgaria|Department of Chemotherapy Sofia Regional Oncology Center, Sofia, Bulgaria|Chemotherapy Clinic Queen Joanna General Hospital, Sofia, Bulgaria|Haematology and Oncology Clinic Military Medical Academy, Sofia, Bulgaria|Chemotherapy Clinic Specialized Oncology Hospital, Sofia, Bulgaria|Department of Chemotherapy Veliko Tarnovo Regional Oncology Center, Tarnovo, Bulgaria|Department of Medicinal Oncotherapy and Palliative Care Dr. Marko Markov Regional Oncology Center, Varna, Bulgaria|Fakultni nemocnice Brno Oddeleni Klinicke Onkologie, Brno, Czech Republic|Masarykuv onkologicky Ustav, Brno, Czech Republic|Krajska nemocnice Pardubice,oddeleni Radiacni Onkologie, Kyjevska, Czech Republic|Onkologicka Klinika, Fakultni nemocnice Olomouc, Olomouc, Czech Republic|Onkologicke Oddeleni, Batova krajska nemocnice Zlin, Zlin, Czech Republic|National Institute of Oncology, Budapest, Hungary|Szent Imre Korhaz Onkologia, Budapest, Hungary|Szent László Kórház, Onkológia, Budapest, Hungary|Vaszary Kolos Korhaz, Esztergom, Hungary|Petz Aladar County Hospital, Department of Oncology, Gyor, Hungary|Baranya megyei Korhaz Onkologial osztaly, Rakoczi, Hungary|Bangalore Institute of Oncology, Bangalore, India|Curie Centre of Oncology, Bangalore, India|Radhakrishan Birla Cancer Centre, Jaipur, India|Jaslok Hospital and Research Centre, Mumbai, India|Sir Ganga Ram Hospital, New Delhi, India|Hospital Universitario ""Dr. Angel Leano"", Zapopan, Jalisco, Mexico|Hospital y Clinica OCA S.A. De C.V., Monterrey, NL, Mexico|Hospital Central ""Dr. Ignacio Morones Prieto"" Departamento de Radioterapia., San Luis Potosi, SLP, Mexico|Hospital regional ISSSTE ""Merida"", Merida, Yucatan, Mexico|Centro Estatal de Cancerologia, Chihuahua, Mexico|Hospital Clinica del Parque, Chihuahua, Mexico|Centro Medico ISSEMYM, Metepec, Mexico|Hospital general ""5 de Diciembre"" ISSSTE, Mexicali, Mexico|Hospital Regional de Especialidades No. 30 IMSS, Mexicali, Mexico|Hospital de Oncologia Centro Medico, Mexico, DF, Mexico|Instituto Nacional de Ciencias Medicas u Nutricion ""Salvador Zubiran"", Mexico, DF, Mexico|Fundeni Clinical Institute, Bucharest, Romania|Trestioreanu Institute of Oncology, Bucharest, Romania|""I. Chiricuta"" Institute of Oncology, Cluj-Napoca, Romania|Craiova Emergency Clinical County Hospital, Craiova, Romania|Timisoara City Hospital, Timisoara, Romania|Institute of Medical Radiology, Russian Academy of Medical Science, Obninsk, Kaluzhskaya Region, Russian Federation|Cheliabinsk Regional Oncology Center, Cheliabinsk, Russian Federation|Irkutsk Regional Oncology Center, Irkutsk, Russian Federation|Clinical Oncology Center, Kazan, Russian Federation|Krasnodar City Oncology Center, Krasnodar, Russian Federation|Blokhin Cancer Research Center, Dept of Clinical Pharmacology and Chemotherapy, Moscow, Russian Federation|Central Clinical Hospital of the presidentof the Russian Federation, Moscow, Russian Federation|Hertzen Research Institute of Oncology, Moscow, Russian Federation|Central Clinical Hospital of the Ministru of Transport n.a. Semashko, Moscow, Russian Federation|Orenburg, Regional Oncology Center, Orenburg, Russian Federation|Samara Oncology Center, Samara, Russian Federation|St. Petersburg, Central Research Institute of Radiology, St. Petersburg, Russian Federation|Medical Academy of Postgraduate Education, St. Petersburg, Russian Federation|St. Petersburg Oncology Center, St. Petersburg, Russian Federation|Mechnikov State Medical Academy, St.Petersburg, Russian Federation|Voronezh Regional Clinical Oncology Center, Voronezh, Russian Federation|Yaroslavl Regional Oncology Center, Yaroslavl, Russian Federation|Dnepropetrovsk City Clinical Hospital, Dnepropetrovsk, Ukraine|Donetsk Regional Antitumor Center, Donetsk, Ukraine|State Communal Healthcare Institution: Kharkov Regional Clinical Oncological Center, Kharkov, Ukraine|Institute of Oncology under the Academy of Medical Sciences of Ukraine, Kiev, Ukraine|Kiev Municipal Clinical Hospital #10, Kiev Center for Biliary, Biliary tracts and Pancreas Surgery, Kiev, Ukraine|Krivoy Rog City Oncology Center, Krivoy Rog, Ukraine|Lugansk Regional Clinical Oncological Center, Lugansk, Ukraine|Nikolaev Regional Oncology Centre, Nikolaev, Ukraine|Odessa Regional Clinical Hospital, Odessa, Ukraine|Vinnitsa Regional Clinical Oncology Center, Vinnitsa, Ukraine|Zaporozhye Medical Academy of Postgraduate Education, Zaporozhye, Ukraine|Zhitomir Regional Clinical Hospital n.a. O.F. Gerbachevsky, Zhitomir, Ukraine","https://ClinicalTrials.gov/show/NCT00099294"
488,"Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Biological: Recombinant Interferon Alfa|Drug: Cisplatin|Drug: Fluorouracil|Radiation: Radiation Therapy","M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00068575"
489,"Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Cetuximab/Gemcitabine|Procedure: Radiotherapy",,"https://ClinicalTrials.gov/show/NCT00225784"
490,"A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer","Recruiting","No Results Available","Stage III Pancreatic Cancer","Drug: SOC|Device: NanoKnife System","Moores Cancer Center, UC San Diego Health, La Jolla, California, United States|University of Florida Health, Gainesville, Florida, United States|Mayo Clinic, Jacksonville, Jacksonville, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|Orlando Regional Healthcare System, Orlando, Florida, United States|University of South Florida, Tampa, Florida, United States|Wellstar Medical Group, Marietta, Georgia, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|University of Iowa Healthcare, Iowa City, Iowa, United States|Norton Healthcare, Louisville, Kentucky, United States|Mercy Medical Center, Baltimore, Maryland, United States|Mayo Clinic, Rochester, Rochester, Minnesota, United States|University of Mississippi, Jackson, Mississippi, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Capital Health, Trenton, New Jersey, United States|NYU Langone, New York, New York, United States|Presbyterian Hospital, Columbia, New York, New York, United States|Atrium Health, Charlotte, North Carolina, United States|St. Luke's University Health Network, Easton, Pennsylvania, United States|University of Texas-Southwestern, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT03899649"
491,"Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Cetuximab|Biological: Pancreatic tumor vaccine|Drug: Cyclophosphamide","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00305760"
492,"Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Biological: carcinoembryonic antigen peptide 1|Biological: hepatitis B antigen peptide","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003434"
493,"Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma","Completed","No Results Available","Pancreatic Cancer","Drug: Vandetanib","Research Site, St Gallen, SG, Switzerland|Research Site, Bellinzona, Switzerland","https://ClinicalTrials.gov/show/NCT00681798"
494,"Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients","Completed","Has Results","Pancreatic Cancer","Drug: Synthetic Human Secretin|Procedure: Secretin-Enhanced Magnetic Resonance Cholangiopancreatography|Procedure: Secretin-Enhanced Endoscopic Ultrasound","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01094561"
495,"A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer","Recruiting","No Results Available","Stage III Pancreatic Cancer","Drug: Modified FOLFIRINOX Regimen|Device: NanoKnife System","Mayo Clinic, Jacksonville, Jacksonville, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|University of South Florida/Tampa, Tampa, Florida, United States|Northwest Community Healthcare, Arlington Heights, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Norton Healthcare, Louisville, Kentucky, United States|Mayo Clinic, Rochester, Rochester, Minnesota, United States|University of Mississippi, Jackson, Mississippi, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Columbia University Irving Medical Center / NYP, New York, New York, United States|St. Luke's Cancer Center, Easton, Pennsylvania, United States|University of Texas-Southwestern, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT03899636"
496,"Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine","Terminated","No Results Available","Pancreatic Cancer","Drug: RP101|Drug: Gemcitabine (1000 mg/m2)","University of Arizona Medical Center, Arizona Cancer Center, Tucson, Arizona, United States|Tower Research Foundation at Tower Oncology, Beverly Hills, California, United States|University of California at San Francisco, San Francisco, California, United States|Integrated Community Oncology Network, LLC, Jacksonville, Florida, United States|Lakeland Regional Cancer Center, Lakeland, Florida, United States|Mid Dakota Clinic, Bismarck, North Dakota, United States|Gabrail Cancer Center, Canton, Ohio, United States|Signal Point Clinical Research Center, LLC, Middletown, Ohio, United States|Providence Portland Medical Center, Portland, Oregon, United States|St. Luke's Cancer Center, Bethlehem, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States|South Texas Oncology and Hematology, PA, San Antonio, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|University of Washington, Seattle, Washington, United States|Cancer Care Northwest, Spokane, Washington, United States|Medical College of Wisconsin, Froedtert Multi-Disciplinary Cancer Center, Milwaukee, Wisconsin, United States|Hospital Italiano Regional del Sur, Bahía Blanca, Buenos Aires, Argentina|Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Hospital Zonal General de Agudos San Roque, La Plata, Buenos Aires, Argentina|Hospital de Caridade de Ijuí, Ijuí, Brazil|Hospital de Clínicas de Porto Alegre, Serviço de Oncologia, Porto Alegre, Brazil|Instituto Nacional do Câncer, Rio de Janeiro, Brazil|Núcleo de Oncologia da Bahia, Salvador, Brazil|Hospital do Câncer-AC Camargo, São Paulo, Brazil|Hospital Militar, Santiago de Chile, Chile|Fundación Arturo López Pérez, Santiago, Chile|Hôpital Gabriel Montpied, Clermont-Ferrand, France|Centre Hospitalier Départemental, La Roche sur Yon Cedex 9, France|Centre Eugene Marquis, Service d'Oncologie Medicale, Rennes, France|Universitätsklinikum Dresden, Med. Klinik I, Dresden, Germany|Klinikum Region Hannover GmbH, Krankenhause Siloah, Hannover, Germany|Klinikum rechts der Isar, Technische Universität München, München, Germany|Petz Aladár Megyei Oktató Kórház Orvostovábbképzo Egyetem Oktató-Továbbképzo Kórháza, Onkoradiológia, Gyor, Budapest, Hungary|Fovárosi Önkormányzat Egyesített Szent István és Szent László Kórház-Rendelointézet, Budapest, Hungary|Fovárosi Önkormányzat Uzsoki utcai Kórháza, Budapest, Hungary|Debreceni Egyetem Orvos és Egészségtudományi Centrum, Onkológiai Tanszék, Debrecen, Hungary|Maaslandziekenhuis, Sittard, Netherlands|Hospital Nacional Guillermo Almenara Irigoyen, La Victoria, Peru|Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru|Instituto Oncocenter, San Borja, Peru|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Wojewódzki, Jelenia Góra, Poland|I Katedra Chirurgii Ogólnej i Klinika Chirurgii Gastroenterologicznej, Kraków, Poland|Wojewódzki Szpital Specjalistyczny im Kopernika w Lodzi, Lódz, Poland|Centrum Medyczne MRUKMED, Rzeszów, Poland|Institutul Clinic Fundeni, Bucuresti, Romania|Institutul Oncologic 'Prof. Dr. A. Trestioreanu', Bucuresti, Romania|Spitalul Clinic de Urgenta Floreasca, Bucuresti, Romania|Spitalul Clinic Universitar de Urgenta, Bucuresti, Romania|Hospital Universitario Arnau de Vilanova, Servicio de Oncologia, Lérida, Spain|Centro Integral Oncológico Clara Campal, Hospital de Madrid Norte-San Chinarro, Madrid, Spain|Hospital 12 de Octubre, Oncology Service, Hospital Materno Infantil, Madrid, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, England, United Kingdom|Mount Vernon Hospital, Middlesex, England, United Kingdom","https://ClinicalTrials.gov/show/NCT00550004"
497,"Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Other: Resection rates",,"https://ClinicalTrials.gov/show/NCT04802993"
498,"Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery","Withdrawn","No Results Available","Pancreatic Cancer","Drug: Synthetic Human Secretin","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01094535"
499,"Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Radiation: radiation therapy","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|MBCCOP - Gulf Coast, Mobile, Alabama, United States|CCOP - Greater Phoenix, Phoenix, Arizona, United States|Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, United States|Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States|Arizona Cancer Center, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California Davis Medical Center, Sacramento, California, United States|Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Veterans Affairs Medical Center - Denver, Denver, Colorado, United States|MBCCOP - Howard University Cancer Center, Washington, District of Columbia, United States|Mayo Clinic, Jacksonville, Florida, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States|MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States|Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States|Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States|Boston Medical Center, Boston, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Veterans Affairs Medical Center - Detroit, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|CCOP - Beaumont, Royal Oak, Michigan, United States|Providence Hospital - Southfield, Southfield, Michigan, United States|CCOP - Duluth, Duluth, Minnesota, United States|Veterans Affairs Medical Center - Biloxi, Biloxi, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, United States|Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi, United States|Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, United States|MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, United States|Veterans Affairs Medical Center - Albany, Albany, New York, United States|Western New York Urology Associates, Buffalo, New York, United States|St. Vincents Comprehensive Cancer Center, New York, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, United States|Barrett Cancer Center, Cincinnati, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Kettering, Ohio, United States|Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States|Veterans Affairs Medical Center - Oklahoma City, Oklahoma City, Oklahoma, United States|Veterans Affairs Medical Center - Portland, Portland, Oregon, United States|CCOP - Columbia River Program, Portland, Oregon, United States|Oregon Cancer Institute, Portland, Oregon, United States|Veterans Affairs Medical Center - Charleston, Charleston, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Veterans Affairs Medical Center - Houston, Houston, Texas, United States|Texas Tech University Health Science Center, Lubbock, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, United States|Veterans Affairs Medical Center - Temple, Temple, Texas, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, United States|Eastern Virginia Medical School, Norfolk, Virginia, United States|CCOP - Virginia Mason Research Center, Seattle, Washington, United States|Swedish Cancer Institute, Seattle, Washington, United States|Veterans Affairs Medical Center - Seattle, Seattle, Washington, United States|CCOP - Northwest, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|British Columbia Cancer Agency, Vancouver, British Columbia, Canada","https://ClinicalTrials.gov/show/NCT00003216"
500,"Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery","Completed","Has Results","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin|Genetic: protein expression analysis|Genetic: proteomic profiling|Other: diagnostic laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00536874"
501,"Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer","Terminated","No Results Available","Malnutrition|Pancreatic Cancer","Biological: proteolytic enzymes|Drug: gemcitabine hydrochloride|Procedure: Gonzalez regimen","Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00003851"
502,"Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan","Active, not recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Onivyde® + 5-FULV","Antwerp University Hosptital, Edegem, Belgium","https://ClinicalTrials.gov/show/NCT05095064"
503,"Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial)","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Chlorambucil, Oral, 2 Mg","IRCCS San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT04692740"
504,"Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Thromboembolism","Drug: dalteparin|Drug: gemcitabine hydrochloride|Other: diagnostic laboratory biomarker analysis","Princess Royal Hospital at Hull and East Yorkshire NHS Trust, Hull, England, United Kingdom|Royal Lancaster Infirmary, Lancaster, England, United Kingdom|Saint Bartholomew's Hospital, London, England, United Kingdom|St. George's Hospital, London, England, United Kingdom|Maidstone Hospital, Maidstone, England, United Kingdom|Nottingham City Hospital, Nottingham, England, United Kingdom|Scarborough General Hospital, Scarborough, England, United Kingdom|Scunthorpe General Hospital, Scunthorpe, England, United Kingdom","https://ClinicalTrials.gov/show/NCT00462852"
505,"Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer","Completed","No Results Available","Neoplasms|Pancreatic Neoplasms","Drug: Glufosfamide|Drug: Gemcitabine","Arizona Cancer Center, Tucson, Arizona, United States|Indiana Cancer Center, Indianapolis, Indiana, United States|Norton Healthcare Cancer Center, Louisville, Kentucky, United States|Hospital de Doenças Cardiovasculares - Biocor, Nova Lima, BH, Brazil|Hospital Mãe de Deus, Porto Alegre, RS, Brazil|Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brazil|Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, SP, Brazil|Universidade Federal de São Paulo - Hospital São Paulo, São Paulo, SP, Brazil|Hospital Israelita Albert Einstein, São Paulo, SP, Brazil","https://ClinicalTrials.gov/show/NCT00102752"
506,"Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice","Completed","No Results Available","Pancreatic Cancer",,"University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT02277834"
507,"Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma","Active, not recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Sarcoma","Drug: Decitabine|Drug: Gemcitabine","University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT02959164"
508,"ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Adenocarcinoma","Drug: ARQ 501 in combination with gemcitabine","University of South Alabama, Mobile, Alabama, United States|Moores UCSD Cancer Center, La Jolla, California, United States|Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California, United States|Scripps Cancer Center, San Diego, California, United States|VA San Diego Healthcare System, San Diego, California, United States|University of Chicago Medical Center, Chicago, Illinois, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Unversity of Kentucky Medical Center - Markey Center, Lexington, Kentucky, United States|The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Jeffrey Meyerhardt, Boston, Massachusetts, United States|Jacobi Medical Center, Bronx, New York, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States|Virginia Cancer Institute, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00102700"
509,"Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride|Other: laboratory biomarker analysis|Radiation: radiation therapy","Centre Radiotherapie Oncologie Moyenne Garonne, Agen, France|Centre Hospitalier d'Aix en Provence, Aix en Provence, France|Centre Paul Papin, Angers, France|Polyclinique Sainte Marguerite, Auxerre, France|Centre Hospitalier d'Auxerre, Auxerre, France|Institut Sainte Catherine, Avignon, France|Hopital Duffaut, Avignon, France|Centre Hospitalier de la Cote Basque, Bayonne, France|Centre Hospitalier de Beauvais, Beauvais, France|Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besancon, France|Hopital de Beziers, Beziers, France|Hopital Saint Andre, Bordeaux, France|Institut Bergonie, Bordeaux, France|Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France|Clinique Tivoli, Bordeaux, France|Hopital Ambroise Pare, Boulogne-Billancourt, France|Centre Hospitalier Pierre Oudot, Bourgoin-Jallieu, France|CHU de Caen, Caen, France|Polyclinique Du Parc, Caen, France|Hopital Beaujon, Clichy, France|Hopital Louis Pasteur, Colmar, France|Centre Hospitalier Compiegne, Compiegne, France|Centre Hospitalier Universitaire Henri Mondor, Creteil, France|Centre Hospitalier de Dax, Dax, France|Centre Hospitalier de Digne les Bains, Digne Cedex, France|Hopital Du Bocage, Dijon, France|Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France|Centre Hospitalier Draguignan, Draguignan, France|CHU de Grenoble - Hopital de la Tronche, Grenoble, France|Centre Hospitalier Departemental, La Roche Sur Yon, France|Centre Hospitalier de Lagny, Lagny Sur Marne, France|Hopital Louis Pasteur - Le Coudray, Le Coudray, France|Centre Hospitalier Universitaire de Bicetre, Le Kremlin Bicetre, France|Clinique Victor Hugo, Le Mans, France|Hopital Robert Boulin, Libourne, France|Polyclinique Du Bois, Lille, France|Polyclinique des Quatre Pavillons, Lormont, France|Centre Hospitalier St. Joseph St. Luc, Lyon, France|Hopital Prive Jean Mermoz, Lyon, France|Hopital de la Croix Rousse, Lyon, France|Centre Leon Berard, Lyon, France|Hopital Edouard Herriot - Lyon, Lyon, France|Centre Hospitalier Chanaux, Macon, France|Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, France|CHU de la Timone, Marseille, France|Centre Gray, Maubeuge, France|Centre Hospitalier de Meaux, Meaux, France|Centre Hospitalier General de Mont de Marsan, Mont-de-Marsan, France|Centre Hospitalier de Montelimar, Montelimar, France|C.H.U. de Nimes - Groupe Hospitals-Universitaire Caremeau, Nimes, France|Clinique De Valdegour, Nimes, France|CHR D'Orleans - Hopital de la Source, Orleans, France|Hopital Pitie-Salpetriere, Paris, France|Hopital Europeen Georges Pompidou, Paris, France|Hopital Bichat - Claude Bernard, Paris, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|Hopital Saint Joseph, Paris, France|Hopital Tenon, Paris, France|Centre Catalan d'Oncologie, Perpignan, France|Hopital Haut Leveque, Pessac, France|Centre Hospitalier Lyon Sud, Pierre Benite, France|CHU Poitiers, Poitiers, France|Hopital Rene Dubos, Pontoise, France|CHU - Robert Debre, Reims, France|Hopital Charles Nicolle, Rouen, France|Centre Hospitalier, Saint-Omer, France|Centre Hospitalier de Tarbes, Tarbes, France|Centre Hospitalier Regional Metz Thionville, Thionville, France|CHRU de Tours - Hopital Trousseau, Tours, France|Nouvelle Clinique Generale, Valence, France|Centre Hospitalier Bretagne Atlantique, Vannes, France","https://ClinicalTrials.gov/show/NCT00634725"
510,"Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer","Recruiting","No Results Available","Resectable Pancreatic Cancer","Other: Blood samples","University Hospital, Toulouse, France","https://ClinicalTrials.gov/show/NCT03435536"
511,"Adavosertib and Gemcitabine in Advanced Pancreatic","Not yet recruiting","No Results Available","Pancreatic Cancer","Drug: Adavosertib|Drug: Gemcitabine","Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT05212025"
512,"QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Metastatic Pancreatic Cancer|Pancreatic Cancer","Other: Placebo|Drug: AMG 479|Drug: AMG 655","Research Site, Alhambra, California, United States|Research Site, Bakersfield, California, United States|Research Site, Fullerton, California, United States|Research Site, La Jolla, California, United States|Research Site, Long Beach, California, United States|Research Site, Los Angeles, California, United States|Research Site, Northridge, California, United States|Research Site, Oxnard, California, United States|Research Site, Rancho Mirage, California, United States|Research Site, Redondo Beach, California, United States|Research Site, San Francisco, California, United States|Research Site, Santa Maria, California, United States|Research Site, Santa Monica, California, United States|Research Site, Miami, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Atlanta, Georgia, United States|Research Site, Marietta, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Harvey, Illinois, United States|Research Site, Baltimore, Maryland, United States|Research Site, Westminster, Maryland, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Henderson, Nevada, United States|Research Site, Albany, New York, United States|Research Site, New York, New York, United States|Research Site, Durham, North Carolina, United States|Research Site, Hickory, North Carolina, United States|Research Site, Columbus, Ohio, United States|Research Site, Eugene, Oregon, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Providence, Rhode Island, United States|Research Site, Greenville, South Carolina, United States|Research Site, Austin, Texas, United States|Research Site, Austin, Texas, United States|Research Site, Austin, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Round Rock, Texas, United States|Research Site, Tyler, Texas, United States|Research Site, Tacoma, Washington, United States|Research Site, Yakima, Washington, United States","https://ClinicalTrials.gov/show/NCT00630552"
513,"Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Neoplasm Malignant Head Primary|Pancreatic Exocrine Insufficiency","Device: Pancreatic stent","Daniel de la Iglesia, Santiago de Compostela, A Coruña, Spain","https://ClinicalTrials.gov/show/NCT05244174"
514,"Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Unresectable Pancreatic Cancer|Metastatic Pancreatic Cancer|Pancreatic Adenocarcinoma","Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)","Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT04002479"
515,"Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer","Active, not recruiting","No Results Available","Metastatic Biliary Tract Carcinoma|Metastatic Colorectal Carcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Metastatic Malignant Digestive System Neoplasm|Metastatic Pancreatic Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7","Drug: Fluorouracil|Drug: Irinotecan Sucrosofate|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Rucaparib","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT03337087"
516,"Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Cancer","Drug: Pembrolizumab|Drug: Olaparib",,"https://ClinicalTrials.gov/show/NCT05093231"
517,"Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Pembrolizumab|Drug: Folfirinox","Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center (BSLMC)., Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05132504"
518,"Prospective Monocentric Clinical-biological Database","Recruiting","No Results Available","Pancreatic Cancer","Other: Biological collection","Institut Régional du Cancer de Montpellier, Montpellier, Occ, France","https://ClinicalTrials.gov/show/NCT04136132"
519,"Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)","Completed","No Results Available","Carcinoma, Pancreatic Ductal","Drug: Atu027 & gemcitabine in lead in safety period|Drug: Atu027 & gemcitabine in treatment arm 1|Drug: Atu027 & gemcitabine in treatment arm 2","Charité - Universitätsmedizin Berlin Charité Centrum für Tumormedizin, Berlin, Germany|Klinikum Dortmund gGmbH Medizinische Klinik Mitte, Dortmund, Germany|Universitätsklinikum Freiburg, Innere Medizin II, Freiburg, Germany|Medizinische Klinik III - Hämatologie/Onkologie Marienhospital Herne, Herne, Germany|Klinikum Kassel GmbH Medizinischen Klinik IV;Onkologie,, Kassel, Germany|Klinikum Nürnberg Nord Medizinische Klinik 5, Nürnberg, Germany|Klinik und Poliklinik für Innere Medizin I Universitätsklinikum Regensburg, Regensburg, Germany|Klinikum Stuttgart Klinik Hämatologie, Onkologie und Palliativmedizin, Stuttgart, Germany|Universitätsklinikum Ulm Zentrum für Innere Medizin, Ulm, Germany","https://ClinicalTrials.gov/show/NCT01808638"
520,"Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Cancer","Drug: Tadalafil|Drug: Pembrolizumab|Drug: Ipilimumab|Drug: CRS-207","Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT05014776"
521,"Intraoperative Radiation Therapy for Resectable Pancreas Cancer","Recruiting","No Results Available","Pancreas Cancer","Radiation: 10 Gy Low-KV IORT|Radiation: 15 Gy Low-KV IORT|Radiation: 20 GY Low-KV IORT","Loyola University Medical Center, Maywood, Illinois, United States","https://ClinicalTrials.gov/show/NCT02599662"
522,"Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement","Recruiting","No Results Available","Pancreas Cancer","Radiation: IORT","University of California, Irvine, Irvine, California, United States|Mayo Clinic, Jacksonville, Jacksonville, Florida, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Rochester, Minnesota, United States|University of North, Carolina Chapel Hill, Chapel Hill, North Carolina, United States|Ohio State University Medical Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT03716531"
523,"Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level","Recruiting","No Results Available","Cancer of Pancreas","Procedure: Blood sample in portal vein","Institut Paoli Calmettes, Marseille, France","https://ClinicalTrials.gov/show/NCT04677244"
524,"Improving REsectability in Pancreatic NEoplasms (IRENE)","Unknown status","No Results Available","Pancreatic Cancer|Stereotactic Body Radiotherapy","Radiation: SBRT plus chemotherapy","Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy","https://ClinicalTrials.gov/show/NCT03460925"
525,"Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine","Recruiting","No Results Available","Pancreatic Cancer, Adult","Drug: GP-2250","Hoag Family Cancer Institute, Newport Beach, California, United States|University of Kansas Cancer Center, Fairway, Kansas, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Allina, Minneapolis, Minnesota, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03854110"
526,"IORT on Borderline Resectable Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Cancer","Radiation: Intraoperative radiotherapy","General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital, Verona, Italy","https://ClinicalTrials.gov/show/NCT04090463"
527,"Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer","Active, not recruiting","No Results Available","Cancer of Pancreas","Radiation: Pre-operative stereotactic ablative body radiotherapy","Addenbrookes Hospital, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT04128332"
528,"A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Gemcitabine|Drug: Nab-Paclitaxel","Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan","https://ClinicalTrials.gov/show/NCT02272738"
529,"Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas","Completed","Has Results","Pancreatic Cancer","Biological: GVAX pancreatic cancer vaccine","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00084383"
530,"Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer",,"Stephensen Cancer Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT01580241"
531,"Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma","Active, not recruiting","No Results Available","Adenocarcinoma of the Pancreas|Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum","Drug: Pembrolizumab|Drug: DEBIO1143","Centre Léon Bérard, Lyon, France","https://ClinicalTrials.gov/show/NCT03871959"
532,"Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine, Abraxane, Gemcitabine)","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: oral azacitidine|Other: Observation|Drug: First-line chemotherapy after recurrence","Johns Hopkins, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01845805"
533,"Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Radiation: Proton radiation|Drug: Gemcitabine","University of Florida Proton Therapy Institute, Jacksonville, Florida, United States|Provision Proton Therapy Center, Knoxville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01553019"
534,"A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: Gemcitabine, Bosutinib","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01025570"
535,"Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Stereotactic Body Radiation Therapy","Drug: Avasopasem (GC4419)|Drug: Placebo|Radiation: Stereotactic Radiation Therapy (SBRT)","Moffitt Cancer Center, Tampa, Florida, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Duke University Medical Center, Durham, North Carolina, United States|UT Southwestern Medical Center, Dallas, Texas, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03340974"
536,"Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Neoplasms","Drug: nab-paclitaxel|Drug: Gemcitabine","Beijing Cancer Hospital, Beijing, PR, China|307 Hospital of Chinese PLA, Beijing, China|Peking Union Medical College Hospital, Beijing, China|Chinese PLA General Hospital, Beijing, China|Sun Yat-sen University Cancer Center, Guangzhou, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China|The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, China|Zhejiang Cancer Hospital, Hangzhou, China|Harbin Medical University Tumor Hospital, Harbin, Heilongjiang, China|Jiangsu Province Hospital The First Hospital affiliated with Nanjing Medical University, Nanjing, China|Fudan University Shanghai Cancer Center, Shanghai, China|Shanghai First People's Hospital, Shanghai, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, China|Xijing Hospital, Xi'an, China|Henan Cancer Hospital, Zhengzhou, China","https://ClinicalTrials.gov/show/NCT02017015"
537,"Claudin18.2 CAR-T (CT041) in Patients With Gastric or Pancreatic Cancer","Recruiting","No Results Available","Gastric Cancer|Pancreatic Cancer","Biological: CT041","University of Southern California, Los Angeles, California, United States|UCSD, San Diego, California, United States|UCSF, San Francisco, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|University of Chicago, Chicago, Illinois, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Mayo Cancer Hospital, Rochester, Minnesota, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Ohio State University, Columbus, Ohio, United States|TX Oncology-Baylor Charles Sammons Cancer Center, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04404595"
538,"Neoadjuvant Treatment in Resectable Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Radiation: External Beam Radiation|Drug: Gemcitabine neoadjuvant|Procedure: Surgery|Drug: Gemcitabine adjuvant","University Freiburg, Freiburg, Baden-Württemberg, Germany|Heidelberg University, Heidelberg, Baden-Württemberg, Germany|Technische Universität München, München, Bayern, Germany|University Regensburg, Regensburg, Bayern, Germany|Klinikum Augsburg, Augsburg, Bayer, Germany|Klinikum Darmstadt, Darmstadt, Hessen, Germany|University of Rostock, Rostock, Mecklenburg-Vorpommern, Germany|Hannover Medical School, Hannover, Niedersachsen, Germany|St. Joseph Hospital Bochum, Bochum, Nordrhein-Westfalen, Germany|Saarland University, Homburg, Saarland, Germany|University of Schleswig-Holstein Kiel, Kiel, Schleswig-Holstein, Germany|University of Schleswig-Holstein Lübeck, Lübeck, Schleswig-Holstein, Germany|Klinikum Gera, Gera, Thüringen, Germany|University of Jena, Jena, Thüringen, Germany|University Medical Center Hamburg-Eppendorf, Hamburg, Germany|Klinikum Karlsruhe, Karlsruhe, Germany","https://ClinicalTrials.gov/show/NCT01900327"
539,"Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma","Completed","No Results Available","Locally Advanced Pancreatic Cancer|Metastatic Pancreatic Cancer","Drug: gemcitabine, oxaliplatin, capecitabine","Cantonal Hospital Bruderholz, Bruderholz, BL, Switzerland|Cantonal Hospital Liestal, Liestal, BL, Switzerland|St. Clara Hospital, Basel, Switzerland|University Hospital Basel, Basel, Switzerland|Cantonal Hospital Lucerne, Lucerne, Switzerland|City Hospital Triemli, Zurich, Switzerland|Oncocenter Hirslanden, Zurich, Switzerland|University Hospital, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT00744640"
540,"A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Neoplasms","Drug: Lipidem fish oil infusion + Gemcitabine chemotherapy","University Hospitals of Leicester : Leicester Royal Infirmary, Leicester, Leicestershire, United Kingdom","https://ClinicalTrials.gov/show/NCT01019382"
541,"Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: Cyclophosphamide|Drug: Nivolumab|Drug: Ipilimumab|Drug: GVAX Pancreas Vaccine|Drug: CRS-207","Johns Hopkins SKCCC, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03190265"
542,"Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis","Recruiting","No Results Available","Pancreatic Cancer","Drug: ABBV-927|Drug: Budiglimab|Drug: modified FOLFIRINOX","Highlands Oncology Group Springdale /ID# 242049, Springdale, Arkansas, United States|UCHSC Anschultz Cancer Pavilion /ID# 227841, Aurora, Colorado, United States|Yale University, Yale Cancer Center /ID# 227685, New Haven, Connecticut, United States|NW Georgia Oncology Centers /ID# 241146, Marietta, Georgia, United States|The University of Chicago Medical Center /ID# 229081, Chicago, Illinois, United States|Johns Hopkins University /ID# 226713, Baltimore, Maryland, United States|Univ Hosp Cleveland /ID# 226807, Cleveland, Ohio, United States|Cleveland Clinic Main Campus /ID# 231135, Cleveland, Ohio, United States|Kettering Adventist Healthcare /ID# 243860, Kettering, Ohio, United States|Penn State Hershey Medical Ctr /ID# 229837, Hershey, Pennsylvania, United States|Monash Medical Centre /ID# 231379, Clayton, Victoria, Australia|Austin Health /ID# 231378, Heidelberg, Victoria, Australia|The Chaim Sheba Medical Center /ID# 226812, Ramat Gan, Tel-Aviv, Israel|Rambam Health Care Campus /ID# 229555, Haifa, Israel|Yonsei University Health System Severance Hospital /ID# 230280, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Seoul National University Hospital /ID# 230278, Seoul, Korea, Republic of|Asan Medical Center /ID# 230282, Seoul, Korea, Republic of|Samsung Medical Center /ID# 230283, Seoul, Korea, Republic of|Hematology and Oncology Institute /ID# 230572, Manati, Puerto Rico|Pan American Center for Oncology Trials, LLC /ID# 228210, Rio Piedras, Puerto Rico|Instituto Catalan de Oncologia (ICO) L'Hospitalet /ID# 230138, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Vall d'Hebron /ID# 230226, Barcelona, Spain|Hospital Universitario 12 de Octubre /ID# 230102, Madrid, Spain|Hospital Universitario Miguel Servet /ID# 230139, Zaragoza, Spain","https://ClinicalTrials.gov/show/NCT04807972"
543,"Borderline Pancreas Study: FOLFIRINOX +SBRT","Completed","No Results Available","Resectable Pancreatic Cancer","Other: Chemotherapy(FOLFIRINOX) + SBRT prior to surgery if applicable|Drug: -Oxaliplatin 85 mg/m2 IV on Day 1|Drug: -Irinotecan 180 mg/m2 IV on Day 1|Drug: -5-FU (Fluorouracil) 2,400 mg/m2 IV over 46-48 hours","University of Maryland Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01992705"
544,"Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients","Completed","No Results Available","Pancreatic Cancer","Drug: LDE225+gemcitabine","Massachusetts General Hospital Dept. of Mass General Hospital, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center MSKCC - SC, New York, New York, United States|University of Utah / Huntsman Cancer Institute Huntsman UT, Salt Lake City, Utah, United States|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT01487785"
545,"A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.","Completed","No Results Available","Unresectable Locally Advanced Pancreatic Carcinoma","Device: OncoSil™","Cedars Sinai Department of Radiation Oncology, Los Angeles, California, United States|Moffitt Cancer Centre, Tampa, Florida, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03076216"
546,"Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases","Withdrawn","No Results Available","Malignant Tumor of Pancreas Metastatic to Liver","Biological: Anti-CEA CAR-T cells|Drug: gemcitabine/nab paclitaxel|Drug: NLIR+FU/FA|Drug: Capecitabine",,"https://ClinicalTrials.gov/show/NCT04037241"
547,"A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane","Completed","No Results Available","Unresectable Locally Advanced Pancreatic Carcinoma","Device: OncoSil™","Corrimal Cancer Care Clinic, 20-22 Underwood St, Corrimal, New South Wales, Australia|Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia|The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia|The Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia|Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia|Institute for Breathing and Sleep -Bowen CentreAustin Health, Heidelberg, Victoria, Australia|Monash Cancer Centre, Melbourne, Victoria, Australia|Institut Jules Bordet, Bruxelles, Belgium|Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom|Leicester Royal Infirmary, Leicester, East Midlands, United Kingdom|Guy's and St Thomas' NHS Foundation Trust,, London, Greater London, United Kingdom|Hammersmith Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03003078"
548,"A Trial of Chemo & Radiation Therapy for Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Gemcitabine/Fluorouracil with External Beam Radiation",,"https://ClinicalTrials.gov/show/NCT00424827"
549,"GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: Cyclophosphamide|Drug: Nivolumab|Drug: GVAX Pancreas Vaccine|Radiation: Stereotactic Body Radiation (SBRT)","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03161379"
550,"Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine","Terminated","No Results Available","Pancreatic Cancer","Drug: pioglitazone hydrochloride|Other: laboratory biomarker analysis|Other: questionnaire administration|Procedure: quality-of-life assessment","Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00867126"
551,"Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Drug: TH-302|Drug: Nab-paclitaxel|Drug: Gemcitabine","Mayo Clinic, Scottsdale, Arizona, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Washington University, Saint Louis, Missouri, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02047500"
552,"A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Carcinoma","Drug: gemcitabine|Drug: capecitabine|Drug: erlotinib","H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT00480584"
553,"BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery","Unknown status","No Results Available","Pancreatic Cancer","Drug: BBR 3464","Arizona Oncology Associates, Tucson, Arizona, United States|Alta Bates Comprehensive Cancer Center, Berkeley, California, United States|Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Oklahoma Oncology Inc., Tulsa, Oklahoma, United States|Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group, Memphis, Tennessee, United States|Cancer Center at the University of Virginia, Charlottesville, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00024362"
554,"A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer","Suspended","No Results Available","Pancreatic Cancer","Drug: placebo + gemcitabine + erlotinib|Drug: Placebo + gemcitabine|Drug: calcitriol + gemcitabine|Drug: calcitriol + gemcitabine + erlotinib","Novacea Investigational Site, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00536770"
555,"Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas","Recruiting","No Results Available","Pancreatic Cancer","Radiation: Proton Radiation|Drug: Capecitabine|Procedure: Surgical resection","University of Florida Proton Therapy Institute, Jacksonville, Florida, United States|Northwestern Medicine Chicago Proton Center, Warrenville, Illinois, United States|Inova Schar Cancer Institute, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT02598349"
556,"Chemoimmunotherapy and Radiation in Pancreatic Cancer","Completed","No Results Available","Locally Advanced Malignant Neoplasm","Drug: Tadalafil|Drug: Gemcitabine|Radiation: Radiation|Procedure: Pancreaticoduodenectomy","Portland Providence Medical Center, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01903083"
557,"DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Diseases|Pancreatic Neoplasms|Pancreatitis","Other: No interventions, this is an observational study","Research unit, Surgical Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark","https://ClinicalTrials.gov/show/NCT02079363"
558,"Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the ""Apact"" Study)","Active, not recruiting","Has Results","Pancreatic Neoplasms|Digestive System Neoplasms|Neoplasms by Site|Neoplasms|Endocrine Gland Neoplasms|Pancreatic Diseases|Digestive System Diseases|Endocrine System Diseases|Gemcitabine|Antimetabolites, Antineoplastic","Drug: nab-Paclitaxel|Drug: Gemcitabine","Mayo Clinic - Arizona, Scottsdale, Arizona, United States|UCSD Moores Cancer Center, La Jolla, California, United States|University of Southern California, Los Angeles, California, United States|UC Davis Cancer Center, Sacramento, California, United States|University of California, San Francisco Cutaneous Oncology and Melanoma Center, San Francisco, California, United States|University of California Los Angeles, Santa Monica, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Rocky Mountain Cancer Centers, LLP [Denver-Midtown], Denver, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|Lynn Cancer Institute, Boca Raton, Florida, United States|Florida Cancer Institute Cancer Spec, Fort Myers, Florida, United States|Gainesville Heme Oncology Associates, Gainesville, Florida, United States|University of Florida, Gainesville, Florida, United States|University of Miami and Sylvester Cancer Center, Miami, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|H Lee Moffitt Cancer Center, Tampa, Florida, United States|Georgia Cancer Specialist, Atlanta, Georgia, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Northshore University Healthsystem Research Institute, Evanston, Illinois, United States|Illinois Cancer Specialists, Niles, Illinois, United States|University of Louisville, Louisville, Kentucky, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel-Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Karmanos Cancer Center Wayne State University, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|MSKCC Basking Ridge, Basking Ridge, New Jersey, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Memorial Sloan-Kettering Cancer Center, Commack, New York, United States|Memorial Sloan Kettering Cancer Center West Harrison, Harrison, New York, United States|NYU Langone Medical Center, Lake Success, New York, United States|Memorial Sloan-Kettering Cancer Center - NYC, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University of Rochester Cancer Center, James P. Wilmot Cancer Center, Rochester, New York, United States|MSKCC at Mercy Medical Center Mercy RockvilleCenter, Rockville Center, New York, United States|MSKCC at Phelps Memorial Hospital Center. Phelps Sleepy Hollow, Sleepy Hollow, New York, United States|State University of New York Upstate Medical Center, Syracuse, New York, United States|Wake Forest Univ. Health Sciences Outpatient Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, United States|University of Cincinnati Medical CenterDivsion of Hematology OncologyThe Barrett Center, Cincinnati, Ohio, United States|Case Western Reserve Center, Cleveland, Ohio, United States|Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, United States|Cleveland Clinic Foundation IRB, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Medical Center, Columbus, Ohio, United States|University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University OHSU, Portland, Oregon, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|UPMC Cancer Pavillion, Pittsburgh, Pennsylvania, United States|Chattanooga Oncology Hematology Care, Chattanooga, Tennessee, United States|Sarah Cannon Research Inst, Nashville, Tennessee, United States|Vanderbilt- Ingram Cancer Center, Nashville, Tennessee, United States|Texas Oncology, Dallas, Texas, United States|Baylor Sammons Cancer Center, Dallas, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Texas Oncology, P.A. - Tyler, Tyler, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|Seattle Cancer Care Alliance - Seattle, Seattle, Washington, United States|Virginia Mason Cancer Center, Seattle, Washington, United States|University of Wisconsin - Madison Cancer Center, Madison, Wisconsin, United States|Canberra Hospital, Garran, Australian Capital Territory, Australia|Northern Cancer Institute, St Leonards, New South Wales, Australia|ICON Cancer Center, Milton, Queensland, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Monash Medical Centre Moorabbin Campus, Bentleigh East, Australia|Saint Vincent's Hospital, Darlinghurst, Australia|Austin Hospital, Heidelberg, Australia|Royal Brisbane and Women's Hospital, Herston, Australia|Cabrini Hospital, Malvern, Australia|Prince of Wales Hospital, Randwick, Australia|The Queen Elizabeth Hospital, Woodville South, Australia|Medical University of Graz, Graz, Austria|Medical University Innsbruck, Innsbruck, Austria|Hospital of Elisabethinen Linz, Linz, Austria|Salzburger Landkliniken St. Johanns-Spital, Salzburg, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, Austria|Hospital Wiener Neustadt, Wiener Neustadt, Austria|Medizinische Universitat Wien, Wien, Austria|Kaiser-Franz-Josef Spital, Wien, Austria|Hopital Erasme, Brussels, Belgium|UZ Antwerpen, Edegem, Belgium|UZ Gent, Gent, Belgium|UZ Leuven, Leuven, Belgium|Tom Baker Cancer Center, Calgary, Alberta, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Centre Hospitalier de L'Universite de Montreal St-Luc, Montreal, Quebec, Canada|Jewish General Hospital, Montreal, Quebec, Canada|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czechia|Krajska nemocnice Liberec, a.s., Liberec, Czechia|Krajska nemocnice T. Bati a.s., Zlin, Czechia|Hæmatologisk afd. B Aalborg Sygehus Syd, Aalborg, Denmark|Herlev Hospital, Herlev, Denmark|Onk.Dep., Odense Universitets hospital, Odense C, Denmark|Helsingin yliopistollinen keskussairaala, Helsinki, Finland|Tampereen yliopistollinen sairaala, Tampere, Finland|Turku University Hospital, Turku, Finland|Center Hospitalier Universitaire d' Angers, Angers cedex 09, France|Hopital Henri Mondor, Creteil, France|CHRU de Lille France, Lille, France|Hopital Edouard Herriot - Hepato-gastroenterologie, Lyon Cedex 3, France|Hopital prive Jean Mermoz, Lyon, France|Hopital Europeen Georges Pompidou, Paris, France|Hopital Saint Antoine, Paris, France|Hopital Pitie Salpetriere, Paris, France|CHU La Miletrie, Poitiers Cedex, France|Pole Des Specialites Medicales, Hopital Purpan, Toulose, France|Klinikum Weiden, Bayern, Germany|Charite - Universitätsmedizin Berlin, Berlin, Germany|Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Germany|Kliniken Essen-Mitte, Essen, Germany|Universitatsklinkum Frankfurt, Frankfurt, Germany|Praxis Internistischer Onkologie und Hamatologie Frechen, Frechen, Germany|Praxis für Innere Medizin, Dr.Oettle Helmut, Friedrichshafen, Germany|Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany|Universitaetsklinik Hamburg - Eppendorf, Hamburg, Germany|Praxis Internistischer Onkologie und Hamatologie Koln, Köln, Germany|Universitatsklinik Magdeburg, Magdeburg, Germany|Klinikum der Johannes Gutenberg Uniervsitaet ,Haematologie, Mainz, Germany|Klinikum der Universitat Munchen-Grosshadern, München, Germany|Klinikum Neuperlach, München, Germany|University of Tubingen, Tübingen, Germany|Universitatsklinikum Würzburg, Würzburg, Germany|Queen Mary Hospital, Hong Kong, Hong Kong|Tuen Mun Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital the Chinese University of Hong Kong, Sha Tin, Hong Kong|Fovarosi Szent Istvan es Szent Laszlo Korhaz es Rendelointezet, Budapest, Hungary|Uzsoki Utcai Korhaz, Budapest, Hungary|Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen, Hungary|Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Gyor, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Szent-Gyorgyi Albert TE AOK Borgyogy, Szeged, Hungary|Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary|Cork University Hospital, Cork, Ireland|St Vincent's University Hospital, Dublin 4, Ireland|Ospedali Riuniti Umberto I GM Lancisi, Ancona, Italy|Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Italy|Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy|Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori (I.R.S.T.), Meldola, Italy|Ospedale San Raffaele S.r.l., Milano, Italy|Azienda Ospedaliera Niguarda Ca Granda, Milano, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|Policlinico Universitario Agostino Gemelli, Roma, Italy|Istituto Nazionale Tumori Regina Elena, Roma, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|Azienda Ospedaliera S Maria di Terni, Terni, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|Seoul National University Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Academisch Medisch Centrum Amsterdam, Amsterdam, Netherlands|Catharina Hospital, Eindhoven, Netherlands|Isala Klinieken, Zwolle, Netherlands|Centro Hospitalar de Lisboa Central - Hospital de Santo António dos Capuchos, Lisboa, Portugal|Hospital Da Luz, Lisboa, Portugal|Hospital de Sao Joao, Porto, Portugal|National University Hospital, Singapore, Singapore|National Cancer Center, Singapore, Singapore|Clinic Barcelona Hospital Universitari, Barcelona, Spain|Instituto Catalan de Oncologia-Hospital Duran, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital General Gregorio Maranon, Madrid, Spain|Ramon y Cajal Univeresity Hospital, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Centro Integral, Madrid, Spain|Hospital General Carlos Haya, Malaga, Spain|Complejo Hospitalario de Navarra, Pamplona/ Navarra, Spain|Hospital Universitario Marques de Valdecilla, Santander, Spain|Hospital Clinico Universitario De Santiago De Compostela, Santiago De Compostela, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Taichung Veterans General Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiana, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan|National Taiwan University Hospital, Tapei, Taiwan|Addenbrookes Hospital, Cambridge, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Weston Park Hospital, Sheffield South Yorkshire, United Kingdom","https://ClinicalTrials.gov/show/NCT01964430"
559,"Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study","Completed","Has Results","Pancreatic Cancer","Drug: dehydrated alcohol","Clarian Health: Indiana University Hospital, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT00578279"
560,"Safety Study of Whole Body Hyperthermia for Advanced Cancer","Recruiting","No Results Available","Advanced Cancer|Pancreatic Cancer Metastatic","Device: Whole body hyperthermia|Drug: Standard of Care (SOC) chemotherapy according to the NCCN guidelines.","University Hospital Antwerp, Edegem, Antwerpen, Belgium","https://ClinicalTrials.gov/show/NCT04467593"
561,"Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)","Unknown status","No Results Available","Pancreatic Cancer Stage II|Pancreatic Cancer Stage III","Drug: Neoadjuvant gemcitabine, capecitabine, and docetaxel|Drug: Gemcitabine, capecitabine, docetaxel followed by radiotherapy","Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01065870"
562,"Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer","Completed","Has Results","Metastatic Pancreatic Cancer","Biological: GVAX Pancreas|Biological: CRS-207|Drug: Cyclophosphamide","H. Lee Moffitt Cancer Center, Tampa, Florida, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland, United States|National Cancer Institute, Bethesda, Maryland, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NYU Langone Medical Center, New York, New York, United States|Herbert Irving Comprehensive Cancer Center of Columbia University, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Providence Portland Medical Center, Portland, Oregon, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Virginia Mason Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01417000"
563,"7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients","Terminated","Has Results","Pancreatic Cancer","Drug: erlotinib","University of Alabama at Birmingham,Comprehensive Cancer Center, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT00841035"
564,"A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer","Completed","Has Results","Pancreatic Neoplasms","Drug: imexon in combination with gemcitabine|Drug: imexon placebo + gemcitabine","Birmingham Hematology and Oncology- US Oncology, Birmingham, Alabama, United States|AZ Onc Associates D.B.A. Hematology Oncology- US Oncology, Tucson, Arizona, United States|Arizona Clinical Research Center, Tucson, Arizona, United States|Rocky Mountain Cancer Center- US Oncology, Denver, Colorado, United States|Ocala Oncology Center- US Oncology, Ocala, Florida, United States|Cancer Centers of Florida- US Oncology, Orlando, Florida, United States|Peachtree Hematology and Oncology Consultants, Atlanta, Georgia, United States|Hematology Oncology Associates of Illinois- US Oncology, Chicago, Illinois, United States|Cancer Care & Hematolog Specialists of Chicagoland- US Oncology, Niles, Illinois, United States|Central Indiana Cancer Centers- US Oncology, Indianapolis, Indiana, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States|Hope Center- US Oncology, Terre Haute, Indiana, United States|University of Kentucky, Hematology/Oncology/BMT Clinical Research, Lexington, Kentucky, United States|Lahey Clinic, Burlington, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Kansas City Cancer Center, LLC- US Oncology, Kansas City, Missouri, United States|Comprehensive Cancer Centers of Nevada- US Oncology, Las Vegas, Nevada, United States|Hunterdon Regional Cancer Center, Flemington, New Jersey, United States|Hematology Oncology Associates, Mount Holly, New Jersey, United States|Hematology Oncology Associates, Albuquerque, New Mexico, United States|University of New Mexico, Albuquerque, New Mexico, United States|University of New Mexico Cancer Center South, Las Cruces, New Mexico, United States|New Mexico Cancer Care Associates- US Oncology, Santa Fe, New Mexico, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Cancer Center of North Carolina- US Oncology, Raleigh, North Carolina, United States|Medical Onc Assoc of Wyoming Valley, PC- US Oncology, Kingston, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Pottstown Memorial Medical Center, Pottstown, Pennsylvania, United States|Associates in Hematology-Oncology P.C. US Oncology, Upland, Pennsylvania, United States|Reading Hospital Regional Medical Center, West Reading, Pennsylvania, United States|Sanford Clinic, Sioux Falls, South Dakota, United States|Texas Oncology - Amarillo- US Oncology, Amarillo, Texas, United States|Mamie Mcfaddin Ward Cancer Center, Texas Oncology- US Oncology, Beaumont, Texas, United States|Texas Oncology P.A.- Bedford- US Oncology, Bedford, Texas, United States|Texas Cancer Center at Medical City- US Oncology, Dallas, Texas, United States|Texas Oncology P.A. - Dallas- US Oncology, Dallas, Texas, United States|Methodist Charlton Cancer Center - Texas Oncology- US Oncology, Dallas, Texas, United States|Texas Oncology - Odessa- US Oncology, Odessa, Texas, United States|Scott and White Hospital and Clinics, Temple, Texas, United States|Texas Oncology Cancer Care and Research Center- US Oncology, Waco, Texas, United States|Texoma Cancer Center- US Oncology, Wichita Falls, Texas, United States|Virginia Oncology Associates- US Oncology, Norfolk, Virginia, United States|Onc & Hematology Assoc. of Southern VA, Inc D.B.A. - US Oncology, Salem, Virginia, United States|Swedish Cancer Institute, Seattle, Washington, United States|Cancer Care Northwest- US Oncology, Spokane, Washington, United States|Northwest Cancer Specialists- US Oncology, Vancouver, Washington, United States","https://ClinicalTrials.gov/show/NCT00637247"
565,"Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Metastatic Cancer|Toxicity","Drug: Oxaliplatine|Drug: Folinic acid|Drug: Irinotecan|Drug: 5-FU","ICO Paul Papin, Angers, France|CH Vendée, La Roche Sur Yon, France|Centre Oscar Lambret, Lille, France|ICM (Val d'Aurelle), Montpellier Cedex 5, France|Centre Eugène marquis, Rennes, France|ICO René Gauducheau, Saint-Herblain, France","https://ClinicalTrials.gov/show/NCT02143219"
566,"Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer","Completed","No Results Available","Pancreatic Neoplasms","Drug: Gemcitabine|Drug: Oxaliplatin|Procedure: Radiotherapy","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Grenoble, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Lyon, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Marseille, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Montpellier, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Paris, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Pierre Benite, France","https://ClinicalTrials.gov/show/NCT00191568"
567,"Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting","Completed","Has Results","2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer","Biological: GVAX Pancreas Vaccine|Biological: CRS-207|Drug: Chemotherapy|Drug: cyclophosphamide","Scottsdale Healthcare Research Institute, Scottsdale, Arizona, United States|University California San Diego Moores Cancer Center, La Jolla, California, United States|University of California Mt Zion Comprehensive Cancer Center, San Francisco, California, United States|University of California Los Angeles, Santa Monica, California, United States|University of Colorado Denver, Aurora, Colorado, United States|University of Miami/Sylvester Cancer Center, Miami, Florida, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Johns Hopkins University, Baltimore, Maryland, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|Washington University, Saint Louis, Missouri, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Duke University Medical Center Morris Cancer Center, Durham, North Carolina, United States|Providence Cancer Center, Portland, Oregon, United States|University of Pittsburgh Medical Center Cancer Pavillion, Pittsburgh, Pennsylvania, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Wisconsin - Carbone Cancer Center, Madison, Wisconsin, United States|Princess Margaret Hospital Princess Margaret Cancer Center, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02004262"
568,"A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .","Withdrawn","No Results Available","Pancreatic Cancer","Other: Neoadjuvant capecitabine, panitumumab and radiation","University of Massachusetts Medical School, Worcester, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01130701"
569,"LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: LDE225; Fluorouracil; Leucovorin; Oxaliplatin; Irinotecan","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01485744"
570,"Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer","Terminated","No Results Available","Metastatic Pancreatic Cancer|Pancreatic Cancer","Drug: IMMU-107|Drug: placebo|Drug: Gemcitabine","Banner MD Anderson, Gilbert, Arizona, United States|City of Hope National Medical Center, Duarte, California, United States|Pacific Shores Medical Group, Long Beach, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Whittingham Cancer Center, Norwalk, Connecticut, United States|Michael and Dianne Bienes Comprehensive Cancer Center - Holy Cross Hospital, Fort Lauderdale, Florida, United States|Baptist Cancer Institute, Jacksonville, Florida, United States|Cancer Specialists of North Florida, Jacksonville, Florida, United States|Mountain States Tumor Institute at St. Luke's Regional Medical Center, Boise, Idaho, United States|Illinois Cancer Specialists, Arlington Heights, Illinois, United States|Indiana University Health Goshen Center for Cancer Care, Goshen, Indiana, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Ashland-Bellefonte Cancer Center, Ashland, Kentucky, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of North Carolina Hospitals, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|The Ohio State University - Comprehensive Cancer Center, Columbus, Ohio, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center/Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|Center for Biomedical Research, Knoxville, Tennessee, United States|University of Tennessee Medical Center, Cancer Institute, Knoxville, Tennessee, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States|Oncology Consultants, Houston, Texas, United States|Texas Oncology - McAllen, McAllen, Texas, United States|Texas Oncology - Tyler, Tyler, Texas, United States|Virginia Oncology Associates, Norfolk, Virginia, United States|University of Washington, Seattle, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Krankenhaus der Elisabethinen Linz, Linz, Austria|Medical University Vienna, Vienna, Austria|University Hospital Leuven, Leuven, Belgium|Cancer Care Manitoba, Winnepeg, Manitoba, Canada|Centre Hospitalier Université de Sherbrooke, Sherbrooke, Quebec, Canada|ICO René Gauducheau, Nantes, Cedex 1, France|Institut Paoli-Calmettes, Marseille, Cedex 9, France|Institut Bergonie, Bordeaux, Cedex, France|Centre Léon Bérard Cancerologie Medicale, Lyon, France|Institut Paoli-Calmettes, Marseille, France|CRLC Val D'Aurelle, Montpellier Cedex 5, France|CRLC Val D'Aurelle, Montpellier, France|Hopital Cochin, Paris, France|Soroka Medical Center, Beer Sheva, Israel|Rambam Medical Center, Haifa, Israel|Centrum Onkologii Instytut im. M. Sklodowskiej-Curie - Warszawa, Warszawa, Poland|Hospital Sant Joan de Reu, Reus, Tarragona, Spain|Hospital Vall D'Hebrón, Barcelona, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Centro Integral Oncologico Clara Campal, Madrid, Spain|Hospital Miguel Servet, Zaragoza, Spain","https://ClinicalTrials.gov/show/NCT01956812"
571,"Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery","Completed","Has Results","Pancreatic Cancer","Biological: GVAX pancreatic cancer vaccine|Drug: cyclophosphamide","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00727441"
572,"Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas","Unknown status","No Results Available","Colorectal Neoplasms|Stomach Neoplasms|Pancreatic Neoplasms|Breast Neoplasms|Ovarian Cancer",,"Hillel Yaffe Medical Center, Hadera, Israel","https://ClinicalTrials.gov/show/NCT00419627"
573,"A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)","Active, not recruiting","No Results Available","Neoplasms|Carcinoma, Non-Small-Cell Lung|Pancreatic Neoplasms|Colorectal Neoplasms","Biological: V941|Biological: Pembrolizumab","Banner MD Anderson Cancer Center ( Site 1008), Gilbert, Arizona, United States|City of Hope ( Site 1002), Duarte, California, United States|University of California at San Francisco ( Site 1006), San Francisco, California, United States|Smilow Cancer Hospital at Yale New Haven ( Site 1005), New Haven, Connecticut, United States|Dana-Farber Cancer Institute (Boston) ( Site 1007), Boston, Massachusetts, United States|Comprehensive Cancer Centers of Nevada ( Site 1012), Las Vegas, Nevada, United States|Tennessee Oncology Nashville Drug Development Unit ( Site 7000), Nashville, Tennessee, United States|START San Antonio ( Site 1004), San Antonio, Texas, United States|Baylor Scott & White Medical Center - Temple ( Site 1009), Temple, Texas, United States|Northwest Medical Specialties, PLLC ( Site 1001), Tacoma, Washington, United States|Kinghorn Cancer Centre ( Site 6000), Darlinghurst, New South Wales, Australia|Southern Oncology Clinical Research Unit SOCRU ( Site 6002), Bedford Park, South Australia, Australia|Monash Health-Monash Medical Centre ( Site 6001), Clayton, Victoria, Australia|Prince of Wales Hospital ( Site 2002), Hong Kong, Hong Kong|Queen Mary Hospital ( Site 2001), Hong Kong, Hong Kong|Asan Medical Center ( Site 0802), Songpagu, Seoul, Korea, Republic of|Seoul National University Hospital ( Site 0801), Seoul, Korea, Republic of|Severance Hospital ( Site 0800), Seoul, Korea, Republic of|New Zealand Clinical Research (Christchurch) ( Site 6501), Christchurch, Canterbury, New Zealand|Auckland City Hospital ( Site 6500), Auckland, New Zealand|National University Hospital ( Site 3006), Singapore, Central Singapore, Singapore|National Cancer Centre Singapore ( Site 3005), Singapore, Central Singapore, Singapore|Tan Tock Seng Hospital ( Site 3007), Singapore, Central Singapore, Singapore|National Cheng Kung University Hospital ( Site 4002), Tainan, Taiwan|National Taiwan University Hospital ( Site 4000), Taipei, Taiwan|Taipei Veterans General Hospital ( Site 4001), Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT03948763"
574,"Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Ipilimumab|Biological: Pancreatic Cancer Vaccine","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00836407"
575,"Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer","Suspended","No Results Available","Pancreatic Cancer","Radiation: PLDR","Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04452357"
576,"Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Avastin (bevacizumab)|Drug: Gemzar (Gemcitabine)|Radiation: external beam radiotherapy","University of Pittsburgh Medical Centers, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00557492"
577,"Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.","Completed","No Results Available","Metastatic Pancreatic Cancer","Drug: Gemcitabine - nabpaclitaxel",,"https://ClinicalTrials.gov/show/NCT03620461"
578,"Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer","Recruiting","No Results Available","Locally Advanced Unresectable Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8","Drug: Gemcitabine|Drug: Nab-paclitaxel|Drug: Telotristat Ethyl","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT03910387"
579,"Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: vismodegib|Drug: gemcitabine hydrochloride|Other: hydrocortisone/placebo","Tower Cancer Research Foundation, Beverly Hills, California, United States|City of Hope Medical Center, Duarte, California, United States|University of Southern California/Norris Cancer Center, Los Angeles, California, United States|City of Hope Medical Group Inc, Pasadena, California, United States|University of California at Davis Cancer Center, Sacramento, California, United States|University of Chicago, Chicago, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University, Springfield, Illinois, United States|Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne, Indiana, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|University of Maryland Saint Joseph Medical Center, Towson, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|Saint John's Mercy Medical Center, Saint Louis, Missouri, United States|Montefiore Medical Center-Weiler Division, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|New York University Clinical Cancer Center, New York, New York, United States|New York University Langone Medical Center, New York, New York, United States|Weill Medical College of Cornell University, New York, New York, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01064622"
580,"Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097","University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora, Colorado, United States|University of Colorado, Denver, Colorado, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01232829"
581,"PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer","Terminated","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: STA-9090|Radiation: Radiologic imaging|Procedure: blood draw","The Jones Clinic, Memphis, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01227018"
582,"Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy","Recruiting","No Results Available","Pancreas Cancer|Pancreaticoduodenal Lymphadenopathy|Pancreas Adenocarcinoma","Procedure: removal of para-aortic lymphnodes (PALN)","Humanitas Research Hospital, Rozzano, Italy/Milan, Italy","https://ClinicalTrials.gov/show/NCT04571294"
583,"Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: saracatinib|Other: pharmacogenomic studies|Other: pharmacological study|Procedure: positron emission tomography|Radiation: fludeoxyglucose F 18|Other: laboratory biomarker analysis","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|University of Colorado at Denver, Aurora, Colorado, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|National University Hospital, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT00735917"
584,"A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Diseases|Pancreatitis|Pancreatic Cyst","Diagnostic Test: Blood Draw|Diagnostic Test: Tumor Tissue Collection|Diagnostic Test: Cyst Fluid","Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (All protocol activities), Montvale, New Jersey, United States|Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor, New York, United States|Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States|New York University, New York, New York, United States|Memorial Sloan - Kettering Cancer Center, New York, New York, United States|Memoral Sloan Kettering Basking Ridge (All protocol activitie), New York, New York, United States|Weill Cornell Medical Center, New York, New York, United States|Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre, New York, United States|Sha'are Zedek Medical Center, Jerusalem, Israel|Weizmann Institute of Science, Reẖovot, Israel|Sheba Medical Center, Tel Hashomer, Israel","https://ClinicalTrials.gov/show/NCT03334708"
585,"Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: alvocidib|Drug: docetaxel","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00331682"
586,"Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Radiation: radiation therapy","Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, United States|University of California San Diego Cancer Center, La Jolla, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States|CCOP - Christiana Care Health Services, Wilmington, Delaware, United States|Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States|Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Veterans Affairs Medical Center - Togus, Togus, Maine, United States|Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Veterans Affairs Medical Center - Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Veterans Affairs Medical Center - Buffalo, Buffalo, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|New York Presbyterian Hospital - Cornell Campus, New York, New York, United States|Mount Sinai Medical Center, NY, New York, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States|State University of New York - Upstate Medical University, Syracuse, New York, United States|Veterans Affairs Medical Center - Syracuse, Syracuse, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Veterans Affairs Medical Center - Durham, Durham, North Carolina, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Veterans Affairs Medical Center - Memphis, Memphis, Tennessee, United States|University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, United States|Vermont Cancer Center, Burlington, Vermont, United States|Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont, United States|Veterans Affairs Medical Center - Richmond, Richmond, Virginia, United States|MBCCOP - Massey Cancer Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00003546"
587,"Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: capecitabine|Radiation: radiation therapy|Biological: bevacizumab|Procedure: therapeutic conventional surgery|Drug: gemcitabine hydrochloride","Radiation Therapy Oncology Group, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00114179"
588,"Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer","Radiation: radiation therapy|Drug: oxaliplatin|Drug: fluorouracil|Drug: gemcitabine hydrochloride","North Central Cancer Treatment Group, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00096070"
589,"NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Ductal Adenocarcinoma|Resectable Pancreatic Ductal Adenocarcinoma|Stage III Pancreatic Cancer AJCC v8","Other: Hafnium Oxide-containing Nanoparticles NBTXR3|Radiation: Radiation Therapy","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04484909"
590,"Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma|Unresectable Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: Gemcitabine Hydrochloride|Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Drug: Metformin Hydrochloride|Dietary Supplement: Therapeutic Dietary Intervention|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment","City of Hope Medical Center, Duarte, California, United States|City of Hope Rancho Cucamonga, Rancho Cucamonga, California, United States|City of Hope South Pasadena, South Pasadena, California, United States|City of Hope West Covina, West Covina, California, United States","https://ClinicalTrials.gov/show/NCT02336087"
591,"Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: paclitaxel|Drug: tipifarnib|Radiation: radiation therapy","Radiation Therapy Oncology Group, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00026104"
592,"Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas","Completed","No Results Available","Pancreatic Neoplasms","Drug: gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin","St. Luke's-Roosevelt Hospital Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00220649"
593,"A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer|Advanced Pancreatic Cancer|Pancreatic Adenocarcinoma|Pancreatic Neoplasms","Drug: anti-EGFR-bispecific antibody armed activated T-cells","Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Virginia (Specimen Analysis), Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT04137536"
594,"iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation","Recruiting","No Results Available","KRAS NP_004976.2:p.G12D|Metastatic Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Drug: Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03608631"
595,"Incidence of POPF in the Resection of the Left Pancreas With RFAT","Unknown status","No Results Available","Pancreas Neoplasm|Pancreas Cancer|Pancreatic Adenocarcinoma|Benign Pancreas Tumor",,"Hospital del Mar, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT03570502"
596,"Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Ovarian Cancer|Biliary Carcinoma|Colorectal Cancer","Drug: LOAd703","Karolinska University Hospital, Huddinge, Stockholm, Sweden|Uppsala University Hospital, Uppsala, Sweden","https://ClinicalTrials.gov/show/NCT03225989"
597,"Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions","Completed","No Results Available","Pancreatic Cyst|IPMN|Mucinous Cyst|Pancreatic Adenocarcinoma","Device: EUS-guided microbiopsy|Diagnostic Test: Next Generation Sequencing","Gastro Unit, Division of Endoscopy, Herlev, Danmark, Denmark","https://ClinicalTrials.gov/show/NCT03578445"
598,"Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors","Completed","No Results Available","Solid Tumour|Adenocarcinoma of the Colorectal|Adenocarcinoma of the Pancreas","Drug: CEP-37250/KHK2804",,"https://ClinicalTrials.gov/show/NCT01447732"
599,"Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)","Terminated","No Results Available","Pancreas Cancer|Pancreatic Cancer|Adenocarcinoma of the Pancreas|Pancreas Adenocarcinoma|Pancreatic Adenocarcinoma","Drug: Gemcitabine|Drug: nab-paclitaxel|Radiation: CyberKnife","MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States","https://ClinicalTrials.gov/show/NCT02707328"
600,"BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer","Completed","No Results Available","Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Biological: Aldesleukin|Biological: Antibody Therapy|Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Oxaliplatin|Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Biological: Sargramostim","Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT02620865"
601,"CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma","Recruiting","No Results Available","Locally Advanced Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8|Unresectable Malignant Solid Neoplasm","Biological: Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949|Drug: VLP-encapsulated TLR9 Agonist CMP-001","HonorHealth Research Institute, Scottsdale, Arizona, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Hoag Memorial Hospital, Newport Beach, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT04387071"
602,"Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer","Completed","No Results Available","Duct Cell Adenocarcinoma of the Pancreas|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: fluorouracil|Radiation: radiation therapy|Other: laboratory biomarker analysis","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01893294"
603,"A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer","Unknown status","No Results Available","Pancreas Cancer|Pancreatic Cancer|Adenocarcinoma of the Pancreas|Pancreas Adenocarcinoma|Pancreatic Adenocarcinoma","Drug: Gemcitabine|Radiation: Stereotactic Radiosurgery","MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States","https://ClinicalTrials.gov/show/NCT02707315"
604,"Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine","Completed","No Results Available","Pancreatic Cancer","Drug: arsenic trioxide","University of Chicago Cancer Research Center, Chicago, Illinois, United States|Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States|Evanston Northwestern Health Care - Evanston Hospital, Evanston, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|LaGrange Memorial Hospital, LaGrange, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph, Saint Joseph, Michigan, United States","https://ClinicalTrials.gov/show/NCT00053222"
605,"Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery","Active, not recruiting","No Results Available","Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7","Drug: Dasatinib|Drug: Erlotinib Hydrochloride|Drug: Gemcitabine Hydrochloride","Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01660971"
606,"CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer","Active, not recruiting","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: 6,8-bis(benzylthio)octanoic acid|Drug: oxaliplatin|Drug: leucovorin calcium|Drug: irinotecan hydrochloride|Drug: fluorouracil|Other: laboratory biomarker analysis","Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01835041"
607,"Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer","Completed","Has Results","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: metformin hydrochloride|Drug: oxaliplatin|Drug: leucovorin calcium|Drug: fluorouracil|Other: laboratory biomarker analysis","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01666730"
608,"Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery","Terminated","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: gemcitabine hydrochloride|Radiation: hyperfractionated radiation therapy|Radiation: intensity-modulated radiation therapy|Radiation: radiosurgery|Procedure: diffusion-weighted magnetic resonance imaging","Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01739439"
609,"Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy","Terminated","Has Results","Pancreatic Cancer","Drug: Gemcitabine","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01938716"
610,"A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Pancreas Adenocarcinoma|Advanced Pancreatic Cancer|Metastatic Pancreatic Cancer|Metastatic Pancreatic Adenocarcinoma","Drug: Pembrolizumab|Drug: paricalcitol|Drug: placebo","HonorHealth Research Institute, Scottsdale, Arizona, United States|City of Hope National Medical Center, Duarte, California, United States|The University of Kansas Cancer Center, Westwood, Kansas, United States|Atlantic Medical Group-Oncology Morristown Medical Center, Morristown, New Jersey, United States|Baylor University Medical Center Charles A. Sammons Cancer Center, Dallas, Texas, United States|Froedtert Hospital and Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03331562"
611,"Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Cancer","Drug: Folfirinox alternating with Gemcitabine-nab-Paclitaxel","Monmouth Medical Center, Long Branch, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States","https://ClinicalTrials.gov/show/NCT04672005"
612,"AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer","Unknown status","No Results Available","Adenocarcinoma","Drug: AXP107-11","Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge, Stockholm, Sweden|Dept. of Oncology-Pathology, Karolinska University Hospital, Solna, Stockholm, Sweden","https://ClinicalTrials.gov/show/NCT01182246"
613,"A Study of Regorafenib in Advanced Pancreatic Cancer Patients","Completed","Has Results","Pancreatic Cancer","Drug: regorafenib","Levine Cancer Institute-Albemarle, Albemarle, North Carolina, United States|Levine Cancer Institute-South Tryon, Charlotte, North Carolina, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Levine Cancer Institute - Pineville, Charlotte, North Carolina, United States|Levine Cancer Institute - Southpark, Charlotte, North Carolina, United States|Levine Cancer Institute - Mallard Creek, Charlotte, North Carolina, United States|Levine Cancer Institute - University, Charlotte, North Carolina, United States|Levine Cancer Institute - Ballantyne, Charlotte, North Carolina, United States|Levine Cancer Institute - Concord, Concord, North Carolina, United States|Levine Cancer Institute-Monroe, Monroe, North Carolina, United States|Levine Cancer Institute - Cleveland, Shelby, North Carolina, United States|Low Country Hematology Oncology, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT02080260"
614,"Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer","Completed","No Results Available","Neoplasms, Pancreas","Biological: cancer stem cell vaccine","Biological treatment center in Fuda cancer hospital, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT02074046"
615,"A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Gemcitabine, local delivery","El Camino Hospital, Oncology, Mountain View, California, United States|Florida Hospital, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT02237157"
616,"Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer, Resected","Biological: TG01","Oslo University Hospital HF the Norwegian Radium Hospital, Oslo, Norway|Centro Integral Oncologico Clara Campal / Hospital HM Universitario Sanchinarro, Madrid, Spain|Queen Elizabeth University Hospital / Edgaston /, Birmingham, United Kingdom|University of Liverpool / Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom|University of Manchester / The Christie NHS Foundation Trust, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT02261714"
617,"Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation","Active, not recruiting","No Results Available","Adenocarcinoma","Drug: Personalised treatment|Drug: Treatment chosen per investigator´s judge","Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario de la Paz, Madrid, Spain|Hospital Miguel Servet, Zaragoza, Spain","https://ClinicalTrials.gov/show/NCT02795650"
618,"Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.","Recruiting","No Results Available","Pancreas Cancer, Duct Cell Adenocarcinoma|Pancreas Adenocarcinoma|Peritoneal Metastases|Peritoneal Carcinomatosis","Diagnostic Test: Whole-body diffusion-weighted magnetic resonance imaging","CHU de Québec, Quebec City, Quebec, Canada","https://ClinicalTrials.gov/show/NCT05340569"
619,"Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer","Completed","No Results Available","Pancreatic Neoplasm","Drug: Nab-paclitaxel|Drug: Gemcitabine",,"https://ClinicalTrials.gov/show/NCT03807999"
620,"Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery","Active, not recruiting","No Results Available","Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Intraductal Papillary-Mucinous Neoplasm|Stage I Pancreatic Cancer AJCC v6 and v7|Stage IA Pancreatic Cancer AJCC v6 and v7|Stage IB Pancreatic Cancer AJCC v6 and v7|Stage II Pancreatic Cancer AJCC v6 and v7|Stage IIA Pancreatic Cancer AJCC v6 and v7|Stage IIB Pancreatic Cancer AJCC v6 and v7","Radiation: 3-Dimensional Conformal Radiation Therapy|Drug: Capecitabine|Drug: Chemotherapy|Drug: Erlotinib Hydrochloride|Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment","Providence Hospital, Mobile, Alabama, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Mercy San Juan Medical Center, Carmichael, California, United States|East Bay Radiation Oncology Center, Castro Valley, California, United States|Community Cancer Institute, Clovis, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Epic Care-Dublin, Dublin, California, United States|Bay Area Breast Surgeons Inc, Emeryville, California, United States|Epic Care Partners in Cancer Care, Emeryville, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Saint Agnes Medical Center, Fresno, California, United States|Marin General Hospital, Greenbrae, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Contra Costa Regional Medical Center, Martinez, California, United States|Memorial Medical Center, Modesto, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|El Camino Hospital, Mountain View, California, United States|Highland General Hospital, Oakland, California, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Hematology and Oncology Associates-Oakland, Oakland, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Valley Medical Oncology Consultants, Pleasanton, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Mercy General Hospital Radiation Oncology Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|Saint Helena Hospital, Saint Helena, California, United States|UC San Diego Medical Center - Hillcrest, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Doctors Medical Center- JC Robinson Regional Cancer Center, San Pablo, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Western States Cancer Research NCORP, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Mountain Blue Cancer Care Center, Golden, Colorado, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Rocky Mountain Cancer Centers-Greenwood Village, Greenwood Village, Colorado, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, United States|North Suburban Medical Center, Thornton, Colorado, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport, Connecticut, United States|Hartford Hospital, Hartford, Connecticut, United States|Midstate Medical Center, Meriden, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|Eastern Connecticut Hematology and Oncology Associates, Norwich, Connecticut, United States|William Backus Hospital, Norwich, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Christiana Gynecologic Oncology LLC, Newark, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|MedStar Washington Hospital Center, Washington, District of Columbia, United States|UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Jupiter Medical Center, Jupiter, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Jackson Memorial Hospital-Holtz Children's Hospital, Miami, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Orlando Health Cancer Institute, Orlando, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Florida Cancer Affiliates, Trinity, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|John B Amos Cancer Center, Columbus, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Saint Joseph Regional Medical Center, Lewiston, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Northwestern University, Chicago, Illinois, United States|John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|Presence Resurrection Medical Center, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Elmhurst Memorial Hospital, Elmhurst, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Presence Saint Mary's Hospital, Kankakee, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Edward Hospital/Cancer Center, Naperville, Illinois, United States|Carle Cancer Institute Normal, Normal, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Radiation Oncology of Northern Illinois, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|OSF Saint Anthony Medical Center, Rockford, Illinois, United States|Saint John's Hospital, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Franciscan Saint Francis Health-Beech Grove, Beech Grove, Indiana, United States|Elkhart Clinic, Elkhart, Indiana, United States|Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Community Howard Regional Health, Kokomo, Indiana, United States|IU Health La Porte Hospital, La Porte, Indiana, United States|Woodland Cancer Care Center, Michigan City, Indiana, United States|Memorial Regional Cancer Center Day Road, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology Oncology PC-South Bend, South Bend, Indiana, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States|Michiana Hematology Oncology PC-Westville, Westville, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Iowa-Wide Oncology Research Coalition NCORP, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Wichita NCI Community Oncology Research Program, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Baptist Health Lexington, Lexington, Kentucky, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Saint Agnes Hospital, Baltimore, Maryland, United States|UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie, Maryland, United States|TidalHealth Peninsula Regional, Salisbury, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Saint Anne's Hospital, Fall River, Massachusetts, United States|Berkshire Medical Center - Cancer Center, Pittsfield, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Bixby Medical Center, Adrian, Michigan, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States|Huron Valley-Sinai Hospital, Commerce, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Green Bay Oncology - Iron Mountain, Iron Mountain, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Mercy Memorial Hospital, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Singing River Hospital, Pascagoula, Mississippi, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, United States|Cox Cancer Center Branson, Branson, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|SSM Health Saint Louis University Hospital, Saint Louis, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Center for Cancer Care and Research, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Saint Louis-Cape Girardeau CCOP, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Cancer Research for the Ozarks NCORP, Springfield, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Montana Cancer Consortium NCORP, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Berdeaux, Donald MD (UIA Investigator), Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists, Missoula, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|GenesisCare USA - Henderson, Henderson, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|GenesisCare USA - Las Vegas, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|Cancer Therapy and Integrative Medicine, Las Vegas, Nevada, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|GenesisCare USA - Fort Apache, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|Nevada Cancer Research Foundation NCORP, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Elliot Hospital, Manchester, New Hampshire, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Cooper Hospital University Medical Center, Camden, New Jersey, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Virtua Memorial, Mount Holly, New Jersey, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|The Valley Hospital-Luckow Pavilion, Paramus, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Sparta Cancer Treatment Center, Sparta, New Jersey, United States|MD Anderson Cancer Center at Cooper-Voorhees, Voorhees, New Jersey, United States|Virtua Voorhees, Voorhees, New Jersey, United States|Valley Health System-Hematology/Oncology, Westwood, New Jersey, United States|New York Oncology Hematology PC - Albany, Albany, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|Sands Cancer Center, Canandaigua, New York, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Glens Falls Hospital, Glens Falls, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Garnet Health Medical Center, Middletown, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Wilmot Cancer Institute Radiation Oncology at Greece, Rochester, New York, United States|Highland Hospital, Rochester, New York, United States|University of Rochester, Rochester, New York, United States|Memorial Sloan Kettering Sleepy Hollow, Sleepy Hollow, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States|Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina, United States|Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|AdventHealth Hendersonville, Hendersonville, North Carolina, United States|Vidant Oncology-Kinston, Kinston, North Carolina, United States|Matthews Radiation Oncology Center, Matthews, North Carolina, United States|UNC Rex Cancer Center, Raleigh, North Carolina, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Southeast Clinical Oncology Research Consortium NCORP, Winston-Salem, North Carolina, United States|Summa Health System - Akron Campus, Akron, Ohio, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|Radiation Oncology Center, Alliance, Ohio, United States|Summa Health System - Barberton Campus, Barberton, Ohio, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Toledo Clinic Cancer Centers-Bowling Green, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Columbus NCI Community Oncology Research Program, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Miami Valley Hospital North, Dayton, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Delaware Radiation Oncology, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Mercy Cancer Center-Elyria, Elyria, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Cleveland Clinic Cancer Center Independence, Independence, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lancaster Radiation Oncology, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States|Summa Health Medina Medical Center, Medina, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|University Hospitals Portage Medical Center, Ravenna, Ohio, United States|UH Seidman Cancer Center at Salem Regional Medical Center, Salem, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio, United States|ProMedica Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Saint Vincent Mercy Medical Center, Toledo, Ohio, United States|University of Toledo, Toledo, Ohio, United States|Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Cancer Treatment Center, Wooster, Ohio, United States|Cleveland Clinic Wooster Family Health and Surgery Center, Wooster, Ohio, United States|Greene Memorial Hospital, Xenia, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Mid-Columbia Medical Center/Celilo Cancer Center, The Dalles, Oregon, United States|Jefferson Abington Hospital, Abington, Pennsylvania, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Mercy Fitzgerald Hospital, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States|Easton Hospital, Easton, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|Riddle Memorial Hospital, Media, Pennsylvania, United States|Allegheny Valley Hospital, Natrona Heights, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Pennsylvania Hospital, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States|Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, United States|Crozer-Chester Medical Center, Upland, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Main Line Health NCORP, Wynnewood, Pennsylvania, United States|WellSpan Health-York Hospital, York, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Radiation Oncology Associates Incorporated, Providence, Rhode Island, United States|Miriam Hospital, Providence, Rhode Island, United States|AnMed Health Cancer Center, Anderson, South Carolina, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Greenville Health System Cancer Institute-Andrews, Greenville, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Gibbs Cancer Center-Pelham, Greer, South Carolina, United States|Carolina Blood and Cancer Care Associates PA-Lancaster, Lancaster, South Carolina, United States|Carolina Blood and Cancer Care Associates PA, Rock Hill, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|The Don and Sybil Harrington Cancer Center, Amarillo, Texas, United States|Texas Oncology-Arlington South, Arlington, Texas, United States|Texas Oncology-Austin Midtown, Austin, Texas, United States|Texas Oncology - Central Austin Cancer Center, Austin, Texas, United States|Texas Oncology - South Austin Cancer Center, Austin, Texas, United States|Texas Oncology Bedford, Bedford, Texas, United States|Texas Oncology - Denison Cancer Center, Denison, Texas, United States|Texas Oncology-Flower Mound, Flower Mound, Texas, United States|Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|UTMB Cancer Center at Victory Lakes, League City, Texas, United States|Texas Oncology - Lewisville, Lewisville, Texas, United States|Texas Oncology-Longview Cancer Center, Longview, Texas, United States|Texas Oncology-McKinney, McKinney, Texas, United States|Texas Oncology-Seton Williamson, Round Rock, Texas, United States|Texas Oncology - Round Rock Cancer Center, Round Rock, Texas, United States|Cancer Care Centers of South Texas- Northeast, San Antonio, Texas, United States|Texas Oncology Cancer Center Sugar Land, Sugar Land, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|Deke Slayton Cancer Center, Webster, Texas, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Logan Regional Hospital, Logan, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Fredericksburg Oncology Inc, Fredericksburg, Virginia, United States|Sentara Cancer Institute at Sentara CarePlex Hospital, Hampton, Virginia, United States|Sentara Norfolk General Hospital, Norfolk, Virginia, United States|Sentara Virginia Beach General Hospital, Virginia Beach, Virginia, United States|MultiCare Auburn Medical Center, Auburn, Washington, United States|Overlake Medical Center, Bellevue, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Tacoma/Valley Radiation Oncology Centers-Gig Harbor, Gig Harbor, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Providence - Saint Peter Hospital, Olympia, Washington, United States|Capital Medical Center, Olympia, Washington, United States|MultiCare Good Samaritan Hospital, Puyallup, Washington, United States|Tacoma/Valley Radiation Oncology Centers-Puyallup, Puyallup, Washington, United States|Cancer Care Northwest - Spokane South, Spokane, Washington, United States|Cancer Care Northwest-North Spokane, Spokane, Washington, United States|MultiCare Allenmore Hospital, Tacoma, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|Northwest NCI Community Oncology Research Program, Tacoma, Washington, United States|Saint Joseph Medical Center, Tacoma, Washington, United States|Tacoma/Valley Radiation Oncology Centers-Saint Joe's, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Compass Oncology Vancouver, Vancouver, Washington, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|West Virginia University Charleston Division, Charleston, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, United States|HSHS Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, United States|Bellin Memorial Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Marshfield Medical Center, Marshfield, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States|Ascension Saint Mary's Hospital, Rhinelander, Wisconsin, United States|Saint Mary's Hospital, Rhinelander, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Ascension Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Green Bay Oncology - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, United States|Diagnostic and Treatment Center, Weston, Wisconsin, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States|Hospital Univ. Erasme, Brussels, Belgium|University Hospital Saint Luc, Brussels, Belgium|Algemeen Ziekenhuis Groeninge Campus Kennedylaan, Kortrijk, Belgium|AZ Turnhout-Campus Saint Elizabeth, Turnhout, Belgium|London Regional Cancer Program, London, Ontario, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada|Ottawa Hospital-Civic Campus, Ottawa, Ontario, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada|CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|Rabin Medical Center, Petach Tikva, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Chaim Sheba Medical Center, Tel Hashomer, Israel","https://ClinicalTrials.gov/show/NCT01013649"
621,"Preop Chemoradiation Resectable Pancreas","Completed","No Results Available","Pancreatic Neoplasms","Drug: Avastin (Bevacizumab)|Drug: Gemcitabine|Procedure: Radiation Therapy","U.T. M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00336648"
622,"Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer|Pancreatic Neoplasm","Drug: Gemcitabine|Drug: Herceptin|Procedure: Radiation therapy","National Cancer Institute (NCI), Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00005926"
623,"Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer","Completed","No Results Available","Advanced Pancreatic Cancer","Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Imatinib","Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT01048320"
624,"Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München","Terminated","No Results Available","Pancreatic Cancer","Procedure: Resection of metastases|Procedure: Resection of infiltrated veins","Department of Surgery and Institute of Statistics Klinikum rechts der Isar der Technischen Universität München Ismaningerstrasse 22 81675 München, Germany, München, Germany","https://ClinicalTrials.gov/show/NCT00855634"
625,"Study With CY, Pembrolizumab, GVAX, and SBRT in Patients With Locally Advanced Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: Cyclophosphamide|Drug: GVAX|Drug: Pembrolizumab|Radiation: SBRT","The Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02648282"
626,"Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable","Terminated","No Results Available","Pancreatic Cancer","Drug: Gemcitabine|Radiation: Radiotherapy|Drug: Tarceva|Drug: Oxaliplatin","Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT01531712"
627,"Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy","Terminated","Has Results","Pancreatic Cancer","Drug: Gemcitabine|Radiation: Radiation Therapy|Drug: Erlotinib|Procedure: Surgery","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00766636"
628,"A Study of Ruxolitinib in Pancreatic Cancer Patients","Terminated","Has Results","Pancreatic Cancer","Drug: Ruxolitinib|Drug: Placebo|Drug: Capecitabine","Huntsville, Alabama, United States|Fayetteville, Arkansas, United States|Beverly Hills, California, United States|La Jolla, California, United States|Aurora, Colorado, United States|Denver, Colorado, United States|Washington, District of Columbia, United States|Fort Myers, Florida, United States|Saint Petersburg, Florida, United States|Athens, Georgia, United States|Atlanta, Georgia, United States|Macon, Georgia, United States|Thomasville, Georgia, United States|Harvey, Illinois, United States|Indianapolis, Indiana, United States|Kansas City, Kansas, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Farmington Hills, Michigan, United States|Kalamazoo, Michigan, United States|Lansing, Michigan, United States|Minneapolis, Minnesota, United States|Saint Louis Park, Minnesota, United States|Bolivar, Missouri, United States|Basking Ridge, New Jersey, United States|Cherry Hill, New Jersey, United States|Voorhees, New Jersey, United States|Commack, New York, United States|Fresh Meadows, New York, United States|Harrison, New York, United States|New York, New York, United States|Rochester, New York, United States|Rockville Centre, New York, United States|Sleepy Hollow, New York, United States|Canton, Ohio, United States|Cincinnati, Ohio, United States|Portland, Oregon, United States|Allentown, Pennsylvania, United States|Hershey, Pennsylvania, United States|Langhorne, Pennsylvania, United States|Greenville, South Carolina, United States|Chattanooga, Tennessee, United States|Knoxville, Tennessee, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Lubbock, Texas, United States|San Antonio, Texas, United States|Temple, Texas, United States|Salt Lake City, Utah, United States|Falls Church, Virginia, United States|Newport News, Virginia, United States|Seattle, Washington, United States|Green Bay, Wisconsin, United States|Graz, Austria|Linz, Austria|Salzburg, Austria|Vienna, Austria|Wein, Austria|Santiago, Chile|Vitacura, Chile|Bogota, Colombia|Medellin, Colombia|Naestved, Denmark|Odense C, Denmark|Bordeaux, France|Brest Cedex, France|Dijon, France|Lyon, France|Nancy, France|Cork, Ireland|Dubin, Ireland|Galway, Ireland|Beer Sheva, Israel|Haifa, Israel|Jerusalem, Israel|Petach Tikva, Israel|Ramat Gan, Israel|Tel Aviv, Israel|Tel Hashomer, Israel|Monterrey, Mexico|Oaxaca, Mexico|Toluca, Mexico|Amsterdam, Netherlands|Maastricht, Netherlands|Nijmegen, Netherlands|Braga, Portugal|Lisboa, Portugal|Porto, Portugal|San Juan, Puerto Rico|Linköping, Sweden|Uppsala, Sweden|Bellinzona, Switzerland|Geneve, Switzerland","https://ClinicalTrials.gov/show/NCT02119663"
629,"Registry Study - Whipple at the Splenic Artery","Completed","No Results Available","Pancreas Cancer","Procedure: Whipple at the Splenic Artery (WATSA)","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01155882"
630,"A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer","Drug: Gemcitabine|Drug: Nab-paclitaxel|Radiation: Radiation Therapy|Procedure: Surgical Resection","Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02481635"
631,"Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer","Terminated","Has Results","Metastatic Pancreatic Cancer","Biological: cetuximab|Biological: bevacizumab|Drug: gemcitabine","ImClone Investigational Site, Jonesboro, Arkansas, United States|ImClone Investigational Site, San Francisco, California, United States|ImClone Investigational Site, Stamford, Connecticut, United States|ImClone Investigational Site, Miami, Florida, United States|ImClone Investigational Site, Orlando, Florida, United States|ImClone Investigational Site, Orlando, Florida, United States|ImClone Investigational Site, Atlanta, Georgia, United States|ImClone Investigational Site, Augusta, Georgia, United States|ImClone Investigational Site, Marietta, Georgia, United States|ImClone Investigational Site, Metairie, Louisiana, United States|ImClone Investigational Site, Billings, Montana, United States|ImClone Investigational Site, Concord, North Carolina, United States|ImClone Investigational Site, Philadelphia, Pennsylvania, United States|ImClone Investigational Site, Charleston, South Carolina, United States|ImClone Investigational Site, Arlington, Texas, United States|ImClone Investigational Site, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00326911"
632,"Chemotherapy and Radiation Following Pancreatic Surgery","Completed","No Results Available","Pancreatic Cancer","Procedure: Pancreatic Surgery|Radiation: Radiation therapy|Drug: Cisplatin|Drug: 5-FU|Drug: Alpha-interferon|Drug: Gemcitabine","Washington University School of Medicine, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00660270"
633,"Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas","Completed","Has Results","Cachexia","Drug: BYM338 active drug|Drug: Placebo","Novartis Investigative Site, Tucson, Arizona, United States|Novartis Investigative Site, Tampa, Florida, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Canton, Ohio, United States|Novartis Investigative Site, San Antonio, Texas, United States|Novartis Investigative Site, Vilnius, Lithuania|Novartis Investigative Site, Bucharest, Romania|Novartis Investigative Site, St. Gallen, Switzerland|Novartis Investigative Site, Edinburgh, United Kingdom","https://ClinicalTrials.gov/show/NCT01433263"
634,"PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen","Unknown status","No Results Available","Pancreatic Cancer","Biological: PANVAC™-VF","University of South Alabama/ Cancer Research Institute, Mobile, Alabama, United States|Moores UCSD Cancer Center, LaJolla, California, United States|Pacific Shores Medical Group, Long Beach, California, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Chao Family Comprehensice Cancer Center, Orange, California, United States|Desert Hematology Oncology Medical Group, Inc, Rancho Mirage, California, United States|Scripps Cancer Center, San Diego, California, United States|VA San Diego Healthcare System, San Diego, California, United States|University of Colorado Health Science Center, Aurora, Colorado, United States|Greeley Medical Clinic, Greeley, Colorado, United States|Loveland Hematology Oncology, Loveland, Colorado, United States|Norwalk Hospital/ Whittingham Cancer Center, Norwalk, Connecticut, United States|Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States|Washington Hospital Cancer Center, Washington, District of Columbia, United States|Jupiter Medical Center, Jupiter, Florida, United States|VA Medical Center, Miami, Florida, United States|Jackson Memorial Hospital, Miami, Florida, United States|Sylvester Cancer Center, Miami, Florida, United States|St. Luke's Mountain States Tumor Institute, Boise, Idaho, United States|North Idaho Cancer Center, Coeur D Alene, Idaho, United States|Carle Cancer Center, Urbana, Illinois, United States|Oncology Associates, Cedar Rapids, Iowa, United States|University of Kentucky, Lexington, Kentucky, United States|Hematology Oncology Life Center, Alexandria, Louisiana, United States|Medical Oncology, LLC, Baton Rouge, Louisiana, United States|Jayne Gurtler, MD and Laura Brinz, MD APMC, Metairie, Louisiana, United States|Tulane Cancer Center, New Orleans, Louisiana, United States|Maine Center for Cancer Medicine and Blood Disorders, Scarborough, Maine, United States|Franklin Square Hospital, Baltimore, Maryland, United States|Tufts-New England Medical Center, The Neeley Center for Clinical Research, Boston, Massachusetts, United States|Josephine Ford Cancer Center, Detroit, Michigan, United States|Kansas City Cancer Center, Kansas City, Missouri, United States|Saint Louis University Cancer Center, St. Louis, Missouri, United States|Washington University School of Medicine, St. Louis, Missouri, United States|Great Falls Clinic, LLP, Great Falls, Montana, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|New York Oncology Hematology, Albany, New York, United States|Winthrop Oncology/Hematology Division, Mineola, New York, United States|Columbia Presbyterian Medical Center, New York City, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Gabrail Cancer Center, Canton, Ohio, United States|Hematology Oncology Consultants, Inc., Columbus, Ohio, United States|Dayton Oncology Hematology, Kettering, Ohio, United States|University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, United States|Temple University Cancer Center, Philadelphia, Pennsylvania, United States|Charleston Hematology Oncology, Charleston, South Carolina, United States|Charleston Cancer Center, Charleston, South Carolina, United States|Cancer Centers of the Carolinas, Greenville, South Carolina, United States|The Sarah Cannon Cancer Center, Nashville, Tennessee, United States|Arlington Cancer Center, Arlington, Texas, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States|Texas Cancer Care, Fort Worth, Texas, United States|Dr. H. Alejandro Preti, F.A.C.P., Houston, Texas, United States|Elkins Pancreas Center, Houston, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|Texas Cancer Care, Weatherford, Texas, United States|Virginia Cancer Institute, Richmond, Virginia, United States|Swedish Cancer Institute, Seattle, Washington, United States|Cancer Care Northwest, Spokane, Washington, United States|Medical Consultants Ltd., Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00088660"
635,"Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma","Completed","No Results Available","Pancreatic Cancer","Biological: G17DT Immunogen",,"https://ClinicalTrials.gov/show/NCT00044031"
636,"Pancreatic Cancer Dietary Assessment Study","Completed","No Results Available","Pancreatic Neoplasm|Pancreas Adenocarcinoma|Well-Differentiated Neuroendocrine Carcinoma|Malignant Neoplasm of Pancreas","Diagnostic Test: Pancreo-KIT breath test","The Christie NHS Foundation Trust, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT03616431"
637,"Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers","Completed","No Results Available","Adenocarcinoma of the Pancreas|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: dovitinib lactate|Drug: gemcitabine hydrochloride|Drug: capecitabine|Other: laboratory biomarker analysis|Other: enzyme-linked immunosorbent assay|Other: pharmacological study","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT01497392"
638,"EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration","Completed","No Results Available","Pancreas Adenocarcinoma|Pancreas Neoplasms|Gastrointestinal Stromal Tumor|Lymphoma","Device: Fine needle biopsy using ProCore needle for histology.|Device: Fine needle aspiration using conventional FNA for cytology","Royal Alexandria Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT01774162"
639,"Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms","Unknown status","No Results Available","Pancreatic Cancer|Pancreatic Neoplasms|Pancreatic Adenocarcinoma|Pancreatic Neuroendocrine Tumor|Pancreatic Ductal Adenocarcinoma","Device: EUSRA RFA needle","Singapore General Hospital, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT03435770"
640,"Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer","Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride|Radiation: radiation therapy|Other: laboratory biomarker analysis","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00063947"
641,"Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: gemcitabine hydrochloride|Biological: bevacizumab|Other: laboratory biomarker analysis","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00028834"
642,"Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)","Completed","No Results Available","Pancreas Cancer|Pancreas Neoplasm, Benign|Chronic Pancreatitis|Pancreas Adenocarcinoma","Device: EUS-FNA needle (Beacon)","The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, Newcastle Upon Tyne, United Kingdom","https://ClinicalTrials.gov/show/NCT03532347"
643,"Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","Has Results","Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic Carcinoma","Drug: Oxaliplatin|Drug: Irinotecan Hydrochloride|Drug: Leucovorin Calcium|Drug: Fluorouracil|Dietary Supplement: Ascorbic Acid","Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02896907"
644,"Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","No Results Available","Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Unresectable Pancreatic Carcinoma","Drug: Akt Inhibitor MK2206|Drug: Dinaciclib|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study","University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora, Colorado, United States|University of Colorado, Denver, Colorado, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01783171"
645,"Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis","Completed","No Results Available","Pancreatic Carcinoma Metastatic|Pancreatic Adenocarcinoma|Pancreatic Neoplasms|Pancreatic Cancer|Pancreatic Cancer, Adult","Other: Celiac Plexus Neurolysis|Other: Radiofrequency Ablation","Center for Interventional Endoscopy - Florida Hospital, Orlando, Florida, United States","https://ClinicalTrials.gov/show/NCT03152487"
646,"Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)","Completed","No Results Available","Pancreatic Cancer|Pancreas Cancer|Pancreatic Adenocarcinoma Resectable|Pancreatic Ductal Adenocarcinoma|Pancreas Metastases","Drug: Ascorbic Acid|Drug: Paclitaxel protein-bound|Drug: Cisplatin|Drug: Gemcitabine","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT03410030"
647,"Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment","Terminated","No Results Available","Malignant Epithelial Mesothelioma|Adenocarcinoma of the Pancreas|Carcinoma, Non-Small-Cell Lung|Adenocarcinoma of the Ovaries","Biological: CRS-207, Live-attenuated Listeria monocytogenes expressing human Mesothelin","The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, United States|National Cancer Institute, NCI, Bethesda, Maryland, United States|University of Pennsylvania Abramson Family Cancer Research Center, Philadelphia, Pennsylvania, United States|Hadassah Hebrew University Medical Center, Jerusalem, Israel","https://ClinicalTrials.gov/show/NCT00585845"
648,"Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer","Active, not recruiting","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage I Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer","Drug: oxaliplatin|Drug: leucovorin calcium|Drug: irinotecan hydrochloride|Drug: fluorouracil|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis","Smilow Cancer Hospital at Fairfield, Fairfield, Connecticut, United States|Smilow Cancer Hospital at Guilford, Guilford, Connecticut, United States|Smilow Cancer Hospital at St. Francis Hospital, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Smilow Cancer Hospital at North Haven, North Haven, Connecticut, United States|Smilow Cancer Hospital at Orange, Orange, Connecticut, United States|Smilow Cancer Hospital at Torrington, Torrington, Connecticut, United States|Smilow Cancer Hospital at Trumbull, Trumbull, Connecticut, United States|Smilow Cancer Hospital at Waterbury, Waterbury, Connecticut, United States","https://ClinicalTrials.gov/show/NCT02047474"
649,"Project Survival-Prospective Biomarker Discovery","Unknown status","No Results Available","Pancreatic Neoplasms|Pancreatic Cancer|Pancreatitis|Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer",,"Banner Health - MD Anderson Cancer Center, Gilbert, Arizona, United States|Mayo Clinic - Arizona, Phoenix, Arizona, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Mercy Health - St. Mary's, Grand Rapids, Michigan, United States|Virginia Piper Cancer Institute - Allina Health, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02781012"
650,"Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","Has Results","Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Biological: ipilimumab|Drug: gemcitabine hydrochloride|Other: laboratory biomarker analysis","Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT01473940"
651,"Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: sorafenib tosylate|Drug: everolimus|Other: laboratory biomarker analysis|Other: pharmacogenomic studies|Other: pharmacological study","University of Colorado at Denver Health Sciences Center, Aurora, Colorado, United States|Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT00981162"
652,"Patient-derived Organoids Drug Screen in Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreas Cancer|Pancreas Neoplasm|Pancreas Adenocarcinoma|Pancreatic Cancer|Pancreatic Neoplasms|Pancreatic Adenocarcinoma","Procedure: Laparoscopic surgical biopsy and organoid generation",,"https://ClinicalTrials.gov/show/NCT05351983"
653,"Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: vismodegib|Drug: sirolimus|Procedure: positron emission tomography|Procedure: computed tomography|Other: pharmacological study|Other: laboratory biomarker analysis|Radiation: fludeoxyglucose F 18","Mayo Clinic Campus in Arizona, Scottsdale, Arizona, United States|Mayo Clinic Campus in Florida, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01537107"
654,"Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer","Completed","Has Results","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: paclitaxel|Drug: bryostatin 1","Montefiore Medical Center, Bronx, New York, United States","https://ClinicalTrials.gov/show/NCT00031694"
655,"Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery","Active, not recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7","Biological: Falimarev|Biological: Inalimarev|Other: Laboratory Biomarker Analysis|Biological: Sargramostim","Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States","https://ClinicalTrials.gov/show/NCT00669734"
656,"Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer","Active, not recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma|Stage II Pancreatic Cancer AJCC v6 and v7|Stage IIA Pancreatic Cancer AJCC v6 and v7|Stage IIB Pancreatic Cancer AJCC v6 and v7|Stage III Pancreatic Cancer AJCC v6 and v7","Drug: Capecitabine|Other: Laboratory Biomarker Analysis|Drug: Nab-paclitaxel|Other: Questionnaire Administration|Radiation: Radiation Therapy","M D Anderson Cancer Center, Houston, Texas, United States|MD Anderson in Katy, Houston, Texas, United States|MD Anderson Cancer Center - League City, League City, Texas, United States|MD Anderson in Sugar Land, Sugar Land, Texas, United States|MD Anderson in The Woodlands, The Woodlands, Texas, United States","https://ClinicalTrials.gov/show/NCT02394535"
657,"Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors","Recruiting","No Results Available","Metastatic Castration-resistant Prostate Cancer|Metastatic Prostate Cancer|Metastatic Pancreatic Ductal Adenocarcinoma|Metastatic Pancreatic Cancer|Metastatic Pancreatic Adenocarcinoma","Biological: BPX-601|Drug: Rimiducid","Moffitt Cancer Center, Tampa, Florida, United States|Emory Winship Cancer Institute, Atlanta, Georgia, United States|John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, United States|Columbia University Medical Center, New York, New York, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, United States|Baylor Sammons Cancer Center, Dallas, Texas, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02744287"
658,"Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Advanced Malignant Solid Neoplasm|ALK Positive|Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: Ceritinib|Drug: Cisplatin|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Other: Pharmacological Study","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT02227940"
659,"Combining Epigenetic And Immune Therapy to Beat Cancer.","Recruiting","No Results Available","Advanced Solid Tumor|Advanced Colorectal Carcinoma|Advanced Soft-tissue Sarcoma|Advanced Pancreatic Adenocarcinoma|Adult Solid Tumor","Drug: Durvalumab|Drug: Tazemetostat","Institut Bergonie, Bordeaux, France|CHRU Brest, Brest, France|CHU Poitiers, Poitiers, France","https://ClinicalTrials.gov/show/NCT04705818"
660,"Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion","Recruiting","No Results Available","Mesothelioma|Non Small Cell Lung Cancer|Malignant Peripheral Nerve Sheath Tumors|Solid Tumor|Pancreatic Adenocarcinoma|Advanced Solid Tumor","Drug: MRTX1719","Memorial Sloan Kettering Cancer Center, New York, New York, United States|Sarah Cannon Research Institute, Nashville, Tennessee, United States|MD Anderson Cancer Center, Houston, Texas, United States|START Center for Cancer Care, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT05245500"
661,"Testing the Addition of an Anti-cancer Drug, BAY 1895344 ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors","Recruiting","No Results Available","Advanced Fallopian Tube Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Ovarian Carcinoma|Advanced Pancreatic Adenocarcinoma|Advanced Primary Peritoneal Carcinoma|Fallopian Tube High Grade Serous Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Ovarian High Grade Serous Adenocarcinoma|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Primary Peritoneal High Grade Serous Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage III Fallopian Tube Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage III Primary Peritoneal Cancer AJCC v8|Stage IV Fallopian Tube Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Primary Peritoneal Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma","Procedure: Biopsy|Drug: Elimusertib|Drug: Gemcitabine","Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04616534"
662,"Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Locally Advanced Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8","Procedure: Biopsy|Drug: Calaspargase Pegol-mknl|Drug: Cobimetinib","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT05034627"
663,"Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreas Cancer|Pancreas Neoplasm|Pancreas Disease|Pancreas Adenocarcinoma|Surgery|Chemotherapy Effect|Quality of Life|Locally Advanced Pancreatic Adenocarcinoma|Borderline Resectable Pancreatic Adenocarcinoma",,,"https://ClinicalTrials.gov/show/NCT05356039"
664,"Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer","Withdrawn","No Results Available","Colon Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Rectal Adenocarcinoma|Stage III Pancreatic Cancer|Stage IIIA Colon Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Rectal Cancer|Stage IV Pancreatic Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer","Drug: Fluorouracil|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Oxaliplatin|Drug: pan FGFR Kinase Inhibitor BGJ398|Other: Pharmacological Study","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT02575508"
665,"A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People With Advanced Pancreatic Cancer and BRCA Mutations","Recruiting","No Results Available","Pancreatic Adenocarcinoma Metastatic|BRCA1 Mutation|BRCA2 Mutation|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer|Metastatic Pancreatic Cancer|Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Melphalan|Drug: BCNU|Drug: Vitamin B12B|Drug: Vitamin C|Drug: Ethanol|Device: Autologous Hematopoietic Stem Cells","Massachusetts General Hospital, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04150042"
666,"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","Recruiting","No Results Available","Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IIIA Hodgkin Lymphoma|Ann Arbor Stage IIIB Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Ann Arbor Stage IVA Hodgkin Lymphoma|Ann Arbor Stage IVB Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma","Drug: Abemaciclib|Drug: Abiraterone|Drug: Afatinib|Biological: Bevacizumab|Drug: Bicalutamide|Procedure: Biospecimen Collection|Drug: Bortezomib|Drug: Cabazitaxel|Drug: Cabozantinib|Drug: Capecitabine|Drug: Carboplatin|Drug: Celecoxib|Drug: Cobimetinib|Drug: Copanlisib|Drug: Dabrafenib|Drug: Dacomitinib|Drug: Darolutamide|Drug: Dasatinib|Drug: Doxorubicin|Biological: Durvalumab|Drug: Enasidenib|Drug: Entrectinib|Drug: Enzalutamide|Drug: Erlotinib|Drug: Everolimus|Drug: Fluorouracil|Drug: Idelalisib|Drug: Imatinib|Biological: Ipilimumab|Drug: Lenvatinib|Drug: Leucovorin|Drug: Lorlatinib|Drug: Losartan|Drug: Nab-paclitaxel|Drug: Neratinib|Biological: Nivolumab|Drug: Olaparib|Drug: Oxaliplatin|Drug: Palbociclib|Drug: Panobinostat|Biological: Pembrolizumab|Biological: Pertuzumab|Drug: Ponatinib|Other: Quality-of-Life Assessment|Drug: Regorafenib|Drug: Ruxolitinib|Drug: Sirolimus|Drug: Sorafenib|Drug: Sunitinib|Drug: Trametinib|Biological: Trastuzumab Emtansine|Drug: Tretinoin|Drug: Vemurafenib|Drug: Venetoclax|Drug: Vismodegib|Drug: Vorinostat","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT03878524"
667,"Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)","Recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Ductal Adenocarcinoma|Locally Advanced Unresectable Pancreatic Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8","Radiation: Hypofractionated Radiation Therapy|Drug: Losartan|Drug: Losartan Potassium|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT04106856"
668,"ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery","Completed","No Results Available","Ampulla of Vater Adenocarcinoma|Gallbladder Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma|Stage III Ampulla of Vater Cancer|Stage III Intrahepatic Cholangiocarcinoma|Stage III Pancreatic Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Hilar Cholangiocarcinoma|Stage IIIB Gallbladder Cancer|Stage IIIB Hilar Cholangiocarcinoma|Stage IV Ampulla of Vater Cancer|Stage IVA Gallbladder Cancer|Stage IVA Hilar Cholangiocarcinoma|Stage IVA Intrahepatic Cholangiocarcinoma|Stage IVA Pancreatic Cancer|Stage IVB Gallbladder Cancer|Stage IVB Hilar Cholangiocarcinoma|Stage IVB Intrahepatic Cholangiocarcinoma|Stage IVB Pancreatic Cancer","Drug: ADH-1|Drug: Cisplatin|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT01825603"
669,"Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors","Active, not recruiting","No Results Available","Head and Neck Squamous Cell Carcinoma|Metastatic Pancreatic Adenocarcinoma|Non-Resectable Cholangiocarcinoma|Pancreatic Adenocarcinoma|Recurrent Gallbladder Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage III Pancreatic Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Gallbladder Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IV Pancreatic Cancer|Unresectable Gallbladder Carcinoma|Unresectable Pancreatic Cancer","Drug: Cisplatin|Drug: Docetaxel|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Other: Pharmacological Study|Biological: Recombinant EphB4-HSA Fusion Protein","USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States","https://ClinicalTrials.gov/show/NCT02495896"
670,"Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer","Completed","No Results Available","Adenocarcinoma of Unknown Primary|Adult Cholangiocarcinoma|Gallbladder Carcinoma|Gastric Adenocarcinoma|Malignant Gastrointestinal Neoplasm|Metastatic Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma|Stage III Ampulla of Vater Cancer|Stage III Pancreatic Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Gastric Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Gastric Cancer|Stage IV Ampulla of Vater Cancer|Stage IV Gallbladder Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer","Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Drug: Leucovorin Calcium|Drug: Irinotecan Hydrochloride|Drug: Fluorouracil|Other: Laboratory Biomarker Analysis","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|NorthShore University Health System, Evanston, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Fort Wayne Medical Oncology/Hematology, Fort Wayne, Indiana, United States|Indiana University Medical Center, Indianapolis, Indiana, United States|The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Virginia Mason, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02333188"
671,"A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors","Active, not recruiting","No Results Available","Metastatic Lung Non-Small Cell Carcinoma|Metastatic Lung Small Cell Carcinoma|Metastatic Pancreatic Adenocarcinoma|Metastatic Triple-Negative Breast Carcinoma|Pancreatic Ductal Adenocarcinoma|Stage III Breast Cancer AJCC v7|Stage III Lung Non-Small Cell Cancer AJCC v7|Stage III Lung Small Cell Carcinoma AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Lung Non-Small Cell Cancer AJCC v7|Stage IIIA Lung Small Cell Carcinoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Lung Non-Small Cell Cancer AJCC v7|Stage IIIB Lung Small Cell Carcinoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Lung Non-Small Cell Cancer AJCC v7|Stage IV Lung Small Cell Carcinoma AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Triple-Negative Breast Carcinoma|Unresectable Lung Small Cell Carcinoma|Unresectable Pancreatic Adenocarcinoma|Unresectable Pancreatic Carcinoma|Unresectable Triple-Negative Breast Carcinoma","Other: 18F-Fluoromisonidazole|Drug: Cediranib Maleate|Other: Laboratory Biomarker Analysis|Drug: Olaparib|Procedure: Positron Emission Tomography","UC San Diego Moores Cancer Center, La Jolla, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|UC San Diego Medical Center - Hillcrest, San Diego, California, United States|UCSF Medical Center-Mount Zion, San Francisco, California, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Moffitt Cancer Center-International Plaza, Tampa, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|M D Anderson Cancer Center, Houston, Texas, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02498613"
672,"High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer","Withdrawn","No Results Available","Metastatic Pancreatic Cancer|Pancreatic Cancer|Pancreas Cancer|Pancreatic Adenocarcinoma Resectable|Pancreatic Ductal Adenocarcinoma|Pancreatic Metastasis","Drug: Ascorbic Acid|Drug: Paclitaxel protein-bound|Drug: Cisplatin|Drug: Gemcitabine","HonorHealth Research Institute, Scottsdale, Arizona, United States|University of California San Diego Moores Cancer Center, San Diego, California, United States|Piedmont Cancer Institute, PC, Atlanta, Georgia, United States|Piedmont Cancer Institute, PC, Fayetteville, Georgia, United States|Piedmont Cancer Institute, PC, Newnan, Georgia, United States|Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03908333"
673,"High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer","Withdrawn","No Results Available","Metastatic Pancreatic Cancer|Pancreatic Cancer|Pancreas Cancer|Pancreatic Adenocarcinoma Resectable|Pancreatic Ductal Adenocarcinoma|Pancreatic Metastasis","Drug: Ascorbic Acid|Drug: Paclitaxel protein-bound|Drug: Cisplatin|Drug: Gemcitabine","UC San Diego Moores Cancer Center, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT03697239"
674,"Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types","Suspended","No Results Available","Bile Duct Cancer|Gall Bladder Cancer|Breast Cancer|Neuroendocrine Tumors|Ovarian Cancer|Pancreatic Adenocarcinoma|Soft Tissue Sarcoma|Vulvar Cancer|Prostate Cancer","Drug: Atezolizumab|Drug: Tivozanib","University of Florida, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT05000294"
675,"Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas","Recruiting","No Results Available","Solid Tumors|Malignant Pleural Mesothelioma|Gastric Adenocarcinoma|Colorectal Adenocarcinoma|Sarcoma|Pancreatic Adenocarcinoma|Ewing Sarcoma|Chondrosarcoma","Drug: INBRX-109|Drug: Carboplatin|Drug: Cisplatin|Drug: Pemetrexed|Drug: 5-fluorouracil|Drug: Irinotecan|Drug: Temozolomide","HonorHealth Research Institute, Scottsdale, Arizona, United States|City of Hope, Duarte, California, United States|Valkyrie Clinical Trials, Los Angeles, California, United States|Sarcoma Oncology Center, Santa Monica, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Emory University - Winship Cancer Institute, Atlanta, Georgia, United States|The University of Chicago, Chicago, Illinois, United States|University of Michigan, Ann Arbor, Michigan, United States|START Midwest Michigan, PC, Grand Rapids, Michigan, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States|UT MD Anderson Cancer Center, Houston, Texas, United States|NEXT Oncology, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT03715933"
676,"RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer","Terminated","No Results Available","Adenocarcinoma of the Pancreas|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer","Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery","Tower Cancer Research Foundation, Beverly Hills, California, United States|City of Hope Medical Center, Duarte, California, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Fort Wayne Medical Oncology and Hematology Inc - State Boulevard, Fort Wayne, Indiana, United States","https://ClinicalTrials.gov/show/NCT01192763"
677,"Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: alisertib|Drug: gemcitabine","UC Davis Comprehensive Cancer Center, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT01924260"
678,"PEN-866 in Patients With Advanced Solid Malignancies","Recruiting","No Results Available","Carcinoma|Endometrial Adenocarcinoma|Neoplasms|Squamous Cell Carcinoma of the Anus|Adenocarcinoma of the Pancreas|Advanced Cancer|Solid Tumor|Solid Carcinoma|Squamous Cell Carcinoma of the Cervix|Squamous Cell Carcinoma|Squamous Cell Carcinoma of the Vulva|Squamous Cell Carcinoma of the Penis|Gastric Cancer|Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Small-cell Lung Cancer|Small Cell Lung Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Adenocarcinoma","Drug: PEN-866 Sodium|Drug: fluorouracil|Drug: Folinic acid|Drug: Niraparib","Highlands Oncology Group, Springdale, Arkansas, United States|Sarah Cannon Reasearch Institute at HealthONE, Denver, Colorado, United States|Florida Cancer Specialists - South, Fort Myers, Florida, United States|Florida Cancer Specialists - North, Saint Petersburg, Florida, United States|Florida Cancer Specialists - East, West Palm Beach, Florida, United States|National Institutes of Health / National Cancer Institute, Bethesda, Maryland, United States|Henry Ford, Detroit, Michigan, United States|Nebraska Cancer Specialists, Omaha, Nebraska, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma, United States|Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Prisma Health - Upstate, Greenville, South Carolina, United States|The West Clinic, Germantown, Tennessee, United States|Tennessee Oncology, Nashville, Tennessee, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03221400"
679,"Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: sorafenib tosylate|Drug: gemcitabine hydrochloride","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00095966"
680,"Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer","Completed","Has Results","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Biological: cetuximab|Drug: gemcitabine hydrochloride|Biological: bevacizumab|Drug: erlotinib hydrochloride","University of Chicago, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00091026"
681,"Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: gemcitabine hydrochloride|Biological: bevacizumab|Other: placebo|Other: laboratory biomarker analysis|Other: pharmacogenomic studies|Other: pharmacological study","Cancer and Leukemia Group B, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00088894"
682,"Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: sunitinib malate|Drug: gemcitabine hydrochloride","Case Western Reserve University, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00462553"
683,"CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: temsirolimus|Other: laboratory biomarker analysis","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00075647"
684,"UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: 7-hydroxystaurosporine|Drug: gemcitabine hydrochloride|Other: pharmacological study|Other: laboratory biomarker analysis","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00039403"
685,"Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: alvocidib|Drug: gemcitabine hydrochloride|Radiation: 3-dimensional conformal radiation therapy|Other: laboratory biomarker analysis","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00047307"
686,"Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors","Completed","No Results Available","Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Drug: gemcitabine hydrochloride|Other: pharmacological study|Other: laboratory biomarker analysis","Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01145456"
687,"Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer",,"Odense University Hospital, Odense C, Denmark","https://ClinicalTrials.gov/show/NCT02646462"
688,"Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies","Terminated","No Results Available","Colorectal Adenocarcinoma|Cholangiocarcinoma|Pancreatic Adenocarcinoma|Hepatocellular Adenocarcinoma|Gastric Adenocarcinoma|Esophageal Adenocarcinoma","Drug: ceritinib","USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Yale University, Yale Cancer Center, New Haven, Connecticut, United States|Laura & Isaac Permutter Cancer Center at NYU Langone, New York, New York, United States|The Ohio State University, James Cancer Hospital, Columbus, Ohio, United States|Swedish Cancer Institute, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02638909"
689,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors","Completed","No Results Available","Dose Escalation|Safety|Preliminary Efficacy|Advanced Solid Tumors|Metastatic Breast Cancer|Advanced Pancreatic Adenocarcinoma|Metastatic Colorectal Cancer|Recurrent Glioblastoma Multiforme|Gastric Cancer|Gastroesophageal Junction Cancer|Triple Negative Metastatic Breast Cancer|Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer","Drug: LDE225|Drug: BKM120","Cedars Sinai Medical Center SC, Los Angeles, California, United States|University of California San Francisco UCSF (SC), San Francisco, California, United States|H. Lee Moffitt Cancer Center & Research Institute Moffitt 4, Tampa, Florida, United States|Dana Farber Cancer Institute Dana SC, Boston, Massachusetts, United States|Mayo Clinic - Rochester Division of Hematology, Rochester, Minnesota, United States|Duke University Medical Center Duke - Baker, Durham, North Carolina, United States|Willamette Valley Clinical Studies Williamette Valley Cancer, Eugene, Oregon, United States|Northwest Cancer Specialists Northwest Cancer, Portland, Oregon, United States|Fox Chase Cancer Center FCCC, Philadelphia, Pennsylvania, United States|Texas Oncology Midtown Texas Oncology, Dallas, Texas, United States|Sammons Cancer Center - Texas Oncology SC-2, Dallas, Texas, United States|University of Texas/MD Anderson Cancer Center SC-3, Houston, Texas, United States|University of Utah / Huntsman Cancer Institute Huntsman, Salt Lake City, Utah, United States|Novartis Investigative Site, Parkville, Victoria, Australia|Novartis Investigative Site, Wilrijk, Belgium|Novartis Investigative Site, Edmonton, Alberta, Canada|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Ancona, AN, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Glasgow, United Kingdom|Novartis Investigative Site, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT01576666"
690,"Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer","Withdrawn","No Results Available","Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: dovitinib lactate|Drug: gemcitabine hydrochloride|Drug: paclitaxel albumin-stabilized nanoparticle formulation|Other: pharmacological study|Other: laboratory biomarker analysis","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT02048943"
691,"Safety Study of Modified Vaccinia Virus to Cancer","Completed","No Results Available","Melanoma|Breast Cancer|Head and Neck Squamous Cell Cancer|Liver Cancer|Colorectal Cancer|Pancreatic Adenocarcinoma","Biological: Vaccinia virus (vvDD-CDSR)","University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00574977"
692,"Targeted PARP or MEK/ERK Inhibition in Patients With Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Ductal Adenocarcinoma|Metastatic Pancreatic Ductal Adenocarcinoma|Resectable Pancreatic Ductal Adenocarcinoma|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8","Drug: Cobimetinib|Drug: Olaparib|Drug: Onvansertib|Drug: Temuterkib","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT04005690"
693,"Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: P276-00|Drug: Gemcitabine","Central India Cancer Research Institute, Nagpur, Ajayonco@hotmail.com, India|Global Hospital, Hyderabaad, Andhra Pradesh, India|Curie Manavata Cancer Centre, Nashik, Maharashtra, India|Deenanath Mangeshkar Hospital & Research Centre, Pune, Maharashtra, India|Sri RamaChandra Medical Centre, Chennai, Tamil Nadu, India|Lifeline Mutispecilaity Hospital, Chennai, Tamil Nadu, India|Meenakshi Mission Hospital & Reasearch Centre, Madurai, Tamil Nadu, India","https://ClinicalTrials.gov/show/NCT00898287"
694,"Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine","Completed","Has Results","Pancreatic Cancer","Drug: gemcitabine|Drug: abraxane|Drug: hydroxychloroquine","Hillman Cancer Center, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01978184"
695,"High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery","Recruiting","No Results Available","Acinar Cell Carcinoma|Ampulla of Vater Adenocarcinoma|Cholangiocarcinoma|Duodenal Adenocarcinoma|Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type|Periampullary Adenocarcinoma","Procedure: Pancreatectomy|Other: Lavage","Case Western Reserve University, Cleveland, Ohio, United States|Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02757859"
696,"Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors","Recruiting","No Results Available","Pancreatic Adenocarcinoma|Pancreatic Cysts|Pancreatic Endocrine Tumors|Chronic Pancreatitis|Cholangiocarcinoma, Extrahepatic|Ampullary Adenocarcinoma|Duodenal Adenocarcinoma","Procedure: Robotic pancreaticoduodenectomy|Procedure: Open pancreaticoduodenectomy","Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04400357"
697,"VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer","Active, not recruiting","No Results Available","Colon Carcinoma Metastatic in the Liver|Colorectal Adenocarcinoma|Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma|Stage I Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage II Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Colorectal Cancer|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer","Biological: Anti-SEMA4D Monoclonal Antibody VX15/2503|Biological: Ipilimumab|Biological: Nivolumab|Procedure: Surgery","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT03373188"
698,"Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Stage IV Pancreatic Cancer","Drug: Nivolumab|Drug: Gemcitabine|Drug: Tegafur-Gimeracil-Oteracil",,"https://ClinicalTrials.gov/show/NCT04377048"
699,"Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions","Completed","No Results Available","Pancreatic Cancer|Pancreatic Neoplasms","Procedure: Intermittent aspiration","Hospital Universitario de la Princesa, Madrid, Spain","https://ClinicalTrials.gov/show/NCT03829748"
700,"Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Adenocarcinoma|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Recurrent Pancreatic Carcinoma","Drug: Gemcitabine|Drug: Sorafenib|Drug: Vorinostat|Radiation: 3-Dimensional Conformal Radiation Therapy|Radiation: Intensity-Modulated Radiation Therapy|Other: RosetteSep|Other: DEPfff","Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT02349867"
701,"Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer","Completed","Has Results","Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma|Stage I Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage II Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer","Procedure: 4-Dimensional Computed Tomography|Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Nelfinavir Mesylate|Biological: Oregovomab|Radiation: Stereotactic Body Radiation Therapy|Procedure: Therapeutic Conventional Surgery","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT01959672"
702,"DC Vaccine in Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: mDC3/8-KRAS Vaccine","University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03592888"
703,"Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: cisplatin|Drug: epirubicin|Drug: gemcitabine|Drug: metformin","Istituto Scientifico H. San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT01167738"
704,"EUS BD vs ERCP TP for Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer|Pancreatic Adenocarcinoma|Biliary Tract Neoplasms|Biliary Duct Obstruction|Unresectable Pancreatic Cancer|Periampullary Cancer|Periampullary Carcinoma Non-Resectable","Procedure: Endoscopic Ultrasound Guided Biliary Drainage|Procedure: ERCP","Weill Cornell Medical College, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03063554"
705,"Peptide-based Immunization for Colon- and and Pancreas-carcinoma","Unknown status","No Results Available","Colon Neoplasm|Colon Adenocarcinoma|Colon Cancer|Colo-rectal Cancer|Rectal Cancer|Rectal Neoplasms|Rectal Adenocarcinoma|Rectal Tumors|Pancreatic Cancer|Pancreas Cancer|Pancreatic Neoplasms|Pancreatic Adenocarcinoma",,"Teaching Hospital UOL Cancer Center, Lahore, Pakistan","https://ClinicalTrials.gov/show/NCT03871790"
706,"Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Cancer","Biological: conatumumab|Drug: capecitabine|Drug: gemcitabine hydrochloride|Radiation: 3-dimensional conformal radiation therapy",,"https://ClinicalTrials.gov/show/NCT01017822"
707,"Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: sunitinib","San Raffaele Scientific Institute, Milan, Italy","https://ClinicalTrials.gov/show/NCT00967603"
708,"Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Radiation: intensity-modulated radiation therapy","Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States","https://ClinicalTrials.gov/show/NCT00878657"
709,"Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","No Results Available","Pancreatic Cancer","Biological: cetuximab|Radiation: 3-dimensional conformal radiation therapy","Cookridge Hospital, Leeds, England, United Kingdom|Christie Hospital, Manchester, England, United Kingdom","https://ClinicalTrials.gov/show/NCT00599833"
710,"NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer","Recruiting","No Results Available","Borderline Resectable Pancreatic Carcinoma|Locally Advanced Unresectable Pancreatic Adenocarcinoma|Resectable Pancreatic Ductal Adenocarcinoma|Stage 0 Pancreatic Cancer AJCC v8|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8","Drug: Capecitabine|Drug: Fluorouracil|Drug: Irinotecan Hydrochloride|Drug: Leucovorin Calcium|Drug: Losartan Potassium|Drug: Oxaliplatin|Radiation: Radiation Therapy|Procedure: Resection","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT04539808"
711,"Laser Tissue Welding - Distal Pancreatectomy Sealing Study","Completed","No Results Available","Pancreatic Tumor, Benign|Pancreatic Neoplasms|Pancreatic Adenocarcinoma|Pancreatic Pseudocyst|Pancreatic Neuroendocrine Tumor|Pancreas; Insulinoma|Pancreatic Cyst|Pancreatic Teratoma|Pancreatic Polypeptide Tumor|Pancreatic Vipoma|Pancreatic Cystadenoma|Pancreas Injury|Pancreatic Gastrinoma|Pancreatic Glucagonoma","Device: Distal Pancreatectomy Sealing Using LTW","Baylor CHI St. Luke's Medical Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03147768"
712,"Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: bevacizumab|Drug: cisplatin|Drug: gemcitabine hydrochloride","UCSF Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00126633"
713,"Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin","Hopital Duffaut, Avignon, France|C.H.G. Beauvais, Beauvais, France|Hopital Drevon, Dijon, France|Centre Hospitalier de Dreux, Dreux, France|Centre Hospitalier Departemental, La Roche Sur Yon, France|Hopital Saint - Louis, La Rochelle, France|Hopital Louis Pasteur - Le Coudray, Le Coudray, France|Clinique Victor Hugo, Le Mans, France|Polyclinique des Quatre Pavillons, Lormont, France|Clinique Saint Jean, Lyon, France|Hopital Saint Antoine, Paris, France|Hopital Tenon, Paris, France|Centre Hospitalier Lyon Sud, Pierre Benite, France|Polyclinique De Courlancy, Reims, France|C.H. Senlis, Senlis, France","https://ClinicalTrials.gov/show/NCT00268411"
714,"Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatin","Centre Hospitalier Universitaire d'Amiens, Amiens, France|Hopital Duffaut, Avignon, France|Centre Hospitalier General, Belfort, France|Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besancon, France|Hopital Avicenne, Bobigny, France|Hopital Saint Andre, Bordeaux, France|Institut Bergonie, Bordeaux, France|Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France|Centre Hospitalier Docteur Duchenne, Boulogne Sur Mer, France|Hopital Ambroise Pare, Boulogne-Billancourt, France|CHU de Caen, Caen, France|Centre Regional Francois Baclesse, Caen, France|Centre Jean Perrin, Clermont-Ferrand, France|CHR Clermont Ferrand, Hotel Dieu, Clermont-Ferrand, France|Hopitaux Civils de Colmar, Colmar, France|Centre Hospitalier Universitaire Henri Mondor, Creteil, France|Hopital Du Bocage, Dijon, France|Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France|Centre Hospitalier Intercommunal St. Aubin les Elbeuf, Elbeuf, France|Clinique Saint Vincent, Epernay, France|Centre Hospitalier Departemental, La Roche Sur Yon, France|CMC Les Ormeaux, Le Havre, France|Centre Oscar Lambret, Lille, France|Hopital Saint Vincent de Paul, Lille, France|Polyclinique des Quatre Pavillons, Lormont, France|Hopital de la Croix Rousse, Lyon, France|Centre Leon Berard, Lyon, France|Hopital Edouard Herriot - Lyon, Lyon, France|Hopital Ambroise Pare, Marseille, France|CHU de la Timone, Marseille, France|CHU Nord, Marseille, France|Hopital Notre-Dame de Bon Secours, Metz, France|Centre Hospitalier General de Mont de Marsan, Mont-de-Marsan, France|Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France|Centre Regional Rene Gauducheau, Nantes-Saint Herblain, France|CHR D'Orleans - Hopital de la Source, Orleans, France|Hopital Bichat - Claude Bernard, Paris, France|Hopital Saint Michel, Paris, France|Centre Hospitalier de Perpignan, Perpignan, France|Centre Hospitalier Lyon Sud, Pierre Benite, France|Institut Jean Godinot, Reims, France|CHU - Robert Debre, Reims, France|Centre Eugene Marquis, Rennes, France|Hopital Charles Nicolle, Rouen, France|Clinique Armoricaine De Radiologie, Saint Brieuc, France|Centre Rene Huguenin, Saint Cloud, France|Clinique Charcot, Sainte Foy Les Lyon, France|Centre Hospitalier de Semur en Auxois, Semur en Auxois, France|Centre Paul Strauss, Strasbourg, France|Hopital Universitaire Hautepierre, Strasbourg, France|Centre Hospitalier de Tarbes, Tarbes, France|Institut Claudius Regaud, Toulouse, France|CHU de Tours, Tours, France|Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT00112658"
715,"Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: docetaxel|Drug: fluorouracil|Radiation: radiation therapy","Centre Paul Papin, Angers, France|Centre Oscar Lambret, Lille, France|Polyclinique des Quatre Pavillons, Lormont, France|Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, France|Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France|Centre Regional Rene Gauducheau, Nantes-Saint Herblain, France|Centre Hospitalier Lyon Sud, Pierre Benite, France|Centre Rene Huguenin, Saint Cloud, France|Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT00112697"
716,"Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: docetaxel|Drug: gemcitabine hydrochloride|Drug: irinotecan hydrochloride","Northeast Alabama Regional Medical Center, Anniston, Alabama, United States|Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Veterans Affairs Medical Center - San Diego, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|Lombardi Cancer Center, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|Veterans Affairs Medical Center - Washington, DC, Washington, District of Columbia, United States|Broward General Medical Center, Fort Lauderdale, Florida, United States|Memorial Regional Hospital Comprehensive Cancer Center, Hollywood, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center, West Palm Beach, Florida, United States|Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States|West Suburban Center for Cancer Care, River Forest, Illinois, United States|Saint Anthony Medical Center, Rockford, Illinois, United States|Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Hematology Oncology Associates of the Quad Cities, Bettendorf, Iowa, United States|Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States|Baptist Hospital East - Louisville, Louisville, Kentucky, United States|Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Veterans Affairs Medical Center - Baltimore, Baltimore, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|Lakeland Medical Center - St. Joseph, Saint Joseph, Michigan, United States|Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota Cancer Center, Minneapolis, Minnesota, United States|Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States|Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Veterans Affairs Medical Center - Las Vegas, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Cooper University Hospital, Camden, New Jersey, United States|Veterans Affairs Medical Center - Buffalo, Buffalo, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Queens Cancer Center of Queens Hospital, Jamaica, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States|Mount Sinai Medical Center, NY, New York, New York, United States|State University of New York - Upstate Medical University, Syracuse, New York, United States|Veterans Affairs Medical Center - Syracuse, Syracuse, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States|Veterans Affairs Medical Center - Asheville, Asheville, North Carolina, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|NorthEast Oncology Associates, Concord, North Carolina, United States|Veterans Affairs Medical Center - Durham, Durham, North Carolina, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, United States|Lenoir Memorial Hospital Cancer Center, Kinston, North Carolina, United States|FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Veterans Affairs Medical Center - Fargo, Fargo, North Dakota, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|Lifespan: The Miriam Hospital, Providence, Rhode Island, United States|Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States|Green Mountain Oncology Group, Bennington, Vermont, United States|Vermont Cancer Center at University of Vermont, Burlington, Vermont, United States|Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont, United States|Martha Jefferson Hospital, Charlottesville, Virginia, United States|Virginia Oncology Associates - Norfolk, Norfolk, Virginia, United States|MBCCOP - Massey Cancer Center, Richmond, Virginia, United States|Oncology and Hematology Associates of Southwest Virginia, Inc., Roanoke, Virginia, United States|St. Mary's Medical Center, Huntington, West Virginia, United States|Ministry Medical Group - Northern Region, Rhinelander, Wisconsin, United States|University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT00012220"
717,"Circulating Tumor DNA Exposure in Peripheral Blood","Unknown status","No Results Available","Colorectal Cancer|Pancreatic Adenocarcinoma|Gastric Cancer|Hepatocellular Carcinoma|Non-small Cell Lung Cancer|Bladder Cancer|Melanoma|Ovarian Cancer|Adrenocortical Cancer|Breast Cancer|Other Cancer",,"University of Arizona Cancer Center, Tucson, Arizona, United States|Florida Hospital Celebration Health, Celebration, Florida, United States|Orlando Health UF Health Cancer Center, Orlando, Florida, United States|Premier Surgical Oncology, Centerville, Ohio, United States|Kettering Medical Center, Dayton, Ohio, United States|University Hospital of Geneva, Geneva, Switzerland","https://ClinicalTrials.gov/show/NCT03517332"
718,"Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: rubitecan","SuperGen, Incorporated, San Ramon, California, United States","https://ClinicalTrials.gov/show/NCT00005871"
719,"Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Cancer","Biological: bleomycin sulfate|Drug: electroporation therapy",,"https://ClinicalTrials.gov/show/NCT00027521"
720,"Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas","Unknown status","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: mitomycin C|Drug: rubitecan","SuperGen, Incorporated, San Ramon, California, United States|Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT00005870"
721,"Identifing Risk Factors for Pancreaticojejunostomy Leakage Following Pancreaticoduodenectomy","Recruiting","No Results Available","Pancreatic Fistula|Whipple Operation|Pancreaticoduodenectomy|POPF","Procedure: Pancreaticoduodenectomy","1st Propaedeutic Department of Surgery, Hippokrateion General Hospital, Athens, Attiki, Greece","https://ClinicalTrials.gov/show/NCT04798560"
722,"Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Gemcitabine|Radiation: radiation therapy","Banner Good Samaritan Medical Center, Phoenix, Arizona, United States|Saint Joseph's Mercy Cancer Center, Hot Springs, Arkansas, United States|California Cancer Center - Woodward Park Office, Fresno, California, United States|Doctors Medical Center, Modesto, California, United States|Memorial Medical Center Cancer Services, Modesto, California, United States|North Colorado Medical Center, Greeley, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, United States|New Britain General Hospital, New Britain, Connecticut, United States|Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States|William W. Backus Hospital, Norwich, Connecticut, United States|Halifax Medical Center, Daytona Beach, Florida, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Emory University Hospital - Atlanta, Altanta, Georgia, United States|Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States|Northeast Georgia Medical Center, Gainesville, Georgia, United States|Cancer Care and Research Pavilion at St. Joseph's/Candler, Savannah, Georgia, United States|Pearlman Comprehensive Cancer Center at South Georgia Medical Center, Valdosta, Georgia, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Hematology and Oncology Associates, Chicago, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|Mercy Hospital and Medical Center, Chicago, Illinois, United States|Swedish Covenant Hospital, Chicago, Illinois, United States|St. Anthony's Memorial Hospital, Effingham, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Evanston Northwestern Health Care - Evanston Hospital, Evanston, Illinois, United States|Galesburg Clinic, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|InterCommunity Cancer Center of Western Illinois, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hinsdale Hematology Oncology Associates, Hinsdale, Illinois, United States|Hopedale Medical Complex, Hopedale, Illinois, United States|Midwest Center for Hematology/Oncology, Joliet, Illinois, United States|Joliet Oncology Hematology Associates, Limited - West, Joliet, Illinois, United States|Provena St. Mary's Wasser Regional Cancer Center - Kankakee, Kankakee, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|La Grange Memorial Hospital, La Grange, Illinois, United States|Deerpath Medical Associates, Lake Forest, Illinois, United States|North Shore Oncology and Hematology Associates, Limited - Libertyville, Libertyville, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Northwest Medical Specialist, PC, Niles, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Swedish American Hospital, Rockford, Illinois, United States|Hematology Oncology Associates - Skokie, Skokie, Illinois, United States|Hematology/Oncology of the North Shore at Gross Point Medical Center, Skokie, Illinois, United States|Midwest Cancer Research Group, Incorporated, Skokie, Illinois, United States|St. Margaret's Hospital, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States|Indiana University Cancer Center, Indianapolis, Indiana, United States|William N. Wishard Memorial Hospital, Indianapolis, Indiana, United States|Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States|Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Saint Joseph Regional Medical Center, South Bend, Indiana, United States|McFarland Clinic, P.C., Ames, Iowa, United States|Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, United States|Mercy Capitol Hospital, Des Moines, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, United States|Burgess Health Center, Onawa, Iowa, United States|Ottumwa Regional Health Center Cancer Center, Ottumwa, Iowa, United States|Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, West Des Moines, Iowa, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Baton Rouge General Regional Cancer Center, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center - Baton Rouge, Baton Rouge, Louisiana, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|Medical Center of Louisiana - New Orleans, New Orleans, Louisiana, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Tufts - New England Medical Center, Boston, Massachusetts, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Green Bay Oncology, Limited - Iron Mountain, Iron Mountain, Michigan, United States|Borgess Medical Center, Kalamazooaa, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, P.C., Lambertville, Michigan, United States|Mercy Memorial Hospital System, Monroe, Michigan, United States|William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States|Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph, St. Joseph, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Miller-Dwan Medical Center, Duluth, Minnesota, United States|St. Mary's - Duluth Clinic Cancer Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|CentraCare Clinic - River Campus, St. Cloud, Minnesota, United States|Park Nicollet Health Services, St. Louis Park, Minnesota, United States|United Hospital, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Good Samaritan Health Systems, Kearney, Nebraska, United States|Bryan LGH Medical Center West, Lincoln, Nebraska, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Methodist Cancer Center at Methodist Hospital - Omaha, Omaha, Nebraska, United States|Immanuel Medical Center, Omaha, Nebraska, United States|Bergan Mercy Medical Center, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Midlands Cancer Center at Midlands Community Hospital, Papillion, Nebraska, United States|CCOP - Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|Hunterdon Regional Cancer Center at Hunterdon Medical Center, Flemington, New Jersey, United States|Fox Chase Virtua Health Cancer Program - Marlton, Marlton, New Jersey, United States|Booker Cancer Center at Riverview Medical Center, Red Bank, New Jersey, United States|Shore Memorial Hospital - Somers Point, Somers Point, New Jersey, United States|Community Regional Cancer Center at Community Medical Center, Toms River, New Jersey, United States|Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital, Cooperstown, New York, United States|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States|Leo W. Jenkins Cancer Center at Pitt County Memorial Hospital, Greenville, North Carolina, United States|Zimmer Cancer Center at New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Wilson Medical Center, Wilson, North Carolina, United States|Forsyth Regional Cancer Center at Forsyth Medical Center, Winston-Salem, North Carolina, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Cancer Care Center at Medcenter One Hospital, Bismarck, North Dakota, United States|Mid Dakota Clinic, P.C., Bismarck, North Dakota, United States|St. Alexius Medical Center, Bismarck, North Dakota, United States|Trinity Cancer Care Center, Minot, North Dakota, United States|St. Elizabeth Boardman Cancer Center, Boardman, Ohio, United States|University Hospitals Ireland Cancer Center at Mercy Medical Center, Canton, Ohio, United States|Aultman Hospital Cancer Center at Aultman Health Foundation, Canton, Ohio, United States|Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio, United States|MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Fremont Memorial Hospital, Fremont, Ohio, United States|St. Rita's Medical Center, Lima, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Firelands Regional Medical Center, Sandusky, Ohio, United States|Promedica Cancer Center at Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical College of Ohio Cancer Institute, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|St. Joseph Health Care Center, Warren, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|St. Elizabeth Cancer Center at St. Elizabeth Health Center - Youngstown, Youngstown, Ohio, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Delaware County Regional Cancer Center at Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Lewistown Hospital, Lewistown, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|Phoenixville Hospital, Phoenixville, Pennsylvania, United States|Veterans Affairs Medical Center - Pittsburgh, Pittsburgh, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburg, Pennsylvania, United States|St. Joseph Medical Center, Reading, Pennsylvania, United States|Guthrie Medical Center - Sayre, Sayre, Pennsylvania, United States|Hematology and Oncology Associates, Scranton, Pennsylvania, United States|Mount Nittany Medical Center, State College, Pennsylvania, United States|Chester County Hospital, West Chester, Pennsylvania, United States|Jennersville Regional Hospital, West Grove, Pennsylvania, United States|Reading Hospital and Medical Center, West Reading, Pennsylvania, United States|CCOP - MainLine Health, Wynnewood, Pennsylvania, United States|Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania, United States|Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States|Avera McKennan Hospital and University Health Center, Sioux Falls, South Dakota, United States|Medical X-Ray Center, P. C., Sioux Falls, South Dakota, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Baptist Regional Cancer Center at Baptist Hospital of East Tennessee, Knoxville, Tennessee, United States|Doctor's Hospital of Laredo, Laredo, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|East Texas Medical Center Cancer Institute, Tyler, Texas, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center - Provo, Provo, Utah, United States|Utah Cancer Specialists at UCS Cancer Center, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Dixie Regional Medical Center, St. George, Utah, United States|Martha Jefferson Hospital Cancer Care Center, Charlottesville, Virginia, United States|Bon Secours Cancer Care at St. Mary's Hospital, Richmond, Virginia, United States|Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, United States|West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division, Charleston, West Virginia, United States|Marshall University Medical Center, Huntington, West Virginia, United States|Central Wisconsin Cancer Program at Agnesian HealthCare, Fond Du Lac, Wisconsin, United States|Green Bay Oncology, Limited at St. Vincent Hospital, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center, Green Bay, Wisconsin, United States|Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Cancer Care Center at Holy Family Memorial Medical Center, Manitowoc, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|University of Wisconsin Cancer Center at Aspirus Wausau Hospital, Wausau, Wisconsin, United States|Pretoria Academic Hospital, Pretoria, 0001, South Africa","https://ClinicalTrials.gov/show/NCT00057876"
723,"Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung","Withdrawn","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Liver Metastases|Lung Metastases|Recurrent Breast Cancer|Recurrent Pancreatic Cancer|Stage IV Breast Cancer|Stage IV Pancreatic Cancer","Procedure: dynamic contrast-enhanced magnetic resonance imaging|Other: pharmacological study|Biological: tumor-homing peptide iRGD","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT01741597"
724,"Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Procedure: adjuvant therapy|Radiation: radiation therapy","Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00010166"
725,"Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors","Recruiting","No Results Available","Colorectal Adenocarcinoma|Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Bile Duct Carcinoma|Hepatocellular Carcinoma|Esophageal Carcinoma|Gastrointestinal Cancer","Drug: CGX1321","Beijing Cancer Hospital, Beijing, China|Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China","https://ClinicalTrials.gov/show/NCT03507998"
726,"Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers","Active, not recruiting","No Results Available","Gastrointestinal Cancer|Colorectal Cancer|Pancreatic Adenocarcinoma|Gastric Cancer|Esophageal Cancer|Cholangiocarcinoma|Hepatocellular Carcinoma|Neuroendocrine Tumors|GIST, Malignant","Behavioral: Serious Illness Conversation Guide (SICG)|Behavioral: Quality of Life (QOL) survey","Stanford Cancer Center, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT04077372"
727,"The Cellularity Yield of Three Different 22-gauge FNA Needles","Completed","No Results Available","Pancreatic or Peripancreatic Lesions|Lesions in the Esophagus, Stomach, Duodenum or Rectum|Mediastinal ( Chest) Masses|Enlarged Lymph Nodes","Procedure: Endoscopic Ultrasound Fine Needle Aspiration (EUS-FNA)","Texas Tech University Health Sciences Center at El Paso, El Paso, Texas, United States","https://ClinicalTrials.gov/show/NCT01916421"
728,"Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer","Active, not recruiting","No Results Available","Colorectal Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Recurrent Colorectal Carcinoma|Recurrent Pancreatic Carcinoma|Stage III Colorectal Cancer|Stage III Pancreatic Cancer|Stage IIIA Colorectal Cancer|Stage IIIB Colorectal Cancer|Stage IV Colorectal Cancer|Stage IV Pancreatic Cancer|Stage IVA Colorectal Cancer|Stage IVA Pancreatic Cancer|Stage IVB Colorectal Cancer|Stage IVB Pancreatic Cancer|Unresectable Pancreatic Carcinoma","Drug: XL888|Biological: Pembrolizumab","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT03095781"
729,"Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors","Recruiting","No Results Available","ER+ Breast Cancer|Ovarian Cancer|Cervical Squamous Cell Carcinoma|Pancreatic Adenocarcinoma|Endometrial Cancer|Renal Cell Carcinoma|Urothelial Cancer|Head and Neck Squamous Cell Carcinoma|Mesothelioma|Melanoma|Hepatocellular Carcinoma|Prostate Cancer|NSCLC|HER2-negative Breast Cancer|Triple Negative Breast Cancer|Bladder Cancer|Colorectal Cancer Metastatic|GastroEsophageal Cancer|NSCL2 Gene Mutation","Combination Product: Obinutuzumab pretreatment (Gazyva®) Naptumomab estafenatox (ABR-217620; NAP) and durvalumab (IMFINZI; MEDI4736)|Combination Product: Naptumomab estafenatox (ABR-217620; NAP) and durvalumab (IMFINZI; MEDI4736)","Rambam Medical Center, Haifa, Israel|Rabin Medical Center, Petah Tikva, Israel|Sheba Medical Center, Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT03983954"
730,"Efficacy of Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors","Recruiting","No Results Available","MSI-H Colorectal Cancer|Melanoma|Anal Carcinoma|Mesothelioma|Triple Negative Breast Cancer|Lung Adenocarcinoma|Cholangiocarcinoma|Cervical Carcinoma|Kidney Clear Cell Carcinoma|Stomach Adenocarcinoma|Esophageal Adenocarcinoma|Uterine Endometrial Carcinoma|Head and Neck Squamous Cell Carcinoma|Sarcoma|Lung Squamous Cell Carcinoma|Bladder Carcinoma|Thyroid Carcinoma|Hepatocellular Carcinoma|Uveal Melanoma|HER2-positive Breast Cancer|Pancreatic Adenocarcinoma|Squamous Esophageal Carcinoma|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma|Small Cell Lung Cancer|Hormone Receptor Positive / HER2-negative Breast Cancer|Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation|Colorectal Adenocarcinoma|Prostate Adenocarcinoma|Carcinoma of Unknown Primary|Other Histology","Drug: Spartalizumab","Ico Badalona, Badalona, Barcelona, Spain|Hospital Universitari Sant Joan de Reus, Reus, Tarragona, Spain|IOB - H. Quironsalud Barcelona, Barcelona, Spain|Hospital Vall Hebron, Barcelona, Spain|Hospital Clinic Barcelona, Barcelona, Spain|Complejo Asistencial Universitario de León, León, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Instituto Valenciano de Oncología (IVO), Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain","https://ClinicalTrials.gov/show/NCT04802876"
731,"ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation","Recruiting","No Results Available","Bladder Carcinoma|Ureter Carcinoma|Renal Pelvis Carcinoma|Non-small Cell Lung Cancer|Invasive Breast Carcinoma|Cutaneous Melanoma|Esophageal Carcinoma|Gastroesophageal Junction Carcinoma|Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Squamous Cell Carcinoma of the Head and Neck|Epithelial Ovarian Carcinoma|Fallopian Tube Carcinoma|Endometrial Carcinoma|Renal Cell Carcinoma","Diagnostic Test: Guardant Reveal","Redwood City, Redwood City, California, United States","https://ClinicalTrials.gov/show/NCT05059444"
732,"TAS102 in Combination With NAL-IRI in Advanced GI Cancers","Recruiting","No Results Available","Colorectal Adenocarcinoma|Gastric Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Non-Resectable Cholangiocarcinoma|Stage IV Colorectal Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer|Stage III Colorectal Cancer|Stage III Gastric Cancer|Stage III Pancreatic Cancer|Unresectable Digestive System Adenocarcinoma|Unresectable Pancreatic Carcinoma","Drug: Nanoliposomal Irinotecan|Drug: Trifluridine and Tipiracil Hydrochloride","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT03368963"
733,"A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial","Recruiting","No Results Available","Pancreatic Acinar Cell Carcinoma|Pancreatic Adenosquamous Carcinoma|Pancreatic Carcinoma|Pancreatic Squamous Cell Carcinoma|Resectable Pancreatic Acinar Cell Carcinoma|Resectable Pancreatic Adenocarcinoma|Resectable Pancreatic Adenosquamous Carcinoma|Resectable Pancreatic Carcinoma|Stage 0 Pancreatic Cancer AJCC v8|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8","Drug: Olaparib|Drug: Placebo Administration","Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Cancer Center at Saint Joseph's, Phoenix, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States|PCR Oncology, Arroyo Grande, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States|Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States|Northbay Cancer Center, Vacaville, California, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|AdventHealth Altamonte, Altamonte Springs, Florida, United States|AdventHealth Celebration, Celebration, Florida, United States|UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States|AdventHealth Kissimmee, Kissimmee, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States|AdventHealth Medical Group Urology at Orlando, Orlando, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|AdventHealth East Orlando, Orlando, Florida, United States|UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States|AdventHealth Winter Park, Winter Park, Florida, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Illinois CancerCare-Dixon, Dixon, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Elmhurst Memorial Hospital, Elmhurst, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Edward Hospital/Cancer Center, Naperville, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Illinois CancerCare - Washington, Washington, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Northwest Cancer Center - Main Campus, Crown Point, Indiana, United States|Northwest Oncology LLC, Dyer, Indiana, United States|Saint Mary Medical Center, Hobart, Indiana, United States|The Community Hospital, Munster, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Saint Anthony Regional Hospital, Carroll, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|Saint Joseph London, London, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|UofL Health Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Ascension Providence Hospitals - Novi, Novi, Michigan, United States|Ascension Providence Hospitals - Southfield, Southfield, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Parkland Health Center - Farmington, Farmington, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Truman Medical Centers, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|GenesisCare USA - Henderson, Henderson, Nevada, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pebble, Henderson, Nevada, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, United States|Desert West Surgery, Las Vegas, Nevada, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States|GenesisCare USA - Las Vegas, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|GenesisCare USA - Fort Apache, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|University Cancer Center, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Radiation Oncology Associates, Reno, Nevada, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Holy Name Hospital, Teaneck, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Main Line Health Center-Collegeville, Collegeville, Pennsylvania, United States|Main Line Health Center-Exton, Exton, Pennsylvania, United States|Riddle Memorial Hospital, Media, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Farmington Health Center, Farmington, Utah, United States|University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|MultiCare Auburn Medical Center, Auburn, Washington, United States|Overlake Medical Center, Bellevue, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|MultiCare Gig Harbor Medical Park, Gig Harbor, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|MultiCare Good Samaritan Hospital, Puyallup, Washington, United States|Valley Medical Center, Renton, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Valley, Spokane Valley, Washington, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane, Washington, United States|MultiCare Deaconess Cancer and Blood Specialty Center - North, Spokane, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States|UW Cancer Center Johnson Creek, Johnson Creek, Wisconsin, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04858334"
734,"TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors","Terminated","No Results Available","Colorectal Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Recurrent Breast Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Melanoma of the Skin|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Renal Cell Carcinoma|Solid Neoplasm|Stage IV Breast Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IV Renal Cell Cancer|Stage IV Skin Melanoma|Stage IVA Colorectal Cancer|Stage IVA Pancreatic Cancer|Stage IVB Colorectal Cancer|Stage IVB Pancreatic Cancer","Drug: Cyclophosphamide|Other: Laboratory Biomarker Analysis|Biological: Pegfilgrastim|Other: Pharmacological Study|Drug: TLR8 Agonist VTX-2337","Mayo Clinic in Arizona, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT02650635"
735,"9-ING-41 in Patients With Advanced Cancers","Recruiting","No Results Available","Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma","Drug: 9-ING-41|Drug: Gemcitabine - 21 day cycle|Drug: Doxorubicin.|Drug: Lomustine|Drug: Carboplatin.|Drug: Nab paclitaxel.|Drug: Paclitaxel.|Drug: Gemcitabine - 28 day cycle|Drug: Irinotecan","Mayo Clinic, Phoenix, Arizona, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Miami Cancer Institute, Miami, Florida, United States|Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States|Kansas University Cancer Center, Kansas City, Kansas, United States|University of Michigan, Ann Arbor, Michigan, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Sanford Research, Sioux Falls, South Dakota, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Netherlands Cancer Institute, Amsterdam, Netherlands|START Madrid-HM CIOCC Hospital Universitario, Madrid, Spain|INCLIVA University of Valencia, Valencia, Spain","https://ClinicalTrials.gov/show/NCT03678883"
736,"A Patient-Centric Platform Trial for Precision Oncology","Recruiting","No Results Available","Oncology",,"Cancer Commons, Los Altos, California, United States","https://ClinicalTrials.gov/show/NCT03793088"
737,"A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies","Active, not recruiting","No Results Available","Melanoma|Non-small Cell Lung Cancer|Breast Cancer|Gastric Cancer|Renal Cell Carcinoma|Ovarian Cancer|Cholangiocarcinoma|Bladder Urothelial Carcinoma|Pancreatic Adenocarcinoma|Colorectal Cancer|Esophageal Cancer|Hepatic Cancer|Head and Neck Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer|Other Solid Tumors|Diffuse Large B-cell Lymphoma (DLBCL)|Mantle Cell Lymphoma|Indolent B-cell Lymphomas|Non-Hodgkin Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Waldenstrom's Disease|Marginal Zone Lymphoma|Mucosa Associated Lymphoid Tissue|Small Lymphocytic Leukemia","Drug: CDX-1140|Drug: CDX-301|Drug: Pembrolizumab|Drug: Chemotherapy","HonorHealth Research Insititute, Scottsdale, Arizona, United States|Northside Hospital, Inc., Atlanta, Georgia, United States|Georgia Cancer Center at Augusta University, Augusta, Georgia, United States|Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha, Nebraska, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Gabrail Cancer Center Research LLC, Canton, Ohio, United States|Providence Portland Medical Center, Portland, Oregon, United States|Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Rhode Island Hospital (RIH) The Miriam Hospital (TMH), Providence, Rhode Island, United States|Houston Methodist, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03329950"
738,"Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors","Recruiting","No Results Available","Bladder Cancer|Head and Neck Squamous Cell Carcinoma|Cancer of the Salivary Gland|Lung Cancer|Breast Cancer|Gastric Cancer|Esophageal Cancer|Colorectal Cancer|Pancreatic Adenocarcinoma|Solid Tumor","Biological: CAdVEC","Baylor St. Luke's Medical Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03740256"
739,"Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients""","Recruiting","No Results Available","Malignant Head and Neck Neoplasm|Malignant Neoplasm|Metastatic Malignant Neoplasm in the Neck|Metastatic Malignant Neoplasm in the Uterine Cervix|Pancreatic Adenocarcinoma|Pancreatic Neuroendocrine Carcinoma|Recurrent Colorectal Carcinoma|Stage I Colorectal Cancer AJCC v6 and v7|Stage I Hypopharyngeal Carcinoma AJCC v7|Stage I Major Salivary Gland Cancer AJCC v7|Stage I Nasopharyngeal Carcinoma AJCC v7|Stage I Oral Cavity Cancer AJCC v6 and v7|Stage I Oropharyngeal Carcinoma AJCC v6 and v7|Stage II Colorectal Cancer AJCC v7|Stage II Hypopharyngeal Carcinoma AJCC v6 and v7|Stage II Major Salivary Gland Cancer AJCC v7|Stage II Nasopharyngeal Carcinoma AJCC v7|Stage II Oral Cavity Cancer AJCC v6 and v7|Stage II Oropharyngeal Carcinoma AJCC v6 and v7|Stage IIA Colorectal Cancer AJCC v7|Stage IIB Colorectal Cancer AJCC v7|Stage IIC Colorectal Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Hypopharyngeal Carcinoma AJCC v7|Stage III Laryngeal Cancer AJCC v6 and v7|Stage III Major Salivary Gland Cancer AJCC v7|Stage III Nasopharyngeal Carcinoma AJCC v7|Stage III Oral Cavity Cancer AJCC v6 and v7|Stage III Oropharyngeal Carcinoma AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVA Hypopharyngeal Carcinoma AJCC v7|Stage IVA Laryngeal Cancer AJCC v7|Stage IVA Major Salivary Gland Cancer AJCC v7|Stage IVA Nasopharyngeal Carcinoma AJCC v7|Stage IVA Oral Cavity Cancer AJCC v6 and v7|Stage IVA Oropharyngeal Carcinoma AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Stage IVB Hypopharyngeal Carcinoma AJCC v7|Stage IVB Laryngeal Cancer AJCC v7|Stage IVB Major Salivary Gland Cancer AJCC v7|Stage IVB Nasopharyngeal Carcinoma AJCC v7|Stage IVB Oral Cavity Cancer AJCC v6 and v7|Stage IVB Oropharyngeal Carcinoma AJCC v7|Metastatic or Locally Unresectable Solid Tumor","Behavioral: Exercise Intervention|Other: Health Telemonitoring|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01365169"
740,"A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours","Completed","No Results Available","Lung Cancer|Melanoma|Head and Neck Carcinoma|Gastroesophageal Cancer|Breast Cancer|Pancreatic Adenocarcinoma|Colorectal Cancer|Biliary Tract Cancer","Drug: Selumetinib|Drug: MEDI4736|Drug: Tremelimumab","Research Site, Chicago, Illinois, United States|Research Site, Boston, Massachusetts, United States|Research Site, Las Vegas, Nevada, United States|Research Site, New Brunswick, New Jersey, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02586987"
741,"Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors","Recruiting","No Results Available","Advanced Solid Tumors|Glioblastoma|Soft Tissue Sarcoma (Excluding GIST)|Endometrial Carcinoma|Epithelial Ovarian Carcinoma|Mesothelioma|Gastroenteropancreatic Neuroendocrine Tumor|SCLC|Gastric Carcinoma|Pancreatic Adenocarcinoma|Colorectal Carcinoma|Neuroendocrine Tumors","Drug: Lurbinectedin|Drug: Irinotecan","Massachusetts General Hospital -, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Virgen Del Rocio, Sevilla, Spain","https://ClinicalTrials.gov/show/NCT02611024"
742,"Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies","Completed","No Results Available","Acinar Cell Adenocarcinoma of the Pancreas|Adenocarcinoma of the Gallbladder|Adenocarcinoma of Unknown Primary|Adult Primary Cholangiocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Diffuse Adenocarcinoma of the Stomach|Duct Cell Adenocarcinoma of the Pancreas|Intestinal Adenocarcinoma of the Stomach|Localized Unresectable Adult Primary Liver Cancer|Metastatic Carcinoma of Unknown Primary|Metastatic Extrahepatic Bile Duct Cancer|Mixed Adenocarcinoma of the Stomach|Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Newly Diagnosed Carcinoma of Unknown Primary|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage III Pancreatic Cancer|Stage IIIA Colon Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Gastric Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Gastric Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Gastric Cancer|Stage IIIC Rectal Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer|Stage IVA Colon Cancer|Stage IVA Gallbladder Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Gallbladder Cancer|Stage IVB Rectal Cancer|Unresectable Extrahepatic Bile Duct Cancer","Drug: oxaliplatin|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: fluorouracil|Other: laboratory biomarker analysis","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Evanston CCOP-NorthShore University HealthSystem, Evanston, Illinois, United States","https://ClinicalTrials.gov/show/NCT01643499"
743,"Safety Study of SEA-CD40 in Cancer Patients","Active, not recruiting","No Results Available","Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous Cell|Hodgkin Disease|Lymphoma|Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse|Melanoma|Neoplasm Metastasis|Neoplasms, Head and Neck|Neoplasms, Squamous Cell|Non-Small Cell Lung Cancer|Non-Small Cell Lung Cancer Metastatic|Non-small Cell Carcinoma|Squamous Cell Cancer|Squamous Cell Carcinoma|Squamous Cell Carcinoma of the Head and Neck|Squamous Cell Neoplasm|Lymphoma, Non-Hodgkin|Pancreatic Adenocarcinoma","Drug: Intravenous (IV) SEA-CD40|Drug: Pembrolizumab|Drug: Subcutaneous (SC) SEA-CD40|Drug: Gemcitabine|Drug: Nab-paclitaxel","University of Alabama at Birmingham, Birmingham, Alabama, United States|HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona, United States|Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States|Angeles Clinic and Research Institute, The, Santa Monica, California, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Karmanos Cancer Institute / Wayne State University, Detroit, Michigan, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Montefiore Medical Center, Bronx, New York, United States|UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill, North Carolina, United States|Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Providence Portland Medical Center, Portland, Oregon, United States|MD Anderson Cancer Center / University of Texas, Houston, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|Seattle Cancer Care Alliance / University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02376699"
744,"A Study of SGN-STNV in Advanced Solid Tumors","Recruiting","No Results Available","Carcinoma, Non-Small Cell Lung|HER2 Negative Breast Neoplasms|Ovarian Neoplasms|Uterine Cervical Neoplasms|Endometrial Neoplasms|Esophageal Neoplasms|Gastroesophageal Junction Carcinoma|Stomach Neoplasms|Colorectal Neoplasms|Exocrine Pancreatic Adenocarcinoma|Appendiceal Adenocarcinoma|Pseudomyxoma Peritonei","Drug: SGN-STNV","Angeles Clinic and Research Institute, The, Los Angeles, California, United States|University of California at San Francisco, San Francisco, California, United States|Shands Cancer Center / University of Florida, Gainesville, Florida, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|South Texas Accelerated Research Therapeutics Midwest, Grand Rapids, Michigan, United States|Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States|University of Ottawa / Ottawa General Hospital, Ottawa, Ontario, Canada|University Health Network, Princess Margaret Hospital, Toronto, Other, Canada|Institut Gustave Roussy, Villejuif Cedex, Other, France|Istituto Europeo di Oncologia, Milan, Other, Italy|Hospital Universitario Vall d'Hebron, Barcelona, Other, Spain|The Royal Marsden Hospital (Surrey), Sutton, Other, United Kingdom","https://ClinicalTrials.gov/show/NCT04665921"
745,"A Study of SGN-B6A in Advanced Solid Tumors","Recruiting","No Results Available","Carcinoma, Non-small Cell Lung|Squamous Cell Carcinoma of Head and Neck|HER2 Negative Breast Neoplasms|Esophageal Squamous Cell Carcinoma|Ovarian Neoplasms|Cutaneous Squamous Cell Cancer|Exocrine Pancreatic Adenocarcinoma|Urinary Bladder Neoplasms|Uterine Cervical Neoplasms|Stomach Neoplasms","Drug: SGN-B6A","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Providence Portland Medical Center, Portland, Oregon, United States|MD Anderson Cancer Center / University of Texas, Houston, Texas, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States|Institut Gustave Roussy, Villejuif-Cedex-France, Other, France|Hospital Universitario Vall d'Hebron, Barcelona, Other, Spain|Hospital Universitario HM Sanchinarro, Madrid, Other, Spain|University Hospital Lausanne CHUV, Lausanne, Other, Switzerland|The Royal Marsden Hospital (Surrey), Sutton, Other, United Kingdom","https://ClinicalTrials.gov/show/NCT04389632"
746,"CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors","Terminated","No Results Available","Colorectal Adenocarcinoma|Metastatic Cholangiocarcinoma|Metastatic Colorectal Carcinoma|Metastatic Digestive System Carcinoma|Metastatic Esophageal Carcinoma|Metastatic Gastric Carcinoma|Metastatic Pancreatic Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Esophageal Cancer AJCC v7|Stage IV Gastric Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7","Biological: Adoptive Immunotherapy|Biological: Aldesleukin|Drug: Cyclophosphamide|Other: Laboratory Biomarker Analysis|Biological: Pembrolizumab","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02757391"
747,"Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction","Withdrawn","No Results Available","Estrogen Receptor Negative|Head and Neck Squamous Cell Carcinoma|HER2/Neu Negative|Hormone-Resistant Prostate Cancer|Metastatic Pancreatic Adenocarcinoma|Progesterone Receptor Negative|Solid Neoplasm|Stage III Mesothelioma|Stage IIIA Gastric Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Small Cell Lung Carcinoma|Stage IIIB Gastric Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Small Cell Lung Carcinoma|Stage IIIC Gastric Cancer|Stage IIIC Ovarian Cancer|Stage IV Mesothelioma|Stage IV Non-Small Cell Lung Cancer|Stage IV Ovarian Cancer|Stage IV Small Cell Lung Carcinoma|Triple-Negative Breast Carcinoma","Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Talazoparib",,"https://ClinicalTrials.gov/show/NCT02567396"
748,"Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients","Completed","Has Results","Adenocarcinoma of the Pancreas|Pancreatic Cancer|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer","Drug: eribulin mesylate","University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00383760"
749,"Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma (PDAC)|Cancer of Pancreas|Pancreatic Cancer, Adult|Pancreas Adenocarcinoma|Pancreatic Neoplasms|Pancreatic Cancer Non-resectable|Pancreatic Cancer Resectable","Drug: Oxaliplatin|Drug: Leucovorin|Drug: Irinotecan Hydrochloride|Drug: 5-FU","University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03977233"
750,"Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: liposomal cisplatin",,"https://ClinicalTrials.gov/show/NCT00416507"
751,"Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: motexafin gadolinium|Radiation: radiation therapy","Johns Hopkins Oncology Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00003798"
752,"Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma","Dietary Supplement: Verum, broccoli sprout grain|Dietary Supplement: placebo","Dept. of General and Transplant Surgery, University Hospital of Heidelberg, Germany, Heidelberg, Germany","https://ClinicalTrials.gov/show/NCT01879878"
753,"Role of Perfusion CT in Pancreatic Cancer","Active, not recruiting","No Results Available","Adenocarcinoma, Pancreas|Neuroendocrine Carcinoma of Pancreas","Drug: iopromide|Procedure: CT","Seoul National University Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT01703650"
754,"Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy","Completed","Has Results","Pancreas Cancer|Pancreas Disease|Pancreas Adenocarcinoma|Pancreas; Fistula|Surgery|Surgery--Complications|Surgery Site Fistula","Device: Hemopatch","Hamilton Health Sciences, Hamilton, Ontario, Canada|Kingston General Hospital, Kingston, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT03410914"
755,"Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Biological: ganitumab|Drug: capecitabine|Drug: gemcitabine hydrochloride|Radiation: 3-dimensional conformal radiation therapy","St. Joseph Hospital Regional Cancer Center - Orange, Orange, California, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States|McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Rhode Island Hospital Comprehensive Cancer Center, Providence, Rhode Island, United States|Northmain Radiation Oncology, Providence, Rhode Island, United States|M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01298401"
756,"Reinforced Staple Line on Leak Rate in Distal Pancreatectomy","Terminated","Has Results","Pancreatic Neoplasms","Device: Mesh reinforced staple line (SEAMGUARD)|Device: Stapled without mesh reinforcement (PER-STRIPS DRY)","Washington University School of Medicine, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01359410"
757,"Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: gemcitabine hydrochloride|Procedure: quality-of-life assessment|Radiation: 3-dimensional conformal radiation therapy","Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom|Addenbrooke's Hospital, Cambridge, England, United Kingdom|Queen Alexandra Hospital, Cosham, England, United Kingdom|Castle Hill Hospital, Cottingham, England, United Kingdom|Diana Princess of Wales Hospital, Grimsby, England, United Kingdom|St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford, England, United Kingdom|Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom|Leicester Royal Infirmary, Leicester, England, United Kingdom|Helen Rollason Cancer Care Centre at North Middlesex Hospital, London, England, United Kingdom|Royal Free Hospital, London, England, United Kingdom|Hammersmith Hospital, London, England, United Kingdom|Northampton General Hospital, Northampton, England, United Kingdom|Scarborough General Hospital, Scarborough, England, United Kingdom|Cancer Research Centre at Weston Park Hospital, Sheffield, England, United Kingdom|Southampton General Hospital, Southampton, England, United Kingdom|Musgrove Park Hospital, Taunton, England, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom|Raigmore Hospital, Inverness, Scotland, United Kingdom|Perth Royal Infirmary, Perth, Scotland, United Kingdom|Ysbyty Gwynedd, Bangor, Wales, United Kingdom|Velindre Cancer Center at Velindre Hospital, Cardiff, Wales, United Kingdom|Glan Clwyd Hospital, Rhyl, Denbighshire, Wales, United Kingdom|Wrexham Maelor Hospital, Wrexham, Wales, United Kingdom|Edith Cavell Hospital, Peterborough, United Kingdom","https://ClinicalTrials.gov/show/NCT01032057"
758,"Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: lapatinib ditosylate","Cork University Hospital, Cork, Ireland|Mercy University Hospital, Cork, Ireland|Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland|St. Vincent's University Hospital, Dublin, Ireland|Mater Misericordiae University Hospital, Dublin, Ireland|Mater Private Hospital, Dublin, Ireland|St. James's Hospital, Dublin, Ireland|Beaumont Hospital, Dublin, Ireland|University College Hospital, Galway, Ireland","https://ClinicalTrials.gov/show/NCT00962312"
759,"Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Biological: RAV12 plus gemcitabine","MacroGenics, Incorporated, South San Francisco, California, United States|Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00625586"
760,"Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery","Completed","Has Results","Pancreatic Cancer","Biological: panitumumab|Drug: capecitabine|Drug: fluorouracil|Drug: gemcitabine hydrochloride|Radiation: radiation therapy","Aurora Presbyterian Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States|St. Anthony Central Hospital, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|CCOP - Colorado Cancer Research Program, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States|North Suburban Medical Center, Thornton, Colorado, United States|Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States|Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Illinois CancerCare - Bloomington, Bloomington%, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Illinois CancerCare - Canton, Canton, Illinois, United States|Illinois CancerCare - Carthage, Carthage, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Illinois CancerCare - Eureka, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Illinois CancerCare - Galesburg, Galesburg, Illinois, United States|InterCommunity Cancer Center of Western Illinois, Galesburg, Illinois, United States|Illinois CancerCare - Havana, Havana, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Illinois CancerCare - Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare - Macomb, Macomb, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Trinity Cancer Center at Trinity Medical Center - 7th Street Campus, Moline, Illinois, United States|Moline, Illinois, United States|Illinois CancerCare - Monmouth, Monmouth, Illinois, United States|OSF Holy Family Medical Center, Monmouth, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Illinois CancerCare - Pekin, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare - Peru, Peru, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Illinois CancerCare - Princeton, Princeton, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Illinois CancerCare - Spring Valley, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, United States|Elkhart Clinic, LLC, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Howard Community Hospital, Kokomo, Indiana, United States|Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States|Reid Hospital & Health Care Services, Richmond, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology-Oncology, PC - South Bend, South Bend, Indiana, United States|Saint Joseph Regional Medical Center, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|McFarland Clinic, PC, Ames, Iowa, United States|Bettendorf, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, Clive, Iowa, United States|Mercy Capitol Hospital, Des Moines, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, United States|McCreery Cancer Center at Ottumwa Regional, Ottumwa, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Hospital District Sixth of Harper County, Anthony, Kansas, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Liberal, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Battle Creek Health System Cancer Care Center, Battle Creek, Michigan, United States|Mecosta County Medical Center, Big Rapids, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Butterworth Hospital at Spectrum Health, Grand Rapids, Michigan, United States|CCOP - Grand Rapids, Grand Rapids, Michigan, United States|Lacks Cancer Center at Saint Mary's Health Care, Grand Rapids, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Dickinson County Healthcare System, Iron Mountain, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, PC, Lambertville, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|Mercy General Health Partners, Muskegon, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|Lakeside Cancer Specialists, PLLC, Saint Joseph, Michigan, United States|Lakeland Regional Cancer Care Center - St. Joseph, St. Joseph, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Duluth Clinic Cancer Center - Duluth, Duluth, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Miller - Dwan Medical Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Minnesota Oncology Hematology, PA - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|St. Francis Cancer Center at St. Francis Medical Center, Shakopee, Minnesota, United States|Regions Hospital Cancer Care Center, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States|Missouri Baptist Cancer Center, Saint Louis, Missouri, United States|Arch Medical Services, Incorporated at Center for Cancer Care and Research, Saint Louis, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Big Sky Oncology, Great Falls, Montana, United States|Great Falls Clinic - Main Facility, Great Falls, Montana, United States|Sletten Cancer Institute at Benefis Healthcare, Great Falls, Montana, United States|Great Falls, Montana, United States|Northern Montana Hospital, Havre, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology at KRMC, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|Mary Rutan Hospital, Bellefontaine, Ohio, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|North Coast Cancer Care - Clyde, Clyde, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Medical Center Cancer Care, Columbus, Ohio, United States|Mount Carmel Health - West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Community Cancer Center, Elyria, Ohio, United States|Hematology Oncology Center, Elyria, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|Fisher-Titus Medical Center, Norwalk, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Mercy Medical Center, Springfield, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anne Mercy Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Mount Carmel St. Ann's Cancer Center, Westerville, Ohio, United States|Clinton Memorial Hospital, Wilmington, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|Adventist Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Cancer Institute at Geisinger Health, Danville, Pennsylvania, United States|Geisinger Hazleton Cancer Center, Hazleton, Pennsylvania, United States|Geisinger Medical Group - Scenery Park, State College, Pennsylvania, United States|Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States|AnMed Cancer Center, Anderson, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|Marshfield Clinic - Chippewa Center, Chippewa Falls, Wisconsin, United States|Center for Cancer Treatment & Prevention at Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Marshfield Clinic Cancer Care at Regional Cancer Center, Eau Claire, Wisconsin, United States|Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center - Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Holy Family Memorial Medical Center Cancer Care Center, Manitowoc, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States|Saint Joseph's Hospital, Marshfield, Wisconsin, United States|Marshfield Clinic - Lakeland Center, Minocqua, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Ministry Medical Group at Saint Mary's Hospital, Rhinelander, Wisconsin, United States|Marshfield Clinic - Indianhead Center, Rice Lake, Wisconsin, United States|Marshfield Clinic at Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Saint Michael's Hospital Cancer Center, Stevens Point, Wisconsin, United States|Door County Cancer Center at Door County Memorial Hospital, Sturgeon Bay, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Marshfield Clinic - Wausau Center, Wausau, Wisconsin, United States|Diagnostic and Treatment Center, Weston, Wisconsin, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00601627"
761,"Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","Has Results","Pancreatic Cancer","Biological: cetuximab|Drug: capecitabine|Drug: oxaliplatin|Procedure: conventional surgery|Radiation: radiation therapy|Drug: Gemcitabine","Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00408564"
762,"ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)","Completed","Has Results","Pancreatic Cancer","Drug: erlotinib hydrochloride","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00313560"
763,"Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer","Not yet recruiting","No Results Available","Stage IV Pancreatic Cancer","Drug: Nivolumab|Drug: ipilimumab|Radiation: Stereotactic body radiation therapy|Radiation: Low dose irradiation","Sheba Medical Centre, Ramat Gan, Israel","https://ClinicalTrials.gov/show/NCT05088889"
764,"Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Biological: bevacizumab|Drug: capecitabine|Drug: gemcitabine hydrochloride","Roswell Park Cancer Institute, Buffalo, New York, United States|Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00100815"
765,"Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Radiation: hypofractionated radiation therapy|Radiation: stereotactic radiosurgery","Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich, Germany","https://ClinicalTrials.gov/show/NCT00425841"
766,"Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatin|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy","UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT00089024"
767,"Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium","Centre Hospitalier d'Abbeville, Abbeville, France|Hopital Duffaut, Avignon, France|Centre Hospitalier de Blois, Blois, France|Centre Hospitalier Docteur Duchenne, Boulogne Sur Mer, France|Centre Hospitalier Universitaire Ambroise Pare - Boulogne, Boulogne, France|C.H. Bourg En Bresse, Bourg En Bresse, France|Centre Hospitalier Pierre Oudot, Bourgoin-Jallieu, France|Centre Hospitalier Universitaire d'Amiens, Caen, France|Centre Hospitalier de Chalons-en-Champagne, Chalons-en-Champagne, France|CHR Clermont Ferrand, Hotel dieu, Clermont-Ferrand, France|Hopital Beaujon, Clichy, France|Hopital Louis Pasteur, Colmar, France|Hopital Du Bocage, Dijon, France|Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France|Centre Hospitalier Draguignan, Draguignan, France|Centre Hospitalier De Dunkerque - CHD, Dunkerque, France|Centre Hospitalier Intercommunal St. Aubin les Elbeuf, Elbeuf, France|CHU de Grenoble - Hopital de la Tronche, Grenoble, France|Clinique Pasteur, Guilherand Granges, France|Hopital Robert Boulin, Libourne, France|Centre Hospital Universitaire Hop Huriez, Lille, France|Centre Hospitalier Regional et Universitaire de Lille, Lille, France|Hopital Edouard Herriot, Lyon, France|Hopital Saint Joseph, Marseille, France|CHU de la Timone, Marseille, France|CHU Nord, Marseille, France|Centre Hospitalier de Martigues, Martigues, France|Centre Hospitalier General de Mont de Marsan, Mont-de-Marsan, France|Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France|CHR Hotel Dieu, Nantes, France|CHR D'Orleans - Hopital de la Source, Orleans, France|Hopital Europeen Georges Pompidou, Paris, France|Hopital Bichat - Claude Bernard, Paris, France|Hopital Haut Leveque, Pessac, France|Clinique Ste - Marie, Pontoise, France|CHU - Robert Debre, Reims, France|Centre Eugene Marquis, Rennes, France|Hopital Charles Nicolle, Rouen, France|Clinique Armoricaine De Radiologie, Saint Brieuc, France|Centre Joliot Curie Des Docteurs Jean-Christophe Chardon Jacques Hernandez Et Laurent Gasnault, Saint Martin Boulogne, France|Centre Hospitalier de Saint-Quentin, Saint-Quentin, France|Centre Hospitalier de Semur en Auxois, Semur en Auxois, France|Centre Hospitalier de Soissons, Soissons cedex, France|Hopital Universitaire Hautepierre, Strasbourg, France|Centre Hospitalier de Tarbes, Tarbes, France|Nouvelle Clinique Generale, Valence, France","https://ClinicalTrials.gov/show/NCT00303758"
768,"The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly","Not yet recruiting","No Results Available","Diabetes Mellitus|Diabetes|Diabetes Mellitus, Type 2|Diabetes type2|Cancer of Pancreas|Pancreas Neoplasm|Pancreas Adenocarcinoma|Pancreatic Cancer",,,"https://ClinicalTrials.gov/show/NCT04164602"
769,"Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors","Terminated","No Results Available","Adenocarcinoma of the Pancreas|Adenocarcinoma of the Stomach|BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Ovarian Mucinous Cystadenocarcinoma|Recurrent Breast Cancer|Recurrent Colon Cancer|Recurrent Gastric Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Pancreatic Cancer|Recurrent Rectal Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Gastric Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Ovarian Germ Cell Tumor|Stage IV Pancreatic Cancer|Stage IV Rectal Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: veliparib|Drug: capecitabine|Drug: oxaliplatin|Other: pharmacological study|Other: laboratory biomarker analysis","University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01233505"
770,"UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: 7-hydroxystaurosporine|Drug: fluorouracil","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00045747"
771,"S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: cetuximab|Drug: gemcitabine hydrochloride","Mobile Infirmary Medical Center, Mobile, Alabama, United States|East Alabama Medical Center, Opelika, Alabama, United States|Alaska Regional Hospital Cancer Center, Anchorage, Alaska, United States|Cancer Center at Providence Alaska Medical Center, Anchorage, Alaska, United States|Banner Thunderbird Medical Center, Glendale, Arizona, United States|Banner Good Samaritan Medical Center, Phoenix, Arizona, United States|CCOP - Western Regional, Arizona, Phoenix, Arizona, United States|Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Ft. Smith, Arkansas, United States|Highlands Oncology Group - Springdale, Springdale, Arkansas, United States|Alta Bates Comprehensive Cancer Center, Berkeley, California, United States|Peninsula Medical Center, Burlingame, California, United States|Mount Diablo Regional Cancer Center, Concord, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|California Cancer Center - Woodward Park Office, Fresno, California, United States|Virginia K. Crosson Cancer Center at St. Jude Medical Center, Fullerton, California, United States|Marin Cancer Institute at Marin General Hospital, Greenbrae, California, United States|Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States|Saint Rose Hospital, Hayward, California, United States|Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States|Highland General Hospital at St. George's University School of Medicine, Oakland, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Summit Medical Center, Oakland, California, United States|Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States|Valley Care Medical Center, Pleasanton, California, United States|University of California Davis Cancer Center, Sacramento, California, United States|Mercy General Hospital, Sacramento, California, United States|California Pacific Medical Center - California Campus, San Francisco, California, United States|J.C. Robinson, M.D. Regional Cancer Center, San Pablo, California, United States|Sutter Solano Medical Center, Vallejo, California, United States|John Muir/Mt. Diablo Comprehensive Cancer Center, Walnut Creek, California, United States|Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital, Whittier, California, United States|University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, United States|Memorial Hospital, Colorado Springs, Colorado, United States|Veterans Affairs Medical Center - Denver, Denver, Colorado, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Montrose Memorial Hospital Cancer Center, Montrose, Colorado, United States|Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States|Praxair Cancer Center at Danbury Hospital, Danbury, Connecticut, United States|Carl and Dorothy Bennett Cancer Center at Stamford Hospital, Stamford, Connecticut, United States|Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States|Sibley Memorial Hospital, Washington, District of Columbia, United States|Lynn Regional Cancer Center at Boca Raton Community Hospital - Main Center, Boca Raton, Florida, United States|Halifax Medical Center, Daytona Beach, Florida, United States|Broward General Medical Center Cancer Center, Ft. Lauderdale, Florida, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Florida Oncology Associates, Orange Park, Florida, United States|Florida Hospital Cancer Institute at Florida Hospital Orlando, Orlando, Florida, United States|West Florida Cancer Institute at West Florida Hospital - Pensacola, Pensacola, Florida, United States|John B. Amos Community Cancer Center, Columbus, Georgia, United States|Northeast Georgia Medical Center, Gainesville, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States|Pearlman Comprehensive Cancer Center at South Georgia Medical Center, Valdosta, Georgia, United States|St. Luke's Mountain States Tumor Institute - Boise, Boise, Idaho, United States|Saint Anthony's Hospital at Saint Anthony's Health Center, Alton, Illinois, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States|Sherman Hospital, Elgin, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Galesburg Clinic, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|InterCommunity Cancer Center of Western Illinois, Galesburg, Illinois, United States|Medical and Surgical Specialists, L L C, Galesburg, Illinois, United States|Delnor Community Hospital - Geneva, Geneva, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hinsdale Hematology Oncology Associates, Hinsdale, Illinois, United States|Hopedale Medical Complex, Hopedale, Illinois, United States|Joliet Oncology Hematology Associates, Limited - West, Joliet, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|La Grange Memorial Hospital, La Grange, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Good Samaritan Regional Health Center, Mt. Vernon, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields, Olympia Fields, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|St. Margaret's Hospital, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|Regional Cancer Center at Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, United States|Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States|Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States|Reid Hospital & Health Care Services, Incorporated, Richmond, Indiana, United States|McFarland Clinic, P. C., Ames, Iowa, United States|Hematology Oncology Associates of the Quad Cities, Bettendorf, Iowa, United States|St. Luke's Hospital, Cedar Rapids, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Heartland Oncology & Hematology, Council Bluffs, Iowa, United States|Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, United States|Genesis Medical Center - West Campus, Davenport, Iowa, United States|Ottumwa Regional Health Center Cancer Center, Ottumwa, Iowa, United States|Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center, Sioux City, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Cedar Valley Medical Specialists, P.C. - West Ridgeway Avenue, Waterloo, Iowa, United States|Covenant Cancer Treatment Center, Waterloo, Iowa, United States|Cancer Center of Kansas, P.A. - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, P.A. - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, P.A. - El Dorado, El Dorado, Kansas, United States|Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, United States|Cancer Center of Kansas, P.A. - Kingman, Kingman, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas, P.A. - Newton, Newton, Kansas, United States|Cancer Center of Kansas, P.A. - Parsons, Parsons, Kansas, United States|Mount Carmel Regional Cancer Center, Pittsburg, Kansas, United States|Cancer Center of Kansas, P.A. - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, P.A. - Salina, Salina, Kansas, United States|Stormont-Vail Cancer Center, Topeka, Kansas, United States|St. Francis Comprehensive Cancer Center, Topeka, Kansas, United States|Cancer Center of Kansas, P.A. - Wellington, Wellington, Kansas, United States|Associates in Womens Health, P.A. - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, P.A. - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, P.A. - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, P.A. - Winfield, Winfield, Kansas, United States|Cancer Care at Our Lady of Bellefonte Hospital, Ashland, Kentucky, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Cancer Treatment Center at Christus Schumpert St. Mary Place, Shreveport, Louisiana, United States|Central Maine Medical Center, Lewiston, Maine, United States|Mercy Hospital, Portland, Maine, United States|Sturdy Memorial Hospital, Attleboro, Massachusetts, United States|Cancer Research Center at Boston Medical Center, Boston, Massachusetts, United States|Cancer Center of Boston - Chestnut Hill, Boston, Massachusetts, United States|Caritas St. Elizabeth's Medical Center, Boston, Massachusetts, United States|Caritas Holy Family Hospital, Methuen, Massachusetts, United States|Caritas Norwood Hospital, Norwood, Massachusetts, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Battle Creek Health System Cancer Care Center, Battle Creek, Michigan, United States|Mecosta County Medical Center, Big Rapids, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|CCOP - Grand Rapids, Grand Rapids, Michigan, United States|Lacks Cancer Center at Saint Mary's Mercy Medical Center, Grand Rapids, Michigan, United States|Spectrum Health Cancer Care - Butterworth Campus, Grand Rapids, Michigan, United States|Metropolitan Hospital, Grand Rapids, Michigan, United States|Holland Community Hospital, Holland, Michigan, United States|Borgess Medical Center, Kalamazooaa, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, P.C., Lambertville, Michigan, United States|Upper Michigan Cancer Center at Marquette General Hospital, Marquette, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital System, Monroe, Michigan, United States|Hackley Hospital, Muskegon, Michigan, United States|Northern Michigan Hospital, Petoskey, Michigan, United States|St. Joseph Mercy Hospital, Pontiac, Michigan, United States|William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Health Services, St. Louis Park, Minnesota, United States|United Hospital, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Keesler Medical Center - Keesler Air Force Base, Kessler AFB, Mississippi, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital, Gape Girardeau, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|David C. Pratt Cancer Center at St. John's Mercy, Saint Louis, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|St. Anthony's Cancer Center, St. Louis, Missouri, United States|CCOP - St. Louis-Cape Girardeau, St. Louis, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare, Billings, Montana, United States|Deaconess Billings Clinic Cancer Center, Billings, Montana, United States|Deaconess Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Internal Medicine Associates of Bozeman, Bozeman, Montana, United States|St. James Community Hospital, Butte, Montana, United States|Big Sky Oncology, Great Falls, Montana, United States|Sletten Regional Cancer Institute, Great Falls, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Eastern Montana Cancer Center, Miles City, Montana, United States|Community Medical Center, Missoula, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Good Samaritan Health Systems, Kearney, Nebraska, United States|Methodist Cancer Center at Methodist Hospital - Omaha, Omaha, Nebraska, United States|Seacoast Cancer Center at Wentworth-Douglass Hospital, Dover, New Hampshire, United States|Valley Hospital - Ridgewood, Ridgewood, New Jersey, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States|San Juan Regional Cancer Center, Farmington, New Mexico, United States|New York Oncology Hematology, PC - Albany, Albany, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Adirondack Cancer Care - Glens Falls, Glens Falls, New York, United States|New York Oncology Hematology, P.C., Latham, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States|CCOP - Hematology-Oncology Associates of Central New York, Syracuse, New York, United States|St. Joseph's Hospital Health Center - Syracuse, Syracuse, New York, United States|Faxton Regional Cancer Center, Utica, New York, United States|Randolph Hospital, Asheboro, North Carolina, United States|Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States|Presbyterian Cancer Center at Presbyterian Hospital, Charlotte, North Carolina, United States|John Smith, Jr./Dalton McMichael Cancer Center at Morehead Memorial Hospital, Eden, North Carolina, United States|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States|Wayne Radiation Oncology, Goldsboro, North Carolina, United States|Moses Cone Regional Cancer Center at Wesley Long Community Hospital, Greensboro, North Carolina, United States|Pardee Memorial Hospital, Hendersonville, North Carolina, United States|Lenoir Memorial Cancer Center, Kinston, North Carolina, United States|Annie Penn Cancer Center, Reidsville, North Carolina, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Iredell Memorial Hospital, Statesville, North Carolina, United States|Wilson Medical Center, Wilson, North Carolina, United States|Forsyth Regional Cancer Center at Forsyth Medical Center, Winston-Salem, North Carolina, United States|McDowell Cancer Center at Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|University Hospitals Ireland Cancer Center at Mercy Medical Center, Canton, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States|Huron Hospital Cancer Care Center, Cleveland, Ohio, United States|Euclid Hospital, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Riverside Cancer Services, Columbus, Ohio, United States|Mount Carmel West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Fremont Memorial Hospital, Fremont, Ohio, United States|Community Oncology Group at Cleveland Clinic Cancer Center, Independence, Ohio, United States|Kenton Oncology, Incorporated, Kenton, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|St. Rita's Medical Center, Lima, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|Hillcrest Cancer Center at Hillcrest Hospital, Mayfield Heights, Ohio, United States|Middletown Regional Hospital, Middletown, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|Firelands Regional Medical Center, Sandusky, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Mercy Medical Center, Springfield, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|Promedica Cancer Center at Flower Hospital, Sylvania, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical College of Ohio Cancer Institute, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|Toledo Surgical Specialists, Toledo, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|South Pointe Hospital Cancer Care Center, Warrensville Heights, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital, Westerville, Ohio, United States|Cleveland Clinic - Wooster, Wooster, Ohio, United States|United States Air Force Medical Center Wright-Patterson, Wright-Patterson Afb, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Tod Children's Hospital - Forum Health, Youngstown, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|St. Charles Medical Center - Bend, Bend, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center, Portland, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Institute of Oncology at Vilnius University, Portland, Oregon, United States|Salem Hospital Regional Cancer Center, Salem, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania, United States|Oncology Hematology Associates of Northern Pennsylvania, P.C. at Hahne Regional Cancer Center, Dubois, Pennsylvania, United States|Easton Regional Cancer Center at Easton Hospital, Easton, Pennsylvania, United States|St. Mary Regional Cancer Center, Langhorne, Pennsylvania, United States|Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Jennersville Regional Hospital, West Grove, Pennsylvania, United States|Rose Ramer Cancer Clinic at Anderson Area Medical Center, Anderson, South Carolina, United States|Roper St. Francis Cancer Center at Roper Hospital, Charleston, South Carolina, United States|Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States|McLeod Regional Medical Center, Florence, South Carolina, United States|Bon Secours St. Francis Health System, Greenville, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States|Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center, Kingsport, Tennessee, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Harrington Cancer Center, Amarillo, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|Presbyterian Hospital of Dallas, Dallas, Texas, United States|Center for Cancer Medicine and Blood Disorders, PA, El Paso, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States|Baylor University Medical Center - Houston, Houston, Texas, United States|Wilford Hall Medical Center, Lackland AFB, Texas, United States|UMC Southwest Cancer and Research Center, Lubbock, Texas, United States|American Fork Hospital, American Fork, Utah, United States|Logan Regional Hospital, Logan, Utah, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center - Provo, Provo, Utah, United States|Dixie Regional Medical Center - East Campus, Saint George, Utah, United States|Utah Cancer Specialists at UCS Cancer Center, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Green Mountain Oncology Group, Bennington, Vermont, United States|Southwestern Vermont Regional Cancer Center, Bennington, Vermont, United States|Martha Jefferson Hospital Cancer Care Center, Charlottesville, Virginia, United States|Danville Regional Medical Center, Danville, Virginia, United States|Southwest Virginia Regional Cancer Center, Norton, Virginia, United States|Auburn Regional Center for Cancer Care, Auburn, Washington, United States|St. Joseph Hospital Community Cancer Center, Bellingham, Washington, United States|Olympic Hematology and Oncology, Bremerton, Washington, United States|Providence Centralia Hospital Regional Cancer Center, Centralia, Washington, United States|St. Francis Hospital, Federal Way, Washington, United States|Skagit Valley Hospital Cancer Care Center, Mt. Vernon, Washington, United States|Providence St. Peter Hospital Regional Cancer Center, Olympia, Washington, United States|Capital Medical Center, Olympia, Washington, United States|Good Samaritan Cancer Center, Puyallup, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Group Health Central Hospital, Seattle, Washington, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, United States|University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States|North Puget Oncology at United General Hospital, Sedro-Wooley, Washington, United States|Cancer Care Northwest - Spokane South, Spokane, Washington, United States|Rockwood Clinic Cancer Treatment Center, Spokane, Washington, United States|Providence Cancer Center at Sacred Heart Medical Center, Spokane, Washington, United States|Providence Cancer Center at Holy Family Hospital, Spokane, Washington, United States|St. Joseph Medical Center at Franciscan Health System, Tacoma, Washington, United States|Allenmore Hospital, Tacoma, Washington, United States|CCOP - Northwest, Tacoma, Washington, United States|MultiCare Regional Cancer Center at Tacoma General Hospital, Tacoma, Washington, United States|St. Clare Hospital, Tacoma, Washington, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|Wenatchee Valley Clinic, Wenatchee, Washington, United States|United Hospital Center, Clarksburg, West Virginia, United States|Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital, Parkersburg, West Virginia, United States|Fox Valley Hematology and Oncology - East Grant Street, Appleton, Wisconsin, United States|Luther Midlelfort Hospital, Eau Claire, Wisconsin, United States|Midelfort Clinic - Luther, Eau Claire, Wisconsin, United States|Vince Lombardi Cancer Center - Elkhorn, Elkhorn, Wisconsin, United States|Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Medical Consultants, Limited, Milwaukee, Wisconsin, United States|All Saints Cancer Center at All Saints Medical Center, Racine, Wisconsin, United States|Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, United States|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Royal Victoria Hospital of Barrie, Barrie, Ontario, Canada|Trillium Health Centre - Mississauga Site, Mississauga, Ontario, Canada|St. Joseph's Health Centre - Toronto, Toronto, Ontario, Canada|Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00075686"
772,"Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine","Completed","Has Results","Pancreatic Cancer","Biological: bevacizumab|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00365144"
773,"Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Capecitabine|Drug: Docetaxel","Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center, Miami Beach, Florida, United States|University of Miami, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT00290693"
774,"Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine","Completed","No Results Available","Pancreatic Cancer","Drug: cetuximab|Drug: trastuzumab","Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France","https://ClinicalTrials.gov/show/NCT00923299"
775,"ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: ISIS 2503","University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States","https://ClinicalTrials.gov/show/NCT00005594"
776,"Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: gemcitabine hydrochloride|Radiation: radiation therapy","CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States|MBCCOP - Howard University Cancer Center, Washington, District of Columbia, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|Siouxland Hematology-Oncology, Sioux City, Iowa, United States|CCOP - Wichita, Wichita, Kansas, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|CCOP - Duluth, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Health Plaza, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Medcenter One Health System, Bismarck, North Dakota, United States|CCOP - Merit Care Hospital, Fargo, North Dakota, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00026403"
777,"Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride","Arizona Clinical Research Center, Tucson, Arizona, United States|Highlands Oncology Group, Springdale, Arkansas, United States|Alta Bates Comprehensive Cancer Center, Berkeley, California, United States|Sutter Health West Cancer Research Group, Greenbrae, California, United States|Loma Linda University Cancer Institute, Loma Linda, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|Kenmar Research Institute, Los Angeles, California, United States|Century City Hospital, Los Angeles, California, United States|David Geffen School of Medicine, Los Angeles, California, United States|Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego, San Diego, California, United States|Davis, Posteraro, & Wasser, MDs, LLP, Manchester, Connecticut, United States|New Britain General Hospital, New Britain, Connecticut, United States|Eastern Connecticut Hematology and Oncology Associates, Norwich, Connecticut, United States|Hematology Oncology, P.C., Stamford, Connecticut, United States|Florida Cancer Specialists, Fort Myers, Florida, United States|Oncology-Hematology Group of South Florida, Miami, Florida, United States|Ocala Oncology Center, Ocala, Florida, United States|Oncology & Hematology Associates of West Broward, Tamarac, Florida, United States|Moffitt Clinic at Tampa General Hospital, Tampa, Florida, United States|Central Georgia Hematology Oncology, P.C., Macon, Georgia, United States|Mountain States Tumor Institute, Boise, Idaho, United States|Northwest Medical Specialists, P.C., Arlington Heights, Illinois, United States|Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, United States|Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States|Midwest Cancer Research Group, Inc., Skokie, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Medical Consultants, Muncie, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States|Norton Healthcare Pavilion, Louisville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Metairie, Louisiana, United States|Tulane Cancer Center, New Orleans, Louisiana, United States|Annapolis Medical Specialists, Annapolis, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Tuft-New England Medical Center, Boston, Massachusetts, United States|St. Elizabeth's Medical Center, Boston, Massachusetts, United States|Berkshire Physicians and Surgeons, P.C., Pittsfield, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Minnesota Cancer Center, Minneapolis, Minnesota, United States|Midwest Oncology Consortium, Kansas City, Missouri, United States|New Hampshire Oncology-Hematology PA, Hooksett, New Hampshire, United States|St. Barnabas Medical Center, Livingston, New Jersey, United States|Hematology-Oncology Associates, Mount Holly, New Jersey, United States|Cooper Cancer Institute, Voorhees, New Jersey, United States|Cancer Center at Glens Falls Hospital, Glens Falls, New York, United States|Arena Oncology Associates, Great Neck, New York, United States|NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States|Beth Israel Medical Center, New York, New York, United States|Interlakes Oncology/Hematology PC, Rochester, New York, United States|Staten Island University Hospital, Staten Island, New York, United States|University Hospital - Stony Brook, Stony Brook, New York, United States|Presbyterian Hospital, Charlotte, North Carolina, United States|Mid Dakota Clinic, P.C., Bismarck, North Dakota, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Earle A. Chiles Research Institute at Providence Portland Medical Center, Portland, Oregon, United States|Hematology-Oncology Association of NE Pennsylvania, Dunmore, Pennsylvania, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|Pennsylvania Oncology Hematology Associates, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Charleston Hematology-Oncology, P.A., Charleston, South Carolina, United States|Sarah Cannon-Minnie Pearl Cancer Center, Nashville, Tennessee, United States|Arlington Cancer Center, Arlington, Texas, United States|Southwest Regional Cancer Center, Austin, Texas, United States|Texas Cancer Care, Fort Worth, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Tyler Hematology Oncology, P.A., Tyler, Texas, United States|Green Mountain Oncology Group, Bennington, Vermont, United States|Hematology & Oncology Associates of Virginia, Mechanicsville, Virginia, United States|Western Washington Oncology, Olympia, Washington, United States|Southwest Washington Medical Center, Vancouver, Washington, United States|Oncology of Wisconsin, Glendale, Wisconsin, United States|Hospital Britanico, Buenos Aires, Argentina|Instituto de Oncologia Angel H. Roffo, Buenos Aires, Argentina|Instituto Alexander Fleming, Buenos Aires, Argentina|Hospital Churruca, Buenos Aires, Argentina|Hospital Italiano, Buenos Aires, Argentina|Hospital Interzonal De Augudos Euita, Lanus, Argentina|Confidence Medical Center, San Isidro, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|Newcastle Mater Misericordiae Hospital, Newcastle, New South Wales, Australia|Institute of Oncology, Randwick, New South Wales, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Ashford Cancer Centre, Ashford, South Australia, Australia|Queen Elizabeth Hospital, Woodville, South Australia, Australia|Frankston Hospital, Frankston, Victoria, Australia|Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Peter MacCallum Cancer Institute, Melbourne, Australia|Institut Jules Bordet, Brussels, Belgium|Nucleo de Oncologia da Bahia, Bahia, Brazil|Hospital Santa Rita Irtmandade Santa Casa De Porto Alegre, Porto Alegre, Brazil|Hospital Israelita Albert Einstein, Sao Paulo, Brazil|Cross Cancer Institute, Edmonton, Alberta, Canada|British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada|Penticton Regional Hospital, Penticton, British Columbia, Canada|British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada|British Columbia Cancer Agency, Victoria, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada|Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia, Canada|Royal Victoria Hospital, Barrie, Barrie, Ontario, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Credit Valley Hospital, Mississauga, Ontario, Canada|Southlake Regional Health Centre, Newmarket, Ontario, Canada|Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada|Peterborough Oncology Clinic, Peterborough, Ontario, Canada|Algoma District Medical Group, Sault Sainte Marie, Ontario, Canada|Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines, Ontario, Canada|Toronto East General Hospital, Toronto, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Ontario Cancer Institute, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Saint Joseph's Health Centre - Toronto, Toronto, Ontario, Canada|Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada|Hopital Du Sacre-Coeur de Montreal, Montreal, Quebec, Canada|L'Hopital Laval, Ste-Foy, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Clinica Las Condes, Santiago, Chile|Pamela Youde Nethersole Eastern Hospital, Hong Kong, China|Queen Mary Hospital, Hong Kong, China|Virchow Klinikum Humboldt Universitaet Berlin, Berlin, Germany|Universitaetsklinik und Strahlenklinik - Essen, Essen, Germany|Stadtische Kliniken Frankfurt-Hochst, Frankfurt, Germany|Tumor Biology Center at the Albert - Ludwigs University, Freiburg, Germany|Martin Luther Universitaet, Halle, Germany|Medizinische Universitaetsklinik und Poliklinik, Heidelberg, Germany|Universitatsklinik, Saarland, Homburg/Saar, Germany|University Wurzburg, Wurzburg, Germany|University Hospital of Heraklion, Iraklion (Heraklion), Crete, Greece|Theagenio Medical Institute, Thessaloniki, Greece|Hippokration Hospital, Thessaloniki, Greece|Prince of Wales Hospital, Shatin, New Territories, Hong Kong|Haemek Medical Center, Afula, Israel|Rambam Medical Center, Haifa, Israel|Rabin Medical Center - Beilinson Campus, Petah-Tikva, Israel|Rabin Medical Center - Golda-Hasharon Campus, Petah-Tikva, Israel|Kaplan Hospital, Rehovot, Israel|Sheba Medical Center, Tel Hashomer, Israel|Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel|Policlinico - Cattedra di Ematologia, Palermo, Italy|Instituto Nac de Cancerologia, Tlalpan, Distrito Federal, Mexico|Centro Estatal de Cancerologia, Dviango, Mexico|Auckland Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Great Poland Cancer Center, Poznan, Poland|Dolnoslaskie Centrum Oncology, Wroclaw, Poland|Institute of Oncology - Bucarest, Bucarest, Romania|Institutul Oncologic-Universitatea de Medicina, Cluj-Napoca, Romania|St. Spiridon University Hospital, Lasi, Romania|Clinical County Hospital of Sibiu, Sibiu, Romania|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|National Cancer Centre - Singapore, Singapore, Singapore|Queen Elizabeth Hospital, Birmingham, England, United Kingdom|North Middlesex Hospital, Edmonton, London, England, United Kingdom|St. Luke's Cancer Center, Guildford, England, United Kingdom|Princess Royal Hospital, Hull, England, United Kingdom|Saint Bartholomew's Hospital, London, England, United Kingdom|Guy's and St. Thomas' Hospitals NHS Trust, London, England, United Kingdom|Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom|Northern Centre for Cancer Treatment, Newcastle upon Tyne, England, United Kingdom|Royal South Hants Hospital, Southampton, England, United Kingdom|New Cross Hospital, Wolverhampton, England, United Kingdom|Belfast City Hospital Trust, Belfast, Northern Ireland, United Kingdom|Velindre Hospital, Cardiff, Wales, United Kingdom|Churchill Hospital, Oxford, United Kingdom","https://ClinicalTrials.gov/show/NCT00026338"
778,"Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: fluorouracil","Hopital de Jolimont, Haine Saint Paul, Belgium|Les Cliniques Saint-Joseph ASBL, Liege, Belgium|Centre Hospitalier de la Cote Basque, Bayonne, France|Centre Jean Perrin, Clermont-Ferrand, France|Centre de Lutte Contre le Cancer, Georges-Francois Leclerc, Dijon, France|Hopital Perpetuel Secours, Levallois-Perret, France|Centre Hospital Regional Universitaire de Limoges, Limoges, France|Hopital Notre-Dame de Bon Secours, Metz, France|Centre Hospitalier de Montlucon, Montlucon, France|Clinique Hartmann, Neuilly sur Seine, France|Hopital Saint-Louis, Paris, France|Hopital Cochin, Paris, France|Centre Rene Huguenin, Saint Cloud, France|Hopital Bellevue, Saint Etienne, France|Clinique de l'Orangerie, Strasbourg, France|Hopital Paul Brousse, Villejuif, France|Wolfson Medical Center, Holon, Israel|Universita G.D'Annunzio Di Chieti, Chieti, Italy|Hospital Fernando Fonseca, Amadora, Portugal","https://ClinicalTrials.gov/show/NCT00003029"
779,"Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: Serine Proteinase Inhibitor WX-671","Charite University Hospital - Campus Virchow Klinikum, Berlin, Germany|Universitaetsklinikum Freiburg, Freiburg, Germany|Otto-Meyerhof-Zentrum Tagesklinik, Heidelberg, Germany|Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, Germany|Johannes Gutenberg University, Mainz, Germany|III Medizinische Klinik Mannheim, Mannheim, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, Germany|Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich, Germany|Hospital Muenchen Bogenhausen, Munich, Germany|Szent Laszlo Korhaz, Budapest, Hungary|Debreceni Egyetem Onkologiai Tanzek, Debrecen, Hungary|Petz Aladar County Hospital, Gydr, Hungary|University of Pecs Faculty of Medicine, Pecs, Hungary|Szeged University, Szeged, Hungary|Centro di Riferimento Oncologico - Aviano, Aviano, Italy|Presidio Ospedaliero di Livorno, Livorno, Italy|Azienda Ospedaliera di Rilievo Nazionale A.Cardarelli, Naples, Italy|Istituto Tumori/Fondazione Pascale, Naples, Italy|Ospedale San Filippo Neri, Rome, Italy|Altai Oncology Center, Barnaul, Russian Federation|Moscow Oncology Hospital, Moscow, Russian Federation|Russian Academy of Medical Sciences Cancer Research Center, Moscow, Russian Federation|Central Clinical Hospital of the President of the Russian Federation, Moscow, Russian Federation|Rostov Research Institute of Oncology - Omsk, Omsk, Russian Federation|Saint Petersburg State Medical University, Saint Petersburg, Russian Federation|Pavlov State Medical University, St. Petersburg, Russian Federation|Hospital de la Santa Cruz i Sant Pau, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Spain|Hospital Universitario de Elche, Elche, Spain|Hospital Virgen de las Nieves, Granada, Spain|Centro Oncologico M.D. Anderson International Espana, Madrid, Spain|Cherkassy Regional Oncology Center, Cherkassy, Ukraine|Bukovinian State Medical University, Chernivtsy, Ukraine|Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine|Donetsk Regional Antitumor Center, Donetsk, Ukraine|Ivano-Frankovsk Regional Oncology Center, Ivano-Frankovsk, Ukraine|Grigoriev Institute for Radiology Academy of Medical Science of Ukraine, Kharkiv, Ukraine|Institute of Oncology, Kiev, Ukraine|Ukrainian Medical Stomatological Academy, Poltava, Ukraine","https://ClinicalTrials.gov/show/NCT00499265"
780,"Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Tarceva","Indiana University Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT00243854"
781,"Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin","Institut Jules Bordet, Brussels, Belgium|Centre Paul Papin, Angers, France|Centre Hospitalier Victor Dupouy, Argenteuil, France|Hopital Beaujon, Clichy, France|Hopital Drevon, Dijon, France|Clinique Saint Jean, Lyon, France|American Hospital of Paris, Neuilly Sur Seine, France|Hopital Saint Antoine, Paris, France|Hopital Tenon, Paris, France|Polyclinique De Courlancy, Reims, France","https://ClinicalTrials.gov/show/NCT00006117"
782,"Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: perillyl alcohol|Procedure: surgical procedure","Indiana University Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT00003769"
783,"A Study of ASN007 in Patients With Advanced Solid Tumors","Completed","No Results Available","Cancer|Malignancy|Neoplasia|Neoplasm|Neoplasm Metastasis|Colon Cancer|Colonic Neoplasms|Colon Cancer Liver Metastasis|Metastatic Cancer|Metastatic Melanoma|Metastatic Colon Cancer|Metastatic Lung Cancer|Non Small Cell Lung Cancer Metastatic|Pancreatic Cancer|Pancreas Cancer|Pancreas Adenocarcinoma|Pancreas Neoplasm|Metastatic Nonsmall Cell Lung Cancer|Metastatic Pancreatic Cancer","Drug: ASN007: ascending doses|Drug: ASN007 RD","H. Lee Moffitt Cancer Center, Tampa, Florida, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|MD Anderson Cancer Center, Houston, Texas, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States|NEXT Oncology, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT03415126"
784,"Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer","Completed","No Results Available","Adenocarcinoma of the Colon|Adenocarcinoma of the Gallbladder|Adenocarcinoma of the Pancreas|Adenocarcinoma of the Rectum|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Gallbladder|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Male Breast Cancer|Mixed Adenocarcinoma of the Stomach|Ovarian Endometrioid Adenocarcinoma|Paget Disease of the Breast With Intraductal Carcinoma|Paget Disease of the Breast With Invasive Ductal Carcinoma|Recurrent Adult Primary Liver Cancer|Recurrent Breast Cancer|Recurrent Colon Cancer|Recurrent Gallbladder Cancer|Recurrent Gastric Cancer|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Pancreatic Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Salivary Gland Adenocarcinoma|Stage II Malignant Testicular Germ Cell Tumor|Stage II Pancreatic Cancer|Stage III Colon Cancer|Stage III Gastric Cancer|Stage III Malignant Testicular Germ Cell Tumor|Stage III Pancreatic Cancer|Stage III Rectal Cancer|Stage III Salivary Gland Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer|Stage IV Rectal Cancer|Stage IV Salivary Gland Cancer|Thyroid Gland Medullary Carcinoma|Unresectable Gallbladder Cancer","Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine|Biological: sargramostim|Biological: recombinant fowlpox GM-CSF vaccine adjuvant","Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00028496"
785,"Pancreatic Stent to Prevent Leak After Distal Pancreatectomy","Withdrawn","No Results Available","Pancreatic Surgery|Pancreatic Duct Stenting|Pancreatic Cancer|Distal Pancreatectomy|Pancreatic Diseases|Pancreatic Cyst|Pancreatic Ducts","Procedure: Pancreatic duct stenting","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00671463"
786,"Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Resectable Pancreatic Ductal Adenocarcinoma (PDAC)|Pancreatic Ductal Adenocarcinoma","Drug: Pembrolizumab|Drug: Defactinib","Samuel Oschin Cancer Center at Cedars-Sinai, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03727880"
787,"MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: Notch signaling pathway inhibitor MK0752|Drug: gemcitabine hydrochloride|Other: imaging biomarker analysis|Other: laboratory biomarker analysis|Other: pharmacological study","Addenbrooke's Hospital, Cambridge, England, United Kingdom|Leicester Royal Infirmary, Leicester, England, United Kingdom|Barts and the London School of Medicine, London, England, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom|St James' Hospital, Leeds, United Kingdom","https://ClinicalTrials.gov/show/NCT01098344"
788,"DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: exatecan mesylate","Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00003951"
789,"Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: gemcitabine hydrochloride","Royal United Hospital, Bath, England, United Kingdom|Royal Bournemouth Hospital, Bournemouth, England, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom|Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, United Kingdom|Derbyshire Royal Infirmary, Derby, England, United Kingdom|Royal Devon and Exeter Hospital, Exeter, England, United Kingdom|Ipswich Hospital NHS Trust, Ipswich, England, United Kingdom|Queen Elizabeth Hospital, King's Lynn, England, United Kingdom|Cookridge Hospital at Leeds Teaching Hospital NHS Trust, Leeds, England, United Kingdom|Leicester Royal Infirmary, Leicester, England, United Kingdom|Lincoln County Hospital, Lincoln, England, United Kingdom|Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, England, United Kingdom|Royal Liverpool University Hospital, Liverpool, England, United Kingdom|St. Thomas' Hospital, London, England, United Kingdom|Christie Hospital NHS Trust, Manchester, England, United Kingdom|Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom|James Cook University Hospital at South Tees Hospitals NHS Trust, Middlesbrough, Cleveland, England, United Kingdom|Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle-Upon-Tyne, England, United Kingdom|Norfolk and Norwich University Hospital, Norwich, England, United Kingdom|Derriford Hospital, Plymouth, England, United Kingdom|Poole Hospital NHS Trust, Poole Dorset, England, United Kingdom|Whiston Hospital, Prescot Merseyside, England, United Kingdom|Royal Preston Hospital, Preston, England, United Kingdom|Salisbury District Hospital, Salisbury, England, United Kingdom|Royal South Hants Hospital, Southampton, England, United Kingdom|University Hospital of North Staffordshire, Stoke-On-Trent, England, United Kingdom|Royal Marsden NHS Foundation Trust - Surrey, Sutton, England, United Kingdom|Warrington Hospital NHS Trust, Warrington, England, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom|Singleton Hospital of the Swansea NHS Trust, Swansea, Wales, United Kingdom","https://ClinicalTrials.gov/show/NCT00032175"
790,"Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer","Completed","No Results Available","Adenocarcinoma","Drug: Cetuximab (Erbitux®) and Gemcitabine","Interdisziplinäres Tumorzentrum (Comprehensive Cancer Center), Fulda, Germany|Nationales Centrum für Tumorerkrankungen (NCT), Universitätsklinikum Heidelberg, Heidelberg, Germany|Klinik für Innere Medizin II, Klinikum der Universität Jena, Jena, Germany|Allgemein-, Viszeral- und Thoraxchirurgie, Klinikum Kassel, Kassel, Germany|Abt. für Chirurgie, Universitätsklinikum Mannheim gGmbH, Mannheim, Germany|Klinikum Giessen und Marburg, Standort Marburg, Marburg, Germany|II Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, TU München, Munich, Germany|Klinik- und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, Regensburg, Germany","https://ClinicalTrials.gov/show/NCT00395252"
791,"Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: gemcitabine hydrochloride|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy","Innsbruck Universitaetsklinik, Innsbruck, Austria|Allgemeines Krankenhaus - Universitatskliniken, Vienna, Austria|Robert Roessle Comprehensive Cancer Center - Charite Campus Buch, Berlin, Germany|Knappschaft Krankenhaus, Bochum, Germany|DIAKO Ev. Diakonie Krankenhaus gGmbH, Bremen, Germany|Krankenhaus Dresden - Friedrichstadt, Dresden, Germany|Universitaet Erlangen, Erlangen, Germany|Arbeitsgruppe Lebermetastasen und Tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie, Frankfurt, Germany|Klinik am Eichert, Goeppingen, Germany|Chirurgische Universitaetsklinik, Heidelberg, Germany|Universitaet Leipzig, Leipzig, Germany|Staedtisches Klinikum Magdeburg, Magdeburg, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, Germany|Klinikum Nuernberg - Klinikum Nord, Nuremberg, Germany|Klinikum der Universitaet Regensburg, Regensburg, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Kantonsspital - St. Gallen, St. Gallen, Switzerland","https://ClinicalTrials.gov/show/NCT00335543"
792,"Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA","Completed","Has Results","Stage IV Pancreatic Cancer","Drug: nab-paclitaxel|Drug: Cisplatin|Drug: gemcitabine","Scottsdale Health Care, Scottsdale, Arizona, United States|Rutgers - Cancer Institute of New Jersey (CINJ), New Brunswick, New Jersey, United States|Vita Medical Associates, PC, Bethlehem, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01893801"
793,"Trial of Curcumin in Advanced Pancreatic Cancer","Completed","Has Results","Pancreatic Neoplasms|Adenocarcinoma","Drug: Curcumin","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00094445"
794,"Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery","Completed","No Results Available","Pancreatic Cancer","Genetic: protein expression analysis|Genetic: western blotting|Other: immunohistochemistry staining method|Other: immunologic technique|Other: laboratory biomarker analysis","Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00900016"
795,"Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Dietary Supplement: genistein|Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride","Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00376948"
796,"AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery","Completed","No Results Available","Pancreatic Cancer","Drug: AZD0530|Drug: gemcitabine hydrochloride","BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|Ottawa Health Research Institute - General Division, Ottawa, Ontario, Canada|Algoma District Cancer Program, Sault Ste. Marie, Ontario, Canada|Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00265876"
797,"Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery","Unknown status","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: oxaliplatin|Radiation: radiation therapy","Institut Sainte Catherine, Avignon, France|Hopital Saint Andre, Bordeaux, France|Clinique Tivoli, Bordeaux, France|Hopital Drevon, Dijon, France|CHU de Grenoble - Hopital de la Tronche, Grenoble, France|Hopital Saint - Louis, La Rochelle, France|Clinique Victor Hugo, Le Mans, France|Clinique Saint Jean, Lyon, France|Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, France|Hopital Saint Antoine, Paris, France|Hopital Tenon, Paris, France","https://ClinicalTrials.gov/show/NCT00275119"
798,"Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Procedure: adjuvant therapy|Radiation: radiation therapy","Hopital Universitaire Erasme, Brussels, Belgium|Universitair Ziekenhuis Gent, Ghent, Belgium|Hopital de Jolimont, Haine Saint Paul, Belgium|Cazk Groeninghe - Campus St-Niklaas, Kortrijk, Belgium|CHU Liege - Domaine Universitaire du Sart Tilman, Liege, Belgium|Algemeen Ziekenhuis Sint-Augustinus, Wilrijk, Belgium|Centre Hospitalier d'Abbeville, Abbeville, France|Centre Hospitalier d'Annecy, Annecy, France|Institut Sainte Catherine, Avignon, France|Hopital Duffaut, Avignon, France|C.H.G. Beauvais, Beauvais, France|Centre Hospitalier de Blois, Blois, France|Clinique Tivoli, Bordeaux, France|Polyclinique Bordeaux Nord Aquitaine, Boucher, France|Centre Hospitalier Universitaire Ambroise Pare - Boulogne, Boulogne Billancourt, France|Centre Hospitalier Docteur Duchenne, Boulogne Sur Mer, France|Centre Hospitalier Pierre Oudot, Bourgoin-Jallieu, France|CHU de Caen, Caen, France|CHR Clermont Ferrand, Hotel dieu, Clermont-Ferrand, France|Hopital Beaujon, Clichy, France|Louis Mourier Hospital, Colombes Cedex, France|Centre Hospitalier Universitaire Henri Mondor, Creteil, France|Centre Hospitalier de Dax, Dax, France|Hopital Du Bocage, Dijon, France|Centre Hospitalier Intercommunal St. Aubin les Elbeuf, Elbeuf, France|CHU de Grenoble - Hopital de la Tronche, Grenoble, France|Centre Hospitalier Departemental, La Roche Sur Yon, France|Clinique Victor Hugo, Le Mans, France|Hopital Robert Boulin, Libourne, France|Centre Hospital Regional Universitaire de Limoges, Limoges, France|Clinique Saint Jean, Lyon, France|Centre Leon Berard, Lyon, France|CHU de la Timone, Marseille, France|Centre Hospitalier General de Mont de Marsan, Mont-de-Marsan, France|Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France|Centre Hospitalier de Mulhouse, Mulhouse, France|C.H.U. de Nimes - Groupe Hospitals-Universitaire Caremeau, Nimes, France|Hopital Europeen Georges Pompidou, Paris, France|Hopital Bichat - Claude Bernard, Paris, France|Hopital Saint Antoine, Paris, France|CHU Pitie-Salpetriere, Paris, France|Hopital Cochin, Paris, France|Hopital Tenon, Paris, France|C.H.G. De Pau, Pau, France|Centre Hospitalier Lyon Sud, Pierre Benite, France|CHU Poitiers, Poitiers, France|Hopital Charles Nicolle, Rouen, France|Centre Paul Strauss, Strasbourg, France|Hopital Universitaire Hautepierre, Strasbourg, France|Centre Hospitalier Universitaire Bretonneau de Tours, Tours, France|Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France|Charite - Campus Charite Mitte, Berlin, Germany|Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin, Germany|Universitaetsklinikum Duesseldorf, Duesseldorf, Germany|Johannes Gutenberg University, Mainz, Germany|Munich Oncologic Practice at Elisenhof, Munich, Germany|Rambam Medical Center, Haifa, Israel|Academisch Medisch Centrum at University of Amsterdam, Amsterdam, Netherlands|Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland","https://ClinicalTrials.gov/show/NCT00064207"
799,"PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca","Completed","No Results Available","Pancreatic Cancer","Biological: cetuximab|Drug: gemcitabine hydrochloride|Radiation: radiation therapy","Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00467116"
800,"Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: capecitabine|Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride","Centre Antoine Lacassagne, Nice, France","https://ClinicalTrials.gov/show/NCT00885066"
801,"Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer","Recruiting","No Results Available","Pancreas Cancer","Drug: Vemurafenib|Drug: Sorafenib","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT05068752"
802,"Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Cancer","Drug: Camrelizumab|Drug: Nab paclitaxel|Drug: Gemcitabine Injection","Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04498689"
803,"Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen","Unknown status","No Results Available","Metastatic Pancreatic Cancer","Drug: Apatinib|Drug: S-1 capsule|Drug: Irinotecan","Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04101929"
804,"Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: sorafenib tosylate","Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, France","https://ClinicalTrials.gov/show/NCT00541021"
805,"Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Drug: S-1|Drug: gemcitabine hydrochloride","University of California, San Francisco, San Francisco, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00429858"
806,"Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery","Terminated","No Results Available","Pancreatic Cancer","Biological: bevacizumab|Drug: gemcitabine hydrochloride|Procedure: adjuvant therapy","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00410774"
807,"Changes in Muscle Tissue in Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Other: physiologic testing","Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00369460"
808,"Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery","Completed","Has Results","Pancreatic Cancer","Drug: Sorafenib|Drug: Erlotinb","Purchase Cancer Group - Paducah, Paducah, Kentucky, United States|Erlanger Cancer Center at Erlanger Hospital - Baroness, Chattanooga, Tennessee, United States|Baptist Regional Cancer Center at Baptist Riverside, Knoxville, Tennessee, United States|Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States|Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00837876"
809,"Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: tacedinaline","Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|Raleigh Hematology/Oncology Associates - Wake Practice, Raleigh, North Carolina, United States|Jewish Hospital of Cincinnati, Inc., Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|West Clinic, P.C., Memphis, Tennessee, United States|Sarah Cannon-Minnie Pearl Cancer Center, Nashville, Tennessee, United States|Tyler Cancer Center, Tyler, Texas, United States|Northern Virginia Oncology Group, Fairfax, Virginia, United States|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Center - General Division, Ottawa, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00004861"
810,"Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: glufosfamide","Herlev Hospital - University Hospital of Copenhagen, Herlev, Denmark|Centre Leon Berard, Lyon, France|CHU de la Timone, Marseille, France|Centre Eugene Marquis, Rennes, France|Centre Henri Becquerel, Rouen, France|Universitats-Krankenhaus Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Haemato-Onkologische Praxis und Tagesklinik, Munich, Germany|Klinikum Nurnberg, Nuremberg, Germany|University of Ioannina, Ioannina, Greece|Rambam Medical Center, Haifa, Israel|Academisch Ziekenhuis der Vrije Universiteit, Amsterdam, Netherlands|Inselspital, Bern, Bern, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Kantonsspital - Saint Gallen, Saint Gallen, Switzerland","https://ClinicalTrials.gov/show/NCT00005053"
811,"Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: docetaxel|Drug: gemcitabine hydrochloride","Institut Jules Bordet, Brussels, Belgium|Hopital Universitaire Erasme, Brussels, Belgium|U.Z. Gasthuisberg, Leuven, Belgium|National Cancer Institute of Egypt, Cairo, Egypt|CHU Ambroise Pare, Boulogne Billancourt, France|Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France|Institut Gustave Roussy, Villejuif, France|Klinikum St. Marien, Amberg, Germany|Universitaetsklinik und Strahlenklinik - Essen, Essen, Germany|Klinikum der J.W. Goethe Universitaet, Frankfurt, Germany|Marien Hospital, Hagen, Germany|Hermann-Holthusen Institute for Radiotherapy, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Praxis Innere Medizin, Neustadt, Germany|Klinikum der Universitaet Ulm, Ulm, Germany|Saint Laurentius Ziekenhuis, Roermond, Netherlands|Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland|Dokuz Eylul University School of Medicine, Izmir, Turkey|Beatson Oncology Centre, Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT00004884"
812,"Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas","Withdrawn","No Results Available","Pancreatic Cancer","Biological: cetuximab|Drug: gemcitabine hydrochloride",,"https://ClinicalTrials.gov/show/NCT00005591"
813,"Sirolimus in Treating Patients With Advanced Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: sirolimus","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00499486"
814,"Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin","Comprehensive Cancer Institute, Huntsville, Alabama, United States|CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States|Medical Center of Aurora - South Campus, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States|Rocky Mountain Cancer Centers - Denver Rose, Denver, Colorado, United States|CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States|St. Mary-Corwin Regional Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers - Thornton, Thornton, Colorado, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States|Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States|Hinsdale Hematology Oncology Associates, Hinsdale, Illinois, United States|La Grange Oncology Associates, La Grange, Illinois, United States|Swedish-American Regional Cancer Center, Rockford, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Indiana University Cancer Center, Indianapolis, Indiana, United States|Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States|CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|CCOP - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Wichita, Wichita, Kansas, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Cancer Center at Tufts - New England Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, United States|Albert Einstein Cancer Center at Albert Einstein College of Medicine, Bronx, New York, United States|NYU Cancer Institute at New York University Medical Center, New York, New York, United States|CCOP - Merit Care Hospital, Fargo, North Dakota, United States|MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|CCOP - Oklahoma, Tulsa, Oklahoma, United States|CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States|Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|CCOP - MainLine Health, Wynnewood, Pennsylvania, United States|Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania, United States|CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States|Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States|Pretoria Academic Hospital, Pretoria, South Africa","https://ClinicalTrials.gov/show/NCT00058149"
815,"Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Gemcitabine + Capecitabine|Drug: Gemcitabine alone","Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria|Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel|Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy|Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples, Italy|Kantonspital Aarau, Aarau, Switzerland|Saint Claraspital AG, Basel, Switzerland|Universitatsspital-Basel, Basel, Switzerland|Inselspital, Bern, Bern, Switzerland|Spitalzentrum Biel, Biel, Switzerland|Ratisches Kantons und Regionalspital, Chur, Switzerland|Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Institut Central des Hopitaux Valaisans, Sion, Switzerland|Kantonsspital - St. Gallen, St. Gallen, Switzerland|Regionalspital, Thun, Switzerland|City Hospital Triemli, Zurich, Switzerland|Oncology Institute of Southern Switzerland, Zurich, Switzerland|UniversitaetsSpital, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT00030732"
816,"Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection","Withdrawn","No Results Available","Pancreatic Cancer|Intraductal Papillary Mucinous Neoplasm","Drug: Secretin",,"https://ClinicalTrials.gov/show/NCT01094626"
817,"Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection","Unknown status","No Results Available","Stage ⅠA Pancreatic Cancer|Stage ⅠB Pancreatic Cancer|Stage ⅡA Pancreatic Cancer|Stage ⅡB Pancreatic Cancer","Drug: nab-paclitaxel|Drug: gemcitabine|Drug: oxaliplatin|Drug: folinic acid|Drug: fluorouracil","Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center,Sun Yat-Sen University, Guangzhou, Guangdong, China|Department of Biliary Pancreatic Surgery, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, Shanghai, China|Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China|Department of Biliary Pancreatic Surgery, Huadong Hospital, Fudan University, Shanghai, Shanghai, China|Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, Shanghai, China|Department of Pancreatic Surgery, Cancer Institute & Hospital, Tianjin Medical University, Tianjin, Tianjin, China|Department of General Surgery,Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT02506842"
818,"Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Stage IV Pancreatic Cancer","Drug: Gemcitabine|Drug: nab-paclitaxel|Drug: FOLFIRINOX|Genetic: Immunohistochemistry (IHC) Analysis|Drug: Metformin|Drug: mFOLFIRI","TGen Clinical Research Services (TCRS), Scottsdale, Arizona, United States|Disney Family Cancer Center, Burbank, California, United States|Virginia Piper Cancer Institute (VPCI), Minneapolis, Minnesota, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Evergreen Hematology and Oncology, Spokane, Washington, United States","https://ClinicalTrials.gov/show/NCT01488552"
819,"Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: dexamethasone|Drug: fluorouracil|Radiation: brachytherapy|Radiation: phosphorus P32|Radiation: radiation therapy","Northside Hospital Cancer Center, Atlanta, Georgia, United States|Center for Molecular Medicine, Garden City, New York, United States","https://ClinicalTrials.gov/show/NCT00002689"
820,"Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: cisplatin|Drug: gemcitabine hydrochloride|Procedure: surgical procedure|Radiation: radiation therapy","NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00003332"
821,"Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: leucovorin calcium|Procedure: conventional surgery|Radiation: radiation therapy","Mayo Clinic Cancer Center, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00003049"
822,"Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: SMOF Kabiven","Onkologische Schwerpunktpraxis und Tagesklinik, Bad Soden, Germany|Krankenhaus Nordwest Frankfurt, Frankfurt am Main, Germany|University Hospital of Heidelberg / National Center for Tumordiseases, Heidelberg, Germany|Asklepios Klinik Weißenfels, Weißenfels, Germany","https://ClinicalTrials.gov/show/NCT01362582"
823,"Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Veliparib|Drug: Gemcitabine|Radiation: Intensity modulated radiation therapy","Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT01908478"
824,"S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: R115777","USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States|University of California Davis Medical Center, Sacramento, California, United States|CCOP - Central Illinois, Decatur, Illinois, United States|CCOP - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Wichita, Wichita, Kansas, United States|CCOP - Kansas City, Kansas City, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|CCOP - Columbus, Columbus, Ohio, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|University of Texas Medical Branch, Galveston, Texas, United States|CCOP - Virginia Mason Research Center, Seattle, Washington, United States|CCOP - Northwest, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00005832"
825,"Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: sargramostim|Biological: telomerase peptide vaccine GV1001|Drug: capecitabine|Drug: gemcitabine hydrochloride","North Devon District Hospital, Barnstaple, England, United Kingdom|Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, England, United Kingdom|Pilgrim Hospital, Boston, England, United Kingdom|Royal Bournemouth Hospital, Bournemouth, England, United Kingdom|Sussex Cancer Centre at Royal Sussex County Hospital, Brighton, England, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom|Addenbrooke's Hospital, Cambridge, England, United Kingdom|Darent Valley Hospital, Dartford Kent, England, United Kingdom|Dorset County Hospital, Dorchester, England, United Kingdom|Royal Devon and Exeter Hospital, Exeter, England, United Kingdom|St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford, England, United Kingdom|Huddersfield Royal Infirmary, Huddersfield, West Yorks, England, United Kingdom|Ipswich Hospital, Ipswich, England, United Kingdom|Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom|Leicester Royal Infirmary, Leicester, England, United Kingdom|Royal Liverpool University Hospital, Liverpool, England, United Kingdom|Saint Bartholomew's Hospital, London, England, United Kingdom|Cancer Research UK Clinical Groups at Guy's King's & St. Thomas' Hospitals, London, England, United Kingdom|St. George's Hospital, London, England, United Kingdom|Royal Marsden - London, London, England, United Kingdom|Christie Hospital, Manchester, England, United Kingdom|Clatterbridge Centre for Oncology, Merseyside, England, United Kingdom|James Cook University Hospital, Middlesbrough, England, United Kingdom|Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle-Upon-Tyne, England, United Kingdom|James Paget Hospital, Norfolk, England, United Kingdom|Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, United Kingdom|Norfolk and Norwich University Hospital, Norwich, England, United Kingdom|Nottingham City Hospital, Nottingham, England, United Kingdom|Churchill Hospital, Oxford, England, United Kingdom|Peterborough Hospitals Trust, Peterborough, England, United Kingdom|Dorset Cancer Centre, Poole Dorset, England, United Kingdom|Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants, England, United Kingdom|Conquest Hospital, Saint Leonards-on-Sea, England, United Kingdom|Salisbury District Hospital, Salisbury, England, United Kingdom|Cancer Research Centre at Weston Park Hospital, Sheffield, England, United Kingdom|Wexham Park Hospital, Slough, Berkshire, England, United Kingdom|Royal Marsden - Surrey, Sutton, England, United Kingdom|Torbay Hospital, Torquay Devon, England, United Kingdom|Royal Cornwall Hospital, Truro, Cornwall, England, United Kingdom|Worthing Hospital, Worthing, England, United Kingdom|Yeovil District Hospital, Yeovil, England, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom|Glan Clwyd Hospital, Rhyl, Denbighshire, Wales, United Kingdom|Wrexham Maelor Hospital, Wrexham, Wales, United Kingdom","https://ClinicalTrials.gov/show/NCT00425360"
826,"Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: oxaliplatin","CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|Siouxland Hematology-Oncology, Sioux City, Iowa, United States|CCOP - Wichita, Wichita, Kansas, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|CCOP - Duluth, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic, Saint Cloud, Minnesota, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Quain & Ramstad Clinic, P.C., Bismarck, North Dakota, United States|CCOP - Merit Care Hospital, Fargo, North Dakota, United States|CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States|CCOP - Geisinger Clinical and Medical Center, Danville, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States|Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00004190"
827,"A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy","Unknown status","No Results Available","Pancreas Cancer","Drug: anakinra|Drug: Oxaliplatin|Drug: Irinotecan|Drug: fluorouracil","Baylor Sammons Cancer Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT02021422"
828,"Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures","Completed","No Results Available","Indeterminate Bile Duct Stricture","Procedure: Multiple brushings|Procedure: Multimodality tissue sampling","Indiana University Health University Hospital, Indianapolis, Indiana, United States|Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01580709"
829,"A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer","Drug: SX-682|Drug: Nivolumab Injectable Product","University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT04477343"
830,"Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Other: high performance liquid chromatography|Other: pharmacological study|Radiation: [18F]-labeled substance P antagonist receptor quantifier","Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00547612"
831,"A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma","Completed","Has Results","Pancreatic Ductal Adenocarcinoma","Drug: Abemaciclib|Drug: LY3023414|Drug: Gemcitabine|Drug: Capecitabine","Yale University School of Medicine, New Haven, Connecticut, United States|Illinois CancerCare, Peoria, Illinois, United States|Research Medical Center, Kansas City, Missouri, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, United States|Tennessee Oncology PLLC, Nashville, Tennessee, United States|Seattle Cancer Care Alliance, Olympia, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Wisconsin-Madison Hospital and Health Clinic, Madison, Wisconsin, United States|For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Blacktown, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sydney, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Brussels, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Edegem, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leuven, Belgium|For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Wilrijk, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lyon, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Paris, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Pessac, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Haifa, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ramat Gan, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tel Aviv, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hospitalet de Llobregat, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Malaga, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tainan, Taiwan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei city, Taiwan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei, Taiwan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei, Taiwan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, United Kingdom","https://ClinicalTrials.gov/show/NCT02981342"
832,"Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)","Terminated","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: GDC-0449","Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT01096732"
833,"The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma","Unknown status","No Results Available","Resectable Pancreatic Ductal Adenocarcinoma","Drug: Metformin Hydrochloride 500Mg Tablet","BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada","https://ClinicalTrials.gov/show/NCT02978547"
834,"Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma","Terminated","Has Results","Pancreatic Ductal Adenocarcinoma","Drug: Atezolizumab|Drug: PEGPH20","Columbia University, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03979066"
835,"A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: CAN04|Drug: FOLFIRINOX","EDOG - Institut Bergonie - PPDS, Bordeaux, France|EDOG Institut de Cancerologie de l'Ouest - PPDS, Nantes, France|EDOG - Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer - PPDS, Rennes, France|Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON, Barcelona, Spain|ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|START MADRID_Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain","https://ClinicalTrials.gov/show/NCT04990037"
836,"Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer","Completed","No Results Available","Colorectal Cancer|Pancreatic Cancer","Biological: QS21|Biological: ras peptide cancer vaccine",,"https://ClinicalTrials.gov/show/NCT00006387"
837,"Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct","Unknown status","No Results Available","Extrahepatic Bile Duct Cancer|Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Procedure: conventional surgery|Radiation: radiation therapy","Clinique De Rochebelle, Ales, France|Centre Hospitalier Victor Dupouy, Argenteuil, France|Centre D'Oncologie Du Pays-Basqu, Bayonne, France|C.H.G. Beauvais, Beauvais, France|Institut Bergonie, Bordeaux, France|CMC Bligny, Briis Sous Forges, France|Clinique Saint-Jean, Cagne-sur-Mer, France|Hopital Fontenoy, Chartres, France|Hopital Beaujon, Clichy, France|Hopital Drevon, Dijon, France|Centre D'Oncologie Dunkerquois, Dunkerque, France|Polyclinique De La Foret, Fontaineblea, France|CHR de Grenoble - La Tronche, Grenoble, France|Centre De Charlebourg, La Garenne Colombes, France|Clinique Du Cap D'OR, LA Seyne Sur Me, France|Hopital Andre Mignot, Le Chesnay, France|Hopital de la Croix Rousse, Lyon, France|Assistance Publique Hopitaux de Marseille Hopitaux Sud, Marseille, France|Hopital Notre-Dame de Bon Secours, Metz, France|Hopital Clinique Claude Bernard, Metz, France|Intercommunal Hospital, Montfermeil, France|Centre Hospitalier De Moulins Yzeure, Moulins, France|Centre Hospitalier de Mulhouse, Mulhouse, France|CHR Hotel Dieu, Nantes, France|American Hospital of Paris, Neuilly Sur Seine, France|CHR D'Orleans - Hopital de la Source, Orleans, France|Hopital Boucicaut, Paris Cedex, France|Hopital Laennec, Paris, France|Clinique Du Mont Louis, Paris, France|Hopital Rothschild, Paris, France|Hopital Saint Joseph, Paris, France|L'Institut Mutualiste Montsouris Jourdan, Paris, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|Hopital Tenon, Paris, France|Hopital De La Croix, Paris, France|Clinique Bizet, Paris, France|Hopital Haut Leveque, Pessac, France|Clinique Ste-Marie, Pontoise, France|Hopital Claude Gallien, Quincy Sous Senart, France|Polyclinique De Courlancy, Reims, France|Oncologie Medicale, Saint Jean, France|Centre du Rouget, Sarcelles, France|C.H. Senlis, Senlis, France|Centre Hospitalier Intercommunal Toulon - La Seyne/Mer, Toulon - Cedex, France|Clinique Pasteur, Toulouse, France|Polyclinique Flemming, Tours, France|Centre Saint-Yves, Vannes, France|Institut Gustave Roussy, Villejuif, France|Hopital de la Ville D'Esch-sur-Alzette, Esch-sur-Alzette, Luxembourg","https://ClinicalTrials.gov/show/NCT00010088"
838,"Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Onvansertib|Drug: Nanoliposomal irinotecan|Drug: Leucovorin|Drug: Fluorouracil","Mayo Clinic Phoenix, Phoenix, Arizona, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, United States|University of Kansas Medical Center, Westwood, Kansas, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Inova Schar Cancer Institute, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT04752696"
839,"Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.","Recruiting","No Results Available","Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)|Pancreatic Ductal Adenocarcinoma","Radiation: Stereotactic Body Radiation (SBRT)|Drug: Nivolumab|Drug: CCR2/CCR5 dual antagonist|Drug: GVAX","Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03767582"
840,"Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","Terminated","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Relacorilant, 100 mg and 25 mg|Drug: Nab paclitaxel","Site #038, Scottsdale, Arizona, United States|Site #171, Duarte, California, United States|Site #076, Los Angeles, California, United States|Site #032, Aurora, Colorado, United States|Site #009, Atlanta, Georgia, United States|Site #184, Goshen, Indiana, United States|Site #065, Baltimore, Maryland, United States|Site #058, Detroit, Michigan, United States|Site #185, Omaha, Nebraska, United States|Site #182, Buffalo, New York, United States|Site #044, New York, New York, United States|Site #222, New York, New York, United States|Site #077, Columbus, Ohio, United States|Site #186, Toledo, Ohio, United States|Site #172, Pittsburgh, Pennsylvania, United States|Site #175, Knoxville, Tennessee, United States|Site #176, Nashville, Tennessee, United States|Site #173, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04329949"
841,"Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Radiation: 68Ga-DOTA-NT-20.3","Nanjing First Hospital, Nanjing, China","https://ClinicalTrials.gov/show/NCT05048810"
842,"High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Device: Ultrasound","University Health Network, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03820661"
843,"A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma","Suspended","No Results Available","Pancreatic Ductal Adenocarcinoma","Device: EUS-RFA using Habib Tm as a probe|Procedure: EUS","Centre de recherche du Centre hospitalier de l'université de Montréal, Montréal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT03444948"
844,"A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Behavioral: The risk assessment questionnaire|Other: Blood specimens|Other: tumor tissue samples will be requested","Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor, New York, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Weill Cornell Medical College (Specimen Analysis), New York, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States|Shaare Zedek Medical Center, Jerusalem, Israel|Weizmann Institute of Science (Specimen Analysis), Reẖovot, Israel|Sheba Medical Center, Tel Hashomer, Israel","https://ClinicalTrials.gov/show/NCT01983410"
845,"Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: NIS793|Drug: Nab-paclitaxel|Drug: Gemcitabine|Drug: Placebo","Highlands Oncology Group, Fayetteville, Arkansas, United States|US Oncology Research, Dallas, Dallas, Texas, United States|Novartis Investigative Site, Perth, Western Australia, Australia|Novartis Investigative Site, Edegem, Antwerpen, Belgium|Novartis Investigative Site, Bonheiden, Belgium|Novartis Investigative Site, Leuven, Belgium|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Hamburg, Germany|Novartis Investigative Site, Jerusalem, Israel|Novartis Investigative Site, Kashiwa, Chiba, Japan|Novartis Investigative Site, Seoul, Korea, Republic of|Novartis Investigative Site, Omsk, Russian Federation|Novartis Investigative Site, Pushkin Saint Petersburg, Russian Federation|Novartis Investigative Site, Santiago de Compostela, Galicia, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain","https://ClinicalTrials.gov/show/NCT04935359"
846,"Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Biological: Autologous Mesothelin-specific TCR-T Cells|Drug: Cyclophosphamide|Drug: Fludarabine","Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04809766"
847,"Pancreatic Cancer Collaborative Registry","Completed","No Results Available","Pancreatic Cancer","Other: medical chart review|Other: questionnaire administration|Other: study of socioeconomic and demographic variables|Procedure: biopsy","UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT00661882"
848,"Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: nab-paclitaxel|Drug: gemcitabine","Samsungj Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT02426281"
849,"BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)","Active, not recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: BMS-813160|Drug: Nivolumab|Drug: Gemcitabine|Drug: Nab-paclitaxel|Procedure: Biopsy|Procedure: Peripheral blood","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT03496662"
850,"Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303","Completed","No Results Available","Pancreatic Cancer","Other: laboratory biomarker analysis",,"https://ClinicalTrials.gov/show/NCT01664169"
851,"Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Locally Advanced Pancreatic Ductal Adenocarcinoma|Metastatic Pancreatic Ductal Adenocarcinoma","Biological: Eryaspase|Drug: FOLFIRINOX","Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT04292743"
852,"KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.","Recruiting","No Results Available","Advanced Pancreatic Ductal Adenocarcinoma","Drug: KN046|Drug: placebo","Shanghai Changhai Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT05149326"
853,"3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: triapine","Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada|London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00078975"
854,"Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma","Completed","Has Results","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: MEDI4736 monotherapy|Drug: tremelimumab+MEDI4736","Research Site, Tampa, Florida, United States|Research Site, New York, New York, United States|Research Site, Vancouver, British Columbia, Canada|Research Site, Oshawa, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Friedrichshafen, Germany|Research Site, München, Germany|Research Site, Tuebingen, Germany|Research Site, Seongnam-si, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Amsterdam, Netherlands|Research Site, Groningen, Netherlands|Research Site, Nijmegen, Netherlands|Research Site, Barcelona, Spain|Research Site, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02558894"
855,"A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Ciprofloxacin","National University Hospital, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT04523987"
856,"Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma","Completed","Has Results","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: MEDI4736 in combination with nab-paclitaxel and gemcitabine|Drug: MEDI4736 in combination with AZD5069","Research Site, Rochester, New York, United States|Research Site, Cambridge, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Wirral, United Kingdom","https://ClinicalTrials.gov/show/NCT02583477"
857,"Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Biological: NIS793|Biological: Spartalizumab|Drug: gemcitabine|Drug: nab-paclitaxel","Emory University School of Medicine/Winship Cancer Institute, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Med, Baltimore, Maryland, United States|Massachusetts General Hospital Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States|University of Pittsburgh Cancer Institute HIllman Cancer Center, Pittsburgh, Pennsylvania, United States|Novartis Investigative Site, Westmead, New South Wales, Australia|Novartis Investigative Site, Melbourne, Victoria, Australia|Novartis Investigative Site, Salzburg, Austria|Novartis Investigative Site, Wien, Austria|Novartis Investigative Site, Liege, Belgium|Novartis Investigative Site, Brno, Czech Republic, Czechia|Novartis Investigative Site, HUS, Finland|Novartis Investigative Site, Paris Cedex 10, France|Novartis Investigative Site, Toulouse Cedex 4, France|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Heidelberg, Germany|Novartis Investigative Site, Ulm, Germany|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Rozzano, MI, Italy|Novartis Investigative Site, Verona, VR, Italy|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, St. Gallen, Switzerland|Novartis Investigative Site, Zurich, Switzerland|Novartis Investigative Site, Taichung, Taiwan|Novartis Investigative Site, Taipei, Taiwan|Novartis Investigative Site, Oxford, United Kingdom","https://ClinicalTrials.gov/show/NCT04390763"
858,"Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer","Unknown status","No Results Available","Pancreas Cancer|Localized Pancreas Cancer|Non-metastatic Pancreas Cancer","Drug: FOLFIRINOX Regimen","Baylor University Medical Center - Texas Oncology, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01771146"
859,"Individualized Drug Treatment for Treating Patients With Pancreatic Cancer","Terminated","Has Results","Pancreatic Cancer","Biological: cetuximab|Drug: capecitabine|Drug: docetaxel|Drug: Erlotinib|Drug: Gemcitabine|Drug: Irinotecan|Drug: mitomycin C|Drug: rapamycin|Procedure: conventional surgery","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00276744"
860,"(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer","Drug: BTH1704|Drug: IMPRIME PGG|Drug: Gemcitabine","UI Cancer Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT02132403"
861,"Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer","Terminated","No Results Available","Chemotherapeutic Agent Toxicity|Pancreatic Cancer|Thromboembolism","Drug: daltéparine|Drug: Chemotherapy at the investigator's discretion","Centre Hospitalier de Meaux, Meaux, France|Centre Hospitalier Intercommunal Le Raincy - Montfermeil, Montfermeil, France|Hopital Bichat - Claude Bernard, Paris, France|Hopital Saint Antoine, Paris, France|CHU Pitie-Salpetriere, Paris, France|Hopital Foch, Suresnes, France","https://ClinicalTrials.gov/show/NCT00662688"
862,"Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma","Terminated","Has Results","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Momelotinib|Drug: Placebo to match momelotinib|Drug: Nab-paclitaxel|Drug: Gemcitabine","Cedars-Sinai Medical Center, Los Angeles, California, United States|Indiana University Health Goshen Center for Cancer Care, Goshen, Indiana, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Northwest Medical Specialties, PLLC, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT02101021"
863,"Perifosine in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: perifosine","Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00053924"
864,"A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma","Terminated","No Results Available","Gastric Cancer|Pancreatic Ductal Adenocarcinoma","Biological: LCAR-C182A cells","The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shanxi, China","https://ClinicalTrials.gov/show/NCT03890198"
865,"The ASCEND Study: Gemcitabine and Nab-Paclitaxel With CEND-1 or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Metastatic Pancreatic Cancer","Drug: CEND-1|Drug: Gemcitabine Injection|Drug: Nab paclitaxel","Border Medical Oncology, Albury, New South Wales, Australia|Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia|Monash Medical Centre, Clayton, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Calvary Mater Newcastle, Newcastle, New South Wales, Australia|Newcastle Private Hospital, Newcastle, New South Wales, Australia|Prince of Wales Hospital, Sydney, New South Wales, Australia|Royal Brisbane and Womens Hospital, Herston, Queensland, Australia|ICON Cancer Centre, Gold Coast University Hospital, Southport, Queensland, Australia|Flinders Medical Centre, Adelaide, South Australia, Australia|Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Launceston General Hospital, Launceston, Tasmania, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Frankston Hospital, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|St John of God, Subiaco, Western Australia, Australia|Dunedin Hospital, Dunedin, New Zealand|Waikato Hospital, Hamilton, New Zealand","https://ClinicalTrials.gov/show/NCT05042128"
866,"Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma","Terminated","Has Results","Previously Untreated Pancreatic Ductal Adenocarcinoma|Relapsed/Refractory Pancreatic Ductal Adenocarcinoma","Drug: Idelalisib|Drug: Nab-paclitaxel|Drug: mFOLFOX6","Scottsdale Healthcare Clinical Research Institute, Scottsdale, Arizona, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Georgetown University, Washington, District of Columbia, United States|Indiana University Goshen Center for Cancer Care, Goshen, Indiana, United States|Dana Farber/ Harvard Cancer Institute, Boston, Massachusetts, United States|University of Rochester, Rochester, New York, United States|Greenville Hospital System, Greenville, South Carolina, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT02468557"
867,"Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma","Active, not recruiting","No Results Available","Untreated Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Nivolumab|Drug: Albumin-bound paclitaxel|Drug: Paricalcitol|Drug: Cisplatin|Drug: Gemcitabine","HonorHealth Research Institute, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT02754726"
868,"Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: imatinib mesylate","Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|CentraState Medical Center, Freehold, New Jersey, United States|Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States|Jersey Shore Cancer Center at Jersey Shore University Medical Center, Neptune, New Jersey, United States|Central Jersey Oncology Group, New Brunswick, New Jersey, United States|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|New Jersey Medical School, Newark, New Jersey, United States","https://ClinicalTrials.gov/show/NCT00161213"
869,"Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Neoplasms","Drug: Gemcitabine with R115777|Drug: Gemcitabine with Placebo",,"https://ClinicalTrials.gov/show/NCT00005648"
870,"Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: gemcitabine hydrochloride|Drug: rubitecan","SuperGen, Incorporated, Dublin, California, United States","https://ClinicalTrials.gov/show/NCT00005869"
871,"Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Biological: allogeneic tumor cell vaccine|Biological: recombinant interferon alfa|Biological: sargramostim|Drug: cyclophosphamide","St. Vincent Medical Center - Los Angeles, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00002773"
872,"Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Radiation: radiation therapy","Clinique De Savoie, Annemasse, France|Clinique Floreal, Bagnolet, France|Clinique Tivoli, Bordeaux, France|Centre Regional Francois Baclesse, Caen, France|Clinique Saint - Jean, Cagne-sur-Mer, France|Polyclinique Saint Jean, Cagnes Sur Mer, France|Hopital Fontenoy, Chartres, France|Hopital Beaujon, Clichy, France|Hopital Louis Mourier, Colombes, France|Hopital Drevon, Dijon, France|Clinique Claude Bernard, Ermont, France|Clinique Pasteur, Evreux, France|Polyclinique Jeanne d'Arc - service de Radiotherapie Oncologie, Gien, France|CHR de Grenoble - La Tronche, Grenoble, France|Hopital Saint - Louis, La Rochelle, France|Centre Jean Bernard, Le Mans, France|Centre Hospital Regional Universitaire de Limoges, Limoges, France|Hopital Laennec, Paris, France|Hopital Saint Antoine, Paris, France|CHU Pitie-Salpetriere, Paris, France|Hopital Tenon, Paris, France|Clinique Ste - Marie, Pontoise, France|Hopital Claude Gallien, Quincy Sous Senart, France|Polyclinique De Courlancy, Reims, France|Clinique Saint Vincent, Saint Gregoire, France|Centre du Rouget, Sarcelles, France|C.H. Senlis, Senlis, France|Centre Medico-Chirurgical Foch, Suresnes, France|Clinique Pasteur, Toulouse, France|Hopital de la Ville D'Esch-sur-Alzette, Esch-sur-Alzette, Luxembourg","https://ClinicalTrials.gov/show/NCT00010062"
873,"BMS-247550 in Treating Patients With Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: ixabepilone","MBCCOP - Gulf Coast, Mobile, Alabama, United States|CCOP - Greater Phoenix, Phoenix, Arizona, United States|Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, United States|Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States|Arizona Cancer Center, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California Davis Cancer Center, Sacramento, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Veterans Affairs Medical Center - Denver, Denver, Colorado, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States|Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Genesis Medical Center, Davenport, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Wichita, Wichita, Kansas, United States|Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, United States|Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States|Boston Medical Center, Boston, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Veterans Affairs Medical Center - Detroit, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|CCOP - Grand Rapids, Grand Rapids, Michigan, United States|CCOP - Beaumont, Royal Oak, Michigan, United States|Providence Hospital - Southfield, Southfield, Michigan, United States|Veterans Affairs Medical Center - Biloxi, Biloxi, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, United States|Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi, United States|Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, United States|MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, United States|Veterans Affairs Medical Center - Albany, Albany, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, United States|Barrett Cancer Center, Cincinnati, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Veterans Affairs Medical Center - Oklahoma City, Oklahoma City, Oklahoma, United States|Veterans Affairs Medical Center - Portland, Portland, Oregon, United States|CCOP - Columbia River Program, Portland, Oregon, United States|Oregon Cancer Institute, Portland, Oregon, United States|Veterans Affairs Medical Center - Charleston, Charleston, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Veterans Affairs Medical Center - Houston, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, United States|Veterans Affairs Medical Center - Temple, Temple, Texas, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, United States|CCOP - Virginia Mason Research Center, Seattle, Washington, United States|Veterans Affairs Medical Center - Seattle, Seattle, Washington, United States|CCOP - Northwest, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00016965"
874,"Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma","Terminated","Has Results","Adenocarcinoma of Head of Pancreas","Drug: Neo-adjuvant Chemotherapy|Radiation: Chemoradiation|Procedure: Surgical Resection","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01677988"
875,"Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: paclitaxel|Radiation: radiation therapy","Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, United States|University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|Huntsville Hospital System, Huntsville, Alabama, United States|Urology Associates - Mobile AL, Mobile, Alabama, United States|MBCCOP - University of South Alabama, Mobile, Alabama, United States|Alabama Oncology, LLC, Montgomery, Alabama, United States|Radiation Oncology Associates of West Alabama, Tuscallosa, Alabama, United States|Providence Cancer Therapy Center, Anchorage, Alaska, United States|Arizona Cancer Center, Tucson, Arizona, United States|Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States|Mount Diablo Medical Center, Concord, California, United States|Beckman Research Institute, City of Hope, Duarte, California, United States|California Cancer Center, Fresno, California, United States|Saint Agnes Cancer Center, Fresno, California, United States|Glendale Memorial Hospital and Health Center, Glendale, California, United States|Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|Kaiser Permanente Medical Center - Los Angeles, Los Angeles, California, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Cancer Care Center, Pomona, California, United States|Mercy Medical Center - Redding, Redding, California, United States|Radiation Oncology Center - Sacramento, Sacramento, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Santa Cruz Radiation Oncology Medical Group, Inc., Santa Cruz, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|Stanford University, Stanford, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Radiation Oncology Center - Walnut Creek, Walnut Creek, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Bridgeport Hospital, Bridgeport, Connecticut, United States|Whittingham Cancer Center, Norwalk, Connecticut, United States|CCOP - Christiana Care Health Services, Wilmington, Delaware, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|Lykes Center for Radiation Therapy, Clearwater, Florida, United States|Halifax Medical Center, Daytona Beach, Florida, United States|Radiation Therapy Associates - Fort Myers, Fort Myers, Florida, United States|University of Florida Health Science Center, Gainesville, Florida, United States|Health First Holmes Regional Medical Center, Melbourne, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Sylvester Cancer Center, University of Miami, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|Florida Radiation Oncology Group, Orange Park, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Gulf Coast Cancer Treatment Center, Panama City, Florida, United States|West Florida Cancer Institute - Pensacola, Pensacola, Florida, United States|Bayfront Medical Center, Saint Petersburg, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|InterCommunity Cancer Center at Rome, Rome, Georgia, United States|South Georgia Medical Center, Valdosta, Georgia, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|CCOP - Central Illinois, Springfield, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|St. John's Medical Center, Anderson, Indiana, United States|Clarion Health Partners Inc., Indianapolis, Indiana, United States|Community Hospitals of Indianapolis - Regional Cancer Center, Indianapolis, Indiana, United States|Ball Memorial Hospital, Muncie, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|St. Joseph's Radiation Oncology Center, South Bend, Indiana, United States|Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Medical Center at Bowling Green, Bowling Green, Kentucky, United States|Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Louisville Radiation Oncology, Louisville, Kentucky, United States|Merle M. Mahr Cancer Center, Madisonville, Kentucky, United States|Western Baptist Hospital, Paducah, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Romagosa Radiation Oncology Center, Lafayette, Louisiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Anne Arundel Oncology Center, Annapolis, Maryland, United States|Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Harbor Hospital Center, Baltimore, Maryland, United States|Radiation Oncology Affiliates of Maryland, P.A., Baltimore, Maryland, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Joint Center for Radiation Therapy, Boston, Massachusetts, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|St. Mary's Medical Center, Saginaw, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Veterans Affairs Medical Center - Saint Louis, Saint Louis, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Mallinckrodt Institute of Radiology, Saint Louis, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Ozarks Regional, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Methodist Cancer Center - Omaha, Omaha, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Elliot Regional Cancer Center, Manchester, New Hampshire, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Elizabeth General Medical Center - West, Elizabeth, New Jersey, United States|South Jersey Hospital - Millville, Millville, New Jersey, United States|Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|St. Francis Medical Center, Trenton, New Jersey, United States|Saint Joseph Medical Center, Albuquerque, New Mexico, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|Veterans Affairs Medical Center - Albany, Albany, New York, United States|Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States|State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Kaplan Cancer Center, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York, United States|Vassar Brothers Hospital, Poughkeepsie, New York, United States|Genesee Hospital - Rochester, Rochester, New York, United States|University of Rochester Cancer Center, Rochester, New York, United States|New York Medical College, Valhalla, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|East Carolina University School of Medicine, Greenville, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|Meritcare Roger Maris Cancer Center, Fargo, North Dakota, United States|UNI-MED Medical Center, Minot, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Christ Hospital, Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Kettering, Ohio, United States|CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States|St. John Medical Center, Tulsa, Oklahoma, United States|Samaritan Regional Cancer Center, Corvallis, Oregon, United States|CCOP - Columbia River Program, Portland, Oregon, United States|Penn State Geisinger Medical Center, Danville, Pennsylvania, United States|Mercy Catholic Medical Center, Mercy Fitzgerald Divison, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Penn State Geisinger Cancer Center, Hershey, Pennsylvania, United States|Allegheny University Hospitals- Hahnemann, Philadelphia, Pennsylvania, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States|Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania, United States|Grand View Hospital, Sellersville, Pennsylvania, United States|Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States|CCOP - MainLine Health, Wynnewood, Pennsylvania, United States|York Hospital, York, Pennsylvania, United States|Lifespan: The Miriam Hospital, Providence, Rhode Island, United States|Roger Williams Medical Center/Brown University, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States|CCOP - Baptist Cancer Institute, Memphis, Tennessee, United States|University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, United States|Vanderbilt Cancer Center, Nashville, Tennessee, United States|Julie and Ben Rogers Cancer Institute, Beaumont, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Wilford Hall - 59th Medical Wing, Lackland Air Force Base, Texas, United States|Bayshore Medical Center, Pasadena, Texas, United States|Dixie Regional Medical Center, Saint George, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|CCOP - Southwestern Vermont Regional Cancer Center, Bennington, Vermont, United States|Green Mountain Oncology Group, Rutland, Vermont, United States|Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont, United States|Martha Jefferson Hospital, Charlottesville, Virginia, United States|Cancer Center, University of Virginia HSC, Charlottesville, Virginia, United States|Virginia Baptist Hospital, Lynchburg, Virginia, United States|Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Swedish Hospital Tumor Institute, Seattle, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Yakima Valley Memorial Hospital, Yakima, Washington, United States|Schiffler Oncology Center, Wheeling, West Virginia, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, United States|Veterans Affairs Medical Center - Madison, Madison, Wisconsin, United States|Southern Wisconsin Radiotherapy Center, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|St. Joseph's Hospital, Milwaukee, Wisconsin, United States|Columbia Hospital, Milwaukee, Wisconsin, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States|Southeastern Wisconsin Regional Cancer Center, Racine, Wisconsin, United States|Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada|Doctor Leon Richard Oncology Centre, Moncton, New Brunswick, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre - Civic Campus, Ottawa, Ontario, Canada|Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario, Canada|Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|McGill University Department of Oncology, Montreal, Quebec, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00003591"
876,"Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer|Thromboembolism","Drug: dalteparin|Drug: gemcitabine hydrochloride|Procedure: quality-of-life assessment","MBCCOP - Gulf Coast, Mobile, Alabama, United States|CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, United States|MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|CCOP - Kansas City, Kansas City, Missouri, United States|CCOP - Hematology-Oncology Associates of Central New York, East Syracuse, New York, United States|University of Rochester Cancer Center CCOP Research Base, Rochester, New York, United States|CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, United States|CCOP - Columbus, Columbus, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Northwest, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00031837"
877,"Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Patients With Locally Advanced or Metastatic Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Hyperpolarized Carbon C 13 Pyruvate|Procedure: Magnetic Resonance Imaging (MRI)","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT04565327"
878,"Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer","Terminated","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: PTP-01","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT01962909"
879,"Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma","Terminated","No Results Available","Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Momelotinib (MMB)|Drug: Capecitabine|Drug: Oxaliplatin","Scottsdale Healthcare Research Institute, Scottsdale, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Tennessee Oncology, Nashville, Tennessee, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT02244489"
880,"Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Other: clinical observation","Institute of Oncology at Prince of Wales Hospital, Randwick, New South Wales, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Cross Cancer Institute at University of Alberta, Edmonton, Alberta, Canada|British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada|British Columbia Cancer Agency - Vancouver Island Centre, Victoria, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Research Institute at Queen's University, Kingston, Ontario, Canada|Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada|London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada|Edmond Odette Cancer Centre at Sunnybrook, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|St. Joseph's Health Centre - Toronto, Toronto, Ontario, Canada|Hopital Charles Lemoyne, Greenfield Park, Quebec, Canada|McGill Cancer Centre at McGill University, Montreal, Quebec, Canada|Institute for Clinical and Experimental Medicine, Preha 4, Czech Republic|Tampere University Hospital, Tampere, Finland|Hopital Tenon, Paris, France|Universitaets-Kinderklinik Heidelberg, Heidelberg, Germany|Agia Olga Hospital, Athens, Greece|Petz Aladar County Hospital, Gydr, Hungary|Policlinico Borgo Roma, Verona, Italy|Kyoto University Hospital, Kyoto, Japan|Uppsala University Hospital, Uppsala, Sweden|Inselspital Bern, Bern, Switzerland|Royal Liverpool University Hospital, Liverpool, England, United Kingdom","https://ClinicalTrials.gov/show/NCT00058201"
881,"Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer","Completed","No Results Available","Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Pancreatic Cancer","Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride|Drug: oxaliplatin|Radiation: radiation therapy|Drug: Oxaliplatin","Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00266097"
882,"Novel MRI Techniques for Pancreatic Cancer","Suspended","No Results Available","Pancreatic Ductal Adenocarcinoma","Diagnostic Test: MRI","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04306861"
883,"EUS Biliary Drainage vs. ERCP","Active, not recruiting","No Results Available","Biliary Obstruction","Procedure: EUS-BD with LAMS|Procedure: ERCP","University of Calgary, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver, Bristish Columbia, Canada|St-Paul Hospital, Vancouver, British Columbia, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|St-Michael's Hospital, Toronto, Ontario, Canada|Centre Hospitalier Universite de Montreal, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hopital Charles Lemoynes, Montréal, Quebec, Canada|Jewish General Hospital, Montreal, Canada|Hôpital Privé des Peupliers, Paris, France","https://ClinicalTrials.gov/show/NCT03870386"
884,"An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer|Gastrointestinal Adenocarcinoma","Diagnostic Test: ultrasound","Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04837833"
885,"Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.","Active, not recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Extended Lymphadenectomy|Procedure: Standard Lymphadenectomy","Shanghai Ruijin Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04115527"
886,"Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Immuncell-LC|Drug: Gemcitabine","Seoul National University Hospital, Seoul, Daehak-ro, Jongno-gu, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04969731"
887,"MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Pegvorhyaluronidase alfa|Drug: Abraxane|Drug: Gemcitabine","Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04134468"
888,"Pancreaticoduodenectomy in Elderly Pancreatic Ductal Adenocarcinoma Patients","Completed","No Results Available","Pancreas Cancer","Procedure: pancreaticoduodenectomy",,"https://ClinicalTrials.gov/show/NCT03659903"
889,"Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients","Terminated","Has Results","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: PF-04136309|Drug: Nab-paclitaxel|Drug: Gemcitabine","Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester Cancer Center Pharmacy, Rochester, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Sampson Regional Medical Center, Clinton, North Carolina, United States|Southeastern Medical Oncology Center, Clinton, North Carolina, United States|Southeastern Medical Oncology Center, Goldsboro, North Carolina, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, United States|Onslow Memorial Hospital, Jacksonville, North Carolina, United States|Southeastern Medical Oncology Center, Jacksonville, North Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|MUSC Hollings Cancer Center, Charleston, South Carolina, United States|MUSC Health East Cooper, Mount Pleasant, South Carolina, United States|MUSC Health North Charleston, North Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT02732938"
890,"Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma","Unknown status","No Results Available","Pancreatic Tubular Adenocarcinoma","Biological: MIS","University Medical Centre Ljubljana, Department for Gastroenterolgy, Ljubljana, Slovenia","https://ClinicalTrials.gov/show/NCT01021800"
891,"Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients","Enrolling by invitation","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Biological: CD40 agonist mitazalimab in combination with chemotherapy","Cliniques Universitaires St-Luc, Brussels, Belgium|Hospital Erasme, Bruxelles, Belgium|UZA Antwerp, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Centre Lyon Berard, Lyon, France|Institute de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France","https://ClinicalTrials.gov/show/NCT04888312"
892,"A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma","Not yet recruiting","No Results Available","Pancreas Cancer|Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer","Drug: Ketorolac Tromethamine","Cedars- Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT05336266"
893,"Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma","Completed","Has Results","Pancreatic Cancer","Drug: Demcizumab|Drug: Abraxane®|Drug: gemcitabine|Drug: Placebo","Banner MD Anderson Cancer Center, Gilbert, Arizona, United States|Providence Saint Joseph Medical Center, Burbank, California, United States|City of Hope, Duarte, California, United States|Scripps Cancer Center, La Jolla, California, United States|University of California, Davis Comprehensive Cancer Center, Sacramento, California, United States|Soulhern California Permanente Medical Group, San Marcos, California, United States|Kaiser Permanente Medical Center, Vallejo, California, United States|Rocky Mountain Cancer Centers, Denver, Colorado, United States|Lynn Cancer Institute, Boca Raton, Florida, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Cancer Center, Westwood, Kansas, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|University of Rochester, Rochester, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|Kaiser Permanente NW Oncology Research, Portland, Oregon, United States|Thomas Jefferson University, Sydney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States|Joe Arrington Cancer Research Treatment Center, Lubbock, Texas, United States|Huntsman Cancer Institute at The University of Utah, Salt Lake City, Utah, United States|Prince of Wales Hospital, Randwick, New South Wales, Australia|Monash Medical Centre, Moorabbin, Bentleigh East, Victoria, Australia|Western Health (Sunshine Hospitals), St Albans, Victoria, Australia|St John of God Murdoch Hospital, Murdoch, Western Australia, Australia|St. John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Hopital Erasme, Brussels, Brussels Capital, Belgium|Tom Baker Cancer Centre, Calgary, Alberta, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, Canada|London Regional Cancer Program, London, Ontario, Canada|Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|St Josephs Health Centre, Toronto, Ontario, Canada|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitari Germans Trias i Pujol - lnstituto Catalan d'Oncologia (!CO), Barcelona, Spain|Hospital General Universitario Gregorio Marafi6n, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Bristol Haematology & Oncology Centre, Bristol, United Kingdom|Sarah Cannon Research Institute UK, London, United Kingdom","https://ClinicalTrials.gov/show/NCT02289898"
894,"Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma","Active, not recruiting","No Results Available","Pancreatic Cancer|Periampullary Adenocarcinoma","Radiation: Stereotactic Body Radiation Therapy (SBRT)","The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01781728"
895,"A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Irreversible Electroporation|Device: NanoKnife System","Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03257150"
896,"Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Combination Product: LINFU™ Technique",,"https://ClinicalTrials.gov/show/NCT04793633"
897,"EUS-RFA for Unresectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: EUS-RFA","Hangzhou First People's Hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04310111"
898,"LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer","Unknown status","No Results Available","Colorectal Cancer|Esophageal Cancer|Gastric Cancer|Pancreatic Cancer","Biological: LMB-9 immunotoxin","Universitaetsklinikum Freiburg, Freiburg, Germany","https://ClinicalTrials.gov/show/NCT00010270"
899,"Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)","Active, not recruiting","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Drug: Lonsurf|Drug: Gemcitabine|Drug: Nab-Paclitaxel","Indiana University Melvin & Bren Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT04046887"
900,"A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma|Homologous Recombination Deficiency (HRD)","Drug: Pembrolizumab|Drug: Olaparib","Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (All protocol activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack, New York, United States|Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States|Memoral Sloan Kettering Basking Ridge (All protocol activitie), New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre, New York, United States","https://ClinicalTrials.gov/show/NCT04666740"
901,"Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas","Unknown status","No Results Available","Lung Adenocarcinoma|Breast Adenocarcinoma|Pancreatic Ductal Adenocarcinoma","Other: their will be no intervention in any of the groups, the study is retrospective",,"https://ClinicalTrials.gov/show/NCT01942629"
902,"A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: SLC-0111|Drug: Gemcitabine Injection","BC Cancer - Vancouver, Vancouver, British Columbia, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03450018"
903,"Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Oxaliplatin|Drug: Irinotecan|Drug: Folinic acid|Drug: 5-fluorouracil|Drug: Gemcitabine|Drug: Capecitabine","Universitätsklinikum Aachen, Studienzentrum Viszeralmedizin Klinik für Allgemeine-, Viszeral und Transplatationschirurgie, Aachen, Germany|Universitätsklinikum Augsburg, III. medizinische Klinik, Augsburg, Germany|St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum, Abteilung für Hämatologie, Onkologie und Palliativmedizin, Studienambulanz, Bochum, Germany|Universitätsklinikum Bonn, Chirurgische Abteilung, Bonn, Germany|DIK Deggendorf, Onkologische Ambulanz, Deggendorf, Germany|Universitätsklinikum Carl Gustav Carus an der TU Dresden, Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Dresden, Germany|Universitätsklinikum Erlangen, Chirurgische Klinik Zentrum für klinische Studien, Erlangen, Germany|Universitätsklinikum Frankfurt, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie,, Frankfurt, Germany|Universitätsklinikum Freiburg, Klinik für Allgemein und Viszeralchirurgie, Abteilung Chirurgie, Freiburg, Germany|Universitätsklinikum Halle (Saale), Klinik und Poliklinik für Innere Medizin I, Halle (Saale), Germany|Universitätsklinikum Hamburg Eppendort, Zentrum für operative Medizin, Klinik und Poliklinik für Allgemein-, Viszeral- und Thoraxchirurgie, Hamburg, Germany|Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Hannover, Germany|Universitätsklinikum Heidelberg, Abteilung für Allgemein-, Viszeral- und Transplantationschirurgie und Nationales Zentrum für Tumorerkrankungen, Medizinische Onkologie, Heidelberg, Germany|Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II und Klinik für Allgemeine Viszeral Gefäß und Kinderchirurgie, Homburg/Saar, Germany|Univeristätsklinikum Jena, Jena, Germany|UKSH Campus Kiel, Medizinische Klinik II, Kiel, Germany|Universität Leipzig, Medizinische Fakultät, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Pneumologie, Leipzig, Germany|Universitätsklinikum Schleswig-Holstein, Klinik für Chirurgie, Onkologisches Zentrum Campus Lübeck, Lübeck, Germany|Universitätsmedizin der Johannes Gutenberg-Universität Mainz, I. medizinische Klinik, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Mainz, Germany|Universitätsklinikum Mannheim, II. medizinische Klinik, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Ernährungsmedizin, Mannheim, Germany|Universitätsklinikum Marburg, Klinik für Innere Medizin, Gastroenterologie, Stoffwechsel und Endokrinologie, Marburg, Germany|Klinikum der Universität München, AG Onkologie der Med Klinik III, München, Germany|Klinikum Rechts der Isar der TU München, Klinik und Poliklinik für Chirurgie, München, Germany|Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg, Germany|Universitätsmedizin Rostock, Klinik III (Hämatologie, Onkologie, Palliativmedizin), Zentrum für Innere Medizin, Rostock, Germany|Caritasklinikum Saarbrücken St. Theresia, Saarbrücken, Germany|Universitätsklinikum Ulm, Klinik für Innere Medizin I Gastroenterologie-Endokrinologie-, Nephrologie-, Ernährung und Stoffwechselkrankheiten, Ulm, Germany|Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II Zentrum für Innere Medizin, Würzburg, Germany","https://ClinicalTrials.gov/show/NCT05314998"
904,"Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Other: application of a diagnostic and therapeutic protocol (multidisciplinary discussion and radiological CT review)","Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy","https://ClinicalTrials.gov/show/NCT03973736"
905,"Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Other: Ketogenic Diet","Honor Health, Scottsdale, Arizona, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Nuvance Health-Danbury Hospital, Danbury, Connecticut, United States|Nuvance Health, Norwalk, Connecticut, United States|Atlantic Health System, Morristown, New Jersey, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States|Baylor Scott and White, Temple, Texas, United States","https://ClinicalTrials.gov/show/NCT04631445"
906,"Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Behavioral: Questionnaires|Other: Exercise|Other: Nutrition Counseling|Behavioral: Phone Calls|Other: Booklet","University of Houston, Houston, Texas, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02295956"
907,"A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma",,,"https://ClinicalTrials.gov/show/NCT04726956"
908,"Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas","Completed","No Results Available","Pancreas|Adenocarcinoma","Procedure: resection of adenocarcinoma of the head of the pancreas","Chu D'Angers, Angers, France|Chu de Bordeaux, Bordeaux, France|Hopital Ambroise Pare, Boulogne, France|Chu de Clermont-Ferrand, Clermont-ferrand, France|Hopital Beaujon, Clichy, France|Hopital Henri Mondor, Creteil, France|Hopital de L'Antiquaille, Lyon, France|Hopital de La Croix-Rousse, Lyon, France|Hospices Civils de Lyon, Lyon, France|Chu La Conception, Marseille, France|Institut Paoli-Calmettes, Marseille, France|Centre Val D'Aurelle Paul Lamarque, Montpellier, France|Hotel Dieu, Nantes, France|Hopital Cochin, Paris, France|Hopital Pitie-Salpetriere, Paris, France|Hopital Tenon, Paris, France|Hopitial Saint Antoine, Paris, France|Hopital Pontchaillou, Rennes, France|Hopitaux Universitaires de Strasbourg, Strasbourg, France|Chu Purpan, Toulouse, France","https://ClinicalTrials.gov/show/NCT00918853"
909,"Nalirinox Neo-pancreas RAS Mut ctDNA Study","Recruiting","No Results Available","Resectable Pancreatic Ductal Adenocarcinoma","Drug: NALRINOX combination","Hestia Duran I Reynals, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Sanchinarro, Madrid, Spain|Hospital Universitari Vall D'Hebron, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT04010552"
910,"New Biomarkers in Pancreatic Cancer Using EXPEL Concept","Recruiting","No Results Available","Oncology",,"Uhmontpellier, Montpellier, France","https://ClinicalTrials.gov/show/NCT03791073"
911,"Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Cancer","Drug: Gemcitabine|Drug: Erlotinib|Drug: Sorafenib","Desert Regional Medical Center, Palm Springs, California, United States|Bellevue Hospital, New York, New York, United States|New York University Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00696696"
912,"Minocycline Study in Pancreatic Cancer Patients","Completed","Has Results","Pancreatic Cancer","Drug: Minocycline|Other: Placebo|Behavioral: Questionnaires","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01693523"
913,"Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer.","Active, not recruiting","No Results Available","Pancreatic Cancer Stage III|Pancreatic Cancer Stage IV","Biological: TBI-1401(HF10)|Drug: Gemcitabine|Drug: Nab-paclitaxel|Drug: TS-1","Clinical Site, Nagoya, Aichi, Japan|Clinical Site, Kashiwa, Chiba, Japan|Clinical Site, Yokohama, Kanagawa, Japan|Clinical Site, Chūōku, Tokyo, Japan|Clinical Site, Koto-Ku, Tokyo, Japan|Clinical Site, Chiba, Japan|Clinical Site, Nagoya, Japan|Clinical Site, Osaka, Japan","https://ClinicalTrials.gov/show/NCT03252808"
914,"Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis","Recruiting","No Results Available","Cancer|Pancreatic Cancer","Procedure: Tumour Biopsy|Other: Serial Collection of Plasma and Serum Samples","Tom Baker Cancer Centre, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|BC Cancer - Vancouver, Vancouver, British Columbia, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02869802"
915,"Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes","Recruiting","No Results Available","Pancreatic Cancer","Other: Oral and rectal swabs for microbiome sequencing","University Medical Centre Goettingen, Göttingen, Germany|University Medical Centre Göttingen, Göttingen, Germany","https://ClinicalTrials.gov/show/NCT04922515"
916,"Minimally Invasive Versus Open Radical Pancreatectomy After Neoadjuvant Chemotherapy for Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Minimally invasive radical pancreatectomy|Procedure: Open radical pancreatectomy","Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04855331"
917,"Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Carcinoma, Pancreatic Ductal","Combination Product: SonoVue|Drug: Chemotherapy","Department of Radiology, St Olavs Hospital, Trondheim, Norway","https://ClinicalTrials.gov/show/NCT04146441"
918,"Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreas Cancer",,"""Agostino Gemelli"" Hospital, Catholic University of Sacred Heart, Rome, Lazio, Italy","https://ClinicalTrials.gov/show/NCT05248750"
919,"A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors","Completed","No Results Available","Non Small Cell Lung Cancer Squamous (NSCLC-Sq)|Head and Neck Squamous Cell Carcinoma (HNSCC)|Small Cell Lung Cancer (SCLC)|Pancreatic Ductal Adenocarcinoma (PDAC)|Colorectal Cancer (CRC)|Metastatic Castration-resistant Prostate Cancer (mCRPC)","Drug: MEDI7247","Research Site, Huntersville, North Carolina, United States|Research Site, Nashville, Tennessee, United States|Research Site, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03811652"
920,"Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas","Active, not recruiting","No Results Available","Contrast Media|Computed Tomography|Imaging|Pancreatic Cancer|Hepatic Cancer","Diagnostic Test: Computed Tomography of the Abdomen","Radiology Department, Karolinska Huddinge university hospital, Stockholm, Sweden","https://ClinicalTrials.gov/show/NCT04813432"
921,"Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas","Withdrawn","No Results Available","Pancreatic Carcinoma Stage I|Pancreatic Carcinoma Stage II","Biological: CVac",,"https://ClinicalTrials.gov/show/NCT02310971"
922,"Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery","Completed","No Results Available","Pancreatic Cancer|Adenocarcinoma","Other: cytology specimen collection procedure","Ohio State University Medical Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT01646697"
923,"A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands","Recruiting","No Results Available","Pancreatic Cancer|BRAF Mutant Colorectal Cancer|Melanoma|Triple Negative Breast Cancer|Head and Neck Squamous Cell Cancer|Cervical Squamous Cell Cancer|Esophageal Squamous Cell Cancer|Lung Squamous Cell Cancer","Drug: LGK974|Biological: PDR001","UCLA School of Medicine, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center Johns Hopkins, Baltimore, Maryland, United States|Dana Farber Cancer Institute SC, Boston, Massachusetts, United States|Dana Farber Cancer Institute SC-7, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center Onc Dept., Ann Arbor, Michigan, United States|Karmanos Cancer Institute Wayne St, Detroit, Michigan, United States|Columbia University Medical Center, New York, New York, United States|University of Texas/MD Anderson Cancer Center MD Anderson 2, Houston, Texas, United States|Novartis Investigative Site, Rotterdam, Netherlands|Novartis Investigative Site, Utrecht, Netherlands|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain","https://ClinicalTrials.gov/show/NCT01351103"
924,"CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma","Not yet recruiting","No Results Available","Pancreatic Cancer","Drug: CEND-1",,"https://ClinicalTrials.gov/show/NCT05052567"
925,"Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Behavioral: Exercise Program|Behavioral: Nutrition Program","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03865875"
926,"PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma","Terminated","Has Results","Adenocarcinoma","Drug: PEGPH20|Drug: Gemcitabine|Drug: Nab-paclitaxel","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT02487277"
927,"Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Tubular Adenocarcinoma","Other: Observation","University Medical Centre Ljubljana; Department for Gastroenterology, Ljubljana, Slovenia","https://ClinicalTrials.gov/show/NCT00947102"
928,"Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.","Not yet recruiting","No Results Available","Pancreas Cancer","Drug: Vactosertib","Samsung Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04258072"
929,"Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma","Unknown status","No Results Available","Pancreatic Cancer","Drug: Paclitaxel protein bound|Drug: Cisplatin|Drug: Gemcitabine|Drug: Paricalcitol","Barts Health NHS Trust, London, London, Greater, United Kingdom","https://ClinicalTrials.gov/show/NCT04054362"
930,"Gene Therapy in Treating Patients With Cancer","Completed","No Results Available","Cancer","Biological: therapeutic autologous lymphocytes","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00004178"
931,"AMG 193, Methylthioadenosine (MTA) Cooperative Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, Alone and in Combination With Docetaxel in Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors","Recruiting","No Results Available","Advanced MTAP-null Solid Tumors","Drug: AMG 193|Drug: Docetaxel","City of Hope National Medical Center, Duarte, California, United States|Community Health Network, Indianapolis, Indiana, United States|American Oncology Partners of Maryland, PA, Bethesda, Maryland, United States|Washington University, Saint Louis, Missouri, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States|Chris OBrien Lifehouse, Camperdown, New South Wales, Australia|Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Aichi Cancer Center, Nagoya-shi, Aichi, Japan|National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan","https://ClinicalTrials.gov/show/NCT05094336"
932,"Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body","Completed","Has Results","Pancreatic Cancer","Radiation: Stereotactic Body Radiation Therapy","University of Cincinnati, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT02208024"
933,"Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Cancer Metastatic|Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer Stage IV","Drug: SBP-101|Drug: Nab-paclitaxel|Drug: Gemcitabine|Other: Placebo",,"https://ClinicalTrials.gov/show/NCT05254171"
934,"Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: INNO-206","Scottsdale Healthcare, Scottsdale, Arizona, United States|Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States|Sarcoma Oncology Center, Santa Monica, California, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Medical College of Wisconsin - Division of Neoplastic Diseases and Related Disorders, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01580397"
935,"A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors","Active, not recruiting","No Results Available","Advanced Solid Tumors Cancer","Drug: ABBV-927|Drug: ABBV-181","The Angeles Clinic and Researc /ID# 156324, Los Angeles, California, United States|The University of Chicago Medical Center /ID# 155264, Chicago, Illinois, United States|Massachusetts General Hospital /ID# 155267, Boston, Massachusetts, United States|Carolina BioOncology Institute /ID# 155265, Huntersville, North Carolina, United States|Tennessee Oncology-Nashville Centennial /ID# 158654, Nashville, Tennessee, United States|University of Texas MD Anderson Cancer Center /ID# 155263, Houston, Texas, United States|Virginia Cancer Specialists - Fairfax /ID# 155266, Fairfax, Virginia, United States|Peninsula Oncology Centre /ID# 164372, Frankston, Victoria, Australia|Austin Health /ID# 171189, Heidelberg, Victoria, Australia|Princess Margaret Cancer Centre /ID# 200819, Toronto, Ontario, Canada|Institut Bergonie /ID# 162665, Bordeaux, Gironde, France|Duplicate_Institut Regional du Cancer /ID# 163609, Montpellier CEDEX 5, Herault, France|Centre Leon Berard /ID# 162663, Lyon CEDEX 08, Rhone, France|Institut Gustave Roussy /ID# 162666, Villejuif Cedex, Val-de-Marne, France|National Cancer Center Hospital East /ID# 216870, Kashiwa-shi, Chiba, Japan|National Cancer Center Hospital /ID# 217758, Chuo-ku, Tokyo, Japan|Yonsei University Health System Severance Hospital /ID# 166292, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Seoul National University Hospital /ID# 166291, Seoul, Korea, Republic of|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 200129, Majadahonda, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz /ID# 200128, Madrid, Spain|Hospital Universitario HM Sanchinarro /ID# 200127, Madrid, Spain|Hospital Universitario y Politecnico La Fe /ID# 200975, Valencia, Spain","https://ClinicalTrials.gov/show/NCT02988960"
936,"Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of ABBV-151 as a Single Agent and in Combination With ABBV-181 in Participants With Locally Advanced or Metastatic Solid Tumors","Recruiting","No Results Available","Advanced Solid Tumors Cancer","Drug: ABBV-151|Drug: Budigalimab","Yale University /ID# 208356, New Haven, Connecticut, United States|AdventHealth Celebration /ID# 224860, Celebration, Florida, United States|AdventHealth Cancer Institute - Orlando /ID# 226953, Orlando, Florida, United States|Indiana Univ School Medicine /ID# 208384, Indianapolis, Indiana, United States|Univ Michigan Med Ctr /ID# 221129, Ann Arbor, Michigan, United States|NYU Langone Medical Center /ID# 209822, New York, New York, United States|Carolina BioOncology Institute /ID# 208358, Huntersville, North Carolina, United States|The Ohio State University - The James /ID# 217611, Columbus, Ohio, United States|NEXT Oncology /ID# 208930, San Antonio, Texas, United States|Chris O'Brien Lifehouse /ID# 213236, Camperdown, New South Wales, Australia|Icon Cancer Centre /ID# 224961, South Brisbane, Queensland, Australia|UCL Saint-Luc /ID# 218466, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|Princess Margaret Cancer Centre /ID# 209423, Toronto, Ontario, Canada|CHU Toulouse - Hopital Purpan /ID# 218667, TOULOUSE Cedex 9, Haute-Garonne, France|Centre Leon Berard /ID# 218515, Lyon CEDEX 08, Rhone, France|Institut Gustave Roussy /ID# 218668, Villejuif Cedex, Val-de-Marne, France|Centre Jean Perrin /ID# 218669, Clermont Ferrand, France|The Chaim Sheba Medical Center /ID# 209037, Ramat Gan, Tel-Aviv, Israel|Tel Aviv Sourasky Medical Center /ID# 222199, Tel Aviv-Yafo, Tel-Aviv, Israel|Rambam Health Care Campus /ID# 222198, Haifa, Israel|National Cancer Center Hospital East /ID# 224808, Kashiwa-shi, Chiba, Japan|National Cancer Center Hospital /ID# 209421, Chuo-ku, Tokyo, Japan|Yonsei University Health System Severance Hospital /ID# 218512, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Seoul National University Hospital /ID# 218513, Seoul, Korea, Republic of|Pan American Center for Oncology Trials, LLC /ID# 217475, Rio Piedras, Puerto Rico|Hospital Clinic de Barcelona /ID# 221106, Barcelona, Spain|Hospital Universitario Fundacion Jimenez Diaz /ID# 220928, Madrid, Spain|Hospital Clinico Universitario de Valencia /ID# 221107, Valencia, Spain|China Medical University Hospital /ID# 218492, Taichung City, Taiwan|National Taiwan University Hospital /ID# 218490, Taipei City, Taiwan","https://ClinicalTrials.gov/show/NCT03821935"
937,"A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma","Terminated","Has Results","Pancreatic Ductal Carcinoma","Other: Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20)|Drug: Placebo|Drug: nab-Paclitaxel|Drug: Gemcitabine","University of South Alabama, Mobile, Alabama, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, United States|Highlands Oncology Group, Fayetteville, Arkansas, United States|St. Jude Hospital Yorba DBA Linda St. Joseph Heritage Health, Fullerton, California, United States|Scripps Clinical Research Services, La Jolla, California, United States|Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States|David Geffen School of Medicine (DGSOM) at UCLA, Los Angeles, California, United States|Chao Family Comprehensive Cancer Center, Orange, California, United States|St. Joseph Hospital, Orange, California, United States|Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California, United States|Cancer Care Associates Medical Group, Inc., Redondo Beach, California, United States|Pacific Hematology Oncology Associates, San Francisco, California, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Pacific Central Coast Health Centers: San Luis Obispo Oncology and Hematology Health Center, San Luis Obispo, California, United States|St Joseph Heritage Healthcare, Santa Rosa, California, United States|Innovative Clinical Research Institution, Whittier, California, United States|Kaiser Permanente Franklin Medical Offices - Denver, Denver, Colorado, United States|US Oncology - Rocky Mountain Cancer Centers - Midtown, Denver, Colorado, United States|St. Mary's Medical Center, Grand Junction, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Memorial Healthcare System - Memorial Cancer Institute, Hollywood, Florida, United States|21st Century Oncology, Jacksonville, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Fort Wayne Medical Oncology/Hematology, INC., Fort Wayne, Indiana, United States|The University Of Kansas Cancer Center, Kansas City, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|Ochsner Health Center, Baton Rouge, Louisiana, United States|Ochsner Clinic CCOP, New Orleans, Louisiana, United States|The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|University of Minnesota Medical School, Minneapolis, Minnesota, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Saint Joseph's Ambulatory Clinic, Clifton, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|Northwell Health/Monter Cancer Center, Lake Success, New York, United States|NYU Langone Medical Center - NYU Langone Arena Oncology, New Hyde Park, New York, United States|Columbia University Medical Center, New York, New York, United States|Mount Sinai School of Medicine - The Tisch Cancer Institute, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Rex Cancer Center, Raleigh, North Carolina, United States|Gabrail Cancer Center Research, Canton, Ohio, United States|The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Univ of Pittsburgh Cancer institute, Pittsburgh, Pennsylvania, United States|Baylor College of Medicine - Baylor Clinic, Houston, Texas, United States|Scott and White, Temple, Texas, United States|University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States|Inova Dwight and Martha Schar Cancer Institute, Fairfax, Virginia, United States|Fort Belvoir Community Hospital, Fort Belvoir, Virginia, United States|Virginia Cancer Institute, Mechanicsville, Virginia, United States|Swedish Cancer Institute/ Swedish Health Services, Seattle, Washington, United States|University of Washington (UW) - Seattle Cancer Care Alliance, Seattle, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|University of Wisconsin Health - UW Carbone Cancer Center, Madison, Wisconsin, United States|Columbia St. Marys, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia|St Vincent's Hospital, Darlinghurst, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia|Flinders Medical Centre, Bedford, South Australia, Australia|Bendigo Health Care Group, Bendigo, Victoria, Australia|Monash Health, Bentleigh East, Victoria, Australia|Peninsula & South Eastern Haematology and Oncology Group, Frankston, Victoria, Australia|Imelda Ziekenhuis, Bonheiden, Antwerpen, Belgium|UZA, Edegem, Antwerpen, Belgium|Cliniques Universitaires Saint-Luc, Brussels, Brussels Capital Region, Belgium|Hôpital Erasme, Bruxelles, Brussels Capital Region, Belgium|AZ Maria Middelares - Campus Maria Middelares, Gent, Oost-Vlaanderen, Belgium|UZ Leuven - Campus Gasthuisberg, Leuven, Vlaams Brabant, Belgium|Centre Hospitalier Universitaire (CHU) de Liege - Domaine Un, Liege, Belgium|CENANTRON - Centro Avançado de Tratamento Oncologico, Belo Horizonte, Minas Gerais, Brazil|Hospital da Cidade de Passo Fundo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital de Clinicas de Porto Alegre - UFRGS, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Occ -Oncologia Clínica De Campinas, Campinas, São Paulo, Brazil|Fundação Amaral Cravalho / Hospital Amaral Carvalho, Jaú, São Paulo, Brazil|Fm Abc/ Cepho, Santo Andre, São Paulo, Brazil|Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil|Fundacao Pio XII Hospital De Câncer de Barretos, Barretos, Brazil|Instituto COI, Rio de Janeiro, Brazil|Instituto Nacional de Câncer - INCA, Rio de Janeiro, Brazil|Royal Victoria Regional Health Centre, Barrie, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Klinicki bolnicki centar Zagreb, Zagreb, Grad Zagreb, Croatia|Klinicki bolnički centar Sestre milosrdnice, Zagreb, Croatia|Masarykuv onkologicky ustav, Brno, Brno-město, Czechia|FN Hradec Kralove, Hradec Kralove, Královéhradecký Kraj, Czechia|Fakultni nemocnice Olomouc, Olomouc, Olomoucký Kraj, Czechia|Nemocnice Na Bulovce (Hospital Na Bulovce), Prague, Czechia|Fakultni nemocnice v Motole, Praha 5, Czechia|Odense Universitetshospital, Odense, South Denmark, Denmark|East Tallinn Central Hospital Oncology Center, Tallinn, Harjumaa, Estonia|North Estonian Medical Centre Foundation Clinic of Oncology, Tallinn, Harjumaa, Estonia|Centre Eugene Marquis, Rennes Cedex, Bretagne, France|Hospitalier Jean Minjoz, Besançon cedex, Franche-Comté, France|ICM Val d'Aurelle Saint Eloi - Departement Oncologie, Montpellier, Hérault, France|ICO - Site Ren Gauducheau, Saint Herblain, Loire-Atlantique, France|CHU Estaing, Clermont-Ferrand, Puy-de-Dôme, France|Hopital Edouard Herriot, Lyon Cedex 03, Rhône, France|Institut De Cancerologie Gustave Roussy, Villejuif, Val-de-Marne, France|Institut de Cancérologie de l'Ouest - Site Paul Papin, Angers Cedex 02, France|Hôpital Haut-Leveque, Bordeaux, France|Henri Mondor - Albert Chevenier, Créteil, France|Centre Lyon Berard, Lyon Cedex, France|Hopital Privé Jean Mermoz, Lyon, France|Institut Mutualiste Montsouris, Paris, France|Pitié Salpetriere Hospital, Paris, France|Hôpital Beaujon, Clichy Cedex, Île-de-France, France|Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany|Klinikum der Universität München - Campus Grosshadern, München, Bayern, Germany|Universitätsklinikum Bonn, Bonn, Nordrhein-Westfalen, Germany|Uniklinik Köln-Klinik für Gastroenterologie und Hepatologie am Abdominalzentrum, Koeln, Nordrhein-Westfalen, Germany|Universitätsklinik Carl-Gustav-Carus Dresden, Dresden, Sachsen, Germany|Universitätsklinikum Leipzig AöR, Leipzig, Sachsen, Germany|Charité - Universitätsmedizin Berlin, Berlin, Germany|Kliniken Essen-Mitte Evang. Huyssens-Stiftung, Essen, Germany|Universitätsklinikum Halle-Universitätsklinik und Poliklinik, Halle, Germany|Facharztzentrum Eppendorf, Hamburg, Germany|Universitätskllinikum Heidelberg, Heidelberg, Germany|Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpo, Szeged, Csongrád, Hungary|Petz Aladár Megyei Oktató Kórház, Győr, Gyor-Moson-Sopron, Hungary|Debreceni Egyetem Klinikai Központ, Debrecen, Hajdú-Bihar, Hungary|Egyesített Szent István és Szent László Kórház-Rendelőintéze, Budapest, Hungary|Magyar Honvédség Egészségügyi Központ, Budapest, Hungary|Országos Onkológiai Intézet, Budapest, Hungary|Semmelweis Egyetem - Isz. Bel, Onkológiai Részleg, Budapest, Hungary|Semmelweis Egyetem - Onkohaematológiai Osztály, Budapest, Hungary|Szent Margit Kórház, Budapest, Hungary|Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár, Hungary|Assaf Harofeh Medical Center, Be'er Ya'aqov, HaMerkaz, Israel|Meir Medical Center, Kfar-Saba, HaMerkaz, Israel|Rabin Medical Center - Beilinson Hospital, Petah Tikva, HaMerkaz, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Tel-Aviv, Israel|Hadassah Medical Organisation, Jerusalem, Yerushalayim, Israel|Ha'Emek Medical Center, Afula, Israel|Soroka Medical Center [Oncology], Beer Sheva, Israel|Hillel Yaffe Medical Center, Hadera, Israel|Rambam Health Care Campus, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|The Chaim Sheba Medical Center [Oncology], Tel Hashomer, Israel|U.O. di Oncologia, San Giovanni Rotondo, Foggia, Italy|Istituto Clinico Humanitas Rozzano, IRCCS, Rozzano, Milano, Italy|PO di Cremona, ASST di Cremona, Cremona, Italy|AO S. Martino, IRCCS, IST-Istituto Nazionale Ricerca Sul Cancro, Genova, Italy|IRCCS Ospedale S.Raffaele, Milano, Italy|Ieo, Irccs, Milan, Italy|Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy|Regina Elena, Istituto Nazionale dei Tumori, IFO, IRCCS, Roma, Italy|Borgo Roma, Policlinico G.Rossi, AOU Integrata Verona, Verona, Italy|Dong-A University Hospital, Busan, Busan Gwang'yeogsi, Korea, Republic of|Keimyung University Dongsan Medical Center, Daegu, Daegu Gwang'yeogsi, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam, Gyeonggido, Korea, Republic of|Asan Medical Center, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Korea University Anam Hospital, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Samsung Medical Center, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi, Korea, Republic of|The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Daugavpils Regional Hospital, Daugavpils, Latvia|P.Stradins Clinical University, Riga, Latvia|SIA ""Rigas Austrumu Kliniska Universitates Slimnica"", Riga, Latvia|National Cancer Institute, Vilnius, Vilniaus Apskritis, Lithuania|Vilniaus Universiteto ligonines Santariskiu Klinikos, Vilnius, Vilniaus Apskritis, Lithuania|Maastricht University Medical Centre, Maastricht, Limburg, Netherlands|Academisch Medisch Centrum Universiteit van Amsterdam, Amsterdam, Netherlands|Spaarne Gasthuis, Hoofddorp, Netherlands|Radboud Universiteit Nijmegen, Nijmegen, Netherlands|Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onko, Brzozow, Podkarpackie, Poland|Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin, Poland|Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Warszawa, Poland|Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|Institut Catalá d´Oncología (I.C.O.), L'Hospitalet De Llobregat, Barcelona, Spain|H.U. de Fuenlabrada, Fuenlabrada, Madrid, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|H.del Mar, Barcelona, Spain|H.Sta.Creu i St.Pau, Barcelona, Spain|H.U.Vall d'Hebrón, Barcelona, Spain|H.C. S.Carlos, Madrid, Spain|H.G.U. G. Marañón, Madrid, Spain|H.U. F. Jiménez Díaz, Madrid, Spain|H.U. R. y Cajal, Madrid, Spain|Hospital Madrid Norte Sanchinarro, Madrid, Spain|F.I. Valenciano de Oncología, Valencia, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Spain|H.U. Miguel Servet, Zaragoza, Spain|China Medical University Hospital, Taichung, Taichung Municipality, Taiwan|Changhua Christian Hospital, Changhua, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Veterans General Hospital- Taipei, Taipei, Taiwan|Addenbrooke's Hospital, Cambridge, Cambridge, Cambridgeshire, United Kingdom|Peterborough And Stamford Hospitals, Peterborough, Cambridgeshire, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Glasgow City, United Kingdom|Sarah Cannon Research Institute UK (SCRI UK), London, London, City Of, United Kingdom|Edinburgh Cancer Centre Western General Hospital, Edinburgh, Midlothian, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Birkenhead, Wirral, United Kingdom|Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom|Castle Hill Hospital, Cottingham, United Kingdom|Coventry Hospital, Coventry, United Kingdom|Hammersmith Hospital, London, United Kingdom|The Royal Marsden NHS Foundation - Sutton, London, United Kingdom|The Royal Marsden NHS Foundation Trust - Chelsea, London, United Kingdom|North Wales Cancer Treatment Centre, Rhyl, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom|The Christie NHS Foundation Trust, Withington, United Kingdom","https://ClinicalTrials.gov/show/NCT02715804"
938,"Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer","Withdrawn","No Results Available","Colorectal Cancer|Esophageal Cancer|Gastric Cancer|Pancreatic Cancer","Other: iodine I 131 monoclonal antibody CC49-deltaCH2","UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00025532"
939,"Safety and Effect of GL-ONC1 Administered IV Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery","Terminated","No Results Available","Solid Organ Cancers","Biological: GL-ONC1","UC San Diego Moores Cancer Center, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT02714374"
940,"Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC","Completed","Has Results","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Palbociclib|Drug: Nab-Paclitaxel","Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale, Arizona, United States|Virginia G. Piper Cancer Pharmacy, Scottsdale, Arizona, United States|UC San Diego Medical Center - La Jolla (Thornton Hospital), La Jolla, California, United States|UC San Diego Moores Cancer Center - Investigational Drug Services, La Jolla, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|UC San Diego Medical Center - Hillcrest, San Diego, California, United States|Anschutz Cancer Pavilion, Aurora, Colorado, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|University of Colorado Denver, CTO (CTRC), Aurora, Colorado, United States|University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora, Colorado, United States|University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP), Aurora, Colorado, United States|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Siteman Cancer Center - West County, Creve Coeur, Missouri, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Washington University Infusion Center Pharmacy, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center - South County, Saint Louis, Missouri, United States|Siteman Cancer Center, Saint Peters, Missouri, United States|University of Utah, Huntsman Cancer Hospital, Salt Lake City, Utah, United States|University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States|Hospital Universitario de Fuenlabrada. Unidad de Farmacia, Fuenlabrada, Madrid, Spain|Hospital Universitario Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitari Vall D'Hebron, Servicio de Oncología Médica, Barcelona, Spain|Hospital Universitario 12 de Octubre Servicio de Farmacia, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02501902"
941,"Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Diagnostic Test: PET Scan","Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05141643"
942,"A Phase II Study of Neoadjuvant FOLFIRINOX","Completed","Has Results","Resectable Pancreatic Ductal Adenocarcinoma","Drug: FOLFIRINOX","Indiana University Simon Cancer Center, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT02178709"
943,"An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies","Terminated","Has Results","Solid Tumors and Hematologic Malignancy","Drug: INCB054329 Monotherapy","Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California, San Francisco, Medical Center at Mount Zion, San Francisco, California, United States|Sarah Cannon Research Institute Research Center, Denver, Colorado, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Horizon Oncology Center, Lafayette, Indiana, United States|John Hopkins, Baltimore, Maryland, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02431260"
944,"Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Locally Advanced Cancer|Metastatic Cancer","Drug: FOLFIRI|Drug: OSE2101","Clinique de l'Europe, Amiens, France|Hôpital Sud CHU Amiens, Amiens, France|CH Beauvais, Beauvais, France|CHRU Jean Minjoz, Besançon, France|Clinique Tivoli Ducos, Bordeaux, France|CHU Morvan, Brest, France|GHPSO Site de Creil, Creil, France|Hôpital Henri Mondor, Créteil, France|Centre Georges François Leclerc, Dijon, France|CHU Dijon, Dijon, France|CHRU Lille, Lille, France|centre Léon Bérard, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital la Croix Rousse, Lyon, France|Hôpital Lyon Sud Hospices Civils de Lyon, Lyon, France|Hôpital Privé Jean Mermoz, Lyon, France|Hôpital Européen, Marseille, France|Institut Paoli Calmette, Marseille, France|Hôpital Pitié Salpêtrière, Paris, France|Hôpital Saint Antoine, Paris, France|Institut Mutualiste Montsouris, Paris, France|CHU Poitiers, Poitiers, France|CHU Robert Debré, Reims, France|Institut Curie, Saint-Cloud, France|Centre Paul Strauss, Strasbourg, France|Clinique Pasteur, Toulouse, France|Hôpital TROUSSEAU, Tours, France|Insitut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France","https://ClinicalTrials.gov/show/NCT03806309"
945,"Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants","Completed","No Results Available","Pancreatic Cancer","Other: This is a non-intervention study for all groups.|Other: study of socioeconomic and demographic variables",,"https://ClinicalTrials.gov/show/NCT00898482"
946,"To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas","Terminated","No Results Available","Pancreas Cancer","Drug: Plerixafor","Weill Cornell Medical College, New York, New York, United States|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT03277209"
947,"Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: BR55","Stanford University Medical Center, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT03486327"
948,"Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel","Unknown status","No Results Available","Metastatic Pancreatic Cancer","Drug: TEW-7197","Samsung Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03666832"
949,"Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer|Pancreatic Neoplasms","Drug: PEGPH20|Biological: Pembrolizumab","Banner Health - MD Anderson Cancer Center, Gilbert, Arizona, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Rutgers - Cancer Institute of New Jersey (CINJ), New Brunswick, New Jersey, United States|University of Washington--Seattle Cancer Care Alliance, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03634332"
950,"Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study","Recruiting","No Results Available","Disease Free Survival|Overall Survival|Pancreatic Cancer","Behavioral: use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins","IRCCS San Raffaele, Milan, Italy","https://ClinicalTrials.gov/show/NCT04245644"
951,"Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)","Recruiting","No Results Available","PDAC - Pancreatic Ductal Adenocarcinoma","Diagnostic Test: 6D-MRI","Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04700488"
952,"Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Periampullary Adenocarcinoma","Drug: capecitabine|Drug: vorinostat|Radiation: Radiotherapy|Procedure: Surgery to remove tumor","Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00983268"
953,"Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer","Drug: Gemcitabine 1000 mg/m2 iv days 1, 8, 15 of a 28 day cycle|Drug: Capecitabine orally days 1 -21|Drug: Erlotinib 100 mg orally days 1-28|Drug: Bevacizumab 5 mg/kg intravenously every 2 weeks","The Royal Marsden Foundation Hospital NHS Trust, London and Surrey, London, United Kingdom","https://ClinicalTrials.gov/show/NCT00260364"
954,"Effects of Different Methods of PDAC Specimen Acquisition on Primary Cell Culture and Application","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: different methods of specimen acquisition","The Third Xiangya Hospital, Central South University, Changsha, Hunan, China","https://ClinicalTrials.gov/show/NCT04797676"
955,"A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer","Drug: siG12D-LODER|Drug: Gemcitabine+nab-Paclitaxel|Drug: Folfirinox","Hackensack Meridian Health, Hackensack, New Jersey, United States|The Mount Sinai Hospital, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|MD Anderson Cancer Center, Houston, Texas, United States|Rambam Medical Center, Haifa, Israel|Rabin Medical Center, Petah Tikva, Israel|Sheba Medical Center (Tel H'shomer), Ramat Gan, Israel|Sourasky MC (Ichilov) Tel Aviv Israel, Tel Aviv, Israel|Assaf Harofeh Medical Center, Tzrifin, Israel","https://ClinicalTrials.gov/show/NCT01676259"
956,"Plasma Biomarkers P-DAC, V1","Terminated","No Results Available","Pancreatic Ductal Adenocarcinoma",,"Beacon Hospital, Bracken Rd, Sandyford Industrial Estate, Dublin 18, Ireland|Our Lady of Lourdes Hospital Drogheda, Drogheda, Louth, Ireland|Bon Secours, Cork, Ireland|Beaumont Hospital, Dublin, Ireland|St Vincent's Hospital, Dublin, Ireland|Galway University Hospital, Galway, Ireland|Midwestern Regional Hospital, Limerick, Ireland|Adelaide Meath National Childrens Hospital, Tallaght, Ireland|Waterford Regional Hospital, Waterford, Ireland","https://ClinicalTrials.gov/show/NCT02050997"
957,"Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer","Terminated","Has Results","Pain|Pancreatic Cancer","Drug: morphine sulfate|Device: Medtronic intrathecal pump","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00660348"
958,"Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.","Withdrawn","No Results Available","Pancreatic Ductal Adenocarcinoma|Colorectal Cancer","Drug: 111In-IPN01087 Low dose|Drug: 111In-IPN01087 High dose","Institut Jules Bordet, Brussels, Belgium|UZ Leuven, Leuven, Belgium|Centre Léon Bérard, Léon, France|CHRU de Nancy - Hôpital de Brabois, Nancy, France|CHU de Nantes - Hôpital Hôtel Dieu, Nantes, France","https://ClinicalTrials.gov/show/NCT04632199"
959,"SERum-bank for PANcreatic Cancer","Recruiting","No Results Available","Adenocarcinoma","Biological: Blood sample","Institut Cancérologique Lucien Newirth (ICLN), Saint-Priest-en-Jarez, France|CHU Saint-Etienne, Saint-Étienne, France","https://ClinicalTrials.gov/show/NCT04374175"
960,"Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma (PDAC)","Procedure: Blood samples|Procedure: Portal vein blood sample","Chu de Bordeaux, Bordeaux, France","https://ClinicalTrials.gov/show/NCT03032913"
961,"Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer","Completed","No Results Available","Drug/Agent Toxicity by Tissue/Organ|Pancreatic Cancer","Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: triacetyluridine","Brookwood Medical Center, Birmingham, Alabama, United States|Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States|Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Scripps Cancer Center at Scripps Clinic, La Jolla, California, United States|Northwest Oncology and Hematology Associates, Coral Springs, Florida, United States|Florida Cancer Specialists - World Plaza, Fort Myers, Florida, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States|Florida Oncology Associates - South Side, Jacksonville, Florida, United States|University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Florida Cancer Institute - New Port Richey, New Port Richey, Florida, United States|St. Joseph's Hospital, Savannah, Georgia, United States|Cancer Care Center, New Albany, Indiana, United States|Cancer Center at Greater Baltimore Medical Center, Baltimore, Maryland, United States|Wellstat Therapeutics, Gaithersburg, Maryland, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Capitol Comprehensive Cancer Care Clinic, Jefferson City, Missouri, United States|David C. Pratt Cancer Center at St. John's Mercy, Saint Louis, Missouri, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States|Queens Medical Associates, PC, Fresh Meadows, New York, United States|New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States|Summit Oncology Associates, Akron, Ohio, United States|Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States|Cancer Centers of the Carolinas - Eastside, Greenville, South Carolina, United States|Corpus Christi Cancer Center, Corpus Christi, Texas, United States|Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Regional Cancer Care at Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada|McGill Cancer Centre at McGill University, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00024427"
962,"Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas","Unknown status","No Results Available","Pancreatic Cancer","Procedure: resection of the nerve plexus on the right half of celiac and SMA associated with extended pancreatoduodenectomy|Procedure: standard pancreatoduodenectomy","Pancreatic Cancer Institute, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT02514928"
963,"RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma (PDAC)","Other: Blood sample","Damien JOLLY, Reims, France","https://ClinicalTrials.gov/show/NCT04575363"
964,"Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors","Completed","Has Results","Neoplasms|Pancreatic Neoplasms","Drug: LMB-100|Drug: Nab-Paclitaxel|Device: Mesothelin Expression","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT02810418"
965,"Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis","Completed","No Results Available","Adenocarcinoma of Head of Pancreas","Device: puncture of head of pancreas","Hopital Saint Joseph, Marseille, France","https://ClinicalTrials.gov/show/NCT02078232"
966,"A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma|Familial Pancreatic Cancer|FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome",,"Stanford Gastroenterology and Hepatology, Stanford, California, United States|Yale University, New Haven, Connecticut, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Massachusetts, Worcester, Massachusetts, United States|New York University Hospital, New York, New York, United States|Columbia University, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|The Ohio State University, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|University of Utah, Salt Lake City, Utah, United States|The Research Institute of the McGill University Health Centre, Montréal, Canada|University Hospital Ramon y Cajal, Madrid, Spain|University Hospital Santiago De Compostela, Santiago De Compostela, Spain|Sahlgrenska University Hospital, Gothenburg, Sweden|Linköping University Hospital, Linköping, Sweden|Karolinska University Hospital, Stockholm, Sweden|Umeå University Hospital, Umeå, Sweden|University Collage London Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03693378"
967,"A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma","Completed","No Results Available","Gastric Neoplasms|Pancreatic Neoplasms","Drug: ASG-5ME","TGen Clinical Research Service at Scottsdale Healthcare, Scottsdale, Arizona, United States|University of California at San Francisco, San Francisco, California, United States|University of Chicago, Chicago, Illinois, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Texas Oncology - Baylor Sammons Cancer Center, Dallas, Texas, United States|Texas Oncology - Tyler, Tyler, Texas, United States|Seattle Cancer Care Alliance / University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01166490"
968,"Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy","Withdrawn","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Albis®|Drug: Placebo",,"https://ClinicalTrials.gov/show/NCT02570529"
969,"Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma","Biological: CD8+NKG2D+ AKT Cell|Drug: Gemcitabine","Shanghai General Hospital, Shanghai, Shanghai, China|Shanghai General Hospital, Shanghai, China","https://ClinicalTrials.gov/show/NCT02929797"
970,"Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract","Terminated","No Results Available","Colorectal Cancer|Esophageal Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastric Cancer|Pancreatic Cancer|Small Intestine Cancer","Biological: carcinoembryonic antigen peptide 1-6D|Biological: incomplete Freund's adjuvant|Biological: sargramostim","University of Texas Medical Branch, Galveston, Texas, United States","https://ClinicalTrials.gov/show/NCT00012246"
971,"Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study","Recruiting","No Results Available","Resectable Pancreatic Cancer|Adjuvant Chemoradiotherapy|Surgery","Other: Follow-up only|Drug: Adjuvant chemotherapy|Radiation: Adjuvant chemoradiotherapy|Radiation: Adjuvant chemoradiotherapy + Adjuvant chemotherapy","Zhongshan Hospital Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04737551"
972,"Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: modified FOLFIRINOX regimen",,"https://ClinicalTrials.gov/show/NCT02440958"
973,"Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer","Unknown status","No Results Available","Pancreas Neoplasms","Drug: Docetaxel|Drug: Oxaliplatin","Städtische Kliniken Esslingen, Esslingen, Baden Württemberg, Germany|Klinikum Schwäbisch Gmünd, Mutlangen, Baden Württemberg, Germany|Universitätsklinikum Ulm Klinik für Innere Medizin I, Ulm, Baden Württemberg, Germany|Universitätsklinikum Giessen und Marburg GmbH, Marburg, Hessen, Germany|Klinik und Poliklinik für Innere Medizin I / Universitätsklinikum Halle, Halle, Germany","https://ClinicalTrials.gov/show/NCT00690300"
974,"Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)","Recruiting","No Results Available","Pancreas Ductal Adenocarcinoma","Drug: PAXG|Drug: mFOLFIRINOX|Drug: short-course chemotherapy|Drug: long-course chemotherapy","Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS, Aviano, Italy|Oncologia Medica Az. Ospedaliera Istituto Tumori ""Giovanni Paolo II"", Bari, Italy|Oncologia ASST pg23, Bergamo, Italy|Oncologia Medica Azienda Universitaria Ospedaliera Policlinico Sant'Orsola-Malpighi, Bologna, Italy|Oncologia Medica dell'Az.Ospedaliera Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy|Oncologia Medica AOU Careggi, Florence, Italy|Oncologia Ospedale Generale Provinciale, Macerata, Italy|Oncologia Medica dell'Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy|Oncologia dell'Istituto Clinico Humanitas, Milan, Italy|IRCCS San Raffaele, Milan, Italy|Oncologia Medica Falck Niguarda, Milan, Italy|Oncologia Medica Az Ospedaliera AOU Cagliari Policlinico Universitario Dullio Casula, Monserrato, Italy|Oncologia Medica AOU FEDERICO II, Naples, Italy|Oncologia Medica 1 Ospedaliera Istituto Oncologico Veneto IRCCS, Padova, Italy|Oncologia Medica Arnas Civico, Palermo, Italy|Oncologia Medica 2 Az. Ospedaliera Universitaria Pisana, Pisa, Italy|Oncologia Medica Az. Ospedaliera Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy|Chirurgia Generale e Oncologica dell'AZ. Ospedaliera Ordine Mauriziano, Torino, Italy|Divisione Chirurgica Az. Ospedaliera AULSS2, Treviso, Italy|SOC di Oncologia Az. Ospedaliera Sanitaria Universitaria Friuli Centrale-P.O. ""S. Maria della Misericordia"", Udine, Italy|Chirurgia generale e del Pancreas Azienda Ospedaliera Universitaria Integrata, Verona, Italy|Oncologia ULSS8 Berica, Vicenza, Italy","https://ClinicalTrials.gov/show/NCT04793932"
975,"QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer","Completed","No Results Available","Metastatic Pancreatic Cancer|Metastatic Colorectal Cancer","Drug: NPC-1C/NEO-102","Moffitt Cancer Center, Tampa, Florida, United States|Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Duke University Medical Center, Durham, North Carolina, United States|UT Southwestern Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01040000"
976,"A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: different number of passes","The Third Xiangya Hospital, Central South University,, Changsha, Hunan, China","https://ClinicalTrials.gov/show/NCT04794140"
977,"Study of NAC of GA Therapy for Patients With BRPC","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel","Hirosaki University, Hirosaki, Aomori, Japan|Kobe University, Kobe, Hyogo, Japan|Hyogo College of Medicine, Nishinomiya, Hyogo, Japan|Nara Medical University, Kashihara, Nara, Japan|Kansai Medical University, Hirakata, Osaka, Japan|Kinki University, Sayama, Osaka, Japan|Osaka University, Suita, Osaka, Japan|Osaka Medical University, Takatsuki, Osaka, Japan|Shiga Medical University, Ōtsu, Shiga, Japan|Chiba University, Chiba, Japan|Gifu University, Gifu, Japan|Hiroshima University, Hiroshima, Japan|Kumamoto University, Kumamoto city, Japan|Kyoto Prefectural University of Medicine, Kyoto, Japan|Kyoto University, Kyoto, Japan|Nagoya University, Nagoya, Aichi, Japan|Osaka City University, Osaka, Japan|Second Department of Surgery, Wakayama Medical University, School of Medicine, 811-1 Kimiidera, Wakayama, Japan","https://ClinicalTrials.gov/show/NCT02926183"
978,"Gemcitabine and CT-011 for Resected Pancreatic Cancer","Terminated","Has Results","Pancreatic Neoplasms|Cancer of the Pancreas|Neoplasms Pancreatic|Pancreatic Cancer|Pancreas Cancer","Biological: CT-011|Drug: Gemcitabine","Georgia Regents University, Augusta, Georgia, United States","https://ClinicalTrials.gov/show/NCT01313416"
979,"Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection","Recruiting","No Results Available","Gastric Adenocarcinoma|Pancreatic Cancer|Gastroesophageal Junction Adenocarcinoma","Drug: CT041 autologous CAR T-cell injection|Drug: Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）","Anhui Provincial Cancer Hospital, Hefei, Anhui, China|Beijing Cancer Hospital, Beijing, Beijing, China|Harbin medical university Affiliated Cancer Hospital, Harbin, Heilongjia, China|Henan Tumor Hospital, Zhengzhou, Henan, China|Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China|Ruijin Hospital, affiliated to Shanghai Jiaotong University, school of medicine, Shanghai, Shanghai, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China|Shanghai Zhongshan Hospital, Shanghai, Shanghai, China|West China Hospital, Sichuan University, Chengdu, Sichuan, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China","https://ClinicalTrials.gov/show/NCT04581473"
980,"Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer","Completed","No Results Available","Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastric Cancer|Pancreatic Cancer|Small Intestine Cancer","Drug: gemcitabine hydrochloride|Genetic: polymerase chain reaction|Other: immunohistochemistry staining method|Procedure: conventional surgery|Radiation: intraoperative radiation therapy|Radiation: radiation therapy",,"https://ClinicalTrials.gov/show/NCT00544193"
981,"RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma","Completed","No Results Available","Cancer","Biological: monoclonal antibody RAV12","Premiere Oncology, Santa Monica, California, United States|Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States|University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States|Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States|Sarah Cannon Cancer Center at Centennial Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00101972"
982,"A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic PC Patients","Active, not recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine","Dana Farber Cancer Institute, Boston, Massachusetts, United States|New York University, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04581343"
983,"A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma","Not yet recruiting","No Results Available","Tumor|Adenocarcinoma","Drug: Pembrolizumab|Drug: lenvatinib","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05273554"
984,"Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder","Completed","No Results Available","Colorectal Cancer|Gallbladder Cancer|Gastric Cancer|Pancreatic Cancer|Small Intestine Cancer",,"Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00489515"
985,"UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer","Completed","No Results Available","Breast Cancer|Colorectal Cancer|Esophageal Cancer|Liver Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer","Genetic: fluorescence in situ hybridization|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: mass spectrometry",,"https://ClinicalTrials.gov/show/NCT00900094"
986,"Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Genetic: Multi-gene Next Generation Sequencing Panel","HonorHealth Research Institute, Scottsdale, Arizona, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02790944"
987,"RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma","Not yet recruiting","No Results Available","Radical Antegrade Modular Pancreatosplenectomy","Procedure: Radical antegrade modular pancreatosplenectomy|Procedure: Standard retrograde pancreatosplenectomy","Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04253847"
988,"Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer","Completed","No Results Available","Breast Cancer|Colorectal Cancer|Gallbladder Cancer|Gastric Cancer|Head and Neck Cancer|Liver Cancer|Ovarian Cancer|Pancreatic Cancer|Testicular Germ Cell Tumor","Biological: TRICOM-CEA(6D)","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00027534"
989,"Alanosine in Treating Patients With Cancer","Completed","No Results Available","Lung Cancer|Malignant Mesothelioma|Pancreatic Cancer|Sarcoma","Drug: L-alanosine","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States|Wilshire Oncology Medical Group, Incorporated - La Verne, La Verne, California, United States|Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States|Lynn Regional Cancer Center West, Boca Raton, Florida, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Midwest Cancer Research Group, Incorporated, Skokie, Illinois, United States|St. Vincent's Comprehensive Cancer Center - Manhattan, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States|MD Anderson Cancer Center at University of Texas, Houston, Texas, United States|U.S. Oncology, Incorporated, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00062283"
990,"Early Detection Initiative for Pancreatic Cancer","Recruiting","No Results Available","Hyperglycemia|Diabetes Mellitus|Pancreas Ductal Adenocarcinoma","Other: Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score|Other: Abdominal imaging","Kaiser Permanente Southern California, Kaiser Permanente Research, Pasadena, California, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04662879"
991,"PHL Treatment in Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Combination Product: Paricalcitol, Hydroxychloroquine, Losartan|Other: Neoadjuvant therapy and surgery only (Control)","Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT05365893"
992,"A Study to Assess YH003 in Combination With Toripalimab(Anti-PD-1 mAb) Injection in Patients With Cancers","Recruiting","No Results Available","Melanoma|Pancreatic Ductal Adenocarcinoma","Drug: YH003|Drug: Toripalimab|Drug: Nab-paclitaxel|Drug: Gemcitabine","Epworth Medical Centre, Richmond, Victoria, Australia","https://ClinicalTrials.gov/show/NCT05031494"
993,"Fecal Microbial Transplants for the Treatment of Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Fecal Microbiota Transplantation|Drug: Fecal Microbiota Transplantation Capsule|Other: Questionnaire Administration|Procedure: Resection|Procedure: Therapeutic Colonoscopy","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04975217"
994,"Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer","Completed","No Results Available","Cancer","Drug: isolated perfusion|Drug: melphalan","Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00096083"
995,"Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Biopsy|Procedure: Therapeutic Conventional Surgery|Other: Uniformly-labeled [13C]glucose","Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States","https://ClinicalTrials.gov/show/NCT05296421"
996,"Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Diagnostic Test: radiomics",,"https://ClinicalTrials.gov/show/NCT04954378"
997,"BCX-1777 in Treating Patients With Refractory Cancer","Completed","No Results Available","Cancer","Drug: forodesine hydrochloride","Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00073944"
998,"Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: H101|Drug: Tislelizumab|Drug: lenvatinib","Fudan University Shanghai Cancer Center, Shanghai, China","https://ClinicalTrials.gov/show/NCT05303090"
999,"Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma","Device: EUSRA electrode needle connected to a radiofrequency generator (VIVA RF generator; STARmed, Seoul, S. Korea)",,"https://ClinicalTrials.gov/show/NCT04164992"
1000,"CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: 64Cu-DOTA-ECLIi|Device: PET/CT","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT03851237"
1001,"Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Pancreaticoduodenectomy with Standard lymphadenectomy|Procedure: Pancreaticoduodenectomy with Extended lymphadenectomy","Shanghai Ruijin Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT02787187"
1002,"S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Tegafur-gimeracil-oteracil potassium|Drug: Oxaliplatin|Drug: Irinotecan",,"https://ClinicalTrials.gov/show/NCT03316326"
1003,"Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: Gemcitabine|Drug: Nab paclitaxel|Drug: NLM-001|Drug: Zalifrelimab","Hospital Universitario Virgen De La Victoria, Málaga, Andalucía, Spain|Hospital Universitario Miguel Servet, Zaragoza, Aragón, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Cataluña, Spain|Hospital Universitario Donostia, San Sebastián, País Vasco, Spain","https://ClinicalTrials.gov/show/NCT04827953"
1004,"CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Diagnostic Test: Computed Tomography Perfusion Imaging","Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03012282"
1005,"Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: JPI-547|Drug: modified FOLFIRINOX|Drug: Gemcitabine-nab-paclitaxel",,"https://ClinicalTrials.gov/show/NCT05257993"
1006,"CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: CPI-613|Drug: mFOLFIRNOX",,"https://ClinicalTrials.gov/show/NCT03374852"
1007,"NGS and TME for Evidence-based Treatment of Pancreatic Cancer","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Genetic: NGS",,"https://ClinicalTrials.gov/show/NCT02767700"
1008,"CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer","Completed","No Results Available","Breast Cancer|Colorectal Cancer|Lung Cancer|Pancreatic Cancer","Drug: CI-1040","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT00033384"
1009,"A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer","Withdrawn","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: LDE225","Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01911416"
1010,"A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer","Terminated","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer","Drug: PEGylated Recombinant Human Hyaluronidase (PEGPH20)|Drug: Avelumab","Hospital Universitario Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Ramon y Cajal, Madrid, Spain","https://ClinicalTrials.gov/show/NCT03481920"
1011,"A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer","Recruiting","No Results Available","Resectable Pancreatic Ductal Adenocarcinoma|Stage 0 Pancreatic Cancer AJCC v8|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8","Drug: Pyrvinium Pamoate","Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT05055323"
1012,"Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma, PDAC",,"Ruijin Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT05168254"
1013,"Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma, PDAC",,"Ruijin Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT05201729"
1014,"Endoscopic Ultrasound PANcreatic CAncer RaDIofrequeNcy AbLation","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma (PDAC)","Device: Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA)|Drug: Neoadjuvant chemotherapy (NAC)","Memorial Hermann Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04990609"
1015,"Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy","Enrolling by invitation","No Results Available","Recurrent Pancreatic Ductal Adenocarcinoma","Radiation: Additional stereotactic body radiation therapy","Amsterdam University Medical Center, VUmc, Amsterdam, Noord-Holland, Netherlands|Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands","https://ClinicalTrials.gov/show/NCT04881487"
1016,"A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy","Terminated","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma","Drug: OFF|Drug: FOLFIRI Protocol","Praxis für Innere Medizin, Friedrichshafen, Germany","https://ClinicalTrials.gov/show/NCT03331640"
1017,"A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer|Adenocarcinoma","Drug: GSK2256098|Drug: Trametinib","Juravinski Cancer Center, Hamilton, Ontario, Canada|London Regional Cancer Centre, London, Ontario, Canada|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02428270"
1018,"Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Adenocarcinoma","Radiation: Preoperative SBRT","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT02347618"
1019,"PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Diagnostic Test: Magnetic resonance imaging (MRI)","Kaiser Permanente Southern California, Pasadena, California, United States","https://ClinicalTrials.gov/show/NCT04883450"
1020,"Peri-operative SLOG for Localized Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreas Cancer","Drug: S-1, leucovorin, oxaliplatin and gemcitabine","Kaohsiung Medical University Hospital, Kaohsiung, Taiwan|National Cheng-Kung University Hospital, Tainan, Taiwan|National Institute of Cancer Research, Tainan, Taiwan","https://ClinicalTrials.gov/show/NCT05048524"
1021,"Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer","Terminated","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Drug: bevacizumab|Drug: 5-Fluorouracil|Drug: Oxaliplatin|Drug: gemcitabine|Procedure: External Beam Radiation Therapy",,"https://ClinicalTrials.gov/show/NCT00307723"
1022,"VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors","Terminated","Has Results","Adenocarcinoma|Pancreatic Neoplasms","Drug: X-82|Drug: Everolimus","Washington University School of Medicine, Saint Louis, Missouri, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01784861"
1023,"CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Drug: CEND-1|Drug: Nab-paclitaxel|Drug: Gemcitabine","Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Alfred Hospital, Melbourne, Victoria, Australia|St John of God Hospital, Subiaco, Western Australia, Australia","https://ClinicalTrials.gov/show/NCT03517176"
1024,"A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation","Completed","No Results Available","Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma","Drug: Rucaparib","Cedars Sinai Medical Center, Los Angeles, California, United States|Mayo Clinic, Rochester, Minnesota, United States|New York University, New York, New York, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|MD Anderson Cancer Center, Houston, Texas, United States|Rambam Healthcare Campus, Haifa, Israel|Hadassah Hebrew University Hospital (Sharett Institute of Oncology), Jerusalem, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT02042378"
1025,"Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer","Recruiting","No Results Available","Metastatic Colorectal Adenocarcinoma|Metastatic Pancreatic Ductal Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7","Drug: Imiquimod|Biological: Pembrolizumab|Biological: Sotigalimab|Biological: Synthetic Tumor-Associated Peptide Vaccine Therapy","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02600949"
1026,"Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer","Terminated","No Results Available","Adenocarcinoma","Drug: Zoledronic acid","Washington University School of Medicine, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00892242"
1027,"Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study","Unknown status","No Results Available","Adenocarcinoma of Head of Pancreas",,"Radiology Department, Ruijing Hospital, Shanghai Jiaotong University, Shanghai, Shanghai, China|Radiology Department, Cancer Hospital, Fuandan University, Shanghai, Shanghai, China|Radiology Department, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China|Radiology Department, Huadong Hospital, Fudan University, Shanghai, Shanghai, China|Radiology Department, Huashan Hospital, Fudan University, Shanghai, Shanghai, China|Radiology Department, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT01455610"
1028,"Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma","Not yet recruiting","No Results Available","Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics","Other: No intervention","RUIJIN Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04525209"
1029,"A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors","Recruiting","No Results Available","Minimal Residual Disease|KRAS G12D|KRAS G12R|NRAS G12D|NRAS G12R|Pancreatic Ductal Adenocarcinoma|Colorectal Cancer|Non-small Cell Lung Cancer|Ovarian Cancer|Cholangiocarcinoma|Bile Duct Cancer|Gallbladder Carcinoma","Drug: ELI-002 2P","City of Hope, Duarte, California, United States|University of California Los Angeles, Los Angeles, California, United States|University of Colorado, Aurora, Colorado, United States|University of Iowa, Iowa City, Iowa, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Cancer Institute, Detroit, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Northwell Health, Lake Success, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Tennessee Oncology - Centennial Clinic, Nashville, Tennessee, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04853017"
1030,"Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer","Recruiting","No Results Available","Metastatic Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8","Biological: Dostarlimab|Drug: Niraparib","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04493060"
1031,"Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer","Completed","No Results Available","Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)","Biological: Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01897415"
1032,"Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma","Recruiting","No Results Available","PDAC - Pancreatic Ductal Adenocarcinoma|FAP","Drug: [68Ga]FAPI-46","NYU Langone Health, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05262855"
1033,"Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA)","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: minimally invasive distal pancreatectomy|Procedure: open distal pancreatectomy","Hôpital Beaujon - APHP, Clichy, France|CHU Saint Eloi - Montpellier, Montpellier, France|Centre Hospitalier Orléans, Orléans, France|Institut Mutualiste Montsouris, Paris, France|Hôpital Paul Brousse, Villejuif, France","https://ClinicalTrials.gov/show/NCT04483726"
1034,"PAXG Out in the Country","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma","Drug: PAXG regimen (cisplatin, nab-paclitaxel, capecitabine, gemcitabine) chemotherapy","IRCCS Centro di Riferimento Oncologico (CRO), Aviano, Italy|Istituto dei tumori Giovanni Paolo II, Bari, Italy|AULSS 1 di Belluno, Belluno, Italy|ASST Papa Giovanni XXIII, Bergamo, Italy|Azienda Ospedaliera Policlinico Sant'Orsola-Malpighi, Bologna, Italy|Azienda Ospedaliera AOU di Cagliari, Cagliari, Italy|Ospedale di Carpi, Carpi, Italy|USL Toscana Nord Ovest, Carrara, Italy|Fondazione Istituto Giglio, Cefalù, Italy|Ospedaliera Sant' Anna di Como Asst Lariana, Como, Italy|Azienda Ospedaliera Universitaria Ospedali Riuniti di Foggia, Foggia, Italy|ASST Rhodense, Garbagnate, Italy|Ospedale Moriggia Pelascini, Gravedona, Italy|Ospedale Generale Provinciale di Macerata, Macerata, Italy|Irccs Irst, Meldola, Italy|ASST Melegnano e Della Martesana, Melegnano, Italy|IRCCS San Raffaele Medical Oncology Unit, Milan, Italy|Istituto Oncologico Veneto IRCCS, Padova, Italy|Ospedale Civico di Palermo, Palermo, Italy|Azienda Ospedaliera di Parma, Parma, Italy|Azienda Ospedaliera di Piacenza, Piacenza, Italy|Giovanni Paolo II-Maria Paternò, Ragusa, Italy|Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy|AULSS 4 Veneto Orientale, San Donà Di Piave, Italy|IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|Azienda Ospedaliera Ordine Mauriziano, Torino, Italy|Presidio Ospedaliero Molinette, Torino, Italy|Azienda Sanitaria Universitaria Integrata, Udine, Italy|ASST Sette Laghi, Varese, Italy|Ospedale San Bortolo Azienda ULSS8 Berica-Distretto Est, Vicenza, Italy","https://ClinicalTrials.gov/show/NCT04480268"
1035,"Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma|Who Have High CTCs Count in Portal Venous Blood|Liver Metastases","Device: Intrahepatic Arterial Infusion","Department of General Surgery,Peking University Third Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT03687853"
1036,"A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer","Completed","No Results Available","Advanced Adenocarcinoma|Metastatic Adenocarcinoma","Drug: Hydroxychloroquine (HCQ)|Drug: Gemcitabine|Drug: Abraxane","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01506973"
1037,"An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects","Recruiting","No Results Available","CAR T-Cell Therapy","Drug: HEC-016(0.5×10^6 CAR-T Cells)|Drug: HEC-016(0.5×10^6.5 CAR-T Cells)|Drug: HEC-016(0.5×10^7 CAR-T Cells)","Shenzhen Luohu Hospital, Shenzhen, Guangdong, China","https://ClinicalTrials.gov/show/NCT05277987"
1038,"Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC","Completed","No Results Available","Breast Cancer|Pancreatic Cancer|Colorectal Cancer|Non-small-cell Lung Cancer|NSCLC|Adenocarcinoma","Drug: MORAb-066","Oklahoma City, Oklahoma, United States|Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01761240"
1039,"Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer","Terminated","No Results Available","Left-sided Pancreatic Cancer|Ductal Adenocarcinoma","Procedure: Radical Antegrade Modular Pancreatectomy with Splenectomy|Procedure: Radical Antegrade Modular Pancreatectomy without splenectomy","Severance Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT01875198"
1040,"PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Metastatic Pancreatic Cancer","Device: Irreversible Electroporation (IRE)|Drug: Nivolumab|Drug: Toll-Like Receptor 9","Amsterdam University Medical Centre (location VUmc), Amsterdam, North-Holland, Netherlands","https://ClinicalTrials.gov/show/NCT04612530"
1041,"Escitalopram to Placebo in Patients With Localized Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Periampullary Cancer","Drug: Escitalopram|Other: Placebo","University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT05289830"
1042,"Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Minimally Invasive Surgery","Procedure: robotic surgery|Procedure: open surgery","Shanghai Ruijin Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04211948"
1043,"Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma","Unknown status","No Results Available","Carcinoma, Pancreatic Ductal","Procedure: Extended lymphadenectomy|Procedure: Standard lymphadenectomy","West China Hospital, Chengdu, Sichuan, China","https://ClinicalTrials.gov/show/NCT02928081"
1044,"Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection","Active, not recruiting","No Results Available","Carcinoma, Pancreatic Ductal","Genetic: Molecular Profiling","Kingston Health Sciences Centre, Kingston, Ontario, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal (CHUM), Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT02750657"
1045,"Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma","Withdrawn","No Results Available","Pancreatic Neoplasms","Drug: Gemcitabine/Gemzar|Procedure: Laparoscopic Distal pancreatectomy","Johns Hopkins University School of Medicine, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01045941"
1046,"Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies","Completed","No Results Available","Adenocarcinoma|Pancreatic Neoplasms","Drug: MLN8237|Drug: nab-Paclitaxel","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01677559"
1047,"Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer","Recruiting","No Results Available","Adenocarcinoma|Pancreatic Cancer Metastatic|Pain","Other: Telemedicine","ICO site St HERBLAIN, Saint-Herblain, France","https://ClinicalTrials.gov/show/NCT04667403"
1048,"A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection","Withdrawn","No Results Available","Pancreatic Cancer","Drug: Durvalumab","University of Colorado, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT03038477"
1049,"Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)","Completed","No Results Available","Adenocarcinoma of Head of Pancreas|Cholangio Carcinoma|Duodenal Adenocarcinoma|Carcinoma of Ampulla of Vater","Procedure: Open surgery|Procedure: Laparoscopic surgery","Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India","https://ClinicalTrials.gov/show/NCT02081131"
1050,"Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma","Procedure: Prehabilitation|Procedure: Standard Procedure","Manchester University NHS Foundation Trust, Manchester, Gtr Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT03770117"
1051,"Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer|Metastatic Pancreatic Cancer","Drug: nab paclitaxel plus gemcitabine","Asan Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04133155"
1052,"SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Cancer","Drug: SHR6390|Drug: Nab-paclitaxel|Drug: Gemcitabine","Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT05185869"
1053,"Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer","Recruiting","No Results Available","Advanced Pancreatic Ductal Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Ductal Adenocarcinoma","Drug: Lenvatinib Mesylate|Biological: Pembrolizumab","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT04887805"
1054,"SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma","Completed","Has Results","Mesothelioma|Adenocarcinoma of Lung|Pancreatic Neoplasms","Drug: Pentostatin|Drug: Cyclophosphamide|Biological: SS1(dsFv)PE38 - lot 073I0809|Biological: SS1(dsFv)PE38 - lot FIL129J01","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01362790"
1055,"Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Cancer","Diagnostic Test: EUS-FNB|Other: Immunohistochemistry",,"https://ClinicalTrials.gov/show/NCT03820921"
1056,"Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.","Recruiting","No Results Available","Metastatic Pancreatic Cancer","Drug: Nab-paclitaxel|Drug: Gemcitabine|Drug: Cisplatin|Drug: Irinotecan|Drug: Capecitabine|Drug: Pembrolizumab|Drug: Olaparib","Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04753879"
1057,"Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer","Not yet recruiting","No Results Available","Pancreatic Cancer Metastatic|Colorectal Cancer Metastatic","Drug: Neoantigen Vaccine with Poly-ICLC adjuvant|Drug: Retifanlimab","Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04799431"
1058,"Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)","Not yet recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Metastatic Pancreatic Cancer|Circulating Tumor Cell","Other: Detection of circulating tumor cells expressing Axl: CTC-AXL(+)",,"https://ClinicalTrials.gov/show/NCT05346536"
1059,"Monitoring and Managing Glucose Levels in People With Pancreatic Cancer","Not yet recruiting","No Results Available","Pancreatic Cancer|PDAC - Pancreatic Ductal Adenocarcinoma|Hyperglycemia","Procedure: Endocrinologist-directed target blood glucose level 4-10 mmol/L using data from a continuous glucose monitor (CGM)|Other: Standard Care",,"https://ClinicalTrials.gov/show/NCT05132244"
1060,"SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer","Unknown status","No Results Available","Biliary Tract Cancer|Periampullary Adenocarcinoma|Pancreatic Cancer","Drug: SOX sequential S-1","Beijing Cancer Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT01811277"
1061,"Macrophages Effect on Chemoresistance","Unknown status","No Results Available","the Focus of the Study is Macrophage-induced Chemoresistance in Pancreatic Carcinoma Cells During Chemotherapy.","Procedure: taking blood samples from healthy people",,"https://ClinicalTrials.gov/show/NCT01921699"
1062,"Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer","Completed","No Results Available","Pancreatic Cancer Metastatic|Pancreatic Cancer Stage IV|Stage IV Pancreatic Cancer","Drug: SBP-101|Drug: nab-paclitaxel|Drug: Gemcitabine Injection","Scripps MD Anderson Cancer Center, La Jolla, California, United States|University of Florida, Gainesville, Florida, United States|University of Rochester Medical Center, Rochester, New York, United States|Blacktown Cancer & Haematology Centre, Blacktown, New South Wales, Australia|John Flynn Private Hospital, Tugun, Queensland, Australia|Ashford Cancer Centre, Kurralta Park, South Australia, Australia|Austin Health, Heidelberg, Victoria, Australia","https://ClinicalTrials.gov/show/NCT03412799"
1063,"Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial","Recruiting","No Results Available","Pancreas Neoplasm Malignant Resectable","Procedure: Laparoscopic distal pancreatectomy|Procedure: open distal pancreatectomy","Seoul National University Bundang Hospital, Seongnam-si, Kyeonggi-do, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03957135"
1064,"Side Population in Pancreatic Ductal Adenocarcinoma (PDAC)","Completed","No Results Available","Neoplasm|Pancreas",,"University Hospital Leuven, Leuven, Vlaams-Brabant, Belgium","https://ClinicalTrials.gov/show/NCT00936104"
1065,"MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC","Recruiting","No Results Available","Pancreatic Cancer","Radiation: SBRT|Drug: SOC chemotherapy","University of Munich, Dep. of Radiation Oncology, Munich, Bavaria, Germany|University Hospital of Heidelberg, Dep. of Radiation Oncology, Heidelberg, Germany|University Hospital of Zurich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT05114213"
1066,"The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer","Completed","No Results Available","Pancreatic Neoplasms|Biliary Tract Neoplasms","Drug: Docetaxel|Drug: Gemcitabine","Hôpital Hôtel Dieu, Paris, France","https://ClinicalTrials.gov/show/NCT00268840"
1067,"Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer","Completed","No Results Available","Neuroendocrine Tumor of Pancreas|Carcinoma, Pancreatic|CT","Other: No intervention","Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04977596"
1068,"Oncologic Impact of Pancreatic Fistula","Completed","No Results Available","PDAC of the Body and the Tail of the Pancreas|CR- POPF",,"Uh Montpellier, Montpellier, France","https://ClinicalTrials.gov/show/NCT04348084"
1069,"According CTC to Compare the Influences of Different Methods to Remove the PDAC","Unknown status","No Results Available","Carcinoma, Pancreatic Ductal|Circulating Tumor Cells","Procedure: routine surgery|Procedure: no-touch surgery|Procedure: laparoscopic surgery","Genaral surgery department of Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China|Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT02451384"
1070,"Study of Tremelimumab in Patients With Advanced Solid Tumors","Active, not recruiting","Has Results","Urothelial Bladder Cancer|Triple-negative Breast Cancer|Pancreatic Ductal Adenocarcinoma","Biological: Tremelimumab monotherapy|Biological: MEDI4736 monotherapy|Biological: MEDI4736 + tremelimumab combination therapy","Research Site, San Francisco, California, United States|Research Site, Memphis, Tennessee, United States|Research Site, Houston, Texas, United States|Research Site, Brussels, Belgium|Research Site, Charleroi, Belgium|Research Site, Wilrijk, Belgium|Research Site, Daejeon, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Groningen, Netherlands|Research Site, Utrecht, Netherlands|Research Site, Gdańsk, Poland|Research Site, Łódź, Poland","https://ClinicalTrials.gov/show/NCT02527434"
1071,"Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer","Recruiting","No Results Available","Locally Advanced Pancreatic Ductal Adenocarcinoma|Metastatic Pancreatic Ductal Adenocarcinoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Ductal Adenocarcinoma","Drug: Gemcitabine Hydrochloride|Drug: Nab-paclitaxel|Drug: Fluorouracil|Drug: Irinotecan Hydrochloride|Drug: Leucovorin Calcium|Drug: Oxaliplatin|Other: Perflubutane Microbubble|Procedure: Contrast-Enhanced Ultrasound|Other: Quality-of-Life Assessment","Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Haukeland University Hospital, Bergen, Norway","https://ClinicalTrials.gov/show/NCT04821284"
1072,"CT Pancreas Perfusion","Completed","No Results Available","Pancreatic Ductal Adenocarcinoma|Chronic Pancreatitis|Autoimmune Pancreatitis","Device: Mayo Interactive Breath Hold Monitor","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00588367"
1073,"Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer","Recruiting","No Results Available","Colorectal Carcinoma|Lung Adenocarcinoma|Malignant Solid Neoplasm|Pancreatic Carcinoma","Drug: Binimetinib|Drug: Palbociclib|Procedure: Therapeutic Conventional Surgery","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT04870034"
1074,"Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer","Unknown status","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreaticoduodenectomy|Mesenteric Approach","Procedure: pancreaticoduodenectomy","Kyusyu University, Fukuoka, Japan|Kansai Medical University, Hirakata, Japan|Hiroshima University, Hiroshima, Japan|Shimane University, Izumo, Japan|Kagoshima University, Kagoshima, Japan|Nara Medical University, Kashihara, Japan|Kumamoto University, Kumamoto, Japan|Nagoya University, Nagoya, Japan|Osaka Medical University, Osaka, Japan|Osaka University, Osaka, Japan|Shiga Medical University, Otsu, Japan|Kinki University, Sayama, Japan|Tokyo Medical University, Tokyo, Japan|Toyama University, Toyama, Japan|Wakayama Medical University, Wakayama, Japan","https://ClinicalTrials.gov/show/NCT03317886"
1075,"The Pancreatic and Periampullary Resection Arginine Immunomodulation (PRIMe) Trial","Recruiting","No Results Available","Pancreatic Cancer|Surgery","Dietary Supplement: Active A|Dietary Supplement: Active B|Dietary Supplement: Lipid bolus|Dietary Supplement: Placebo oil","The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04549662"
1076,"PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer","Terminated","No Results Available","Neoplasms Pancreatic","Drug: FOLFOX-A|Drug: AG","Western General, Edinburgh, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|Royal Free Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT04176952"
1077,"Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy","Completed","Has Results","Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage IV Pancreatic Cancer","Drug: Akt Inhibitor MK2206|Drug: Fluorouracil|Drug: Oxaliplatin|Drug: Selumetinib","The University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States|The University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States|Kaiser Permanente-Bellflower, Bellflower, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Mills - Peninsula Hospitals, Burlingame, California, United States|East Bay Radiation Oncology Center, Castro Valley, California, United States|Valley Medical Oncology Consultants-Castro Valley, Castro Valley, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Epic Care-Dublin, Dublin, California, United States|Bay Area Breast Surgeons Inc, Emeryville, California, United States|Epic Care Partners in Cancer Care, Emeryville, California, United States|Kaiser Permanente Hospital, Fontana, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Valley Medical Oncology Consultants-Fremont, Fremont, California, United States|Kaiser Permanente, Fresno, California, United States|Saint Jude Medical Center, Fullerton, California, United States|Kaiser Permanente - Harbor City, Harbor City, California, United States|Kaiser Permanente-Irvine, Irvine, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Kaiser Permanente-Cadillac, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Contra Costa Regional Medical Center, Martinez, California, United States|Fremont - Rideout Cancer Center, Marysville, California, United States|Mercy UC Davis Cancer Center, Merced, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|El Camino Hospital, Mountain View, California, United States|Sutter Cancer Research Consortium, Novato, California, United States|Highland General Hospital, Oakland, California, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Hematology and Oncology Associates-Oakland, Oakland, California, United States|Tom K Lee Inc, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Kaiser Permanente - Panorama City, Panorama City, California, United States|East Bay Medical Oncology Hematology Medical Associates Inc-Pleasant Hill, Pleasant Hill, California, United States|Valley Medical Oncology Consultants, Pleasanton, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Kaiser Permanente-Riverside, Riverside, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|Saint Helena Hospital, Saint Helena, California, United States|Kaiser Permanente-San Diego Mission, San Diego, California, United States|Kaiser Permanente-San Diego Zion, San Diego, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Marcos, San Marcos, California, United States|Doctors Medical Center- JC Robinson Regional Cancer Center, San Pablo, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Tahoe Forest Cancer Center, Truckee, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Kaiser Permanente, Woodland Hills, California, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Kaiser Permanente-Franklin, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Exempla Saint Joseph Hospital, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Colorado Cancer Research Program CCOP, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Comprehensive Cancer Care and Research Institute of Colorado LLC, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|Mountain Blue Cancer Care Center, Golden, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Rocky Mountain Cancer Centers-Greenwood Village, Greenwood Village, Colorado, United States|Kaiser Permanente-Rock Creek, Lafayette, Colorado, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Kaiser Permanente-Lone Tree, Lone Tree, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Middlesex Hospital, Middletown, Connecticut, United States|Stamford Hospital/Bennett Cancer Center, Stamford, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Christiana Gynecologic Oncology LLC, Newark, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Regional Hematology and Oncology PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|Nanticoke Memorial Hospital, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|Baptist Cancer Institute, Jacksonville, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|University Cancer and Blood Center LLC, Athens, Georgia, United States|Georgia Regents University Medical Center, Augusta, Georgia, United States|Dekalb Medical Center, Decatur, Georgia, United States|Northeast Georgia Medical Center, Gainesville, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|South Georgia Medical Center, Valdosta, Georgia, United States|Oncare Hawaii Inc-Pali Momi, Aiea, Hawaii, United States|Pali Momi Medical Center, Aiea, Hawaii, United States|Oncare Hawaii Inc-POB II, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|OnCare Hawaii-Liliha, Honolulu, Hawaii, United States|Oncare Hawaii Inc-Kuakini, Honolulu, Hawaii, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Castle Medical Center, Kailua, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Weiss Memorial Hospital, Chicago, Illinois, United States|Cancer Care Center of Decatur, Decatur, Illinois, United States|Central Illinois CCOP, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Advocate Sherman Hospital, Elgin, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Hematology Oncology Associates of Illinois-Highland Park, Highland Park, Illinois, United States|Joliet Oncology-Hematology Associates Limited, Joliet, Illinois, United States|Presence Saint Mary's Hospital, Kankakee, Illinois, United States|NorthShore Hematology Oncology-Libertyville, Libertyville, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Illinois Cancer Specialists-Niles, Niles, Illinois, United States|West Suburban Medical Center, River Forest, Illinois, United States|Hematology Oncology Associates of Illinois - Skokie, Skokie, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Franciscan St. Francis Health-Beech Grove, Beech Grove, Indiana, United States|Elkhart Clinic, Elkhart, Indiana, United States|Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|IU Health Central Indiana Cancer Centers-East, Indianapolis, Indiana, United States|Franciscan Saint Francis Health-Indianapolis, Indianapolis, Indiana, United States|Community Howard Regional Health, Kokomo, Indiana, United States|IU Health La Porte Hospital, La Porte, Indiana, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, United States|Cancer Care Partners LLC, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana, United States|Reid Hospital and Health Care Services, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology Oncology PC-South Bend, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|Northern Indiana Cancer Research Consortium CCOP, South Bend, Indiana, United States|Michiana Hematology Oncology PC-Westville, Westville, Indiana, United States|Hematology Oncology Associates-Quad Cities, Bettendorf, Iowa, United States|Genesis Medical Center - East Campus, Davenport, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Providence Medical Center, Kansas City, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Kansas City CCOP, Prairie Village, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas - Main Office, Wichita, Kansas, United States|Via Christi Regional Medical Center, Wichita, Kansas, United States|Wichita CCOP, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Oncology Hematology Care Inc-Crestview, Crestview Hills, Kentucky, United States|Hematology/Oncology Clinic LLP, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Ochsner Health Center-Summa, Baton Rouge, Louisiana, United States|Cancer Center of Acadiana, Lafayette, Louisiana, United States|DeSoto Regional Health System, Mansfield, Louisiana, United States|University Health-Conway, Monroe, Louisiana, United States|Louisiana State University Health Science Center, New Orleans, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ochsner Baptist Medical Center, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Highland Clinic, Shreveport, Louisiana, United States|Harold Alfond Center for Cancer Care, Augusta, Maine, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Union Hospital of Cecil County, Elkton MD, Maryland, United States|Bixby Medical Center, Adrian, Michigan, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Michigan Cancer Research Consortium CCOP, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|Spectrum Health Big Rapids Hospital, Big Rapids, Michigan, United States|Huron Valley-Sinai Hospital, Commerce, Michigan, United States|Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Genesys Regional Medical Center, Grand Blanc, Michigan, United States|Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Mercy Memorial Hospital, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Saint Joseph Mercy Port Huron, Port Huron, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Providence Hospital-Southfield Cancer Center, Southfield, Michigan, United States|Lakeland Hospital, St. Joseph, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Sanford Clinic North-Bemidgi, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology and Hematology PA-Woodbury, Woodbury, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Capital Region Medical Center-Goldschmidt Cancer Center, Jefferson City, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|North Kansas City Hospital, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Phelps County Regional Medical Center, Rolla, Missouri, United States|Saint John's Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Joseph Oncology Inc, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Cancer Research for the Ozarks NCORP, Springfield, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Montana Cancer Consortium NCORP, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Frontier Cancer Center and Blood Institute-Billings, Billings, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Big Sky Oncology, Great Falls, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Kalispell Medical Oncology, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists, Missoula, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Nevada Cancer Research Foundation CCOP, Las Vegas, Nevada, United States|Cooper Hospital University Medical Center, Camden, New Jersey, United States|Veterans Adminstration New Jersey Health Care System, East Orange, New Jersey, United States|AtlantiCare Surgery Center, Egg Harbor Township, New Jersey, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|UMDNJ - New Jersey Medical School, Newark, New Jersey, United States|Albert Einstein College of Medicine, Bronx, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Kings County Hospital, Brooklyn, New York, United States|State University of New York Downstate Medical Center, Brooklyn, New York, United States|Mary Imogene Bassett Hospital, Cooperstown, New York, United States|Glens Falls Hospital, Glens Falls, New York, United States|Orange Regional Medical Center, Middletown, New York, United States|Winthrop University Hospital, Mineola, New York, United States|Columbia University Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Staten Island University Hospital, Staten Island, New York, United States|Randolph Hospital, Asheboro, North Carolina, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|Kinston Medical Specialists PA, Kinston, North Carolina, United States|FirstHealth of the Carolinas-Moore Regional Hosiptal, Pinehurst, North Carolina, United States|Annie Penn Memorial Hospital, Reidsville, North Carolina, United States|Iredell Memorial Hospital, Statesville, North Carolina, United States|Southeast Cancer Control Consortium CCOP, Winston-Salem, North Carolina, United States|Mid Dakota Clinic, Bismarck, North Dakota, United States|Saint Alexius Medical Center, Bismarck, North Dakota, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Roger Maris Cancer Center, Fargo, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Sanford Medical Center-Fargo, Fargo, North Dakota, United States|Summa Akron City Hospital/Cooper Cancer Center, Akron, Ohio, United States|Akron General Medical Center, Akron, Ohio, United States|Summa Barberton Hospital, Barberton, Ohio, United States|Cleveland Clinic Cancer Center Beachwood, Beachwood, Ohio, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Toledo Clinic Cancer Centers-Bowling Green, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Oncology Hematology Care Inc-Eden Park, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Mercy West, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Oncology Hematology Care Inc - Anderson, Cincinnati, Ohio, United States|Oncology Hematology Care Inc - Kenwood, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Blue Ash, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Columbus CCOP, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Health Center, Dayton, Ohio, United States|Dayton CCOP, Dayton, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Delaware Radiation Oncology, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Hematology Oncology Center Incorporated, Elyria, Ohio, United States|Mercy Cancer Center-Elyria, Elyria, Ohio, United States|Oncology Hematology Care Inc-Healthplex, Fairfield, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lancaster Radiation Oncology, Lancaster, Ohio, United States|Saint Rita's Medical Center, Lima, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio, United States|Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|The Toledo Hospital/Toledo Children's Hospital, Toledo, Ohio, United States|Saint Vincent Mercy Medical Center, Toledo, Ohio, United States|University of Toledo, Toledo, Ohio, United States|Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio, United States|Mercy Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Cleveland Clinic Wooster Specialty Center, Wooster, Ohio, United States|Greene Memorial Hospital, Xenia, Ohio, United States|Genesis HealthCare System, Zanesville, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oklahoma Oncology Inc, Tulsa, Oklahoma, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Warren Cancer Research Foundation, Tulsa, Oklahoma, United States|Tulsa Cancer Institute, Tulsa, Oklahoma, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Legacy Emanuel Hospital and Health Center, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Abington Memorial Hospital, Abington, Pennsylvania, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Geisinger Medical Oncology-Pottsville, Pottsville, Pennsylvania, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, United States|Geisinger Medical Group, State College, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Mainline Health CCOP, Wynnewood, Pennsylvania, United States|Sanford Cancer Center-Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Erlanger Medical Center, Chattanooga, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|The Don and Sybil Harrington Cancer Center, Amarillo, Texas, United States|Texas Tech University Health Sciences Center, Lubbock, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Danville Hematology Oncology, Danville, Virginia, United States|Danville Regional Medical Center, Danville, Virginia, United States|Fredericksburg Oncology Inc, Fredericksburg, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Swedish Medical Center-Edmonds, Edmonds, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Seattle Cancer Care Alliance at EvergreenHealth, Kirkland, Washington, United States|Skagit Valley Hospital, Mount Vernon, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Harborview Medical Center, Seattle, Washington, United States|Minor and James Medical PLLC, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Group Health Cooperative of Puget Sound Oncology Consortium, Seattle, Washington, United States|Group Health Cooperative-Seattle, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|United General Hospital, Sedro-Woolley, Washington, United States|Cancer Care Northwest - Spokane South, Spokane, Washington, United States|Evergreen Hematology and Oncology PS, Spokane, Washington, United States|Rockwood Clinic, Spokane, Washington, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States|West Virginia University Charleston, Charleston, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, United States|Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Marshfield Clinic - Ladysmith Center, Ladysmith, Wisconsin, United States|Dean Hematology and Oncology Clinic, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Saint Joseph's Hospital, Marshfield, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Oconomowoc Memorial Hospital-ProHealth Care Inc, Oconomowoc, Wisconsin, United States|Marshfield Clinic at James Beck Cancer Center, Rhinelander, Wisconsin, United States|Saint Mary's Hospital, Rhinelander, Wisconsin, United States|Marshfield Clinic-Rice Lake Center, Rice Lake, Wisconsin, United States|Marshfield Clinic Cancer Care at Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, United States|Diagnostic and Treatment Center, Weston, Wisconsin, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, United States|Saint Clare's Hospital, Weston, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT01658943"
1078,"Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer","Completed","Has Results","Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage IV Pancreatic Cancer","Drug: Carboplatin|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Biological: Wild-type Reovirus","MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Montefiore Medical Center-Weiler Hospital, Bronx, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT01280058"
1079,"Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors","Not yet recruiting","No Results Available","Gastric Adenocarcinoma|Pancreatic Cancer|Gastroesophageal Junction Adenocarcinoma","Drug: CT048 Autologous Injection (CT048)",,"https://ClinicalTrials.gov/show/NCT05393986"
1080,"Recurrence After Whipple's (RAW) Study","Recruiting","No Results Available","Pancreatic Cancer|Ampullary Cancer|Bile Duct Cancer|Cholangiocarcinoma, Extrahepatic|Cholangiocarcinoma Resectable|Cholangiocarcinoma of the Extrahepatic Bile Duct|Pancreatic Ductal Adenocarcinoma|Pancreatic Ductal Carcinoma|Surgery|Survivorship|Recurrent Cancer|Cancer Recurrent|Cancer Recurrence|Local Recurrence of Malignant Tumor of Pancreas","Procedure: Pancreaticoduodenectomy","Monash Medical Centre, Clayton, Victoria, Australia|Medical University Innsbruck, Anichstr. 35 A, Innsbruck, Austria|Azienda Ospedaliero - Universitaria Di Sassari, Sassari, Sardinia, Italy|Azienda Ospedaliero - Universitaria Policlinico Umberto I, Rome, Italy|Salvador Zubirán National Institute of Health Sciences and Nutrition, Tlalpan, Mexico City, Mexico|Hospital Universitario Miguel Servet, Zaragoza, Spain|Ibn Sena Specialized Hospital, Khartoum, Sudan|Derriford Hospital, Plymouth, Devon, United Kingdom|Royal Blackburn Teaching Hospital, Blackburn, Lancashire, United Kingdom|Royal Surrey County Hospital, Guildford, Surrey, United Kingdom|Singleton Hospital, Swansea, Wales, United Kingdom|University Hospital Coventry, Coventry, Warwickshire, United Kingdom|Queen Elizabeth Hospital, Birmingham, West Midlands, United Kingdom|St. James's University Hospital, Leeds, West Yorkshire, United Kingdom|Hull Royal Infirmary, Hull, Yorkshire, United Kingdom|Bristol Royal Infirmary, Bristol, United Kingdom|Royal Infirmary of Edinburgh, Edinburgh, United Kingdom|Royal Free Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom|Hammersmith Hospital, London, United Kingdom|Manchester Royal Infirmary, Manchester, United Kingdom|Queens Medical Centre, Nottingham, United Kingdom|Churchill Hospital, Oxford, United Kingdom|Northern General Hospital, Sheffield, United Kingdom|Southampton General Hospital, Southampton, United Kingdom","https://ClinicalTrials.gov/show/NCT04596865"
1081,"The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer Stage III|Pancreatic Cancer Stage IV|Pancreatic Ductal Adenocarcinoma|Pancreatic Neoplasms","Procedure: Blood draw","Nuvance Health, Norwalk, Connecticut, United States","https://ClinicalTrials.gov/show/NCT04406831"
1082,"Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Cancer|Pancreatic Neoplasms|Pancreatic Ductal Adenocarcinoma|Advanced Cancer","Drug: Cyclophosphamide|Drug: Fludarabine|Biological: Mutant KRAS G12V-specific TCR transduced autologous T cells|Drug: Anti-PD-1 monoclonal antibody","Changhai Hospital, Shanghai, China","https://ClinicalTrials.gov/show/NCT04146298"
1083,"PanDox: Targeted Doxorubicin in Pancreatic Tumours","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer Stage IV|Pancreatic Cancer Non-resectable|Pancreatic Cancer Metastatic","Device: Focused Ultrasound|Drug: Doxorubicin|Drug: ThermoDox","Oxford University Hospitals NHS Trust, Oxford, United Kingdom","https://ClinicalTrials.gov/show/NCT04852367"
1084,"Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8","Device: Activity Monitor|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","University of Nebraska Medical Center, Omaha, Nebraska, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT04400903"
1085,"Pancreatic Cancer Recurrence in the Netherlands","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer|Pancreas Cancer|PDAC",,"UMC Utrecht, Utrecht, Netherlands","https://ClinicalTrials.gov/show/NCT04605237"
1086,"Pancreatic Cancer Early Detection Consortium","Recruiting","No Results Available","Pancreas Cancer|Pancreas Cyst|Pancreatic Ductal Adenocarcinoma|Genetic Predisposition",,"City of Hope, Duarte, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Yale University, New Haven, Connecticut, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, United States|University of Miami, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|University of Chicago Medicine, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Umass Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|New York University Langone Health, New York, New York, United States|Icahn School of Medicine At Mount Sinai, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center (Upmc), Pittsburgh, Pennsylvania, United States|MD Anderson Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Inova Schar Cancer Institute, Fairfax, Virginia, United States|University of Washington, Seattle, Washington, United States|British Columbia Cancer Agency, Vancouver, British Columbia, Canada|Uhn Mount Sinai Hospital, Toronto, Ontario, Canada|McGill University Health Centre, Montreal, Quebec, Canada|Sheba Medical Center, Ramat Gan, Israel|Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy|Ramón y Cajal University Hospital, Madrid, Spain|University of Liverpool, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT04970056"
1087,"Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors","Not yet recruiting","No Results Available","HER2-negative Breast Cancer|Gastric Adenocarcinoma|Cholangiocarcinoma|Pancreatic Cancer","Drug: Niraparib|Drug: Anlotinib","Beijing Cancer Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04764084"
1088,"Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma","Active, not recruiting","No Results Available","Malignant Solid Neoplasm|Metastatic Colorectal Adenocarcinoma|Metastatic Ovarian Carcinoma|Metastatic Pancreatic Ductal Adenocarcinoma|Platinum-Resistant Ovarian Carcinoma|Recurrent High Grade Ovarian Serous Adenocarcinoma|Recurrent Ovarian Carcinosarcoma|Refractory Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8","Biological: Autologous Tumor Infiltrating Lymphocytes MDA-TIL|Drug: Cyclophosphamide|Drug: Fludarabine|Biological: Interleukin-2|Other: Quality-of-Life Assessment","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03610490"
1089,"CAR T Cell Immunotherapy for Pancreatic Cancer","Active, not recruiting","No Results Available","Pancreatic Cancer|Cancer of the Pancreas","Biological: huCART-meso cells","University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03323944"
1090,"Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy","Recruiting","No Results Available","Pancreatic Ductal Adenocarcinoma|Surgery|Periampullary Cancer","Procedure: Total laparoscopic pancreaticoduodenectomy|Procedure: Open pancreaticoduodenectomy","Tongji Hospital, Wuhan, Hubei, China","https://ClinicalTrials.gov/show/NCT03138213"
